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In this work, lipopolyamine gene vectors have been designed and synthesised for non-viral gene 
therapy (NVGT) applications. A ^^-Dioleoylsperm ine and A^-cholesteryl spermine carbamate 
were designed based on tetracationic spermine conjugated to two C18 oleoyl chains and 
cholesterol respectively to mimic membrane lipids. Ethidium bromide fluorescence quenching 
and UV light scattering assays are used to assess the DNA-binding affinity and quality of DNA 
condensation.
The gene delivery efficacy of both vectors in primary cells and in a carcinoma cell culture model 
is demonstrated. High efficiency in gene delivery is reported in both cell models. Particularly, 
the new non-liposomal system with A^A^-dioleoylspermine has the ability to transfect primary 
skin cells more efficiently than the commercially available liposomal Lipofectin. These vectors 
show low toxicity and high cell survival while maintaining their high transfection efficiency.
DNA condensation processes are studied at a single nanoparticle (equivalent to a single 
molecule) level by using the technique of fluorescence correlation spectroscopy (FCS) using 
PicoGreen (PG). The interaction of lipopolyamine vectors and plasmid DNA is monitored 
through DNA nanoparticle formation. Time-resolved FCS is also introduced to monitor the 
dynamics of PG in interactions with DNA duplex. A reliable and novel PG-based platform to 
monitor the formation of a single DNA nanoparticle has been established and validated, based 
on detailed understanding of the behaviour of this fluorescent probe.
The NVGT mechanism is also investigated, focusing on the cellular membrane barriers in 
lipopolyamine-mediated gene delivery. The membrane activity of NVGT vectors is 
demonstrated by reference to polyalkylpyridinium salt (a marine sponge polymer) as a model of 
a membrane-active NVGT vector. Fluorescent lipospermidine probes have been designed and 
synthesized to use as tools to gain a better understanding of each step in gene delivery. 
Additionally, fluorescently-labelled DNA is also prepared as a useful tracking molecule in 
NVGT research and development. A refereed paper, two edited book chapters, and several 
abstracts from presentations of the studies at international meetings are included in an Appendix.
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Introduction to non-viral gene therapy
Introduction
Following the solving of the structure of DNA and its function in human life,1 DNA 
technology has been used in many fields of biomedical science. Gene therapy, one example 
of gene technology, is a new treatment strategy which is primarily expected to treat genetic 
disorders, known as corrective gene therapy. Unlike conventional chemical-based medicines, 
the therapeutic DNA in gene therapy was used as the “pharmacologically-active” ingredient 
and formulated in proper forms for administration into patients’cells, aiming for desired gene 
expression. The desired outcome of therapy is not only limited to the missing proteins in 
patients (such as the chloride ion channel protein in cystic fibrosis (CF)), but also the 
inhibitory protein to stop the progression of disease or abnormal protein production.2-6 Gene 
expression modulation using gene therapy is also useful in the treatment of other non-genetic 
diseases, especially cancer. The suicidal gene therapy strategy is exploited by the 
destruction of target cells using a cytotoxic pathway such as apoptosis and oncogene 
suppression.7 “Suicide genes” can be also delivered to cancer cells to make them more 
susceptible to chemotherapeutics or toxins. Currently, cancer gene therapy dominates more 
than 60% of gene therapy clinical trials. Since 1989, the number of approved clinical trials 
has increased 10-times worldwide. Nevertheless, the success rate in gene therapy still drags 
behind expectations. Currently, most of the 630 completed or ongoing trials are in Phase I 
and n . There have been only 2% of clinical trials (from 1076 trials in total, data as of Aug 
2005) proceeding through to Phase HI.8 Therefore, the development of safe and efficient 
gene therapy is still urgently required. A concise overview of gene therapy development and 
the major problems that hold back this technology are presented in this chapter.
There are two critical components in any successful gene therapy. Firstly, selection of the 
right therapeutic DNA, normally prepared in circular plasmid form, is important. The 
sequencing of the human genome offers many excellent opportunities for therapeutic gene 
selection for disease treatment. There are nearly 1,000 documented disease genes with 
correlations between the function of the gene product and features of the disease, such as age 
of onset, or mode of inheritance.9 The other critical component is the gene vector with 
appropriate design to deliver the desired DNA into cells (either in vivo or ex vivo) efficiently 
and safely.10 The development of suitable methods for gene delivery has been regarded as 
the greatest task in gene therapy.10,11 The optimal vector design must incorporate these 
characteristics: specific cell targeting, long-term expression, high transfection, maximised 
DNA payload, and low immunogenicity/toxicity. The DNA delivery vector is the major 
research area in gene therapy and can be generally classified into 2 key groups, i.e. viral and 
non-viral vectors. Both gene vectors present their own distinctive advantages and 
disadvantages.6
Viral vectors
Viral delivery systems are derived from naturally evolved or recombinant viruses capable of 
transferring their genetic materials into host cells. Many viruses have been explored as 
transfection vectors. Viral vectors gain cell entry through their infectivity mechanisms, such 
as binding to cell membrane receptors. Both DNA and RNA viruses have been used in gene 
therapy. These viruses have been modified to eliminate their viral toxic genome and 
maintain their high gene transfer capability. Retroviruses were the first viral vectors used, 
whose RNA genome is converted into DNA in transfected cells. Retroviral vectors are 
capable of infecting only dividing cells. Lentiviral vectors such as human immunodeficiency 
virus (HIV), can infect both dividing and non-dividing cells. Lentiviruses offer longer 
periods of gene expression than retroviruses. Adenovirus is a family of DNA viruses 
causing benign respiratory tract infections in humans. It can infect cells in all stages of cell 
division. Their genomes contain more genes than other viral vectors typically used, and they 
do not usually integrate into the host DNA. The problems with adenovirus are transient gene 
expression (i.e. only for 1 week post-transfection) and high, undesirable immune responses. 
Adeno-associated virus (AAV) is a less toxic, single-stranded DNA virus with additional 
genes to replicate from other helper viruses (usually adenovirus). The size of the viral 
particle also limits the DNA payload in these vectors, for example, AAV can accommodate 
only DNA with 3.5-4.0 kilobasepair (kbp) size. Retrovirus and lentivirus have a bigger 
payload (DNA of 7.0-7.5 kbp), while adenoviral vectors can deliver DNA up to 30 kbp. 
Additionally, the production of viral vectors is very complicated, especially with regard to 
the control of toxic viral contamination in the manufacturing batch, low viral yield, and the 
high cost of production.12"14
Though viral vectors generally give high and sustained gene expression, they also cause 
safety concerns particularly immunogenicity. Viral vector toxicity is the major concern, 
especially the random integration of retroviral or lentiviral DNA into the host chromosome. 
As a process of gene delivery, the inserted viral gene (and transgene) will become a part of 
the host genome. This may alter the oncogenes’ or tumour suppressor genes’ function in 
host cells. Furthermore, expression of the viral protein (e.g. E2 protein in adenovirus) 
provokes inflammatory reactions and toxicities, both the cell-killing “cellular” response and 
the antibody-producing “humoral” response. In the cellular response, virally infected cells 
are killed by cytotoxic T-lymphocytes. Most of the human population also have antibodies 
to adenovirus from previous infections with naturally occurring viruses. This limits the 
repeated application of adenoviral vectors. It has been shown that the remaining low level of 
viral replication of first generation vectors induces CD4+ and CD8+ dependent immune
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responses which lead to a reduced duration of gene expression in vivo. This immunity 
problem was also found in AAV vectors.12'14
Non-viral (synthetic) vectors
Considering the problems in virus-based gene therapy, an alternative approach called non- 
viral gene therapy (NVGT) has been intensively studied. The ideal NVGT vector would 
keep the high transfectivity demonstrated in viruses, but with no toxicity and no DNA 
payload limitation. Non-viral vectors are generally cationic compounds in nature which are 
typically polyamines. The simplicity of these chemical-based vectors permits chemical 
modification, such as addition of a lipophilic moiety, controlling the regiochemical 
distribution of positive charges, or conjugation to add desired functional groups. This 
expansive possibility has resulted in many classes of NVGT vectors. NVGT vectors have 
the advantages of safety, simplicity of preparation, and high gene encapsulation capability, 
though they are currently less efficient than viral vectors.11
In 1997, Feigner et al.15 published the standardised NVGT vector classification and their 
nomenclature guidelines. The guidelines grouped these diverse synthetic gene delivery 
vectors into the two classes, which are lipoplex (cationic lipids-nucleic acid complex) e.g. 
lipopolyamines, cationic liposomes etc., and polyplex (cationic polymer-nucleic acid 
complex) e.g. polyethylenimine (PEI), poly-L-lysine (PLL) etc. Cationic lipid refers to all 
cationic amphiphiles, including cationic cholesterol and bile salt derivatives, as well as other 
micelle-forming cationic amphiphiles. In these guidelines, there is also an agreement on the 
expression of composition of DNA-vector complexes in the unit of charge ratios.
The effort to improve NVGT development is not only limited to chemical modification. 
There are many studies to find the right physico-chemical properties of DNA complexes to 
achieve high transfection. For example, the particle size and zeta potential are important to 
improve the cellular uptake of DNA complexes. The composition of lipid mixtures (e.g. 
cationic liposomal formulation) can also enhance gene delivery efficiency. Thus the addition 
of helper lipid may aid in the endosomal escape process for gene complexes.11
Recently, direct DNA delivery into the target cells or organ, by injection, has been 
introduced as a route for gene therapy without vectors (naked DNA).16,17 Naked DNA (with 
no protection from vectors) goes through rapid degradation upon systemic administration 
and this causes low gene expression. Some direct-to-site delivery by physical techniques 
have been developed to resolve this low yield problem, e.g. gene gun, electroporation, 
ultrasound-mediated gene delivery, nucleus injection etc.18 However, this improved result
has introduced complications in DNA administration requiring medical devices. 
Nevertheless, synthetic vector research is still the biggest group with intense competition in 
this NVGT research area.
Cellular polyamines in NVGT
Polyamines are polycationic at physiological pH and have many important roles in living 
cells, such as cell growth and differentiation control. Many mammalian cells also possess an 
active polyamine uptake system, but little is known about its function.19 Spermine (Figure 
1.1 (i)) and spermidine (Figure 1.1 (ii)) were firstly discovered in the nuclei of sperms, 
which help to package DNA. The phosphate anions of DNA, (pATa ~ 1.5),20,21 are fully 
ionized at physiological pH (7.4). For example, a 5 kbp DNA plasmid has a molecular 
weight of about 3.3 MDa and carries 10,000 negative charges. This highly negatively 
charged DNA is not able to cross the cell membrane (which is a lipophilic layer with a 
negatively charged surface). These poly amines (pATa = 8-10) help neutralise the negative 
charges of the phosphate ions in DNA. This initiated the DNA helix’s axis bending, 
resulting in DNA condensation into a compact (condensed) structure. In the NVGT 
applications of spermine, it was found that nanoparticles of DNA were formed on 
condensation by spermine. They are able to go across cell membranes and lead to the gene 
expression of delivered DNA.22,23 The structure-activity relationships of DNA binding by 
polyamines are also critical to the efficiency of DNA condensation.24*29
However, most mammalian cells use histone proteins to condense nuclear DNA to form 
chromatin.30 The histones are translated in the cytoplasm like other cellular proteins, though 
they are in need for DNA packaging in the nucleus. They undergo some post-translational 
modification, for example, acetylation, phosphorylation etc. Then, these histones are 
imported back into the nucleus. The histones found in chromatin are categorized as core 
histone (subunit H2A, H2B, H3, H4) and the linker histone (HI), forming an octamer (108 
kDa) which binds to DNA. Lysine (Figure l.l(iii)) and arginine (Figure l.l(iv)), positively 
charged amino acids, are found in most histone proteins (an example of some part of histone 
H2A is shown in Figure 1.1 (v)). Lysine (Lys, K) is the amino acid with (CH2)4NH3+ side 
chain, while arginine (Arg, R) contains a guanidine group. Both are basic amino acids and 
their side-chains are positively charged in the cell. The pJ^s of lysine and of arginine are 
10.0 and 12.0 respectively. The HI subunit has about 20% of Lys/Arg, the biggest number 
among histone subunits, which is required for its nucleosomes linking responsibility.
Histone is more efficient in DNA condensation than spermine or spemidine, due to its 
number and unique distribution of positive charges. The histone octamer is capable of 
condensing 200 bp DNA (67 nm length, 130 kDa).31
Histone proteins were also tried in NVGT applications. The JL-2 and single chain IL-12 
(scIL-12, fusion protein) gene was delivered by 37-amino acid TV-terminal peptide of histone 
H2A, with superior transfection compared to Superfect dendrimer.32,33 The other study was 
on the transgene expression of luciferase gene (pCMV Luc) on ECV 304 human endothelial 
cells. Similarly, DNA complexed with histone HI, in toroidal forms, also gives high 










Figure 1.1 Natural DNA condensing agents: (i) spermine, (ii) spermidine, (iii) lysine, (iv) 
arginine, and (v) histone 2A K( 13)AKTRSSR(20) (underlined amino acids indicate some 














Figure 1.2 Polyethylenimine in (i) linear and (ii) branched form
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Development of synthetic polyamine vectors in NVGT
A widely known synthetic polyamine in gene delivery, polyethyleneimine (PEI) (Figure 1.2), 
was first introduced by Behr and co-workers35 in 1995. PEI has high positive charge number, 
with ammonium groups at every 3-7 nitrogen atoms at pH 7.35'37 This enables PEI with high 
buffering capacity, known as a “proton sponge”35 which is considered to be critical to 
endosomal escape of DNA complexes. From Godbey and co-workers’ study, the endosomes 
containing PEI complexes were found to grow in number and size and were occasionally 
seen to lyse.38 However, the charge density of PEI (particularly free PEI in polyplexes, 
typically found at 80% of total PEI) is also related to its high toxicity.39
PEI molecular weight (MW) and shape also play an important role in DNA delivery. Linear 
(Figure 1.2 (i)) and branched PEI (Figure 1.2 (ii)), with MW lower than 25 kDa, show better 
transfection than the higher MW PEI, possibly due to the higher DNA-PEI dissociation of 
low MW PEI.40’41
Apart from PEI, several cationic polymers have been synthesised for nucleic acid delivery, 
by employing building blocks from amino acids (e.g. Lys, Om, Arg, Hist). For example, 
poly-L-lysines (PLL) (Figure 1.3 (i)) of varying molecular weight average (4, 24,54, 224 
kDa) were used to condense DNA and studied by ethidium bromide assay and photon 
correlation spectroscopy.42 The size of nanoparticles obtained (37 - 207 nm diameter) is in 
linear relationship to the degree of PLL polymerization. Complexes based on larger PLL 
showed a sigmoidal destabilisation (more stable particles) by polyanion while complexes 
based on smaller PLL showed more linear disruption.42
The shape of PLL is also important in DNA delivery. Linear PLL is more efficient in 
condensing DNA than most dendritic PLL. Cellular uptake of PLL/DNA complexes was 
high. However, the overall transfection level of PLL is low, possibly due to inadequate 
endosomal escape or poor release of DNA from the complexes 43 The addition of 
chloroquine was found to improve PLL transfection, presumably as an endosomolytic
44agent.
Ornithine is an amino acid which is not used in mammalian peptide synthesis, but which has 
a similar pATato lysine. In a NVGT context, poly-L-omithine (PLO),45 Figure 1.3(ii), showed 
superior (10-times higher) in vitro transfection of DNA complexes compared to PLL. There 
is no difference in physico-chemical properties of both PLL- and PLO-DNA complexes. 
However, PLO is able to condense DNA at a lower mass ratio than PLL. This greater 
affinity of PLO for DNA may be related to the observed in vitro transfection efficiency.
H ,N H ,N
C O O H
H ,N
NH. NH.
C O O HH ,N '
n h 2
Figure 1.3 Synthetic polyamines based on basic amino acid monomers: (i) poly-L-lysine, (ii) 
poly-L-omithine
Poly-L-arginine (PLA), Figure 1.4 (i), has been regarded as a potential gene cargo carrier. 
Apart from the presence of arginine in histones, many membrane-permeable peptides, for 
example HIV-1 Tat-(48-60) peptide, also contains this amino acid. PLA (MW 5-15 kDa) 
and oligoarginine (4-16 residues) were found to be able to transfect cells, similar to Tat 
protein when used as a gene delivery vector (comparable to Lipofectamine).46 The higher 
molecular weight PLA (i.e. degree of polymerisation = 217) was also able to transfect cells, 
but less efficiently.44 Homopolymers of L-arginine (6 arginines or more) entered cells far 
more effectively than polymers of equal length composed of other positively charged amino 
acids (i.e. lysine, ornithine and histidine). Rothbard, Wender and co-workers47,48 found that 
the guanidine group of arginine is the critical moiety for this surprising biological activity 














C O O HH,N '
Figure 1.4 (i) Poly-L-arginine and (ii) poly-L-histidine
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Histidine is another basic amino acid with the pKa of its amino group at 9.2. Interestingly, 
the imidazole group in histidine ( p = 6.0) helps DNA delivery into the cytosol after their 
protonation in endosomes (which are acidified to pH 5.5) which mediates membrane 
destabilization. This imidazole protonation exhibits a buffer effect in an acidic medium, 
facilitating the swelling and destabilization of vesicles as the case of chloroquine and PEI.49 
Poly-L-histidine (PLH), Figure 1.4 (ii), is insoluble in aqueous solutions at pH > 6.0. The 
conjugation with water-soluble units, such as gluconic acid, or preparation in a co-polymer 
with lysine (known as HK-polymer), was reported to improve its solubility at physiological
Recently, there is some interest in bio-polyamines such as amino-sugars, especially for their 
biocompatibility and low toxicity. Chitin is a polysaccharide found in the exoskeleton of 
insects and crustaceans. When chitin is deacetylated in alkaline pH, chitosan which is a 
copolymer of D-glucosamine (Figure 1.5 (i)) (pA'a = 6.2-7.0) and A-acetyl-D-glucosamine 
(Figure 1.5 (ii)) is obtained. Transfection efficiencies of the DNA/chitosan complexes were 
dependent on the pH of the culture medium (acidic pH is required to enable protonation in 
chitosan) and on the molecular mass of chitosan. Chitosan of MW > 100 kDa gave poorer 
transfection than smaller chitosan polymers. It was also found that chitosan-DNA 
complexes had high resistance to serum and minimal cytotoxicity.51'53
Figure 1.5 Chemical structures of (i) D-glucosamine and (ii) A-acetyl glucosamine.
Figure 1.6 Example of fi-cyclodextrin polyamine (m, n = 4-10)54
(i) (ii)
The carbohydrate moiety has been found to lessen the toxicity of NVGT vectors. Davis’s 
research group demonstrated, through a series of (3-cyclodextrin (CD)-polyamine conjugates 
(an example of these compounds is shown in Figure 1.6), that a shorter alkyl chain between 
the CD and the charge centres in the polycation backbone minimise toxicity. The CD unit 
also provides a unique property, with the ability to be modified by compounds that form 
inclusion complexes with CD, without disruption of the polymer-nucleic acid interactions.54'
56
Development of lipopolyamines for NVGT
Polyamine vectors have been regarded as efficient DNA condensing agents, but the DNA 
delivery performance still needs improvement. The development of lipid-polyamine 
conjugates (called lipopolyamines) aims to keep the high DNA packaging function, and 
improve in vivo transfection results. These molecules have a lipophilic moiety (mainly long 
chain hydrocarbon or steroidal lipids) and positively charged amine group(s), such as 
spermidine, spermine, amino sugar, or synthetic polyamines as previously mentioned.57 A 
more general term “cationic lipids” is sometimes used if they are conjugates of lipids and 
simple amine or quaternary ammonium ions. Currently, lipopolyamines are considered to be 
the major gene carriers among NVGT systems. Lipopolyamines can be either liposomal or 
non-liposomal non-viral delivery vectors.
Liposomal cationic lipids vectors
Liposomal delivery vectors usually contain two types of lipid, a cationic lipid and a neutral 
helper lipid. For example, in Figure 1.7, Lipofectin liposome is comprised of V-[l-(2,3- 
dioleyloxy)propyl]-W,W,W-trimethylammonium chloride (DOTMA)58,59 for DNA 
condensation and cellular membrane interaction, and dioleoylphosphatidylethanolamine 
(DOPE) to increase transfection efficiency. DOPE is the helper lipid mainly used due to its 
membrane fusion promoting ability.60"62
(i)
(ii)
Figure 1.7 Lipofectin liposomal vector, a mixture of cationic lipid - (i) DOTMA and (ii) 
helper lipid - DOPE (1:1 w/w)
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In 1991, Huang et al.63 also introduced 3f3-|W-(W,W-dimethylaminoethane)- 
carbamoyl]cholesterol (DC-Chol), as a first cholesterol-based cationic lipid for NVGT 
(Figure 1.8). The liposome formulation of DC-Chol:DOPE is highly efficient for delivering
Figure 1.8 DC-Chol
Pyridinium compounds have also been utilized in cationic lipid design. From the previous 
study of Engbert's research group65 on pyridinium-based transfection agents, the SAINT 
(Synthetic Amphiphile INTeraction) series was developed. This involved the conjugation of 
two fatty acid chains (tail groups) with pyridinium (head group), which results in high 
transfection efficiency when used in a liposomal formulation with DOPE. From structure- 
activity relationship studies, it was found that unsaturated fatty acids enhanced the 
transfection efficiency. Head-group modification, by introducing another pyridinium group 
linked with an alkyl spacer, also significantly improved the transfection efficiency. In the 
SAINT series, SAINT-2 (Figure 1.9) showed a 3-6-fold higher transfection than Lipofectin.65
Figure 1.9 SAINT-2 
Self-assembly lipopolyamine vectors
The efficiency of liposomal vectors is variable and DNA encapsulation is a lengthy and 
complicated process.66 This inspires NVGT researchers to develop self-assembly 
lipopolyamine vectors which combine both the characteristics of cationic and helper lipids in 
one molecule. These lipopolyamines are believed to form a structured complex with DNA, 
which protects DNA from the external environment (such as DNAase) and assists in 
intracellular gene delivery. In 1989, the synthesis of non-liposomal lipopolyamines (or more 
precisely called lipospermine) dipalmitoylphosphatidylethanolaminyl-spermine (DPPES) 
(Figure 1.10 (i)) and dioctadecylamidoglycyl-spermine (DOGS or Transfectam) (Figure 1.10 
(ii)) was carried out by Behr and co-workers66 as effective transfecting agents.






Figure 1.10 (i) DPPES and (ii) DOGS
This success led to more interest in the synthesis of novel lipospermines, e.g. RPR 120535,67 
l,3-dioleoyloxy-2-(6-carboxyspermine)propylamide (DOSPER)68 and 2,3-dioleyloxy-A-[2- 
(spermine carboxamido)ethyl]-./V,./V-dirnethyl-1 -propanaminium trifluoroacetate (DOSPA, 
also used in Lipofectamine liposome which is a mixture of DOSPArDOPE 3:1 w/w) (Figure 
1.11). The design of a novel lipopolyamine formula for DNA condensation and cellular 
delivery relies on previous and continuing studies of the structure-activity relationships of 
DNA binding and condensation by polyamines. The effects of the distribution of positive 
charges along the polyamine moiety in DNA condensing agents were studied by Geall et 
al.21'69 DNA condensation is dependent upon three characteristic properties of polyamines: 
number of positive charges, regiochemical distribution of charges (determined by the pKa of 
each amino group), and local salt concentration.24'29 Long-chain hydrophobic hydrocarbons, 
which mimic the fatty acids commonly found in cellular membrane’s phospholipids (e.g. 








Figure 1.11 (i) RPR120535, (ii) DOSPER, and (iii) DOSPA
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Vierling et al.10 introduced the fluorinated double-chain lipospermines (an example is shown 
in Figure 1.12), one or both of these chains ending by a highly fluorinated tail of various 
lengths, which are close analogues of DOGS for NVGT. These fluorinated lipopolyamines 
are able to condense and transfect cells with and without DOPE. The modified lipid chain, 
which is both lipophobic and hydrophobic by nature, provided the protection of DNA from 
both lipophilic and hydrophilic biocompounds.70
N.
Figure 1.12 Example of fluorinated lipospermine [F4C11][C14]-GS
Steroid lipids are also of interest in lipopolyamine design. GL#67 (Figure 1.13 (i)) was 
developed by Genzyme,71 consisting of a cholesterol anchor linked to a spermine head-group, 
apparently in a “T-shape” configuration. This lipid was used in combination with DOPE to 
replace the defective gene in CF patients. Lehn et al.72,73 synthesised bis(guanidinium)-tren- 
cholesterol (BGTC) (Figure 1.13 (ii)) for gene therapy in airway epithelial cells for CF. This 
BGTC has been successfully used with or without DOPE. The multi-lamellar ordered 
structure of lipoplexes was detected by using transmission electron microscopy. This 






Figure 1.13 Steroidal lipopolyamines (i) GL#67 and (ii) BGTC
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Recently, the membrane-activity of steroidal lipopolyamines was shown in hemolytic 
experiments using bovine erythrocytes.74 It was found that the steroid structure and its 
substituents, polyamine-chain length influenced this activity. This hemolysis observation 
support the fact of membrane interaction with steroidal lipids.74 A series of cholesteryl 
spermine carbamates was also synthesised and used in DNA condensation and gene 
delivery.27,69,75 Other steroids have been conjugated to spermine as a polyamine backbone; 
Blagbrough and co-workers reported that lithocholic acid gave more efficient gene packing 
ability than cholesterol, possibly due to its higher hydrophobicity.76
Cationic lipids are not only prepared from the conjugation of lipid moiety with linear 
polyamines. Lehn et al.77 reported the use of cyclic polyamines, such as aminoglycoside 
kanamycin A, in lipopolyamine design. Aminoglycosides are natural polyamines known to 
bind to nucleic acids, provide a multifunctional scaffold for the synthesis of a variety of 
cationic lipids. KanaChol (Figure 1.14 (i)) was synthesised by the conjugation of kanamycin 
A and cholesterol through a carbamate functional group. The guanidinylated derivative of 
KanaChol (Figure 1.14 (ii)) was also produced. Both lipids are highly efficient for gene 
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Figure 1.14 (i) KanaChol and (ii) its guanidinylated derivative
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Mechanism of gene delivery using NVGT vectors
Gene therapy is a complex drug delivery strategy, thus there are no conclusive general 
characteristics of efficient NVGT vectors. Vector design involves either the invention of 
new DNA condensing agents or the modification of existing condensing agents. In vitro 
transfection efficiency of polyplexes or lipoplexes depends on a variety of factors e.g. 
physico-chemical properties of complexes, cell types and their physiological activities, and 
incubation conditions. In addition, DNA has to be delivered across cellular barriers to reach 
its site of action (nucleus) and to attain the desired therapeutic effect. Moreover, the 
correlation between in vitro and in vivo transfection is unpredictable, and this is also viewed 
as a major hurdle in gene therapy. In general, for any vectors to reach the nuclei of target 
cells, there are 5 key steps involved: DNA condensation, cellular uptake, endosomal escape, 
nuclear localisation and nuclear entry, followed finally by gene expression (Figure 1.15).
DNA condensation - the first step in NVGT
Learning from viral vectors, a self-assembled complex is the most commonly used strategy 
in NVGT. Condensation can be achieved in vitro using the naturally occurring polyamines. 
As described in Manning’s counterion theory,78 negatively charged (due to the phosphate 
groups) DNA is neutralized by salt formation (titration) with the positively charged in 
vectors. This results in condensed nanometre-sized particles typically 50-150 nm in outer 
diameter.23,79 DNA nanoparticles, toroidal in shape, were observed in polyamine-induced 
DNA condensation. As an example, toroidal condensates of circumferentially wrapped T5 
phage DNA (120 kbp) were formed with spermine.80 Similar toroidal shape particles were 
also found with T4 phage condensed by a high concentration of spermidine.81 DNA 
condensation of a phage DNA with hexamine cobalt (HI), investigated by cryoelectron 
microscopy, also resulted in toroidal DNA particles with hexagonal packing.82,83
Bloomfield28,84 proposed statistical mechanics for the collapse of stiff polymer chains of 
DNA. From an experimental survey, DNA condensation occurs when about 90% of its 
charge is neutralized by counterions.78 The collapse of the expanded wormlike coil causes 
the entropy loss and small change in free energy. The stiffness of DNA sets limits on tight 
curvature to form structured toroids. The main contributions were believed to be from salt 
(or bound multivalent ions) and water, which help overcome the electrostatic repulsions of 
phosphate groups. Hydration accommodates the water structure surrounding surface groups 
on the DNA helix as they approach the confined toroidal shape. The paths toward this 
morphology may include winding around a ring, along a chain, or folding through rod 
states.85 This DNA compaction facilitates stability in extracellular compartments, cellular 
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Figure 1.15 Mechanism of gene delivery using NVGT: DNA is typically complexed with 
vectors to form a nanoparticle. The DNA complex can be uptaken into cells by many routes, 
depending on its size and chemical design, including receptor-mediated entry, endocytosis 
and pore/channel formation etc. Typically, DNA complexes are encapsulated in the 
endosomal vesicles, which are susceptible to enzymatic degradation. These particles must 
be released from the endosomes before the lysosome is fused to the endosomes. Thus, this 
endosomal escape is regarded as a critical barrier in NVGT. Nuclear translocation into the 
nucleus is also required for successful gene expression.
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Cellular uptake of DNA complexes
Cell membrane is a lipid bilayer with various integral proteins which selectively allows 
molecules to enter the cell. Cell surfaces are negatively charged, due to their content of 
glycoproteins, proteoglycans, and phospholipids. The electrostatic interactions between the 
surface of DNA particles and cell membranes are expected to be an initial process prior to 
cellular uptake.87,88 Polycations are not all equal in their capacity to neutralize the cell 
surface. Flexible molecules were more effective in destabilising the membrane than ones 
with rigid structure.89 Complex size is also another factor determining the mode of cell entry 
of NVGT vectors. Endocytosis, the major route of cell entry, is allowable for DNA 
complexes in the diameter range 50-200 nm.23 Results were different between different cell 
lines. For example, hepatic cells engulfed 93 and 220 nm in diameter particles, but not 560 
nm. The bladder carcinoma cell (ECV304) can ingest large particles of up to 1 pm in 
diameter. Confluent cells also allow less particle uptake or altogether lose their ability to 
ingest larger particles.90
Polyplexes, such as PEI, use adsorptive endocytosis following the clathrin coated pit 
mechanism.38,91 Lipoplexes bind to the negatively charged cell surface, use endocytosis, 
possibly with fusion to cellular membranes.92 Alternatively, a cholesterol-dependent 
clathrin-mediate might be a pathway.87,88 The magnitude of binding both lipoplex and 
polyplex to the cell surface and high complexes internalisation does not necessarily correlate 
to the gene expression level.
DNA condensing agents conjugated to membrane receptors’ ligands (e.g. integrin, transferrin, 
sugars, folate, B12) have also been used to target the entry to specific cells.93 For example, 
gene delivery into parenchymal liver cells was found to be useful, because these cells can 
serve as a host of post-translational modifications for certain gene products. At the surface 
of hepatocytes, there are a large number of high-affinity asialoglycoprotein-binding receptors. 
Asialoglycoprotein (glycoproteins with clustered galactose residues, as a receptor 
recognition and binding unit) ligand was covalently bound to polylysine, and studied for its 
liver cells transfection by Wu et al,93 The result shows high gene expression in rat’s liver 
cells within 24 hour post-injection, but this effect declined within 2-3 days. Transferrin is 
another glycoprotein example (which carries iron into cells), and is efficiently taken up into 
cells by the receptor-mediated endocytosis. Transferrin receptors are found on the surface of 
most proliferating cells, but highly presented on many kinds of tumours. Transferrin 
conjugated to polylysine has been reported to deliver DNA molecules into targeted tumour 
cells successfully. Though cell targeting is improving the cellular uptake of gene, there is 
still a need to improve the duration of gene expression in those cells.93
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Endosomal escape of DNA
It has been shown in many studies that endosome escape of the DNA is one major critical 
barrier to efficient transfection.86 Early endosomes are formed by the inversed cell 
membrane upon DNA particles endocytosis, which are eventually degraded into late 
endosomes by internalization into lysosome vesicles. The “proton sponge” hypothesis has 
been proposed for endosome escape of polycation (such as PEI) or lipopolyamine (e.g. 
DOSPA).94 The protons are pumped into endosomes (at pH 7.4) by V-ATPase proton pump 
at their membrane while polycations (p£a of primary amine is around 10)69 work as a pH 
buffer material. This results in an increased proton/water flux and finally pH is lowered to
5.5. Membrane disruption by swelling and finally osmotic lysis allows DNA complexes to 
escape from these vesicles prior to enzymatic degradation.
An alternative to this “proton sponge” is lipid membrane mixing between endosomal 
membrane and cationic lipid vectors.86,95,96 Cationic lipids were found to promote the 
formation of non-bilayer lipid structures, preferentially adopting the inverted hexagonal (H- 
II) phase. Helper lipids or cholesterol also enhance the formation of the H-II phase.97 The 
"flip-flop” mechanism was proposed by Zelphati et al.9* Upon the contact of lipoplexes with 
anionic lipids from the cytoplasmic facing monolayer, endosomal anionic lipids laterally 
diffuse into the complex and form a charged neutralized ion-pair with the cationic lipids.
This leads to displacement of the oligonucleotide from the cationic lipid and its release into 
the cytoplasm.
For high yield gene transfection, efficient escape of DNA from the endosome is required. In 
addition to helper lipids (DOPE), membrane disruptive peptides have also been used to help 
DNA complex pass through cellular membrane. Most of the membrane active peptide 
elements have an amphipathic character, with a distinctive stretch of apolar amino acids 
(called “fusion sequence”). These sequences vary from short stretches (3-6 amino acids) to 
longer sequences (24-36 amino acids) and are mostly located at the TV-terminal of the fusion 
protein. The secondary peptide structure normally includes the amphipathic helices with 
hydrophobic amino acids on one helical face and the apolar residues on the other, or of 
stretches of apolar amino acids.99 These membrane disruptive and fusogenic peptides have a 
tendency to undergo conformational change in a pH-dependent manner.100 The presence of 
a-helical structure in at least part of the fusion peptide is strongly correlated with activity, 
whereas (3-structure tends to be less prevalent, associated with non-native experimental 
conditions, and more related to vesicle aggregation than fusion.101 Examples are either 
synthetic peptide (e.g. GALA,102 KALA)103 or natural toxin (e.g. influenza virus 
haemagglutinin).104
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Nuclear localisation and entry
Released DNA complexes will be in the cytoplasm and translocate to the nucleus. Naked 
DNA has a half-life in cytoplasm shorter than 90 min,105 so the DNA complex form offers 
the protection to nuclease. The compact DNA particles also diffuse faster than free DNA, 
resulting in less exposure to nuclease before reaching the nucleus. The mechanism of DNA 
nuclear translocation is not well understood. There are two processes by which delivered 
genes enter the nucleus. During mitosis, the nuclear membrane disassembles which allows 
large macromolecules including plasmids to gain access. During non-mitotic phases in cell 
division, nuclear envelope remains intact with double phospholipid layers and nuclear 
lamina, a fibrous meshwork that provides structural support to the nucleus. The lamina is 
thought to serve as a site of chromatin attachment at the inner side of membrane. The inner 
and outer membranes join together at the nuclear pore complex (NPC). The NPC is a large 
structure with an assembly of eight spikes attached to rings on the cytoplasmic and nuclear 
sides of the nuclear envelope, called “cytoplasmic ring” and “nuclear ring” accordingly, with 
a formed central channel. The central channel is approximately 40 nm in diameter for the 
transportation of large particles across the nuclear membrane.
NPC is really the only way for plasmids to gain entry to the nucleus. Passive diffusion is 
only possibly with small molecules of 9 nm diameter, and size less than 50 kDa. The bigger 
molecules including DNA are transported by energy-dependent mechanism through this 
NPC. This selective transport of these macromolecules to and from the nucleus requires the 
nuclear localisation signals (NLS) to direct their traffic through the NPC.106
NLS are small peptides which help delivered plasmids to reach the nucleus. NLS binds with 
the a- subunit of the importin receptor on the nuclear membrane, then the P-subunit of the 
importin binds to the nuclear pore with the help of GTP binding protein (called Ran). The 
P-subunit is retained at the inner face of pore complex.106 According to the amino acid 
sequence analysis of NLS, e.g. SV40 T-antigen, HTV tat protein etc., positively charged 
amino acids are commonly found as their unique characteristic e.g. lysine and arginine.106 
Synthetic NLS (PKKKRKVEDPYC) was used by Behr et a/.,107 and it was found that 
transfection of cells with the NLS-DNA conjugate remained effective. Transfection was 
increased 10- to 1,000-fold as a result of this signal peptide, irrespective of the cationic 
vector or the cell type used. The study by Tachibana et a l revealed that the transfection 
efficiency measured is also related to the number of plasmid copies delivered into the 
nucleus.108
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DNA dissociation and gene expression
DNA complex dissociation is critical to gene transcription and finally translation into the 
desired protein. Xu and Szoka presented a model which described that plasmid DNA is 
released from the complex on escaping from endosomes.109 The nuclear microinjecion of 
cationic liposome-DNA complexes prevent the gene expression, thus this suggested that 
DNA cannot dissociate from the liposomal vector in the nucleus.110 However, from Godbey 
and co-workers ’ study,38 PEI was found in complexed form with DNA (and also in free form) 
inside the nucleus of successfully transfected cells, suggesting that PEI may dissociate from 
DNA in the nucleus. Histone HI in active chromatin is also tightly bound to DNA, this may 
also support that the proposal of complex dissociation, polycation (Lys and Arg in HI) 
bound to DNA, takes place in the nucleus. Thus, the mechanism of the transfer of plasmid 
DNA, complexed with non-viral carriers, to the nucleus remains highly speculative.111
Another aspect of gene expression is the design of the DNA plasmid itself. The careful 
selection of gene sequence, e.g. promoter, is also critical to the magnitude of gene expression. 
The use of tissue-/tumour-specific promoter allows precise control of gene transcription, 
which will increase the efficacy and reduce the toxicity of treatment.112
Fluorescence techniques to determine the efficiency of lipopolyamines in gene delivery
The development of gene-based medicines as a new class of pharmaceuticals is clearly 
important. As previously discussed, lipopolyamines are good candidates for DNA delivery 
studies. The vectors can self-assemble with DNA, especially without a need to form 
liposomes. The safety profile of lipopolyamines is also more favourable than the commonly 
used polybasic polymeric amines (e.g. PEI, PLL).
Fluorescence spectroscopy and microscopy techniques are highly specific to the studied 
molecules or systems. They also allow a non-invasive way to gain insights into NVGT, and 
can aid in the development of high-throughput assays. In 1967, LePecq and Paoletti113 
introduced ethidium bromide (EthBr) (Figure 1.16) to study DNA binding. EthBr, 
intercalated in stacks of DNA base pairs, fluoresces at 600 nm by direct excitation at 546 nm, 
or more efficiently through energy transfer from DNA base by excitation at 260 nm. This 
EthBr assay was later applied to measure condensation efficiency of vector systems. This 
improved method by Geall and Blagbrough114 offers a rapid and sensitive analysis of 
lipoplex formation. On DNA condensation, at increasing ammonium/phosphate (N/P) 




Figure 1.16 Ethidium bromide (DNA probe)
Fluorescamine, a non-fluorescent molecule, is also useful in studying NVGT.53,116 
Fluorescamine easily reacts with primary amine functional groups of polyamines, forming a 
fluorescent molecule (Figure 1.17). On salt formation between DNA phosphates and 
polyammonium ions, the reactivity to fluorescamine of these primary amine groups is 
eliminated. This observation allowed a study of DNA-polyamine interactions,117 including 
polyamine-mediated DNA condensation. Thus, the reaction between free (i.e. unbound to 
DNA) primary amines on polyamines and added fluorescamine was used to determine the 
level of condensation. There is fluorescence from the product formed between 
fluorescamine and these amine groups, observed using 392 nm and X«m 480 nm.
+ R-NH2
Figure 1.17 Fluorescamine (amine probe) and its fluorescent product from a reaction with a 
primary amino group.
Fluorescent lipopolyamines -  probes derived from DNA delivery agents
Fluorescent lipopolyamine probes which maintain their DNA condensing properties, gene 
delivery ability, are useful tools in NVGT research. They can be detected by various 
fluorescence methods, such as: fluorescence steady-state spectroscopy, fluorescence 
resonance energy transfer (FRET),98’118 and confocal fluorescence microscopy38 etc. Thus, 
by introducing this probe to the DNA to be delivered, NVGT events can be followed 
spectroscopically and microscopically. The designed fluorescent lipopolyamines are 
important tools to study the intracellular fate of DNA nanoparticles.119 An example of 
fluorescent lipopolyamine synthesised by employing Fmoc (fluoren-9-ylmethoxycarbonyl) 




Figure 1.18 An example of our novel fluorescent lipopolyamine conjugates, carrying a DNA 
condensing moiety (from spermine), a lipophilic steroid (a trans-AB-oxygenated 
cholestane), and coupled to a fluorescent tag
Figure 1.19 Recently reported fluorescent lipopolyamine and liposomal lipids: (i) RPR- 
121653, (ii) A-Lissamine rhodamine phosphatidylethanolamine (A-Rh-PE), (iii) A- 
nitrobenzoxadiazole-phosphatidylethanolamine (NBD-PE)
Byk, Scherman, and co-workers67,121,122 have designed and synthesised polyamine- 
hydrocarbon lipid conjugates. A rhodamine derivative of a lipopolyamine (RPR 121653) 
was also synthesised and studied as an NVGT probe (Figure 1.19 (i)).67 Structure- 
modification was also carried out by introducing a disulfide bridge (a reduction-sensitive 
functional group) at different positions in the backbone of the lipids. The disulfide is 
incorporated in order to afford another escape mechanism for the DNA from the 
lipopolyamine carrier, taking advantage of the cytosolic cellular reducing medium, such as 
the plasma membrane or by cytoplasmic reductases. Early reduction led to undesirable DNA 
release, i.e. total disruption of the particles in the early phase of delivery yielded total loss of 
transfection, but some positions for the disulfide bridge afforded increased transfection 
efficiency.121,122
Fluorescent derivatives of a small lipid molecule such as W-Rh-PE (1,2-dioleoyl-sn-glycero- 
3-phosphatidylethanolamine-AMissamine rhodamine B sulfonyl) and NBD-PE (N-4- 
nitrobenzo-2-oxa-l,3-diazole phosphatidylethanolamine) are commercially available (Avanti 
Polar Lipids, AL, USA). These molecules (Figure 1.19 (ii) and (iii)), incorporated into 
cationic liposomes in NVGT, enable the ability to track fluorescently the progress of 
transfection from liposomes (vide m/ra).98,123 Fluorescent labelling of polyplex NVGT 
carriers has also recently been reported, with Oregon Green-PEI38 and Texas Red-chitosan 
(vide infra).51
Ideal fluorophores are primarily chosen for their photostability profile. Naylor et al,124 
showed in interesting experiments that the cellular uptake and metabolism of fluorescent 
fatty acid analogues were different. The polar fluorophore has poor cellular uptake, and 
anthracene or pyrene fluorophores (Figure 1.20) were regarded as the most extensively 
incorporated into cellular lipids. From these findings, it is expected that the molecular 
hydrophobicity of fluorophores may play an important role in fluorescent lipid-based NVGT 
vector design.
Figure 1.20 (i) Anthracene and (ii) pyrene fluorophore
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Preparation of fluorescent macro molecules
DNA can be labelled with fluorescent molecules by chemical techniques such as photo­
crosslinking (e.g. ethidium monoazide,92,125 /?-azido-tetrafluoro-benzyl-lissamine,126 
dinitrophenyl127). Aryl azides can be photoactivated with UV light to generate highly 
reactive aryl nitrenes which bind to the aromatic bases of DNA. Fluorescent DNA has also 
been used to study NVGT barriers, such as cell entry92,128 and nuclear entry.92,129 
In addition to using fluorescent plasmids as a probing strategy for NVGT, protein markers 
have been employed to follow the transfection outcome i.e. gene expression. Such protein 
markers include: green fluorescent protein (GFP) of the jellyfish Aequorea victoria which 
absorbs light A*x 395 nm, and emit fluorescence at A*m = 510 nm. Comack et al.130 studied 
the mutant form of GFP with 2 amino acid mutations (at position 64 from phenylalanine to 
leucine and at 65 from serine to threonine), and established (enhanced) green fluorescent 
protein (EGFP) which fluoresces naturally and more intensely (20- and 35-fold) than the 
wild GFP. The excitation maxima of the three mutants are red-shifted by about 100 nm, 
permitting efficient excitation at 488 nm which is a typical excitation laser used for 
fluorescent-activated cell sorting (FACS) to detect fluorescein. The chemistry which 
underpins the use of these reporter systems is highlighted below. By using pEGFP130 as 
delivered DNA, the EGFP chromophore (a substituted 4-hydroxybenzylidene 
imidazolidinone, Figure 1.21) was detected in successfully transfected cells by FACS 
(fluorescent-activated cell sorting).
Figure 1.21 The fluorophore in EGFP (i) EGFP amino acid sequence L(64)TYGV(68) 
shown (ii) Post-translational cyclisation of amino acids 65-67 forming hydroxybenzylidene- 
imidazolidinone, an EGFP fluorophore with A** = 488 nm (red-shifted from wild GFP 
protein) and = 507 nm
(i) (ii)
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Apart from GFP, there are various other naturally fluorescent proteins which can be used as 
gene expression markers. DsRed,131 as an example shown in Figure 1.22, is a red fluorescent 
protein found in coral reef Discosoma spp. The biosynthesis of DsRed’s chromophore 
includes one more step that extends the conjugated 7t-system of the GFP chromophore. It 
was also found that a single amino acid replacement in GFP (T into Q) could convert it into 
Ds-Red-like protein. The multi-colour range of fluorescent protein allows researchers to 





N - R - 64
Figure 1.22 DsRed chromophore, amino acid sequence F(65)QYGS(69)
p-D-galactosidase
p-D-galactosidase
Figure 1.23 Fluorescein-di-fi-D-galactopyranoside (FDG), its hydrolysed product 
(fluorescein monogalactoside), and finally fluorescein.
Gene expression markers such as enzymes are also widely used to determine the efficiency 
of transfection. For example, (3-galactosidase is the gene product of pLacZ transfection. 
When cells are treated with a fluorogenic substrate, e.g. fluorescein-di-P-D- 
galactopyranoside (FDG) shown in Figure 1.23, cell transfection efficiency can be detected
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fluorescently. Fluorescein was locked into the non-fluorescent spirolactone form by bis-0- 
glycosylation with two (3-D-galactopyranoside sugars. |3-galactosidase enzyme catalyses the 
sequential hydrolysis of [3-glycosidic bonds, to obtain a fluorescein molecule. Nolan et al.132 
also reported the application of this FDG in cell sorting experiments of mammalian cells 
transfected with pLacZ. This FDG assay is very sensitive and as few as 5 copies of 
(3-galactosidase per cell can be detected using FACS analysis.
Luciferase, the protein encoded by pGL3, drives luciferin oxidation and generates light. 
Luminescence involves chemical reactions producing structurally different products which 
emit light. This bioluminescence method has been also used to quantify the NVGT 
efficiency.133 Firefly luciferase (Photinus pyralis),m  which is widely used for gene 
expression, catalyses luciferin oxidation generating oxyluciferin and detectable yellow light. 











+  AMP +  C02 -F yellow light
Oxyluciferin
Figure 1.24 The biochemical reaction of luciferin oxidation by luciferase to oxyluciferin
Fluorescence techniques can potentially play important roles in all areas of NVGT research. 
EthBr and other DNA intercalating dyes (as a simple, rapid analytical screen) contribute to 
the discovery of novel DNA condensing agents. NVGT efficiency can be evaluated by 
using plasmids encoding for either fluorescent protein or luminescence-associated enzymes. 
In these studies, fluorescent lipopolyamines were designed and synthesised, enabling the 
intracellular tracking of DNA complexes to reveal spectroscopically the key steps and 
barriers in gene delivery. Moreover, fluorescent labelling of DNA can be used together with 
lipopolyamine probes for studies of fluorophore interactions, e.g. by fluorescence resonance 
energy transfer (F^RET) for studies of the (diss-)association of DNA and its cationic carrier, 
NLS or other biomolecules or intracellular organelles.
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Aims of this thesis
The aims of this thesis are to understand, design, and prepare lipopolyamines for NVGT. 
The thesis starts with a concise literature review of the period prior to the start of these 
studies. This provides the background in the chemistry and biology of NVGT vectors. The 
review is also focused on fluorescent techniques for NVGT research.
The research will focus on conjugates of naturally-occurring polyamines (e.g. spermine and 
spermidine) and lipid (long chain fatty acids and cholesterol) and evaluate them using 
fluorescence techniques. The study also extends to lipopolyamines with respect to the 
transportation of biomolecules across cell membranes. The first step in NVGT, DNA 
nanoparticle formation, will be studied for the synthesised compounds, to understand the 
effect of vector structure, e.g. lipid moiety and positive charge distribution, on the efficiency 
of DNA condensation. In vitro transfection and toxicity in both an immortalized cancer cell 
line (HtTA-1 HeLa) and a primary skin cell line (FEK4) will be investigated. The results 
will be used to develop safer and more efficient NVGT vectors.
In this study, the DNA condensation process will be also investigated at the single 
nanoparticle level by using fluorescence correlation spectroscopy (FCS). A small probe, 
such as PicoGreen, will be evaluated as a reporter for the interactions of lipopolyamines and 
polynucleotides. A technique to monitor the dynamics of such a probe interacting with the 
DNA duplex, time-resolved fluorescence correlation spectroscopy, will also be used. The 
aim of this part of the research is to establish a reliable and novel fluorescence-based 
platform for the study of a single DNA nanoparticle, as well as to understand such a 
monitoring mechanism.
There are several membrane-related steps in the gene delivery process, i.e. cellular uptake, 
endosomal escape, and nuclear entry. Membrane interaction models, e.g. endocytosis, 
membrane destabilisation, and pore-forming will be studied. This work aims to aid in the 
development of membrane-disruptive NVGT vectors, which will ultimately enhance the 
overall efficiency of non-viral gene delivery system.
To better understand the efficiency of gene delivery, more novel tracking molecules are 
needed. Fluorescent lipopolyamine probes were therefore designed and synthesised. The 
aim is to use them as biosensors in monitoring the intracellular processes of gene delivery. 
Additionally, fluorescent-labelled DNA will be also included in the study. Such a label may 
be suitable for use with selected fluorescent vectors as a complementary fluorescent pair.
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Chapter 2
Synthesis and testing of lipopolyamines for NVGT
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Introduction
Polyamines, such as spermine and spermidine, are natural condensing agents that mammals 
use to store DNA in the limited space of the nucleus. Their DNA neutralisation property has 
inspired researchers to try to use them as a vector for gene delivery without using viruses. 
Several studies have been carried out to understand and improve spermine in both DNA 
condensation and its applications in gene delivery. From the regiochemical distribution of 
positive charges along polyamines, it was found that a 3 or 4 carbon spacing between the 
amine groups in spermine and spermidine facilitates DNA condensation.27 In our synthetic 
experiments, spermine was used as a backbone polycation for our lipopolyamines. The lipid 
moieties selected are inspired by the lipid membrane bilayer. Phospholipids typically 
contain two hydrocarbon fatty acid chains (an example is given in Figure 2.1(i)). Oleic acid 
is one of the fatty acids commonly found, with one (cis) double bond at C9-10 position 
creating a kink in the molecules. When oleic acid is placed in the bilayer membrane, it 
decreases lipid packing order and provides membrane fluidity.134 DOPE (Figure 2.1 (ii)) is a 
membrane fusogenic lipid used as an adjuvant in lipoplexes. Cholesterol (Figure 2.1 (iii)) is 
also another abundant lipid found in mammalian cell membranes. The “planar” steroidal 
ring system and the hydrophobic tail direct cholesterol to be placed within the membrane 
core, and the 3-|3-hydroxyl group of cholesterol will orient the molecule to the surface of the 
bilayer. The structure of cholesterol allows it to reduce the freedom of movement of 
phospholipid acyl chains, thus rigidifying the membrane, which can have a dramatic impact 
upon membrane function.135 GL#67 (Figure 2.1 (iv))71 is an example of cholesterol 




Figure 2.1 (i) Natural l-stearoyl-2-oleoyl-5n-glycero-3-phosphoethanolamine, (ii) 1,2- 
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), (iii) cholesterol, and (iv) GL-67
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As described in the Experimental (Chapter 5), the lipospermines synthesized for DNA 
condensation and gene delivery studies are A4,N9-dioleoylspermine and A'-cholesteryl 
spermine carbamate. Both lipopolyamines were compared to spermine, their parent 
molecule. The gene delivery transfection was performed to assess the ability of these NVGT 
vectors in cell cultures. The efficacy was also evaluated along with toxicity studies using the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.136
Synthesis of lipopolyamines as NVGT vectors
A/^A^-Dioleoylspermine (Figure 2.2) was prepared in a one-pot synthesis as shown in Figure 
2.3. A selective protection strategy for primary amine functional groups (A1 and A12), by 
reaction with ethyl trifluoroacetate (2 eq to spermine) to yield A',A12- 
ditrifluoroacetylspermine, was followed. The yield of trifluoroacetylated product was 
previously reported at 93%.137 In this experiment, one major product on TLC analysis 
(MeOH/NFLjOH 4/1 v/v, Rf = 0.8) was also found and it stained purple with ninhydrin 
solution, with a small spot of unreacted spermine still near the baseline (Rf = 0.1, using the 
same mobile phase). Thus, the next step of oleic acid conjugation was continued without 
further purification of the A1 ,A12-di-protected spermine. Oleic acid conjugation (2.2 eq) to 
protected spermine was achieved by using 1,3-dicyclohexylcarbodiimide (DCC) and A- 
hydroxybenzotriazole (HOBt) as catalysts. The last stage of deprotection of di- 
trifluoroacetyl dioleoylspermine was carried out by adding to ammonium hydroxide solution 
(pH 11.0) and leaving for 20 h. A4,A9-Dioleoylspermine was obtained as a pale yellow oil 
(12 % yield overall).
Figure 2.2 A4,A9-Dioleoylspermine
When this experiment was started, it was found that Kirby’s research group previously 
reported the synthesis of gemini surfactant (A1 ,A’2-di(Lys-Lys-Lys-Ser)-A\A9- 
dioleoylspermine and A^^-di-Lys-A^^-dioleoylspermine) for luciferase gene delivery in 
CHO cells.138,139 A^A^Dioleoylspmerine was published as an intermediate in their work to 
obtain these cationic surfactants. Their research paper did not report any intention to explore 
the use of this substance as an NVGT vector.138,139 There are also no other research groups 
who have reported the synthesis or activity of A4 ^ -dioleoylspermine in NVGT.
NH,
F
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Figure 2.3 Synthetic scheme for A^A^-dioleoylspermine
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The synthetic detail used by Kirby and co-workers is also different from the synthetic 
scheme in this work. They use /V-ethylcarboxyphthalimide to protect both primary amines 
and oleic acid chloride was used in the conjugation reaction. Whereas, we used ethyl 
trifluoroacetate as a primary amine protecting group and oleic acid (carboxylic acid) to 
conjugate with spermine in a DCC/HOBt catalysed system.
Dansylation reaction was then used to detect TV4,/^-dioleoylspermine by HPLC-fluorescence. 
The reaction is shown in Figure 2.4. This analytical protocol for lipopolyamines is based on 
Escribano and Legaz's work,140 and it was successfully applied to detect /V4,7V9- 
dioleoylspermine by a short and convenient reaction (11 min). Efficient resolution (Figure 
2.5) was performed with a reversed-phase HPLC (ABZ+Plus) column to detect dansylated 
products (tR = 11 min), using the conditions given in the Experimental. In Figure 2.5,7V1- 
dansyl-7'/4,/^-dioleoylspermine was eluted at 11 min (HPLC-fluorescence, MeOH/H20  95/5 
v/v, 1.3 ml/min). The di-dansylated derivative was not eluted until MeOH was used to clean 
the column. Using LC-MS with a higher flow rate (1.6 ml/min) on the same column, 7V1- 
dansyl-TV4,/^-dioleoylspermine (tR = 8.24 min) and /V1,/V12-didansyl-/V4,/V9-dioleoylspermine 
(tR = 12.99 min) were resolved.
/^/^-dioleoylspermine (1 eq) 5-(dimethylamino)-1 -naphthalene sulfonyl 
chloride (dansyl chloride) (2.2 eq)
+ triethylamine (1 eq, pH 9.0), 
DCM, heat at 70 °C, 10 min
A/1 -dansyl, N4, /^-dioleoylspermine
A/1 A/12 -didansyl,/y,/y-dioleoylspermine
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Figure 5 HPLC-fluorescence trace of dansylated /V^-dioleoylspermine using column 
Supercosil ABZ+ Plus, MeOH/H^O (95/5 v/v, 1.3 ml/min), chart speed 1 cm/min, sample 
(top) blank reaction (without /V4,/V9-dioleoylspermine) and (bottom) dansylation of 
dioleoylspermine with a peak at 11 min which is /V'-dansyl-A^^-dioleoylspermine.
A1-Cholesteryl spermine carbamate (Figure 2.6) is another lipopolyamine which was 
previously reported for its efficient DNA condensation by Blagbrough and co-workers.69 
The interesting aspects of this molecule are its cholesterol moiety (which is similar to DC- 
Chol) and the positive charge distribution found in the spermidine equivalent backbone. 
Below is the scheme for this synthetic strategy (Figure 2.7).
Figure 2.6 A1-Cholesteryl spermine carbamate
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Figure 2.7 Synthetic scheme for /V1 -cholesteryl spermine carbamate
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Two protective reagents were used to achieve N l ^ ^ -tri-B oc-sperm ine. Similar to our 
synthesis of A^^-dioleoylspermine, ethyl trifluoroacetate was chosen to protect the primary 
amine group. A single amine group protection (to yield A^-trifluoroacetyl spermine) was 
performed stoichiometrically (at mole ratio 1:1 eq) at low temperature (-78°C) to minimize 
the /V1 ,A^-ditrifluoroacety 1 spermine byproduct. From this synthesis with (Boc)20  (8 eq) and 
trifluoroacetyl deprotection, a pale yellow oil of /V1, A4 ^ -tri-B oc spermine was obtained by 
column chromatography in 43% yield. In this study, cholesteryl chloroformate was chosen 
to form a carbamate bond with an amine group of tri-Boc spermine. Tri-Boc cholesteryl 
spermine carbamate was purified over silica gel (75% yield), to remove the unreacted tri-Boc 
spermine. The Boc-protected cholesteryl spermine conjugate was finally deprotected by 
using a strong acid i.e. trifluoroacetic acid. The final step of purification was modified from 
Geall's work69 by employing a simple re-crystallization technique, instead of HPLC-UV 
which faces the low sensitivity of UV wavelength (220 nm) used to detect a cholesterol 
chromophore. The final product was re-crystallized in EtOAc to yield a white powder (Rf= 
0.2, DCM/MeOH/NH3 50/10/1 v/v/v).
DNA condensation studies
Polycationic compounds such as polyamines or synthetic lipopolyamines interact with DNA 
by charge neutralization, leading to DNA condensation into nanoparticles. This is a first step 
to overcome the problem of DNA size and its high number of charges, which prevent 
translocalisation through membrane bilayers. DNA used in gene therapy is mostly prepared 
as a circular plasmid, which promotes DNA strength and stability, unlike linear forms which 
have a greater tendency to break or are more vulnerable to enzyme degradation. Two 
circular plasmids, pEGFP (4.7 kbp) and pGL3 (5.3 kbp) were amplified by Maxiprep as 
described in the Experimental. The production yields are in the range 1.1 -  5.5 mg/ml and 
A260/A280 between 1.75-1.90.141'143 Both plasmids were used in both DNA condensation and 
in vitro transfection studies.
To understand the effect of lipopolyamines in DNA condensation, a series of experiments 
was conducted. First, spermine (Figure 2.8 (i)), which is the polyamine used in our synthesis, 
was used to condense pEGFP. Ethidium bromide (EthBr) displacement assay114 was 
employed to monitor the change in DNA conformation. EthBr (Figure 2.8 (ii)) is a cationic 
dye that displays a significantly increased fluorescence (h*  = 546 nm, = 600 nm) upon 
binding with DNA through intercalation of the phenanthridinium-moiety between adjacent 
base-pairs of DNA.113,114 EthBr may be excited directly at 546 nm, or by energy transfer 
from nucleic bases following irradiation at 260 nm.
-35-
Figure 2.8 (i) Spermine and (ii) ethidium bromide
EthBr solution was added into HEPES (20 mM NaCl, pH 7.4), before the addition of pEGFP. 
The (background) fluorescence of free EthBr obtained is usually small and negligible. When 
pEGFP (6 |ig, 1 (ig/|il) was added into EthBr-HEPES buffer, significantly high fluorescence 
was recorded indicating that EthBr readily intercalated between base-pairs. The 
concentration of spermine added was expressed as N/P charge ratio. The positive charge 
equivalents of spermine (3.8 charges/molecule) to the negative charges of DNA phosphate (2 
charges/DNA base-pair) were used in the N/P calculation. When spermine was added, the 
fluorescence started to decrease indicating its interactions with DNA, causing the 
displacement of EthBr from its binding sites (decreased fluorescence as less bound EthBr), 
or at least preventing re-intercalation of EthBr on bending the DNA during the condensation 
process, distorting the intercalation binding sites from parallel base-pairs.
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Figure 2.9 Spermine-mediated pEGFP condensation by EthBr displacement assay, by direct 
excitation at 546 nm, or by energy transfer from nucleic bases at 260 nm (n = 3, error bars 
are S.D.), monitored by the decrease of reading (absolute) fluorescence
As the energy of excitation light is reciprocal to its wavelength, the relative energy 
difference between 260 and 546 nm is approximately 2 times. However, in Figure 2.9, the 
indirect excitation of EthBr at 260 nm produces a much higher level of fluorescence at 10-15
-36-
times. We conclude that efficient energy transfer from DNA to EthBr may be related to the 
close proximity of intercalated nucleic bases and EthBr molecules.
Fluorescence data were normalised to percentages, shown in Figure 2.10. There is no 
difference in % fluorescence decrease between the two approaches. However, from Figure 
2.9, the excitation through DNA is a more sensitive assay to detect fluorescence. This 
method was chosen for our further experiments especially when a low amount of DNA (6 pg) 
was used. In Figure 2.10, at N/P charge ratio 2.5, the residual fluorescence was approaching 
a plateau at 50% in all experiments. According to Bloomfield,28 the full condensation of 
DNA occurs when about 90% of the charge on DNA is neutralised (i.e. 10% residual 
fluorescence). Thus, (free) spermine is not considered as an efficient DNA condensing agent, 
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Figure 2.10 Spermine-mediated pEGFP condensation by EthBr displacement assay, by 
direct excitation at 546 nm, or by energy transfer from nucleic bases at 260 nm (n = 3, error 
bars are S.D.), reported in the units of % fluorescence
Effect of DNA type and their condensation
Preparation of circular plasmids is a complicated and time-consuming process. More 
importantly, these plasmids though in less than milligram amounts are generally expensive. 
Given this, an alternative DNA which is commercially available, such as linear calf thymus 
DNA (CT-DNA) was introduced in our study for initial experiments. Some DNA 
condensing agents show base selectivity, for example, spermine and its analogues induce 
structural changes specific to alternating A-T sequences.22 Steroidal polyamines also show a 
preference to binding A-T rich sequences.144 CT-DNA is comprised of random sequence 
double stranded polynucleotide with A-T (58%) and G-C (42%),145 which make this DNA 
ideal for our studies.
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CT-DNA is a polydispersed DNA with varied lengths of polynucleotide. For example, CT- 
DNA used in this experiment, as obtained from Sigma-Aldrich, UK (product code D4522), 
has the minimum size of 13 kbp. From the recent work by Yoshikawa et a/.,146 the 
polydispersity does not affect DNA condensation, for any DNA in the range 15-150 kbp. 
DNA conformational transition (from uncondensed to condensed DNA) is sharp and the 
coexistence of uncondensed and condensed DNA as reported by Yoshikawa et al. and 
Kleideiter et al. is within a narrow concentration range of DNA condensing agents 
used.146'147
An aim of this experiment is to validate the use of CT-DNA in DNA condensation studies. 
CT-DNA and two circular plasmids (pEGFP and pGL3) were condensed with spermine 
using similar EthBr experimental conditions. In Figure 2.11, the fluorescence decrease 
curves for all three DNA condensed by spermine are similar, especially at N/P 0.0-2.0. At 
N/P 2.5, CT-DNA condensation still continued until it reached 30% (at N/P 3.0), while at 
N/P 2.5 pEGFP and pGL3 had already reached their constant level at 50% EthBr 
fluorescence quenched. This may be related to the size of CT-DNA which is higher than 
both of the plasmids used. The collapse of DNA requires a higher amount of polycation 
(higher N/P) to reach the plateau than the theoretical N/P of 1.0. However, both 50% and 
30% residual fluorescence are not regarded as complete DNA condensation, so (free) 
spermine is not an excellent DNA condensing agent.
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Figure 2.11 pEGFP, pGL3, and CT-DNA condensation studied by EthBr displacement assay 
(A** = 260 nm and Aem = 600 nm) (n = 3, error bars are S.D.), using spermine
Light scattering (LS) experiment, by measuring the apparent UV absorbance at 320 nm 
(where there is no DNA absorbance above 300 nm), was previously employed to identify 
DNA nanoparticle formation.27 148,149 The concentration of DNA used in light scattering 
experiments is ten times the concentration used in fluorescence quenching experiments
-38-
which is mainly due to the lack of sensitivity of the light scattering experiment compared 
with the fluorescence assay. When the DNA particles are being formed, these particles 
cause the scattering of input light and this reduces light intensity at the UV detector. The 
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Figure 2.12 pEGFP, pGL3, and CT-DNA condensation studied by light scattering assay (X = 
320 nm) (n = 3, error bars are S.D.), using spermine
The upward curves in Figure 2.12 indicate the formation of DNA particles of pEGFP, pGL3, 
and CT-DNA upon interaction with spermine. Particle formation was also confirmed by LS 
assay with significantly increased apparent absorbance at N/P ratio 2.5-3.0. The 
condensation profiles of both plasmids were found to be similar, possibly relative to their 
similar plasmid sizes. Both plasmids reach their maximum absorption at N/P 2.5, which is 
similar to the range found in the corresponding EthBr assays. It was also found that CT- 
DNA complexed with spermine has higher UV absorbance at higher N/P. This could be due 
to its large DNA size, resulting in higher particle sizes and higher light scattering. Though 
the apparent UV absorbance is not an accurate way to determine the size of DNA complexes, 
it shows the formation of DNA complexes as particles capable of scattering light. We 
concluded that there is essentially no difference between linear and circular DNA plasmids 
in DNA condensation using (free) spermine.
V4^ V9-Dioleoylspermine-mediated DNA condensation study
Spermine condensed DNA to the 30-50% residual fluorescence level in the EthBr assay.
With an aim to improve the gene packing ability of spermine, lipophilic moieties were 
covalently bound to spermine to construct NVGT vectors, lipopolyamines. V4,^9- 
Dioleoylspermine is our synthetic lipopolyamine with two chains of Cl 8 oleic acid, and two 
ammonium groups at pH 7.4 (p/fa = 10.8).31 CT-DNA was used in the initial experiment to 
determine the DNA charge neutralisation effect of this compound.
-39-
Figure 2.13 shows the ability of the studied lipopolyamine to displace EthBr from CT-DNA. 
Lipophilicity modification of this structure led to efficient DNA condensation (6% residual 
fluorescence at N/P charge ratio 2.0) compared to the tetracationic spermine (50% DNA 
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Figure 2.13 CT-DNA condensation studied by EthBr displacement assay (A<,x = 260 nm and 
= 600 nm) (n = 3, error bars are S.D.), using A^A^-dioleoylspermine
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Figure 2.14 CT-DNA condensation studied by light scattering assay (A, = 320 nm) (n = 3, 
error bars are S.D.), using A/^A^-dioleoylspermine
Figure 2.14 also reveals that DNA nanoparticles were formed at similar N/P (1.5-2.0) as 
shown in the EthBr assay. Vijayanathan et al.15° reported a similar finding that the A-phage 
DNA condensed particles (by spermine) were formed in the size range 50-100 nm. In 
Dunlap et al.'s work, another lipospermine (Transfactam) was able to condense pSfiSVneo, 
pSifiSV19, and pCISfi-ylFN DNA to smaller particle sizes 50-70 nm.151 The efficient 
condensation by Transfactam over spermine, resulting in smaller particles sizes 
(nanoparticles), may also promote more effective transfection via increased cellular uptake.
-40-
A^A^-Dioleoylspermine is a better and more efficient DNA condensing agent than spermine. 
Given this, we extended the confirmatory study on the use of linear vs. circular plasmid 
DNA, using this molecule. It was found that there is no significant variation in the 
condensation ability of the studied lipopolyamine on the type of DNA (CT-DNA, pEGFP, 
and pGL3). These results (Figures 2.15 and 2.16) support the use of a linear DNA (such as 
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Figure 2.15 pEGFP, pGL3, and CT-DNA condensation studied by EthBr displacement assay 
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Figure 2.16 pEGFP, pGL3, and CT-DNA condensation studied by light scattering assay (A, = 
320 nm) (n = 3, error bars are S.D.), using A/^A^-dioleoylspermine
pEGFP and pGL3, carrying marker genes, were used to determine the final result of gene 
delivery, by measuring the expression of those marker genes. In Figures 2.17 and 2.18 
where EthBr and LS data were plotted together on the same graph, A^A^-dioleoylspermine 
condensed both pEGFP and pGL3 effectively at N/P charge ratio = 1.5-2.0. The plateaus of 
fluorescence and apparent UV absorbance were found in at the same N/P region. This shows
-41-
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Figure 2.17 pEGFP condensation studied by EthBr assay (X«x = 260 nm and A*.m = 600 nm) 
and LS assay (A, = 320 nm), using A^A^-dioleoylspermine (n = 3, error bars are S.D.)
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Figure 2.18 pGL3 condensation studied by EthBr assay (A*x = 260 nm and Aem = 600 nm) 
and LS assay (A = 320 nm), using A^A^-dioleoylspermine (n = 3, error bars are S.D.)
iV'-Cholesteryl spermine carbamate-mediated DNA condensation study
/V'-Cholesteryl spermine carbamate is another lipopolyamine synthesised and used in this 
study. The number of positive charges in this molecule was calculated from pA  ^ data (10.9,
8.6, 7.3) reported by Blagbrough's research group,27 to be 2.4 ammonium eq/molecule. This 
is higher than A^A^-dioleoylspermine (2.0 ammonium eq/molecule).
Figure 2.19 shows the efficient CT-DNA condensation of A'-cholesteryl spermine, achieving 
10% residual fluorescence, and the highest apparent absorbance at about N/P 2.0 (Figure 
2.20). The efficiency for gene condensation is slightly lower than /V^A^-dioleoylspermine 
(residual 6%), but much higher than its parent molecule, spermine. The binding of lipophilic
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Figure 2.19 CT-DNA condensation studied by EthBr displacement assay (A*x = 260 nm and 
= 600 nm) (n = 3, error bars are S.D.), using /V‘-cholesteryl spermine carbamate
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Figure 2.20 CT-DNA condensation studied by light scattering assay (A, = 320 nm) (n = 3, 
error bars are S.D.), using /V'-cholesteryl spermine carbamate
When comparing the condensation of pEGFP, pGL3, and CT-DNA, there is no significant 
difference in EthBr (Figure 2.21) and LS data (Figure 2.22) among different types of DNA 
used. The N/P ratios at which A/'-cholesteryl spermine carbamate achieved its lowest 
residual fluorescence is the same in all DNAs used in this experiment. EthBr/LS plotted 
graphs were also drawn for pEGFP and pGL3 condensed with A/'-cholesteryl spermine 
carbamate. The EthBr (Figure 2.23) and LS assays (Figure 2.24) show the full condensation 
of plasmids at N/P 2.0. This is in agreement that there is no significant difference in DNA 
condensation from the type of DNA used in the experiments, which again supports the use of 
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Figure 2.21 pEGFP, pGL3, and CT-DNA condensation studied by EthBr assay (Xex = 260 
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Figure 2.22 pEGFP, pGL3, and CT-DNA condensation studied by light scattering assay (X 











Figure 2.23 pEGFP condensation studied by EthBr assay (Xex = 260 nm, Xem = 600 nm) and 
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Figure 2.24 pGL3 condensation studied by EthBr displacement (XeX = 260 nm and = 600 
nm) and LS assay (A, = 320 nm), using /V'-cholesteryl spermine carbamate (n = 3, error bars 
are S.D.)
In Figure 2.25, it was found that /V'-cholesteryl spermine carbamate is less efficient than 
A^A^-dioleoylspermine in both final residual fluorescence (10 vs. 6 %) and it also reaches 
the plateau of EthBr assay curves at higher N/P charge ratio (1.5 vs. 2.0). To quantify the 
difference in DNA condensation of both lipopolyamines, binding constants (Kb) were 
calculated (as ammonium equivalents) using the estimation method described in the 
Experimental (Chapter 5).
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Figure 2.25 Effect of lipid conjugation to spermine, shown by pEGFP condensation - EthBr 
displacement study (AeX = 260 nm and = 600 nm) (n = 3, error bars are S.D.)
The binding ability was calculated from the experiment using pEGFP as a model DNA. 
Calculated Kb are in the order: A^/'/’-dioleoylspermine (1.1 x 107M ') > N'-cholesteryl 
spermine carbamate (0.7 x 107M'') > spermine (0.2 x 107M'’). From this binding analysis, 
A^A^-dioleoylspermine binds to pEGFP more than /V'-cholesteryl spermine carbamate, and
-45-
actually in the same magnitude of EthBr (1.0 x 107 M'1).152 This could be due to the 
difference in both charge number and lipid moiety. We think that the lipid moiety may be 
more important than the total number of positive charges, given that the higher positively 
charged compound (A^-cholesteryl spermine carbamate) showed less efficient DNA 
packaging properties than A4,A/9-dioleoylspermine with its 2.0 positive charges.
Transfection of lipoplexes in a primary cell line
From EthBr and LS studies, A/^A^-dioleoylspermine and Nl -cholesteryl spermine carbamate 
are efficient DNA condensing agents. It is important to assess their efficiency in gene 
delivery. Many previous studies showed that there is no conclusive correlation between 
DNA condensing ability and in vitro transfection, but also many researchers agree that good 
quality condensed DNA is a prerequisite to successful gene therapy. In this study, pEGFP 
and pGL3 were used as delivered DNA. Both plasmids carry marker genes, and their gene 
expression products could be indicators for gene delivery efficiency. pEGFP is a plasmid 
encoding for enhanced green fluorescent protein (EGFP) which contains a fluorophore 
detected in successfully transfected cells by FACS (fluorescent-activated cell sorting). pGL3 
is a plasmid encoding for firefly luciferase enzyme. This enzyme level was detectable by the 
addition of its substrate, and any luminescent light produced was measured.
Human primary cell is a cell or cell line taken directly from a human. The cell line is not 
immortalized, e.g. FEK4 cells used in our studies are from a neonatal foreskin explant.153 
The efficient gene transfer into primary cells is unfortunately still problematic, while these 
cells are an extremely important model (or target) in gene therapy. Additionally, gene 
delivery studies in primary cells may also find application in other difficult-to-transfect cell 
lines, such as stem cells.154,155
The commonly used liposomal formulation, Lipofectin (DOTMA/DOPE =1:1 w/w, 
Invitrogen, Figure 2.26), was used in this study as the reference transfection. DOTMA 
functions as a cationic lipid (with one positive charge) and DOPE is added as a helper lipid. 
DOPE was used to help membrane fusion in cellular processes, especially to promote the 
endosomal escape of DNA nanoparticles.
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Figure 2.27 EGFP-containing fluorescent cells measured in FEK4 transfected with pEGFP 
(2 (ig/well) using Lipofectin at different N/P charge ratios (A*x = 488 nm and = 530 nm) 
(n = 3, error bars are S.D.)
Lipofectin was found to be ineffective in gene transfer in FEK4 cells. The fluorescent cell 
number (as a percentage) is achieved at 30% at N/P charge ratio 2.0 (Figure 2.27). At other 
N/P values, the result is as low as 10%. This is not unexpected as FEK4 cell is a difficult-to- 
transfect cell line. Hamm et a/.155 recently reported that liposome-mediated transfection did 
not satisfactorily deliver genes into human primary cells. Electroporation,154,155 a direct-to- 
nucleus gene transfer technique, which bypasses both extracellular and intracellular barriers 
in gene delivery, was only able to transfect in primary cells with improved efficiencies upto 
45%. In Figure 2.27, the optimality of charge ratio is also observed in Lipofectin-mediated 
transfection.
Figure 2.28 EGFP-containing fluorescent cells measured in FEK4 transfected with pEGFP 
(2 |ig/well) using A^A^-dioleoylspermine at different N/P charge ratios (A** = 488 nm and 
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/V^A^-Dioleoyl spermine was then tested for transfection at several N/P charge ratios (1.0, 1.5, 
2.0, 2.5, 5.0, and 10.0), which N/P ratios were calculated in the same manner as described in 
the Experimental for the DNA condensation study. Lipoplexes were then formed (after this 
simple titration) by gentle mixing of plasmid DNA and condensing agent, and regarded as a 
non-liposome formulation. N/P ratios of Lipofectin (as liposomes) were calculated taking 
account of the mole ratio of its mixture and positive charge from DOTMA (1 charge/ 
molecule). FEK4 was used in these experiments at 2.5 x 104 cells/well, followed by 4 h 
incubation with lipoplexes, and gene expression was determined 48 h post-transfection.
Figure 2.28 shows the transfection result of pEGFP V^-dioleoylspermine complexes, 
which achieve high transfection efficiency (50-70%) from N/P 2.0. The transfection 
efficiency remains high until N/P 10.0, where it reaches a plateau.
The optimal charge ratio for FEK4 transfection with pEGFP-A^A^-dioleoylspermine 
complex starts from 2.0, which corresponds to the optimal DNA condensation N/P ratio.
From EthBr assay data, the fluorescence intensity decrease is approaching a plateau from 
N/P 2.0. From our results, fluorescent cell counts (%) observed in /V^A^-dioleoylspermine- 
mediated transfection are higher than the experiments using Lipofectin, at all N/P ratios.
This high transfection may result from our strategy to conjugate C l8 oleic acid to spermine, 
which makes it similar to DOPE, a helper (fusogenic) lipid in Lipofectin formulation.
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Figure 2.29 EGFP-containing fluorescent cells measured in FEK4 transfected with pEGFP 
(2 fig/well) using /V'-cholesteryl spermine carbamate at different N/P charge ratios (X«x = 488 
nm and Km = 530 nm) (n = 3, error bars are S.D.)
A/’-Cholesteryl spermine carbamate was also studied in FEK4 cells and we found a similar 
high transfection efficiency at 60%, but at higher N/P ratios. Figure 2.29 shows the optimal 
transfection at N/P 10.0-15.0. We conclude that cholesterol facilitates gene delivery less 
efficiently than two oleoyl chains on a spermine template.
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Unlike immortal cell lines whose passage numbers do not affect their transfectivity, it is 
recommended to use FEK4 cells only from passage 9-16.156,157 In our transfection study, 
different FEK4 passages were used according to the stock availability. Transfection 
experiments were not necessarily performed using FEK4 from the same passage number. 
This may raise some concerns over the data analysis from cells at different ages, as their 
cell's susceptibility to xenobiotics may be different. Transfectivity of FEK4 cells in different 
passage number with A^A^-dioleoylspermine-pEGFP lipoplexes was studied at N/P ratios 
2.0 and 2.5. In Figure 2.30, there is no difference in transfection efficiency using FEK4 from 
different passages. Thus, passage number does not affect the transfection, as long as it is 
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Figure 2.30 Effect of FEK4 passage number in transfection efficiency, using pEGFP at 2 
(ig/well, complexed with A/4,A/9-dioleoylspermine at N/P charge ratios 2.0 and 2.5 (AeX = 488 
nm and A«m = 530 nm) (n = 3, error bars are S.D.)
In our FEK4 experiments, DNA complexes were prepared by using 2 pg/well DNA, as 
recommended in the manufacturer’s protocol of Lipofectin-mediated transfection (Invitrogen 
Ltd.). A simple study was performed using two concentrations of pEGFP-A/4,^9- 
dioleoylspermine complexes prepared at the N/P ratios 2.0 and 2.5, which offer high 
transfection levels. At each N/P, lipoplexes formed with pEGFP 1 and 2 pg/well were used 
in FEK4 transfection. The standard transfection conditions were used in this study. From 
Figure 2.31, there is no significant difference between the two doses of lipoplexes at both 
N/P ratios. Recently, Walker et a/.158 reported a similar finding that the dilution of pEGFP- 
lipoplexes (with pUC18, blank plasmid) in COS-7 cells does not compromise transfection 
efficiency. Their study was different from our experiments, given the DNA plasmid dilution 
was performed with blank plasmid (similar to diluents in pharmaceutical preparations), and 
the lipoplex dose remain unchanged. However, their study also supports out conclusion that 
plasmid DNA dose dilution (either lipoplex or active plasmid) does not alter transfection.
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This conclusion has practical advantages in lipoplex preparation, and allows researchers to 
use less plasmid to minimise cost in studies, and ultimately less DNA condensing agent to 
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Figure 2.31 Effect of lipoplex dose in FEK4 transfection, with pEGFP at 1 and 2 |ig/well, 
using A^A^-dioleoylspermine at N/P charge ratios 2.0 and 2.5 (X«x = 488 nm and = 530 
nm) (n = 3, error bars are S.D.)
Transfection with pGL3 using Lipofectin and A^A^-dioleoylspermine was studied, using the 
protocol in the Experimental. Luciferase enzyme, a protein expressed by pGL3, catalyses 
luciferin oxidation generating oxyluciferin and detectable yellow light (Figure 2.32).133 The 
light unit was measured in relative light units (RLU) and normalized by the unit of total 
cellular protein. Lipofectin enables the high expression of luciferase in FEK4, at N/P 2.0-2.5 
(1200-1600 RLU/mg) (Figure 2.33). Lipofectin’s optimal N/P charge ratio found in this 
experiment was similar to the one used in pEGFP transfection (Figure 2.27). However, the 
efficiency of FEK4 transfection with pGL3 is maintained until N/P 5.0, while pEGFP 
expression diminished at smaller N/P charge ratios. This suggests that the difference in 
plasmid construct, such as promoter gene, may lead to different levels of gene expression.
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Figure 2.33 FEK4 transfected with pGL3 (2 pg/well) using Lipofectin at different N/P 
charge ratios, with luminescence measured in RLU/mg of total protein (n = 3, error bars are 
S.D.)
Luciferase gene transfer experiments were then carried out using A^A^-dioleoylspermine 
(Figure 2.34). The obtained RLU/mg shows that N/P charge ratio = 2.5 provides a 
significant high transfection compared to N/P = 5.0. This is in agreement with the results 
obtained in the expression of pEGFP by A^A^-dioleoylspermine based gene transfer. FEK4 
transfection efficiency of pGL3 is comparable to Lipofectin (1200 RLU/mg at N/P 2.5). The 
loss of superiority of /V4,/*/9-dioleoylspermine over Lipofectin may be related to the actual 
DNA itself, not due to the gene delivery systems. pGL3 is under SV40 promoter and pEGFP 
has a CMV promoter in its construct. Young et al.159 recently reported that the inclusion of 
the SV40 promoter/enhancer into plasmids enhance non-viral gene delivery, possibly 
through the increase of gene uptake by the nucleus. Thus, the observed relative improved 










1.50 2.50 3.00 5.00
N/P charge ratio
10.00
Figure 2.34 FEK4 transfected with pGL3 (2 pg/well) using A^A^-dioleoylspermine at 
different N/P charge ratios (n = 3, error bars are S.D.)
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Transfection of lipoplexes in a carcinoma cell line
Gene therapy is not currently limited to genetic disease treatment where gene delivery in 
primary cells is important. Cancer gene therapy has been recently developed, aiming to treat 
cancer by genetic modification of cancer cells to inhibit their growths or increase their 
susceptibility to other cancer therapies. In our experiments, HeLa cell line is used to 
understand the DNA delivery mechanism and efficacy in a carcinoma model. HeLa cells are 
the first continuous cancer cells isolated from the glandular cervical cancer by Gey159 in 
1951. These cells can be cultivated in vitro, immortalized, and also have lost their ability of 
intercellular adhesion.160,161 Immortalized cell lines are generally easier to transfect than 
primary cells of the same given tissue origin.162 A study by Banks et al.163 shows that HeLa 
cells uptake genes faster than other cells, which contribute to highly efficient gene 
expression.
Specifically, HtTA-1 is a modified HeLa cell line used in these studies. It incorporates a 
tetracycline-controlled transactivator (tTA) consisting of the tet repressor fused with the 
activating domain of virion protein 16 of herpes simplex virus (HSV). This tTA sequence 
stimulates transcription from a minimal promoter sequence and it is sensitive to the 
concentration of tetracycline.164,165 A^A^-Dioleoylspermine and A'-cholesteryl spermine 
carbamate were studied for their gene delivery ability in HtTA-1 HeLa, using both pEGFP 
and pGL3 as reporter genes.
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Figure 2.35 EGFP-containing fluorescent cells measured in HtTA-1 HeLa transfected with 
pEGFP (2 |ig/well) using A^A^-dioleoylspermine at different N/P charge ratios (A*x = 488 
nm and = 530 nm) (n = 3, error bars are S.D.)
The graph (Figure 2.35) shows the highest transfection efficacy (90%) in HtTA-1 HeLa cells 
from N/P 2.0. These results are similar to the previous experiments on FEK4, however the 
expression levels of pEGFP in HeLa cells continued at higher N/P. The percentage of
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fluorescent cells in HeLa cells is significantly higher (2 times) than FEK4 cells at every 
charge ratio. Similar experiments on pGL3 (Figure 2.36) revealed the optimal charge ratio 
for A^A^-dioleoylspermine-mediated transfection at 2.0 with very much higher RLU/mg 
protein than the ones in FEK4 (more than 1000-fold). The high transfection for both 
FEK4/HeLa and pEGFP/pGL3 is at N/P = 2.0 which could be used as a single N/P charge 
ratio value for future studies. Additionally, the significantly high expression in HeLa cells 
will be helpful to understand the intracellular factors contributing to effective gene delivery, 
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Figure 2.36 EGFP-containing fluorescent cells measured in HtTA-1 HeLa transfected with 
pGL3 (2 fig/well) using A^A^-dioleoylspermine at different N/P charge ratios (A,* = 488 nm 
and Xem = 530 nm) (n = 3, error bars are S.D.)
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Figure 2.37 EGFP-containing fluorescent cells measured in HtTA-1 HeLa transfected with 
pEGFP (2 pg/well) using /V'-cholesteryl spermine carbamate at different N/P charge ratios 
(Kx = 488 nm and Km = 530 nm) (n = 3, error bars are S.D.)
Unlike A/^A^-dioleoylspermine, in Figure 2.37, A/'-cholesteryl spermine carbamate seems to 
display lower transfection efficiency, and high transfection was only observed at higher N/P
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ratios (N/P 15, with % fluorescent cells = 80%). This suggests that cholesterol facilitates 
gene delivery less efficiently than two oleoyl chains, which is a similar result to that obtained 
in our study in FEK4 cells. Given the high efficiency in transfection of the HtTA-1 HeLa 
cell model, naked DNA (uncomplexed DNA), which though it shows low efficiency in gene 
delivery is still in some clinical trials, was used in the experiment as a control. Somewhat as 
expected (Figure 2.38), naked pEGFP and blank media did not show any fluorescent cells. 
This is probably due to the charge repulsion of negative DNA phosphate and negatively 
charged cell membrane. Uncomplexed DNA is also more vulnerable to extracellular and 
intracellular enzymatic degradation, than lipoplexes. This emphasizes the importance of 
















Figure 2.38 EGFP-containing fluorescent cells measured in HtTA-1 HeLa transfected with 
pEGFP (2 (ig/well) without and with A4,A9-dioleoylspermine at different N/P charge ratios 
(X^ = 488 nm and Xem = 530 nm), compared to blank media (10% FCS EMEM only) (n = 3, 
error bars are S.D.)
Toxicity study of lipoplex gene delivery
The safety of our synthetic lipopolyamines has been studied using the MTT assay.136 
Soluble tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) was added to cells treated with lipopolyamines and their lipoplexes. Only live cells 
are able to convert MTT into insoluble formazan violet crystals (detectable by UV at 550 
nm), as shown in Figure 2.39.
N = N N  N
Figure 2.39 MTT assay, a substrate (MTT) was converted into formazan in live cells
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IC5o (the concentration at which cell viability is 50%)166 values of A^A^-dioleoylspermine in 
FEK4 and HtTA-1 HeLa cells were 25 and 30 (ig/ml respectively (Figures 2.40 and 2.41), 
and for the lipoplex were 25 and 31 p.g/ml respectively. The results indicate that there is no 
significant difference in the toxic effects (IC50) of the free lipopolyamine over the lipoplex in 
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Figure 2.40 Viability of FEK4 cells when exposed to different concentrations of A /^V9- 
dioleoylspermine and lipoplexes (A^^-dioleoylspermine + pEGFP) in 96-well plates, using 
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Figure 2.41 Viability of HtTA-1 HeLa cells when exposed to different concentrations of 
A^A^-dioleoylspermine and lipoplexes (A^A^-dioleoylspermine + pEGFP) in 96-well plates, 
using the MTT assay (n = 3, error bars are S.D.)
IC50 results also revealed that V4,A9-dioleoylspermine toxicity in the case of FEK4 cells is 
not significantly different from that in HtTA-1 HeLa. However, HtTA-1 HeLa is more 
susceptible to toxicity of lipoplexes than FEK4 at higher concentrations beyond the IC50.
For example, the % surviving cells of FEK4 (Figure 2.40) is around 40% while it is 20% for 
HtTA-1 HeLa (Figure 2.41), when exposed at 40 |ng/ml. This could be due to the higher
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uptake rate of gene complex in HeLa cells,163 thus the bioavailable doses of lipopolyamine 
are also higher in HtTA-1 cells than the ones in FEK4 cells.
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Figure 2.42 Viability of FEK4 cells when exposed to different concentrations of Nl- 
cholesteryl spermine carbamate and lipoplexes (V1-cholestery 1 spermine carbamate + pEGFP) 
in 96-well plates, using the MTT assay (n = 3, error bars are S.D.)
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Figure 2.43 Viability of HtTA-1 HeLa cells when exposed to different concentrations of Nl- 
cholesteryl spermine carbamate and lipoplexes (/V'-cholesteryl spermine carbamate + pEGFP) 
in 96-well plates, using the MTT assay (n = 3, error bars are S.D.)
In Figures 2.42 and 2.43, IC50 values of V’-cholesteryl spermine carbamate and the lipoplex 
in FEK4 and HtTA-1 HeLa cells were about 15 (ig/ml. The results indicate that there is no 
significant difference in the toxic effect (IC5o) of the free lipopolyamine over the lipoplex in 
both cell lines. V'-Cholesteryl spermine carbamate shows equally low toxicity in both FEK4 
and HtTA-1 HeLa cell lines, and this lipopolyamine displays higher toxicity than A^V9- 
dioleoylspermine.
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Optimisation of transfection efficiency and toxicity
To optimise the concentration suitable for transfection, IC50 values were converted into their 
equivalent N/P ratios. Figures 2.44 and 2.45 show that the optimal N/P charge ratios for 
A4,A9-dioleoylspermine-mediated transfection are at 2.0-5.0. At this optimal N/P range, 
yV^A^-dioleoylspermine achieves high transfection both FEK4 and HtTA-1 HeLa cells with 
high survival rates in FEK4 (more than 80%). At higher N/P charge ratios, the lipoplex 
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Figure 2.44 Survival of FEK4 cells transfected with pEGFP complexed with A4/ / 9- 
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Figure 2.45 Survival of HtTA-1 HeLa cells transfected with pEGFP complexed with A4^ -  
dioleoylspermine (n = 3, error bars are S.D.)
In Figure 2.46, the enhanced pEGFP delivery by A'-cholesteryl spermine carbamate at N/P = 
10-15 was compromised by its toxicity, for example at N/P 10.0 (60 % efficiency, 60% 
survival rate), or at N/P 15.0 (70% efficiency, 40% survival rate). A similar finding was 
found in HtTA-1 HeLa cells (Figure 2.47), high toxicity is coupled with high transfection. 
This toxicity at high N/P charge ratio may be from the high level of free polycation.167 From
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our results, the optimal transfection using /V'-cholesteryl spermine carbamate is concluded 
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Figure 2.46 Survival of FEK4 cells transfected with pEGFP complexed with /V'-cholesteryl 
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Figure 2.47 Survival of HtTA-1 HeLa cells transfected with pEGFP complexed with /V1- 
cholesteryl spermine carbamate (n = 3, error bars are S.D.)
In this Chapter, the synthesis of lipopolyamines using spermine conjugated with oleic acid 
and cholesterol has been discussed, i.e. dioleoylspermine and /V'-cholesteryl spermine 
carbamate. Both molecules are capable of condensing DNA efficiently and much more 
efficiently than free spermine. The transfection results obtained with our synthetic vectors 
are higher than those achieved with commercially available and widely used Lipofectin in 
both primary and carcinoma cells models, while the safety of our vectors has not been 
compromised at the concentrations used in gene delivery. To understand more about their 
mechanisms of action, studies on the first step in NVGT (DNA nanoparticle formation) by 
these vectors are discussed in Chapter 3.
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Chapter 3
Fluorescence correlation spectroscopy studies of 
a single tipopolyam ine-DNA nanoparticle
Introduction
DNA binding by lipopolyamines plays an important role in gene delivery success. DNA 
condensation affords nanoparticles with the appropriate size to enter cells, as well as giving 
protection from nuclease (DNase), and these are important properties when considering 
serum stability for in vivo applications. Disassociation of DNA from the vector at the right 
time is crucial, possibly after escaping from the endosome and just before reaching or right 
after entering the nucleus. However, the mechanism of association and dissociation between 
these lipopolyamines and DNA are still not weil understood.29,38,86,92
Fluorescence Correlation Spectroscopy (FCS) is a new technique to study molecular 
interactions based on fluorescence, combining steady state fluorescence spectroscopy and 
confocal microscopy. In conventional fluorescence spectroscopy, a relatively large volume 
of sample is illuminated by an excitation laser. The average fluorescence intensity is 
recorded with high background noise, leading to limitation in resolution and sensitivity.
With the confocal microscopy technology, it is possible to focus sharply a laser beam to 
excite a very small volume of sample (called the “confocal volume”, Figure 3.1) of about 1 
femtolitre. This volume is small enough to host only one molecule; hence, FCS is also 
regarded as a single molecule spectroscopy (SMS). This small volume also eliminates any 
interference from background signals. A single molecule diffuses through this illuminated 
volume over time, and give out photons which are recorded by the detection unit. 
Fluctuations in the detected fluorescence from small fluorescent molecules in this confocal 
volume are calculated by the autocorrelation function. This autocorrelation function allows 
faster and slower diffusing particles to be differentiated. This technique was used to study 
the dynamic processes, on the molecular scale, including DNA nanoparticle formation.168' 173
2(»= 0.58pm
Figure 3.1 Illustration shows a confocal volume in FCS (typical volume is 1x1015 litre), 
which is small enough to host only one molecule. The dimension o f the volume element was 
determined by using standard fluorophores (Rhodamine-6G and Alexa Fluor 488).
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Measurement of the confocal volume in FCS
In this experiment, two fluorescent molecules, Rhodamine-6G (R6G, ^eX = 495 nm, = 
519 nm) and Alexa Fluor-488 (AF488, = 525 nm, = 555nm) (Figure 3.2) were chosen
to measure the confocal volume in FCS. These fluorophores have high absorption 
coefficients (R6G = 116,000 M ’em'1, A488 = 71,000 M 'cm"1), and less photobleaching 
which support their use as standard dyes.
(i) (ii)
NH,H,N
C O O -
C O O -
Figure 3.2 Standard fluorophores in FCS's confocal volume determination, (i) Rhodamine- 
6G and (ii) Alexa Fluor 488
The shape of the confocal volume for calculation purposes was assumed to be a cylinder, 
based on a special optical situation and this volume (V) is V = 7tC0i2(2(02), given co/ and co2 
are the lateral and axial radii of the detection volume. The fluorescence signal from R6G or 
AF488 in HEPES buffer was measured by FCS. Diffusion time (Td) was determined from 




Given the standard diffusion coefficient (D) of both dyes is 2.8 x 10'10 m2/s, and. xDfrom 
experiments, the excitation volume was determined to be about 1 femtolitre (0.9 ± 0.1 
femtolitre) regardless of the dye used. The dimensions of the confocal volume in our 
experiments are: CO] = 0.29 ± 0.05 pm, 0)2 = 1.69 ± 0.02 pm, as illustrated in Figure 3.1.
Efficient probe in DNA condensation by FCS
This DNA-intercalation with ethidium bromide (EthBr) study was firstly reported by Webb’s 
research group,174,175 using the FCS technique. The DNA-binding constant of EthBr and 
DNA diffusion coefficient using FCS were reported. Krai et a/.176,177 recently studied DNA 
condensation by using EthBr and propidium Iodide (PI) in FCS. The count rate (CR), 
diffusion time (xD), and particle number (PN) observed by FCS at the single molecule level,
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and their correlations, can be used to differentiate the nature of DNA/oligonucleotide- 
polycation interactions.176'180
Though EthBr is a commonly used dye in DNA condensation studies, it was found to have 
effects on DNA structure at high concentration. The helical axis of DNA was dislocated 
+1.0 A°, and the helix was twisted by 10°, giving rise to an angular unwinding of -26°, and 
the intercalated base pairs are tilted relative to one another by 8°.181 Manning’s theory of 
counterion condensation of polyelectrolytes78 suggested that EthBr intercalation lengthens 
the DNA by about 0.27 nm.182 This possible DNA conformational alteration is generally not 
a concern in steady-state fluorescence spectroscopy with a larger population to be measured, 
but this is detectable with the high sensitivity of FCS. Additionally, the higher rate of EthBr 
release from DNA may also lead to a significant reduction in fluorescence, making 
fluorescence analysis more complex. This in turn leads to the search for new fluorescent 
dyes which can be used without significant change in DNA conformation, and also possess 
high absorption coefficients (which allows them to be used at low concentrations), to avoid 
interference in the DNA condensation behaviour mediated by NVGT vectors.
Figure 3.3 PicoGreen® (PG) - an unsymmetrical monomethine cyanine dye containing a 
polyamine side-chain to improve DNA-binding affinity with three mesomers (a, b, c)
Recently, a new unsymmetrical monomethine cyanine dye, PicoGreen® (PG) (Figure 3.3), 
was introduced as a patented fluorescent dye from Roth, Haughland and co-workers at
/ /
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Molecular Probes.183,184 Its chemical structure was recently reported by Vitzthum and co- 
workers, confirmed by NMR and MS techniques and named as [2-[/V-bis-(3-dimethyl- 
aminopropyl)-amino]-4-[2,3-dihydro-3-methyl-(benzo-l,3-thiazol-2-yl)-methylidene]-l- 
phenyl-quinolinium]+ (Figure 3.3-a).185 However, this name could better be (Chem. Abs. 9th 
Cl): 2-[bis(3-dimethylaminopropyl)amino]-4-(3-methyl-2(3H)-benzothiazolylidene)methyl- 
1-phenyl-quinolinium186 [178918-98-4] and/or 2-[bis-(3-dimethylaminopropyl)amino]-l- 
phenyl-4(lH)-quinolinylidene)methyl)-3-methyl-benzothiazolium187 [771577-99-2]. The 
charge due to quatemization of the aromatic //-atoms is delocalized, probably equally well 
shown residing on the //-methyl-benzothiazolium (Figure 3.3a)187 and on the /V-phenyl- 
quinolinium (Figure 3.3b),186 in a solvent and environment dependent manner. There is also 
a contribution from the third mesomer, including the lone-pair electrons on the anilino- 
tertiary amine, as its ammonium ion (Figure 3.3c).188
From DNA-intercalation structure-activity relationship considerations, PG carries three 
positive charges i.e. one on nitrogen in the conjugated, mesomeric heteroaromatic system 
and two at the 3-dimethylaminopropyl residues. The cationic side chain of PG (compared to 
EthBr) contributes to higher affinity for dsDNA. Biphasic mode binding was reported for 
PG interaction with dsDNA. Base-pair intercalation happens at low dye/base-pair ratio, and 
external binding (minor groove) was found at higher dye/base-pair ratio. At low dye/base- 
pair ratio, PG shows no base sequence specificity. Zipper et a/.185 recently reported that 
there is no difference in binding on polydA.dT and polydG.dC, using differential absorption 
spectroscopy at 494 nm, if PG labelling ratio smaller than 100 dye/kbp was used. However, 
the fluorescence intensities of PG/DNA complexes were related to the DNA sequence at 
higher ratios.185 The increase in fluorescence intensity of PG upon binding to DNA is about 
1000-fold (absorption coefficient 70,000 M^cm'1) and this makes the background 
fluorescence from free dye negligible. A small red-shift of the peak absorption (from 498 
nm for free dye to 500 nm for the bound dye) was observed for PG.189 Interestingly, PG 
binds selectively to ssDNA (low affinity) and dsDNA (high affinity) at 525 nm, unlike EthBr 
at 610 nm. Thus, the use of PG with EthBr simultaneously at dual wavelength (525 and 610 
nm) was recently established as a novel efficient tool to determine the DNA unwinding 
condition (ss:dsDNA ratio).190,191 The low affinity of PG for ssDNA helps to ensure that the 
fluorescence detection mainly arises from dsDNA-PG interactions.
Calf thymus DNA-PicoGreen interaction study
CT-DNA is a linear DNA which minimum kbp =13 (MW 8,580 MDa). As calculated from: 
L = Nona x a, given NDNa is the average number of DNA monomer (base pairs), and a = 
monomer length (i.e. 0.34 nm for DNA duplex), its contour length is 4.4 Jim. PG was used
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in our study to monitor CT-DNA. PG intercalation affinity to dsDNA is higher, and it also 
has a higher absorption coefficient than EthBr. Fluorescence of free PG is low, thus 
background fluorescence is negligible. In our experiments, fluorescence fluctuation was 
observed and recorded over the increase of PG concentration (i.e. labelling ratio). 
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Figure 3.4 Examples of normalized autocorrelation functions, G(x) [a] and the relative count 
rates [b] for CT-DNA 1 nM (200 pi) intercalated with PG (l.lxl0"6 M) 30 pi and Cdye/kbP is 
13. The nature of multi-labelling DNA (long-chain molecules) causes an overestimation of 
PN (apparent PN), compared to the PN of singly-labelled small molecules
Typical normalized autocorrelation functions G(x), are plotted as shown in Figure 3.4. 
Additionally, the segmental motion of DNA lead to partial detection in the confocal volume, 
the loop-like structure of DNA chain (not as a stretched chain) would increase the important 
parameter, Particle Number (PN). PN is defined as the average number of the fluorescent 
particles in the confocal volume. Thus, more fluorescent events, which increase apparent PN,
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would be detected in longer DNA. Consequently, G(x) of CT-DNA was determined to be 
different resulting from the different apparent concentration of DNA, though the real 
concentration for CT-DNA is 1 nM.
The objective of PG calibration assay is to explore the useful range of DNA labelling ratio 
by PG. The ideal ratio should give sufficient fluorescence signal with less interference in 
DNA conformation from intercalating dyes. PG, when intercalating into dsDNA, give 
fluorescence fluctuation signals directly recorded as “count rate” (CR). From Figure 3.5(i), 
CR increases in linear relationship with the amount of PG added i.e. dye/kbp ratio at 5-40. 
More tolerance to the higher labelling ratio is a general trend for mono-intercalating dyes. 
Therefore, the sensitivity of the nucleic acid labelling dye to the ratio may be primarily 
dependent on the dissociation constant of its secondary binding mode. The higher the dye 
dissociation of second binding mode, the greater the useful range of labelling ratio 
(compared to TOTO-1).189
Another two parameters in FCS, diffusion time (xD) (Figure 3.5 (ii)) and PN, (Figure 3.5 (iii)) 
remain constant as initial values at the start of experiments based on the mono-component 
diffusion model. This suggests that PG has no influence over the hydrodynamic properties 
of DNA molecules. PG can be used at a very low level (i.e. 5-40 dye molecules/kbp), 
compared to a similar study using EthBr.176,177,179 The stability of PG labelled DNA samples 
is also high, which means that the dilution of sample does not affect the accuracy of the 
measurement.189 The stability of the dye-DNA complexes after dilution is also important for 
a titration study of DNA condensation, which involves the dilution of the sample (i.e. 
volume addition of DNA condensing agent).
The diffusion coefficients of (PG-labelled) CT-DNA was calculated by considering DNA as 
a rod-like molecule.176,177,179 Considering the characteristics of DNA, CT-DNA has a high xD 
which is due to its significantly greater size than circular plasmids; different length DNAs 
diffuse differently in solution. The previous fluorescence-recovery after photobleaching 
study (FRAP) using FlTC-labelled DNA revealed that Dw (diffusion coefficient in water) 
was dependent on DNA size, Dw = 4.9 x 10'10 m2/s x [bp size]'0 72 (for 21-6000 bp linear 
dsDNA). DNA diffusion coefficient decreased by increasing DNA size indicating the 
complex hydrodynamic properties of DNA with respect to translational diffusion.192 
Similarly, Rigler and co-workers193 reported that the relative translational diffusion 
coefficient decreased linearly with the length of double-stranded DNA fragments (at least up 
to 500 bp) by using fluorescence correlation spectroscopy technique in the study of DNA 
products formed during PCR. Dw of CT-DNA from calculation (5.3xl013 m2/s) is similar to
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the result as found in FCS experiments (7x l013 m2/s). Deviation of xD found in our FCS 
experiments and from calculation in CT-DNA may be related to the polydispersity of CT- 
DNA, which means that different lengths of linear DNA were measured together. However, 
as the DNA condensation process is regarded as an all-or-none process, it is possible to 
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Figure 3.5 PG labelling calibration using CT-DNA. Different volumes of PG (1.1 pM) were 
added into 200 pi of 1 nM DNA and incubated for 10 min. G(t) was recorded at each dye 
labelling ratio. FCS parameters were calculated and plotted against dye concentration i.e. (i) 
count rate (CR), (ii) particle number (PN), and (iii) diffusion time (td).
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In Figure 3.5, CR increased linearly with dye concentration showing the high efficiency of 
PG fluorescence on DNA binding, with little effect on DNA hydrodynamic changes from the 
dye itself. The useful concentration range of PG from the data shown lies within dye 
molecules/kbp = 5-40.
FCS enables the direct measuring of the average number of fluorescent molecules, the 
Particle Number (PN), diffusing through the volume element. PN was interpreted from the 
autocorrelation curve, described as G(0) = 1+(1/N). From Figure 3.5(i), PN calculated from 
G(t) of PG molecules bound to CT-DNA was at 43.1 ±8.1. This may be explained from the 
length of DNA, as CT-DNA (contour length = 4.4 pm) is considerably bigger than the 
confocal element (coj = 0.58 pm, 0)2 = 3.38 pm). In a recent paper,194 it is proposed that long 
DNA may have internal conformation diffusion of its chain (segmental motion). This leads 
to a high number of fluctuations in the fluorescence intensity, i.e. lower G(t), especially 
when considering that the laser focus could excite at least one part of the entire chain, and 
thus finally leading to a higher PN.
CT-DNA condensation by lipopolyamines
Two lipopolyamines were synthesized and used in these experiments. Both are designed to 
incorporate a spermine backbone conjugated with a lipophilic moiety i.e. the oleoyl group 
(amide link) (Figure 3.6(i))195 and the cholesteryl group (carbamate link) (Figure 3.6(ii)).69 
Both our novel DNA vectors show effective condensation (i.e. yielding 90% fluorescence 





Figure 3.6 (i) A/4.A^-Dioleoylspermine, (ii) A1-cholesteryl spermine carbamate
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The aim of this study is to understand more of the mechanisms that by which these two 
vectors interact with DNA, as a single molecule (in this case, specifically regarded as a 
single nanoparticle) by FCS using PG.
From the calibration curve (Figure 3.5 (i)), optimal dye ratio used for CT-DNA labelling was 
in the range of 5-40. PG was prepared in 1:200 dilution (according to the manufacturer’s 
protocol), using too much dye would alter the total volume of sample solution. In the DNA 
condensation experiment, the PG volume added was 30 |_il (which is equivalent to dye/kbp 
ratio = 13). Fluorescence fluctuation was monitored while adding A^A^-dioleoylspermine 
and /V'-cholesteryl spermine carbamate in solution to a sample containing PG-labelled DNA.
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Figure 3.7 FCS study of DNA nanoparticle formation: CT-DNA (1 nM, 200 jul) was 
condensed with lipopolyamines, using PG as a reporter probe.
(i) CT-DNA condensation by A^A^-dioleoylspermine (PG at dye/kbp = 13)
(ii) CT-DNA condensation by /V'-cholesteryl spermine carbamate (PG at dye/kbp = 13)
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When the N/P ratio was increased (Figure 3.7), DNA phosphate groups were gradually 
neutralized by positively charged ammonium groups of /V^A^-dioleoylspermine and N]- 
cholesteryl spermine carbamate. G(x) was recorded and FCS parameters (diffusion 
coefficient and PN) were then calculated throughout the DNA condensation process. The 
indication for DNA condensation occurrence is the dramatic decrease of xD and PN 
particularly for a system with macromolecules where a single monitored molecule is not 
small enough to fit in the confocal volume. From Figure 3.7, the diffusion coefficient (D) 
increased upon the addition of lipopolyamines in both DNA condensation experiments. As 
faster movement of DNA resulted from condensation, we conclude that smaller (compacted) 
DNA nanoparticles have been formed. PN also decreased (Figure 3.7) while measured CR 
remained constant.
Point-like molecule detection in CT-DNA condensation
PN is a direct parameter to prove the number of fluorescent molecules, which here reports on 
the DNA concentration. In the model with point-like molecules, PN is described by the 
equation PN = C x V x Na, where C = molarity of detected molecules (DNA 1 nM), V = 
confocal volume (1 femtolitre), and NA = 6.023 x 1023. By using this equation, and as the 
DNA concentrations used in our experiments were kept constant at 1 nM, the theoretical PN 
to be achieved is around 0.6. The PN achieved at N/P = 1.0-1.5 for CT-DNA condensed by 
/V^A^-dioleoylspermine, was 0.7. This evidence confirms that DNA was condensed into a 
point-like molecule by the C18-substituted lipopolyamine, which fulfils the assumptions of 
FCS and validates the use of FCS as a sensitive method in DNA formulation studies (which 
is indeed a point-like molecule, when compared to the typical confocal volume). This result 
is in agreement with other physical studies on DNA particle size, when completely 
condensed at the nanoscale level. Similar results were also found for DNA condensation 
with A^-cholesteryl spermine carbamate, decrease in xD and PN. The PN value 5.2 was 
achieved at N/P = 1.5-2.5 for CT-DNA condensed by A^-cholesteryl spermine carbamate. 
From a comparison of these PN results with those obtained with A^^-dioleoylspermine, we 
conclude that A^-cholesteryl spermine carbamate is a poorer DNA condensing agent than 
A4^ V9-dioleoylspermine. Additionally, condensation occurred at higher N/P ratios (N/P =
1.5-2.5) than condensation achieved with A^^-dioleoylspermine (N/P = 1.0-1.5). 
Considering the positive-charge number of A^^-dioleoylspermine is less than that of N1- 
cholesteryl spermine carbamate (i.e. 2.0 compared to 2.4), we conclude that more efficient 
DNA condensation is possibly due to the respective regiochemical distribution of these two 
positive charges together with their lipid moieties (C l8 vs cholesterol).
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Point-like molecules obtained from CT DNA condensation by A^^-dioleoylspermine have 
an average xD of 12.0 ms (D = 1.8 x 10"12 m2/s). These nanoparticles diffuse about 3-times 
faster than free DNA (D = 0.71 x 10'12 m2/s). Similar diffusion behaviour of CT-DNA 
complexed with A^-cholesteryl spermine carbamate was also found at 14.0 ms (D =
1.3 x 1012 m2/s), though the PN has not fulfilled the point-like molecules hypothesis (i.e. not 
approximating to 0.6). Considering the change in the magnitude of diffusion coefficient (D) 
between free and condensed DNA, mediated by both our two lipopolyamines and at 
appropriate N/P ratios to achieve full DNA condensation, provides evidence for the dramatic 
change that is DNA condensation. Moreover, D is, in general for point-like molecules, a 
rather insensitive parameter and could incorporate some error (about 10%). On the other 
hand, PN is much more sensitive, and it accurately shows differences between both 
condensing agents. Thus, A^A^-dioleoylspermine is a more efficient DNA condensing agent 
(PN approaching 0.6) than A^-cholesteryl spermine carbamate.
In the steady state EthBr fluorescence quenching study, it was shown that there is no 
significant difference found in the condensation of CT-DNA and plasmids. However FCS is 
a single molecule technique with high sensitivity, it is possible to observe the difference of 
linear (and big) DNA behaviour and plasmid DNA in a 1 femtolitre confocal volume. We 
have therefore also studied plasmid DNA nanoparticle formation by FCS/PicoGreen which is 
discussed in the following section of this Chapter.
Plasmid DNA-PicoGreen labelling study
pGL3 and pEGFP are two circular plasmids used in FCS experiments, which have similar 
size and contour length. It was expected that the smaller size of both plasmids (compared to 
CT-DNA) would result in higher diffusion coefficients and lower particle number (PN), 
when they are detected using FCS and PG.
Table 3.1 Plasmids used in these studies
pGL3 pEGFP
Primary structure Circular plasmid
Number of base pairs (kbp) 5.3 4.7
Mean molecular weight (MDa) a 3.4 3.0
Contour length (|im) b 0.9 0.8
a calculated from 330 Da average per nucleotide.21
b obtained by calculation: L=Ndna x  a, given Ndna is the average number of DNA monomer 
(base pair), and a = monomer length (i.e. 0.34 nm for DNA duplex). Contour length of 
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Figure 3.8 Examples of normalized autocorrelation functions, G(t) [a] and the count rates 
tracking [b, c] for pGL3 (black line) and pEGFP (grey line) 1 nM (200 pi) intercalated with 
PG (1.1 pM) 18 pi and pEGFP 1 nM (200 pi) intercalated with PG (1.1 pM) 18 pi Cdye/kbp 
are 18 and 21 respectively.
pGL3 and pEGFP was prepared in HEPES buffer (20 mM NaCl, pH 7.4) in 1 nM 
concentration and used at 200 pi. Increasing amounts of PG (as a 1.1 pM solution) were 
added into both plasmids to perform the measurements simulating the different states of PG 
binding. Experimental G(t) functions were satisfactorily fitted to a theoretical diffusion 
model with two-population fluorescent type, which a major population (more than 95%) of
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slow diffusion species (D = 10 ms). The other minor component is the fast moving 
component (D = 0.01 ms). Typical normalized autocorrelation functions G(x) are plotted in 
Figure 3.8. The nature of multi-labelling on plasmid DNAs causes an overestimation of PN 
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Figure 3.9 PG labelling calibration using pGL3 (□) plasmid. Different volumes of PG 
(1.1 pM) were added into 1 nM DNA (200 pi) and incubated for 10 min. G(x) was recorded 
at each (Cdye/kbP) ratio. FCS parameters were calculated and plotted against dye 
concentration i.e. (i) count rate (CR), (ii) diffusion time (xD), and (iii) particle number (PN).
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Figure 3.10 PG labelling calibration using pEGFP (■) plasmid. Different volumes of PG 
(1.1 |_iM) were added into 1 nM DNA (200 pi) and incubated for 10 min. G(x) was recorded 
at each (Cdye/kbp) ratio. FCS parameters were calculated and plotted against dye 
concentration i.e. (i) count rate (CR), (ii) diffusion time (td), and (iii) particle number (PN).
From the titration curve of pGL3 (Figure 3.9 (i)) and pEGFP (Figure 3.10 (i)), the useful 
range of DNA labelling ratio by PG was determined from dye molecule/kbp ratio at 10-25. 
From Figure 3.9(i) and 3.10(i), CR increases in linear relationship with the amount of PG 
added i.e. dye/kbp ratio at 10-25. At this range, there is also less interference in DNA 
conformation. Diffusion times (td) (Figures 3.9 (ii) and 3.10 (ii)) remain essentially constant 
as initial values at the start of experiments based on the two-component diffusion model.
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Particle numbers (PN) (Figures 3.9 (iii) and 3.10 (iii)) increased at the first stage of PG- 
labelling, and then reached it plateau. The hydrodynamic properties of DNA molecules were 
not disturbed by the PG labelling. Additionally, PG can be used at a very low level (i.e. 10- 
25 dye molecules/kbp), compared to the similar study using EthBr which is typically used in 
an excess concentration (to the number of DNA base-pair equivalents).176,177,179
Diffusion behaviour of PG-labelled plasmid DNA
The diffusion coefficients (Figure 3.9 (ii) and 3.10 (ii)) of both pGL3 and pEGFP were 
calculated by considering DNA as a rod-like molecule.176,177,179 It was observed that both 
DNAs diffused at mean diffusion coefficient 1.95 x 1 O'12 and 2.05 x 10"12 respectively. The 
circular plasmid shape plays a role to increase diffusion coefficient comparing to previous 
experiments using linear CT-DNA (7 x l0 13 m2/s), which is 3-times faster. This diffusion 
information could further extend to DNA behaviour in cytoplasm and ultimately in the 
nucleus when dissociated from its lipopolyamine vector.196 It is also important in NVGT 
vector design to achieve complexes which diffuse at a favourable rate, aiming to promote 
mobility and localization to target organelles.
From Figures 3.9 (iii) and 3.10 (iii), PN calculated from G(x) of PG molecules bound to 
pGL3 was similar to that of pEGFP (i.e. 8.7 ± 0.8 and 7.0 ±1.1 respectively). Considering 
the confocal element (coi = 0.29 ± 0.01 pm, © 2  = 1.69 ± 0.02 pm), both pGL3 and pEGFP 
are relatively too big to fit this volume (contour length = 0.9 and 0.8 pm respectively). Both 
plasmids still fluctuate across the focal volume, thus the effect of multiplied PN was 
observed.
pGL3 and pEGFP condensation by lipopolyamines
From the calibration curves (Figures 3.9 (i) and 3.10(i)), optimal dye molecule/kbp ratio 
used for DNA labelling was in the range of 10-25. PG was prepared in 1:200 dilution 
(according to the manufacturer’s protocol), using too much dye would alter the total volume 
of the sample solution. In the DNA condensation experiment, the PG dilution volume added 
was kept identical for both pGL3 and pEGFP, at 18 pi (which is equivalent to dye/kbp ratios 
= 18 and 21 respectively). Two synthetic lipopolyamines were studied in our DNA 
experiments. The previous EthBr assay (Figure 3.11) shows highly efficient DNA 
condensation (i.e. much more efficient than spermine) with only 10% residual fluorescence, 
evidence that DNA is in the condensed state. Fluorescence fluctuation was monitored while 




8 0  -©o
§  6 0  -w
©
§  4 0  -
LL
*  20 -








0.0 1.0 2.0 3 .0 4 .0 5 .0 6.0
(ii) N/P ratio
Figure 3.11 DNA condensation study of A^A^-dioleoylspermine (•), /V'-cholesteryl 
spermine carbamate (■) and spermine (A)  using pGL3 (5.3 kbp, (i)) and pEGFP (4.7 kbp, 
(ii)) using EthBr displacement assays. EthBr assay shows a decrease of fluorescence 
intensity (A«x = 260 nm, and A«m = 600 nm) DNA condensing agent concentration expressed 
in ammonium/DNA phosphate (N/P) ratios were increased. Both lipopolyamines condense 
DNA efficiently with 10% residual fluorescence at N/P ratios around 1.5-2.5.
DNA phosphate groups of pGL3 (Figure 3.12) and pEGFP (Figure 3.13) were gradually 
neutralized by positively charged ammonium groups of A/^A^-dioleoylspermine and /V1- 
cholesteryl spermine carbamate, when the N/P ratio was increased. Throughout the DNA 
condensation process, G(x) was recorded and FCS parameters (diffusion coefficient and PN) 
were then calculated. The indication for DNA condensation occurrence is the dramatic 
decrease of xD and PN particularly for a system with macromolecules where a single 
monitored molecule is not small enough to fit in the confocal volume. From Figures 3.12 
and 13, the diffusion coefficient (D) continuously increased upon the addition of 
lipopolyamines in both DNA condensation experiments. As faster movement of DNA 
resulted from condensation, we conclude that smaller (compacted) DNA nanoparticles have 
been formed. PN also decreased while measured CR remains constant. The CR range was
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maintained in the range at 40 - 60 kHz during the DNA condensation, which is a positive 
indication that PG exhibits high affinity to DNA and was not released from binding to the 
polynucleotide chain. This lack of PG release confirms that DNA hydrodynamic change is 
the major contribution to any changes in fluorescence signal found during DNA 
condensation under the experimental conditions described above.
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Figure 3.12 FCS study of DNA nanoparticle formation: pGL3 (1 nM, 200 pi) were 
condensed with lipopolyamines, using PG as a reporter probe. Particle number (□) and 
diffusion coefficient (■) were measured during the following condensation studies:
(i) pGL3 condensation by A^A^-dioleoylspermine (PG at dye/kbp = 18)
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Figure 3.13 FCS study of DNA nanoparticle formation: pEGFP (1 nM, 200 p.1) were 
condensed with lipopolyamines, using PG as a reporter probe. Particle number (□) and 
diffusion coefficient (■) were measured during the following condensation studies:
(ii) pEGFP condensation by A^A^-dioleoylspermine (PG at dye/kbp = 21)
(iv) pEGFP condensation by /V’-cholesteryl spermine carbamate (PG at dye/kbp = 21)
In these studies aiming for point-like molecules, PN is described by PN = C x V x NA, where 
C = molarity of detected molecules, V = confocal volume, and NA = 6.023 x 1023. By using 
this equation, and as the DNA concentrations used in our experiments were kept constant at 
1 nM, the theoretical PN to be achieved is around 0.6. The PN achieved at N/P = 2.0-2.5 for 
pEGFP, condensed by A/4,A9-dioleoylspermine was 0.9. From these experimental data, the 
PN error was calculated as 0.3. Thus the achieved PN = 0.9 is within the experimental error 
in PN determination.This evidence suggests that pEGFP was condensed into a point-like 
molecule by the C 18-substituted lipopolyamine, which fulfils the assumptions of FCS and 
validates the use of FCS as a sensitive method in DNA formulation studies (which is indeed 
a point-like molecule, when compared to the typical confocal volume) (Figure 3.14). As 
expected, DNA condensation with /V'-cholesteryl spermine carbamate, there was a decrease 
in td and PN, but the PN values achieved at N/P = 2.0-2.5 for pGL3 and pEGFP, condensed
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by V-cholesteryl spermine carbamate, were 2.6 and 2.1 respectively. Therefore, N l- 
cholesteryl spermine carbamate is a poorer DNA condensing agent than vV^ /V9- 
dioleoylspermine.






Circular plasmid DNA Interaction of DNA with Condensed DNA
labeled with PG lipopolyamines leading (nanoparticle formation)
to conformation change
Figure 3.14 Illustration o f DNA molecules in the FCS confocal excitation volume (V, green 
cylindrical volume); V is an approximate cylinder o f 1 ft.
Left: a free (no lipopolyamine) plasmid molecule (ribbon) labelled by intercalated PG 
(both open- and red-circles), but only a fraction of fluorophores (red-circles) lie within the 
confocal volume, and are therefore excited. PN was found to be higher than real 
concentration o f DNA due to this fluorescence fluctuation.
Middle'. Phosphate groups of DNA molecule interacts with lipopolyamines, which 
alters DNA conformation. Smaller apparent PN was observed, due to smaller size of DNA 
and higher number o f intercalated PG in excitation volume (red-circles).
Right: a lipopolyamine-condensed DNA where all the PG reporter molecules now lie 
within the confocal volume, and all are therefore excited; this nanometer-sized complex acts 
as a point-like molecule (a single nanoparticle)
Point-like molecules obtained from pEGFP condensation by A^A^-dioleoylspermine have an 
average xD of 4.7 ms (D = 4.30 x 10'12 m2/s). These nanoparticles diffuse about 2 times 
faster than free DNA (D = 1.95 x 10'12 m2/s). pGL3 condensed by A^^-dioleoyl-spermine 
also had a similar average i D of 5.8 ms (D = 4.2 x 10 12 m2/s) at the size of 2 times faster than 
free pGL3 (D = 2.05 x 10 12 m2/s). Similar diffusion behaviour of pGL3 and pEGFP 
complexed with A'-cholesteryl spermine carbamate was also found at 7.2 ms (D = 2.9 x 10'12
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m2/s) and 7.1 ms (D = 3.0 x 10'12 m2/s), though the PN has not fulfilled the point-like 
molecules hypothesis. D values usually have 10% error, PN values are one way to show 
differences between DNA condensing agents. Thus, A^A^-dioleoylspermine (PN 
approaching 0.6) is a more efficient DNA condensing agent than A^-cholesteryl spermine 
carbamate.
Behaviour of PG during DNA condensation
PicoGreen has been primarily used for DNA quantification with high sensitivity (25 pg/ml 
dsDNA).184 It labels nucleic acids uniformly and without any concentration-dependence or 
artefacts.189,197 Rapid binding of PG to DNA was also studied by flow cytometry. High- 
quality burst size distribution histograms of DNA samples were obtained immediately after 
sample staining, dilution, or mixing. The measured association rates of PicoGreen 
intercalating into dsDNA were on the order of 108 M'1 s'1, suggesting a diffusion-controlled 
process. Re-equilibration can be reached in seconds upon staining, dilution, or mixing, from 
model simulation. These favourable kinetics also make PG one of the most efficient and 
versatile DNA probes.198
Phenanthridinium dyes, e.g. EthBr, showed monoexponential decays with ssDNA and 
dsDNA, and with no discrimination between them.199 Binding of PG to dsDNA 
preferentially occurs by intercalation between alternating GC base pairs, which was 
characterized by a monoexponential fluorescence decay rate constant of (0.23 +/- 0.02) ns'1. 
It was found that binding to the exterior of DNA (the second binding mode of PG) may also 
efficiently compete with intercalation. Dye molecules in other configurations exhibit 
fluorescence decay rate constants of about 0.5-0.8 ns'1, and are observed at dye:base-pair 
ratios larger than 0.30 in CT-DNA. Fluorescence decay is multi-exponential in all types of 
ssDNA and the dominant mode is intercalation between two different bases (G, T).191
In NVGT research, PG was recently used to determine the quantity of free DNA 
(uncomplexed DNA) to assess the DNA condensation property of gene vectors, e.g. 
polyamidoamine dendrimer,200 amine-functionalized carbon nanotube,201 and protamine 
sulfate.202 This is an “indirect” method to measure the DNA condensation. PG was added as 
a final step, into the DNA complex solutions at different charge ratios. The DNA 
condensation efficiency at each N/P charge ratio was calculated from the ratio of free DNA 
over total DNA which is usually expressed in units of percentage. Similarly, the free DNA 
released from hydrogels of crosslinked polymer oligo(poly(ethylene glycol)fumarate 
incorporating plasmid DNA (at 37 °C, agitation at 70 rpm, 80-day study), which aid 
understanding of controlled-released gene delivery.202
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These indirect DNA condensation (and dissociation) assays200'203 through free DNA 
measurement may not sufficiently explain the quality of gene complexes in the (complex) 
processes of their formation. At the present time, there is only one report on using PG to 
study DNA condensation directly. The PG dye-exclusion technique was been firstly 
published to monitor the pCMVlacZ condensation by protamine sulfate.204 The assay is 
similar to the EthBr assay,114 which monitors the steady-state fluorescence measurement of 
PG-labelled DNA directly. When the DNA is condensed, PG is excluded from the binding 
site, thus the drop in fluorescence intensity was measured and interpreted as DNA 
condensation efficiency.204 This PG exclusion study is done at the high dye/kbp ratio, 
around 540 i.e. 0.27 pg DNA/pl PG reagent (220 pM). This high loading of PG may affect 
the DNA structure (e.g. extend the length of DNA etc.) which makes monitoring the process 
of DNA condensation complicated.204 However, the photo-physical behaviour of PG bound 
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Figure 3.15 Time-tagged time-resolved (TTTR) data acquisition mode enables the 
monitoring of individual fluorescent photons. The information with time-tagged is 
converted into autocorrelation function G(i) of fluorescence intensity. Decay kinetics of 
different fluorescent species are calculated from TCSPC time. This TR-FCS helps the 
separation of different fluorescent photons in term of G(x) and lifetime (x).
In our studies, we have applied the recently established time-resolved FCS technique (TR- 
FCS)205 to monitor the behaviour of PG on DNA at low-labelling ratios (40 dye/kbp) 
throughout the condensation process. TR-FCS allows the simultaneous monitoring of DNA 
condensation (through FCS measurement) and PG lifetime (through using the time-resolved
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mode). A confocal microscope with (a) pulsed pico-second diode laser excitation, (b) a fast 
single photon avalanche diode detector, and (c) PicoQuant TimeHarp 200 board was set-up 
for this experiment. The time-tagged time-resolved (TTTR) mode of TimeHarp was used to 
capture the fluctuations and the fluorescence decay kinetics o f individual photon (Figure
3.15).
PG intercalation in DNA plasmid and its fluorescence decay
PG labelling of plasmid DNA and PG behaviour upon DNA condensation were studied by 
TR-FCS, using the FCS upgrade set-up. Alexa488 (approx 2 nM) was used to determine the 
confocal excitation element (V), and found to be ©i = 0.26 ± 0.01 pm, ©2 = 1.87 ± 0.30 pm 
and volume (V) = 0.8 ± 0.1 femtolitre. This is a typical volume for FCS measurement as 
found in the classical set-up of ConfoCor ® I. Different volume of PG (1.1 pM) in the 
region o f 0-30 dye molecule/kbp was added into pGL3 and pEGFP, left for 10 min to 
equilibrate before the fluorescence intensity measurement as described in the Experimental.
dye/kbp = 24.0 
dye/kbp = 18.0 
dye/kbp = 12.0 
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Figure 3.16 Fluorescence decay profiles for PG bound to circular plasmid DNA ((i) pGL3 
and (ii) pEGFP) obtained from TTTR data acquisition, using TR-FCS setting.
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To understand the nature of DNA-binding of PG, fluorescence TTTR data were recorded at 
different PG dye/kbp ratios using pGL3 and pEGFP. The intensity decay was obtained from 
TTTR data and fitted by MicroTime200 (Figure 3.16, plotted in OriginPro7.0). The tail 
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Figure 3.17 (i) Major fraction of fluorescent species (97%) and (ii) lifetime of the major 
fluorescent population over a range of dye labelling ratio. Major fluorescent species of 
DNA-bound PG shows consistent lifetime, indicating that there is no dye release or dye- 
environment change.
Fluorescent count data from PG-labelled DNA were best represented by the bi-exponential 
model, which were better fitted than using the mono-exponential model. From this fitting 
calculation, there are two populations of DNA-bound PG fluorescent species (a) x = 4.0 ns 
(intensity fraction 97%) and (b) x = 1.0 ns. Considering that the fraction of other PG species 
(with x 1.0 ns) is very small, it suggested that x 4.0 ns species is the major fluorescent PG 
(Figure 3.17). This is corresponded well to the previous study by fluorescence lifetime 
measurement with a streak camera, reported by Schweitzer and Scaiano,191 which also shows
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that PG is adequately fitted by monoexponential decays when complexed to dsDNA (but 
with ± 5% error). In term of model fit, the bi-exponential model has improved £  value over 
from the mono-exponential model, but the tri-exponential model failed to improve further 
the £  value. Thus, this model fitting was used throughout our experiments.
From Figure 3.17, it is clear that the majority of PG, in the range of 0-30 dye molecule/kbp, 
bound to both plasmid DNAs through a single and unified mechanism. PG-labelled DNA 
showed negative in a circular dichroism study,199 indicating that the majority of dyes are 
intercalated between DNA base-pairs. The PG concentration selected in our study is much 
lower than the saturation of acridine dyes intercalation (i.e. 500 dye/kbp). However, our 
model also indicates the presence of short-lived PG (1.0 ns), though in very small number. 
This observation may be related to the higher sensitivity of our confocal microscope in 
fluorescence detection, compared to the population-based time-resolved study. The constant 
lifetime of DNA-bound PG at 4.0 ns, also confirms that there is no change in environment 
surrounding PG intercalating site (which shorten PG lifetime). This ensures that there is no 
major DNA conformational change due to PG intercalation, which is one of desirable 
properties of good fluorescent DNA probes.
FCS analysis of intercalated PG on plasmid DNA
In these experiments, the application of time-resolved measurement was used to derive the 
FCS parameters of DNA-bound PG, hence named TR-FCS. pGL3 and pEGFP plasmids (1 
nM in HEPES 20 mM NaCl, pH7.4) were labelled with different concentrations of PG. The 
FCS parameters of PG on pGL3 and pEGFP were simultaneously analysed using TTTR data 
and a mathematically-derived filtering technique. From the time-resolved study, it was 
found that there are two sub-populations with 97% from 4.0 ns species. TR-FCS allows the 
separation of G(t) of both species on the basis of decay time difference. However, in our 
DNA experiments, all detectable fluorescent PG (with any lifetime) are on the same DNA 
molecule. Thus, the separation of different G(x) for both species was not able to be 
performed.
According to G(x) obtained from TTTR data analysis (Figure 3.18), both PG-labelled 
plasmids show similarity in the autocorrelation. This similar diffusion coefficient 
corresponds to their similar size and the structure of pGL3 and pEGFP. Both DNA also 
show the over-estimated PN rather than the theoretical PN (calculated by the real 
concentration of DNA used). This is caused by the size of multi-labelled plasmid DNA,
-83-
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Figure 3.18 Example of CR plot and normalized G(x) were constructed from TTTR data. 
The count rates tracking ([a] pEGFP, [b] pGL3) and G(x) ([c]) for pGL3 1 nM (200 pi) 
intercalated with PG (1.1 pM) 18 pi (black line) and pEGFP 1 nM (200 pi) intercalated with 
PG (1.1 pM) 18 pi (grey line), Cdye/kbPare 18 and 21 respectively. The nature of multi­
labelling DNA (long-chain molecules) causes an overestimation of PN (apparent PN).
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FCS parameters (Figures 3.19 and 3.20), calculated from G(x) (Figure 3.18) and confocal 
volume obtained from Alexa488 calibration, are complementary to the lifetime information 
of fluorescent PG. The constant increase of CR when more PG was added confirmed that 
PG intercalation is the most preferable binding mode in the low-labelling condition (less than 
40 kbp). This is important to DNA probe selection which the unity of binding mode may 
simplify the data interpretation.
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Figure 3.19 FCS parameter in TR-FCS, i.e. PN, CR and diffusion time (or coefficient) of 
PG-labelled pGL3 (□) was analysed from G(x). PG was added into DNA solution achieve 
different dye/kbp ratio.
In Figure 3.19, the constant PN is around 3 and diffusion coefficient is slightly fluctuated in 
the region of 0.9 x 1012 m2/s. This suggests that DNA-bound PG molecules does not alter 
the hydrodynamic property of pGL3 (i.e. not to induce DNA bending or DNA condensation).
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PN and diffusion coefficient of labelled pEGFP (Figure 3.20) were found to be constant in 
the PG titration experiments, which were similar to the ones with pGL3.
Diffusion coefficient of pEGFP(1.3 x 10'12 m2/s) is higher than pGL3 (0.9 x 10'12 m2/s), 
given its smaller plasmid size. However the PN values of PG-labelled pEGFP were slightly 
increased and finally get to a constant level. This slight increase of PN did not affect PG 
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Figure 3.20 FCS parameter in TR-FCS, i.e. PN, CR and diffusion time (or coefficient) of 
PG-labelled pEGFP (■) was analysed from G(x). PG was added into DNA solution to 
achieve different dye/kbp ratio.
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FCS analysis of intercalated PG on plasmid DNA through the condensation process
Two lipopolyamines, A^A^-dioleoylspermine (data shown in Figures 3.21 and 3.22) and Nl- 
cholesteryl spermine carbamate (data shown in Figures 3.23 and 3.24) were used in this 
study to condense pGL3 and pEGFP. The FCS parameters were obtained from G(x) (derived 
from TTTR data).
DNA conformational change toward a condensed DNA was reflected in lower PN values 
with the increase in N/P. More structured DNA would have less segmental movement, thus 
reduce the PN value. Based on our classical FCS studies, these two lipopolyamines can 
achieve the point-like molecule condition (i.e. DNA was seen as one nanoparticle in the 
confocal volume). Complete DNA condensation was also illustrated by the increase of 
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Figure 3.21 FCS parameters derived from TTTR data in TR-FCS, during the condensation 
process of pGL3 by /V^A^-dioleoylspermine, PG used at 18 dye/kbp
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In these studies using TR-FCS (Figures 3.21 and 3.22), A^A^-dioleoylspermine condensed 
pGL3 and pEGFP at N/P = 1.5-2.0. PN measured at the condensation N/P is about 0.9 
(theoretical PN = 0.6). From these experimental data, the PN error was calculated as 0.3. 
Thus the achieved PN = 0.9 is within the experimental error in PN determination.This 
evidence suggests that pEGFP was condensed into a point-like molecule by this vector. 
Diffusion coefficient of a DNA nanoparticle is 2.1 x 10'12 m2/s (for pGL3) and 2.5 x 10'12 
m2/s (pEGFP), which is approximately 2-times higher than free DNA (1 x 1012 m2/s). These 
diffusion coefficients also indicate the formation of compact DNA structured, from the use 
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Figure 3.22 FCS parameters derived from TTTR data in TR-FCS, during the condensation 
process of pEGFP by A^A^-dioleoylspermine, PG used at 21 dye/kbp
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Figures 3.23 and 3.24 show the similar results of DNA condensation with A1-cholesteryl 
spermine carbamate, there was an increase in diffusion coefficient and a decrease in PN.
The PN values achieved at N/P = 1.3-1.5 (pGL3) and 2.5-3.0 (pEGFP). The PN achieved in 
these TR-FCS experiment was improved from the classical FCS, i.e. 0.3 (pGL3) and 0.5 
(pEGFP). Diffusion coefficient of a DNA nanoparticle was 2.4 x 10'12 m2/s (for pGL3) and 
2.8 x lCf12 m2/s (pEGFP), which is approximately 2-times higher than free DNA (1 x 10'12 
m2/s). The observation of fast-moving particles shows that DNA was packaging into a 
condensed DNA by A1 -cholesteryl spermine carbamates.
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Figure 3.23 FCS parameters derived from TTTR data in TR-FCS, during the condensation 
process of pGL3 by /V1-cholesteryl spermine carbamate, PG used at 18 dye/kbp
From this TR-FCS, we concluded that both DNA condensing agents: A^A^-dioleoylspermine 
and A1-cholesteryl spermine carbamate are highly efficient in DNA packaging. We also
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demonstrated that TR-FCS is capable to monitor the DNA condensation, We observed the 
difference in FCS parameters between TR-FCS and classical FCS. Given all photon events 
were collected and tagged (for their time of being detected) as an individual data point in 
TR-FCS, this technique offers more data for analysis. In the classical FCS, all photon data 
were calculated as a single average value by the correlator (hardware component) in the 






0.0 0.5 1.0 2.01.5 2.5 3.0 3.5
.CO
CVJ
E 3 .0 x 1 0 1 2 -1
2 .8 x 1 0 12:
c 2 .6 x 1  O'12-
Q)
' o 2 .4 x 1 0 ‘12:
i t 2 .2 x 1 0 12 :
0)
o 2 .0 x 1 0 12:
o 1.8x10" 12-
c
o 1 .6 x 1 0 12:
(f)
3 1.4x1 O’12 -  
1 .2 x 1 0 '12-4=
Q
N/P
























1.0 1.5 2 .0  2.5 3.0 3.5
N/P
Figure 3.24 FCS parameters derived from TTTR data in TR-FCS, during the condensation 
process of pEGFP by N1 -cholesteryl spermine carbamate, PG used at 21 dye/kbp
Behaviour of PG on DNA undergoing condensation process
Count rate (CR) is a parameter reporting the fluorescence intensity in the system i.e. 
intercalated PG. Free form of PG (unbound species) was 1000-times less fluorescent than 
intercalated PG, thus the signal from PG is wholly from bound dyes. In our decay studies of
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DNA-bound PG at different dye/kbp ratios (where there was no DNA condensing agent 
added), there was no CR decrease found at any labelling ratios. This showed that PG dyes 
bound to both pGL3 and pEGFP strongly and did not release from the intercalation sites, 
unless there lipopolyamines were added into DNA solutions.
In the DNA condensation experiments using PG as a probe (Figures 3.21, 3.22, 3.23 and 
3.24), the small decrease of fluorescence (0-20 %) was observed reported as CR values 
during the initial phase of the DNA condensation process. We defined this initial step of the 
DNA condensation as the stage where there is no significant change in the diffusion 
coefficient o f PG-labelled DNA, but PN change is observable (N/P = 0-1.0).
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Figure 3.25 Fluorescence decay profiles for PG bound to circular plasmid DNA ((i) pGL3 
and (ii) pEGFP) obtained from time-tagged time-resolved data acquisition, which undergoes 
DNA condensation using A^^-dioleoylspermine
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In the next step of DNA condensation (N/P more than 1.0), DNA was further reduced in size. 
FCS parameter i.e. diffusion coefficient was sharply increased, approximately 2-times, 
compared to PG-labelled DNA with no lipopolyamines. The degree of CR decrease is also 
higher in this phase of DNA condensation. We conclude that there is a significant change in 
the DNA conformation, mediated by /^^-d io leoylsperm ine and /V1-cholesteryl spermine 
carbamate. However, the information from FCS calculation is not sufficient to study the 
fluorescent signalling behaviour of PG on DNA chains.
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Figure 3.26 Fluorescence decay profiles for PG bound to circular plasmid DNA ((i) pGL3 
and (ii) pEGFP) obtained from time-tagged time-resolved data acquisition, which undergoes 
DNA condensation using A 1-cholesteryl spermine carbamate.
In these experiments, TR-FCS offers additional information to explain the behaviour of PG 
when DNA is in the condensed state. The decay profile of DNA-bound PG was calculated 
by employing a bi-exponential model. The decay plots are shown in Figures 3.25 and 3.26.
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Both DNAs were labelled with PG (1.1 |J.M) (18 jlxI ) . The decay model shows the major 
population at 4.0 ns with the intensity fraction = 97%.
In Figure 3.27, the major population of fluorescent species in condensed DNA was at 97% 
consistently through the condensation process, with lifetime at 4.0 ns, which is the same as 
previously noted in the experiments using uncondensed DNA in Figure 3.17. This 
emphasizes that most PG molecules remained in the same binding site, and that there was no 
detectable migration to other binding sites (e.g. minor groove). Lifetime of 4.0 ns dye 
species was constant in the first stage of DNA condensation (N/P 0-1.0). This showed that 
there is no change in the environment of intercalation sites. In other words, there is no 
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Figure 3.27 Major fluorescent species of DNA-bound PG shows there is no intensity 
fraction of major population (4.0 ns dye species) change during DNA condensation process.
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In the DNA condensation where N/P is more than 1.0, the lifetime values found in our 
experiments started to significantly decrease from 4.0 to 3.0-3.5 ns. We conclude that even 
though PG molecules were still located in their intercalation binding sites (i.e. t  of the major 
population of fluorescent species is still around 4.0, and the % of fluorescent species of 1.0 
ns was not significantly increased) at this stage, there were some changes in the surrounding 
environment (which refers to DNA intercalation site) which accelerate the fluorescence loss 
at a quicker rate (i.e. quenching). This reflected in the decrease of lifetime values. This was 
probably due to the packing of DNA into nanoparticles, which altered the intercalation sites 
and the proximity of PG to other quenching agents in the condensed DNA environment, 
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Figure 3.28 Lifetime and CR change during DNA condensation process of (i) pGL3 + 
A^A^-dioleoylspermine, (ii) pEGFP + /V^A^-dioleoylspermine
The decrease in lifetime may be related to the migration of PG from one binding mode 
(intercalation) to another one (e.g. minor groove binding mode), thus the surrounding
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environment of PG changed. However, we found that 4.0 ns species are still the major 
fraction of population (97%) and there is no significant increase in the population of shorter 
lifetime fluorescent species (1.0 ns). Thus, there is no change or switch of binding mode of 
PG. The consistent lifetime was observed through the DNA condensation.
To incorporate both FCS information and decay kinetics of PG, both CR and lifetime were 
normalized in to percentage of the relative fluorescence unit (Figures 3.28 and 3.29) and 
plotted on the same graph. However, CR and lifetime are the parameters expressed in 
different units (intensity unit vs time). The conversion of lifetime (time unit) to fluorescence 
was performed, based on the relationship of fluorescence quantum and lifetime which is 
described in equation (2) where F0 = initial fluorescence quantum, F = fluorescence quantum, 
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Figure 3.29 Lifetime and CR change during DNA condensation process of (i) pGL3 + Nl 
cholesteryl spermine carbamate and (ii) pEGFP + A1-cholesteryl spermine carbamate
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In Figures 3.28 and 3.29, the CR values were reported as % relative CR. The CR values 
represent the total fluorescent intensity detected in the confocal volume. The decrease in CR 
could be from dye release (physical loss of dye out from DNA, thus total fluorescence 
intensity dropped) and dye quenching (no physical loss of dye, but shorter lifetime, thus 
fluorescence intensity dropped). Quenching process is a process which acts on the excited 
population and thus decreases the mean decay time of the excited state population.
During the first stage of DNA condensation (N/P = 0-1.0), only dye release process leads to 
the decrease in CR. There is no contribution from dye quenching given there is no change in 
PG lifetime values. This is supported by the constant life-time (4.0 ns) in this N/P range in 
Figure 3.27, during the dye release process. Dye release process is a process that some PG 
molecules are released from the intercalation sites. However, the released PG molecules are 
so low in fluorescence (lower than the intercalated PG 1000 times) that they are not 
detectable by TR-FCS, and only the fluorescent species (intercalated PG) were monitored. 
The conformational change of DNA, when lipopolyamines start to interact and initiate the 
bending of DNA chains, may induce the release of PG from their binding sites. The similar 
dye release of DNA intercalators is commonly observed in EthBr.113 In conclusion, dye 
release process by itself does not decrease the decay time of intercalated PG.
At N/P charge ratios higher than 1.0, lifetime of fluorescent species started to decrease from 
4.0 to 3.0-3.5 ns. Dynamic quenching of PG was then proposed as the principal process 
leading to fluorescence (CR) loss. According to the equation (2), the shorter lifetime of 
intercalated PG was in proportional to the decreased CR. In Figures 3.28 and 3.29, the 
degree of CR decrease was also comparable to the degree of lifetime shortening at this stage 
of DNA condensation. This supports our proposal that dye quenching is the main source of 
fluorescence intensity decrease. When considering the FCS parameters, diffusion time of 
PG-labelled DNA was significantly increased and PN was approaching the theoretical value 
(PN = 0.6). The formation of DNA nanoparticles may lead to the significant change in the 
intercalation sites, thus reflecting in the lifetime shortening of DNA-bound PG.
The behaviour of PG on DNA through the DNA condensation was proposed and illustrated 
in Figure 3.30. PG molecules efficiently intercalated between DNA base-pairs (step I: dye 
binding) with a single binding mode with 4.0 ns lifetime, and no interference in DNA 
hydrodynamics. After lipopolyamines were added into DNA, PG molecules were then 
excluded from DNA in the low level (step II: dye release). It was worthy to note that the 
fluorescence decrease is not an indicator for the complete DNA nanoparticle formation.
DNA was then condensed into a single nanoparticle, resulting in the quenching of PG
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fluorescence (step III dye quenching). Dye quenching through the lifetime determination is 
an effective indicator for the nanoparticle formation detection. In this stage, PN, a reliable 
parameter for FCS measurement, was also approaching theoretical PN.
I. Dye binding II. Dye release III. Dye quenching
o
Free DNA DNA condensation DNA nanoparticle 
formation
Figure 3.30 PG behaviour through the DNA condensation process
From our studies, the key advantage of using PG in DNA condensation studies is its single 
mode of binding and high affinity to DNA, compared to other dyes such as EthBr. It can 
also be used at very low concentrations due to its high absorption coefficient. The 
fluorescence signal reduction, being observed in the assay, was proved to be from two 
distinctive mechanism: (i) dyes release and (ii) dyes quenching. Lifetime information of 
DNA intercalator is also a reliable and helpful parameter in DNA condensation studies, 
obtained from TR-FCS.
Conclusions
Employing the reported FCS experiments, we were able to monitor lipopolyamine-DNA 
complex formation at the single molecule level. In comparison to other DNA markers, PG 
used in our FCS study has several advantages: it does not change the hydrodynamic 
properties of DNA, and it does not influence the lipopolyamine concentrations necessary for 
condensation. Additionally, due to its high brightness, PG requires 10-fold lower staining 
when compared with previously used markers. PG has higher affinity than EthBr and other 
related dyes for dsDNA, in part, because o f the polyamine moiety structural modification 
which efficiently forms salt bridges with DNA phosphate anions, taken together with DNA 
intercalation, this is known as biphasic binding. Finally, count rate is practically invariant to
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the condensation process, indicating that dye release is not interfering with the condensation 
process.
As demonstrated using our lipopolyamines, FCS directly visualises the condensation process 
by tracking changes in diffusion coefficients and particle numbers. In the experiments 
reported herein, the PN value, which is the most accurate read-out parameter of a FCS 
experiment, gives quantitative information on the packing density of DNA- lipopolyamine 
aggregates. Thus, direct information on the quality of condensing molecules can be derived. 
This analytical platform, FCS provides detailed information and insight about DNA and its 
interaction with gene carriers, which is crucial to the development of safe and effective non- 
viral gene delivery vectors.
TR-FCS offers an access to lifetime information which is from I 'l 'l  K data and analysed 
simultaneously with FCS analysis. In this study, the upgraded ConfoCor® I and TimeHarp 
setting was used. pGL3 and pEGFP condensation with A4^ -dioleoylspermine and Nl- 
cholesteryl spermine carbamate was as a model. We are able to define the fluorescent 
signalling behaviour of PG through the process from dye binding, dye release and then dye 
quenching. Dye release was suggested as the indicator for DNA conformational change, but 
not for the nanoparticle formation. Dye quenching, through the observation of change in 
lifetime, is a more important event reporting that a single nanoparticles was existed. FCS 
data derived from TR-FCS is found to be similar and comparable to the classical FCS.
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Chapter 4
NVGT mechanistic studies using fluorescent techniques and tools
Introduction
Non-viral gene therapy is a multi-step DNA (as a prodrug) delivery protocol. After DNA 
condensation, there are several barriers prior to nuclear entry. DNA nanoparticles formed by 
lipopolyamines must be uptaken into cells, escape from endosomes, traffick to and enter the 
nucleus for gene expression. Transmembrane delivery is therefore important to the success 
of gene delivery. Cell membranes are constructed from phospholipid bilayers. The outer 
membrane contains glycolipids, phophatidylcholine (PC), and sphingomyelin while the inner 
membrane has phosphatidylethanolamine (PE), phosp'natidylserine (PS) and 
phosphatidylinositol. Cholesterol is found in both the inner and outer layers of the 
membrane. It rigidifies the membrane and thereby modulates membrane integrity.106
Unlike hydrophobic molecules which can cross the membrane by passive diffusion, larger 
molecules (including DNA nanoparticles) are normally uptaken by ATP-dependent 
endocytosis.206 This could be receptor-mediated endocytosis through membrane receptors, 
e.g. clathrin-coated pits (Figure 4.1). These receptors bind with macromolecules and form 
clathrin-coated vesicles. The transition o f a bud to a vesicle involves membrane fusion, and 
is associated with GTP-binding protein.88,106 The clathrin units then dissociate from the 
vesicle coat. This is the “early endosome” and its membrane composition remains the same 
as cellular membranes. The “early endosome” further develops to the “late endosome” and 
fuses with lysosome. At lower pH (5.5), endo-lysosomal vesicle membranes rupture and 
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Figure 4.1 Clathrin-mediated endocytosis. The assembly o f the clathrin coat introduces 
curvature into the membrane and then the formation of uniformly sized coated buds 
(engulfing). Once internalized in to cells, the coat of clathrin-coated vesicles is removed and 
recycled back to the cell membrane leading to the formation o f endosomes.
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There was also a recent report on clathrin-independent cellular uptake mode at the membrane 
sites called caveolae. Caveolae are enriched in lipid (cholesterol and sphingolipids) and 
have a protein coat (called caveolin). It was found that they could uptake fluids as large 
vesicles (0.15-5.0 pm).207,208 Strong evidence has now been established that caveolae are 
static fixed domains and are not involved in endocytosis (not through endosomes). Their 
trafficking involves the microtubule network (e.g. kinesin and dyneins) and the association 
of this pathway to gene delivery is still not well understood.209 Pathways of internalization 
of DNA complexed with cationic lipids or polymers by phagocytosis206 and 
macropinocytosis210 have also been reported.
Endocytosis of NVGT lipoplexes
Cellular uptake, especially endocytosis, is important to initiate the gene delivery process in 
cells. To understand the process of cellular entry of gene complexes, using our synthetic 
vectors (N4.A^-dioleoylspermine and A1-cholesteryl spermine carbamate, Figure 4.2), both 
primary (FEK4) and carcinoma cell line (HtTAl HeLa) models were used in our studies. 
Commercially available cationic lipid vectors - Lipofectin (DOTMA/DOPE) and 
Lipofectamine (DOSPA/DOPE) were included as reference lipofection models.
(i)
(ii)
Figure 4.2 (i) A/4^ -Dioleoylspermine, (ii) A1-cholesteryl spermine carbamate
Lucifer yellow carbohydrazide211 (LY) (Figure 4.3) is used as a non-toxic fluorescent marker 
for endocytosis (A*x = 427 and A«m = 535 nm). It is highly soluble in water, lipid-insoluble, 
and ionised at physiological pH. The two negative charges in the molecule prevent the 
cross-membrane passage by passive diffusion, and LY enters cells by endocytosis.211 The 
effect of temperature on fluid phase endocytosis and the membrane physical state was 
reported by Wolkers et al.m  using Fourier transform-infrared spectroscopy (FT-IR) and 
fluorescence anisotropy. The results show that there is a main membrane phase transition at
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approximately 8-12 °C. Endocytotic processes are usually blocked at temperatures below 12 
°C. For example, LY uptake into pig platelets by fluid phase endocytosis occurs above 15 
°C.212
n h 2
Figure 4.3 Lucifer yellow carbohydrazide (LY) - a marker molecule for endocytosis
The study of cell incubation at 12 °C, where fluid-phase lipid underwent phase transition, 
was selected for endocytosis investigation in these studies. This low temperature protocol is 
comparable to other endocytotic studies using endocytosis inhibitors (or ATP depletion 
agents) such as oligomycin,213 cytochalasin B.214 FEK4 and HtTAl HeLa transfection were 
performed at selected optimal N/P charge ratios. Cells at 50-70% confluence were exposed 
for 4 h at 12 °C to pEGFP lipoplexes formed by A^A^-dioleoylspermine or A1-cholesteryl 
spermine carbamates. Then the DNA complexes were removed and replaced with regular 
media according to the cell line. Cells were then incubated at 37 °C for another 44 h. The 
EGFP expression results were obtained after 48 h post transfection using FACS analysis.
In Figure 4.4, FEK4 cells incubated with lipoplexes of A^A^-dioleoylspermine (N/P 2.5 and 
5.0), A1-cholesteryl spermine carbamate (N/P 5.0), Lipofectin (N/P 2.0), and Lipofectamine 
(N/P 3.0) show high transfection at 37 °C with high cell survival rate > 80%, as discussed in 
Chapter 2. When the transfection was carried out at 12 °C, a significant decrease of 
transfection efficiency was found in the reference lipofection systems, as well as in the 
experiments using our synthetic vectors. The loss of endocytosis results in less DNA 
complexes being delivered across the membrane and finally affects gene expression. Matsui 
et a/.210 also show the relationship of cellular entry of lipoplexes and the transfection 
efficiency in differentiated airway epithelial cells. Cells in the centre part of the well (well- 
differentiated) which uptake less liposomal complexes (pCMV beta/LipofectACE = 1:5 
(w/w)) than poorly-differentiated ones at the edge of the well, displayed a significantly lower 
transfection result.210 Figure 4.5 shows that all lipid-based NVGT vectors at 12 °C still 
retain their ability to deliver DNA into FEK4 when the process of endocytosis was stopped. 
From these data, we conclude that it is highly possible that endocytosis is not the only route 
for lipoplexes to gain access to cells. A/^A^-Dioleoylspermine at N/P 5.0 shows a




significantly higher relative fluorescent cell percentage than the one at N/P 2.5 (i.e. 30 and 
10% respectively). The excess of cationic lipid in the complexation at N/P 5.0 may be 
related to facilitating the non-endocytosis pathway(s) of cell entry. Even though lipoplexes 
get into cells mainly by endocytosis, NVGT vectors which are capable of cell entry by 
multiple routes may help boost the overall level of efficiency in reaching the delivery target.
mat 37C  


































Figure 4.4 Effect of temperature on pEGFP delivery in FEK4 using A^A^-dioleoylspermine, 
/V1-cholesteryl spermine carbamate, Lipofectin, and Lipofectamine. Endocytosis was found 
to be the major cellular entry route of DNA nanoparticles, (n = 3, error bars are S.D.)
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Figure 4.5 Relative gene expression level of pEGFP complexed with /V4,/V9- 
dioleoylspermine, A1-cholesteryl spermine carbamate, Lipofectin, and Lipofectamine in 
FEK4 at 12 °C. (Mean value was used in this graph, considering the gene expression at 37 
°C control conditions as 100%)
Similar transfection experiments at low-temperature (12 °C) were also performed in a 
carcinoma cell model. In Figure 4.6, HtTAl HeLa cells incubated with lipoplexes of /V4,/V9- 
dioleoylspermine (N/P 2.5 and 5.0), A1-cholesteryl spermine carbamate (N/P 5.0), and
-103-
Lipofectamine (N/P 3.0) show a significant decrease in transfection at 12 °C, as found in 
FEK4 cells. In comparison to Figure 4.4, the level of gene expression through the non- 
endocytotic cellular entry into HtTAl HeLa cells is slightly lower than in FEK4 cells. This 
observation is in agreement with the fact that carcinoma cells uptake more DNA complexes 
than primary cells.163 Thus, the magnitude of cellular uptake reduction was apparently 
greater in HeLa cells. Transfection in HtTAl HeLa (Figure 4.7) also shows a smaller 
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Figure 4.6 Effect of temperature on pEGFP delivery in HtTAl HeLa cells using N4,A/9- 
dioleoylspermine, A1-cholesteryl spermine carbamate, and Lipofectamine. Endocytosis was 
found to be the major cellular entry route of DNA nanoparticles, (n = 3, error bars are S.D.)
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Figure 4.7 Relative gene expression level of pEGFP complexed with 
dioleoylspermine, A1-cholesteryl spermine carbamate, and Lipofectamine in HtTAl HeLa 
cells at 12 °C. (Mean value was used in this graph, considering the gene expression at 37 °C 
control conditions as 100%)
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From these studies, we conclude that endocytosis plays the major role in the cellular uptake 
of A^A^-di oleoy 1 spermine and A1-cholesteryl spermine carbamate lipoplexes. However, 
non-endocytotic cell entry modes also exist and may play roles as auxiliary pathways in non- 
viral gene delivery.
Novel pore-forming NVGT vector
PolyAPS (polyalkylpyridinium salts) (Figure 4.8),215-217 a marine toxin extracted from 
Reniera sarai was obtained as a gift from Dr. RH Scott (University of Aberdeen, U.K.) and 
used in our studies. This toxin primarily contains two polymeric 1,3-alkylpyridinium salts of 
5.5 and 19 kDa. This compound shows the electrophysiological action in HEK 293 cells 
(dorsal root ganglion neurons). At high concentration (50 (ig/ml), it caused irreversible 
depolarisation in membrane potential and reduction in input resistance. This increased Ca2+ 
permeability and flux in cells. The effect was less and also was reversible at low dose (50 
ng/ml). This unique pore-formation property (membrane permeability alteration) and its 
poly-positively charged characteristic make poly APS a good candidate for a gene delivery 
vector. Transfection of pEGFP and plasmid for human tumour necrosis factor receptor 2 
was reported in HEK 293 cells.218 Stable transfection was achieved with poly-APS although 
it was less efficient than Lipofectamine.218 However, apart from this transfection study, 
there is no published study on the interaction of this polycationic toxin with DNA. Our first 
study is therefore to explore the effect of its DNA condensation properties, which can lead to 
a better understanding of its gene delivery mechanism.
Figure 4.8 Polyalkylpyridinium salt (polyAPS) C8 alkyl chain, existing in two fractions with 
polymeric units n = 19-29 and n = 99 respectively
Figure 4.9 shows the DNA condensation with poly APS, using different DNA: pEGFP (4.7 
kbp), pGL3 (5.3 kbp), and calf thymus DNA (13 kbp). EthBr displacement assay shows the 
decrease of fluorescence intensity (excitation at 260 nm, emission at 600 nm) when polyAPS 
concentration (expressed in a mole ratio of ammonium/DNA phosphate (N/P)) was increased. 
For N/P calculation, the number of positive charges in polyAPS was obtained by counting 
one positive charge on every monomer unit. All three DNA samples used in our study 
(pEGFP, pGL3, and CT-DNA) were efficiently (and similarly, see Figure 4.9) condensed by 
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Figure 4.9 pEGFP, pGL3 and CT-DNA condensation study by EthBr displacement assay 
(Xex = 260 nm and Km = 600 nm) (n = 3, S.D. were shown in error bars), using 
polyalkylpyridinium salt (polyAPS)
Light scattering in Figure 4.10 confirmed that polyAPS-DNA complexes were formed, as the 
apparent absorbance at 320 nm increases significantly from the DNA only solution. Optimal 
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Figure 4.10 pEGFP, pGL3 and CT-DNA condensation study by light scattering assay (k  = 
320 nm) (n = 3, S.D. were shown in error bars), using polyalkylpyridinium salt (polyAPS)
In Figure 4.11, the binding ability was calculated from the experiment using pEGFP as a 
model DNA. Calculated Kb are in the order; /V^A^-dioleoylspermine (1.1 x 107 M'1) > N l- 
cholesteryl spermine carbamate (0.7 x 107M'') > polyAPS (0.3 x 107M'‘). From this 
binding analysis, both A^^-dioleoylspermine and N] -cholesteryl spermine carbamate binds 
to pEGFP more than polyAPS. The higher affinity to DNA of synthetic lipopolyamines is 
from the regiochemical distribution of positive charges along the vector molecule (i.e. 
carbon spacing in lipospermine = 3 or 4, and in polyAPS = 8) and the lipid moiety.
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Although the Kb of polyAPS is similar to spermine (Kb = 0.2 x 107M'1), the fluorescent 
residual of polyAPS-mediated DNA condensation is comparable to the one achieved by our 
synthetic lipopolyamines. The pyridinium headgroup and its degree of polymerization in 
polyAPS (n= 19-29 and n=99) may contribute to its superior DNA condensation over 
spermine.
100 N4,N9-dioleoylspermine 
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Figure 4.11 pEGFP condensation by polyAPS compared to //^-dioleoylsperm ine, Nl- 
cholesteryl spermine carbamate and spermine, using EthBr displacement assay (K* = 260 nm 
and Km = 600 nm) (n = 3, error bars are S.D.)
Given polyAPS is a highly efficient DNA condensing agent; it is possible to develop 
polyAPS as an NVGT vector. In addition to cell entry facilitation by pore formation, this 
membrane perturbation could also help in endosomal escape process (i.e. induce pore 
formation of endosomal membrane), which is one of key barriers in gene delivery. In nature, 
the pore-formation of polyAPS may act in chemical defence; it may also provide a novel 
mechanism of natural horizontal genetic material transfer between marine microorganisms. 
The mechanism by which poly-APS delivers macromolecules into cells and achieves 
transfection is unknown.215'217
Several cell-based membrane leakage assays, which have been used in cell toxicity 
characterisation, have been re-applied to determine membrane integrity.214,219 These assays 
are performed in either a leaking-out or a diffusing-in direction. The first approach involves 
leaking out of intracellular enzymes (such as luciferase,214 lactate dehydrogenase157,214) and 
some pre-loaded fluorescent probes help identify the presence of vectors-membrane 
interaction. Fluorescein O-diacetate (FDA) (Figure 4.12),214,219,220 an acetate ester of 
fluorescein, was non-fluorescent and readily diffuses through intact cells. FDA undergoes 
hydrolysis catalysed by cellular esterase into fluorescein (K x = 490 nm and Km = 513 nm),
-107-
which is hydrophilic and non-permeant. The cellular retention of fluorescein is 
compromised in cells with disrupted membrane.
+  2 CH3COOH
Figure 4.12 Fluorescein O-diacetate (FDA) (i) readily diffuses passively across cell 
membranes when it is hydrolysed to get fluorescein (ii) which is highly fluorescent, polar 
and non-permeant.
In FDA release experiments of polyAPS in FEK4 (Figure 4 .13), Mi is the population with 
high FDA-loaded cells in the control group (no polyAPS) in the range of log Fi 
(fluorescence intensity in log unit, using F] emission filter) at 102-104 M2 represents FEK4 
cells which released fluorescein out from their cells, showing log Fi less than 103(mean 
fluorescence in the control group). The reduction in fluorescence level of Mi and the 




Figure 4.13 Histograms in the FDA release studies of polyAPS (red line = blank group with 
no FDA, grey shade = control group with FDA only, blue line = polyAPS 1 pg/ml) show 
sub-population Mi and M2 groups of FEK4.
PolyAPS at 1 pg/ml was selected as this concentration shows induce the poration in HEK 
293 cells in Scott et al. ’s studies.215'217 Histogram of polyAPS-treated cell in blue line shows 
that FEK4 cells was less fluorescent and number of FDA-released cells were increased,
c e l lu la r
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compared to the control group (grey shade), indicating the change of membrane permeability. 
From the red-line histogram, the blank sample (without FDA) was found no fluorescence in 
the log Fi range used for monitoring, which confirms that there is no interference from 
intrinsic cellular fluorescence.
Another approach to study the interaction of vector-membrane is the use of non-permeant 
substances such as fluorescent dyes, fluorescent macromolecules (e.g. FITC-dextran214,221) or 
protein (e.g. HRP - horseradish peroxidase222). The magnitude of these substances 
translocated into intact cells when applying with interested fusogens, was measured to 
understand the effect to membrane. Propidium iodide (PI) 214,220 is a positively charged 
probe (Figure 4.14). It free form is low in fluorescence, and does not get into cells with 
intact membrane. PI is also widely used as a marker used to determine cell death (i.e. 
detecting the loss o f the membrane integrity). Once PI is inside the cells and gets into the 
nucleus, PI is able to intercalate between nuclear DNA basepair and become fluorescent (A,ex 




Figure 4.14 Propidium iodide (PI), a non-permeant fluorescent probe, is used for membrane 
integrity studies. Cells with compromised membrane integrity allow PI uptake
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Figure 4.15 Histograms in PI uptake studies (grey shade = control group, yellow line = 
polyAPS 1 pg/ml) show a sub-population Mj group of FEK4 used in analysis.
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In PI uptake experiments (Figure 4.15), Mj is the population with Pl-uptake cells (Pi-loaded 
only, without lipopolyamines) when log F3 (fluorescence intensity in log unit, using F3 
emission filter) at more than 10*. The increase in fluorescence level of Mi (mean calculated 
from log F3 value) and the increased number of Mi cells in the population were analysed to 
determine the level of PI uptake. PolyAPS at 1 pg/ml (yellow line in Figure 4.15) shows 
that the treated cells were more fluorescent and number of Pl-uptake cells was slightly 
increased, compared to the control group (grey shade), indicating the change of membrane 
permeability.
Results from both experiments (FDA release and PI uptake) are compared and presented in 
Figure 4.16, which are found to be concordant. Figure 4.16 (left) shows that the % cells with 
FDA release or PI uptake is 20-30%, compared to polyAPS untreated cells (0%). The mean 
fluorescence intensity of fluorescein is reduced to 60% of untreated FEK4 cells.
Fluorescence intensity of PI is also significantly increased at 2.8-times the control group.
This membrane instability result is also in agreement with the electrophysiological studies by 
Scott and co-workers.215'217 From our DNA condensation and membrane studies, it is 
concluded that polyAPS is a novel NVGT vector with high efficiency of DNA condensation 
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Figure 4.16 PolyAPS in FDA release and PI uptake studies in FEK4 cells (control = 
polyAPS untreated cells) (n = 3, error bars are S.D.)
Potential membrane fusion/penetration activity of lipopolyamines
From the low-temperature transfection studies (Figures 4.5 and 4.7), non-endocytotic cellular 
entry pathway are involved in non-viral gene delivery about 5-30%. This leads to our
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interests to study if  there is any other interaction between synthetic lipopolyamines and 
cellular membrane. In Figure 4.17, the positive charges o f DNA complexes facilitate the 
electrostatic interaction with negatively charged phospholipids, allowed the cellular uptake. 
Lipophilic groups in lipopolyamines vector are usually selected or modified from the natural 
membrane lipids. These lipids may initiate the lipid mixing process in the membrane which 
alters the ordemess of lipids in membrane and the loss o f membrane integrity or 
permeability . 1' 4
Figure 4.17 Lipopolyamines - A^V^-dioleoylspermine (ii), A1-cholesteryl spermine 
carbamate (iii) containing two important parts in NVGT delivery, unlike spermine (i). 
Polyamine moiety helps in DNA condensation and membrane binding (electrostatic). Lipid 
moieties (such as steroidal lipid or fatty acids) facilitate the packing and delivery of DNA.
The NVGT process was widely known to be problematic in practice, due to major 
intracellular barriers in delivery. These barriers include cell entry, endosomal escape (to 
minimize DNA degradation from endosomal-lysosomal DNase), and nuclear entry. All of 
these share the common ground as problems involving the interaction of DNA particles with 
lipid bilayer membranes (i.e. cell membrane, endosomal membrane and nuclear membrane). 
Thus, the investigation of membrane interaction properties o f lipopolyamines would be 
beneficial better to understand how these DNA carriers deliver DNA into the nucleus. This 
would help in a design o f efficient NVGT vectors which can both effectively condense DNA 
and interact well with various membranes during the process of DNA delivery.
M embrane fusion modulation by spermine
Membrane fusion process was defined by Meers et a l 223 as a process with two steps i.e. (a) 
aggregation of two vesicles (Vi) to form a dimer (V2), and (b) fusion of dimer membrane 
resulting in a fused vesicle (F2). Fusogen is defined as an agent that affects the overall fusion
.NH.
I 1 Polyam ine m oiety
I I Lipophilic moiety
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rate, through aggregation (Cn) or fusion rate (Fn), as described in the following process, 
illustrated in Figure 4.18.
aggregation fusion
^ 1 1  ^11
V, + V, -  V2------------ -- F2
Dn
deaggregation
Figure 4.18 Process of spermine-induced membrane fusion
Spermine alone only aggregates, but does not fuses phosphatidate (PA) and PS liposomes. 
Only in liposomes made from high PE, spermine is able to cause fusion which may be from 
the fusogenic nature of PE. When used with fusogen like Ca2+, spermine was observed to 
induce the overall fusion rate of PA liposomes at 70% by promoting higher Ca2+binding. 
Calcium ions, at optimal concentration, were known to increase Cn by the neutralization of 
surface charge. Unlike spermine, calcium is also able to dehydrate the surface of membranes 
and the flexibility of bond angles, allowing bilayer shaping in fusion process. This 
spermine-mediated effect was not detected in PS liposomes. PS has a serine group which 
minimize the exposure of phosphate group at vesicle surface (i.e. less binding site for 
spermine), unlike PA. Thus, spermine is regarded as an aggregation promoter, not a fusogen. 
Nevertheless, a spacing bridge between two vesicles formed by spermine interacted with 
bilayer phosphate groups, is a first step to membrane fusion.223 The Gouy (1910)-Chapman 
(1913)-Stem (1924) theory224 suggests that surface charge density was reduced when 
cationic polyamines bind to anionic membrane surfaces. The association of spermine to 
membrane (PC/PS liposomes) 225 was found at Kb= 91±12 M'1. This is valid for samples 
with spermine content lower than half of phospholipids. At the higher concentration of 
spermine, Kb shifts to higher values. Hydrophobicity is lowered to some extent by the 
spermine bound to the membrane surface; the effect is common to all position in the chain, 
indicating that water penetration extends up to the higher hydrophobic region at the centre of 
the bilayer.
Membrane lipids integrity disturbance by lipid molecules
Most bilayer membranes contain phospholipids (mainly PC and PE at 50 and 20% of total 
phospholipid mass respectively) 226 and cholesterol, which support their structure. Acyl 
groups in phospholipid are C l4-18 fatty acid, such as palmitic acid, oleic acid etc. Oleic 
acid is a C l8  ds-unsaturated fatty acid and widely known as a skin penetration enhancer. 
Lipid phase separation is expected to be the key mechanism for this membrane activity. The 
FT-IR technique227 was employed to determine the change of wavelength number of CH2 
group after the treatment of pig stratum comeum (4 cm2) and its extract lipids with per-
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deuterated oleic acid (30 pi of 300 pg/pl solution) at different temperatures. Oleic acid 
disorders 6-10 alkyl groups near the polar group of bilayer (highly order region) with no 
effect on the terminal methyl group. This increases the fraction of lipid in “liquid phase”, 
and creates the permeable interfacial defect (Figure 4.19). The liquid phase was between 
solid phase membranes, which reduce the diffusional path length/resistance of membrane. 
The fluorescence anisotropy study228 in modelled bilayers (human buccal epithelial cells) 
revealed the similar effect of oleic acid over the lipid packing order. The trans-form of oleic 
acid (elaidic acid) was also able to disrupt membrane, but in less degree than the m-form.229
Temporary pore (membrane defect)
0 =  Membrane lipid ^  \  Oleic acid
Figure 4.19 Proposed role of C18-oleic acid in membrane disturbance, due to its cis- 
conformation of double bond at C9_io
Membrane studies using FDA were carried out using spermine and oleic acid. Spermine is a 
poor DNA condensing agent and no reports on the use of spermine as a NVGT vectors were 
found. In this study, we briefly examined a single concentration of spermine (2 pg/ml).
This selected dose is non-toxic, as confirmed by the good quality of cells obtained for FACS 
analysis. Additionally, in cardiomyocytes (primary cell line from Sprague-Dawley rats), it 
was reported that spermine at 20 pg/ml or less is not toxic to cells.230 The selected 
concentration of spermine (2 pg/ml) is also significantly higher than the previously reported 
concentration inducing the PA vesicle aggregation (5.5 pM).223 As expected, spermine 
(green line in Figure 4.20) showed no membrane disruption at this concentration. This is in 
agreement with Meers et a/.’s report that spermine by itself does not fuse the membrane, but 
only modulates the fusing process.223
On the other hand, oleic acid was reported to alter the highest membrane permeability at 0.7 
mM (200 pg/ml) in a buccal mucosal cell suspension, using the fluorescence anisotropy 
technique.228 In our study, oleic acid was used at 200 pg/ml (in EtOH). From Figure 4.20, 
oleic acid (red line) showed no membrane effect at this concentration. The difference in our
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result from the study of Turunen et al.228 may be from the nature of the cells in culture. The 
adherent monolayer cell culture of FEK4 (less contact surface area) may require a higher 
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Figure 4.20 Histograms in FDA release studies (grey shade = control group with FDA only, 
green line = spermine 2 pg/ml, red line = oleic acid 200 pg/ml) show sub-population Mi and 
M2 groups of FEK4.
Dioleoylphosphatidyl ethanolamine (DOPE) (Figure 4.21) is a helper phospholipid 
frequently used in liposomal NVGT systems.62,231,232 The presence o f phosphatidyl- 
ethanolamine in the liposomes greatly enhanced fusion whereas the presence of 
phosphatidyl-choline inhibited fusion. Inclusion of cholesterol (40 mol%) in the liposomes 
substantially decreased liposomal leakage without impairing fusion.233
o
Figure 4.21 DOPE, a helper lipid with two C18-oleoyl chains
Fusogenic lipopolyamines: possible synergistic effects from polyamines and lipid
Lipopolyamines’ fusogenic activity has not been widely studied, unlike fusogenic peptides 
(i.e. polyamine) and fusogenic phospholipids. However, from chemical structure of 
lipopolyamines, it may be possible to modulate the formation of “salt bridge” of 
ammonium/guanidinium groups in polyamines and lipid-mediated membrane phase 
destabilization. Recently, steroid-polyamine conjugates series74 was studied for haemolytic 
activity (bovine erythrocyte). The conjugates consist o f a hydrophobic, rigid steroid, a
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flexible hydrophilic polyamine which can be protonated at physiological pH. From 
structure-activity-relationship aspect, it was found that the two nitrogen atoms with C4 
spacing on polyamine backbone (used at 10-100 (iM) are important to higher membrane 
activity. Examples of hemolytic steroidal-polyamine conjugates74 are shown in Figure 4.22. 
The hydrophobic substituent on the steroid side-chain (e.g. propyl group) also enhances 
membrane fusion. Spermidine was also used as a control, showing no haemolysis, this 







Figure 4.22 Example of hemolytic cholesteryl spermine conjugates74
Studies of interaction between lipopolyamines and cellular membrane
Based on our results that A^^-dioleoylspermine and N] -cholesteryl spermine carbamate do 
not only enter cells via an ATP-dependent process (e.g. endocytosis), further studies of both 
lipopolyamines, at a non-toxic concentration (minimum survival rate 70%), were 
investigated in an FEK4 model. FEK4 cells were treated with lipopolyamines at different 
concentrations, following the procedure described in the Experimental. Figure 4.23 is an 
example of FEK4 cells obtained in FACS samples of A^A^-dioleoylspermine-treated and 
control, shown in a Dot-plot of light signals from forward-scattered (FSC) and side-scattered 
(SSC). FSC is a parameter in proportional to cell size, and SSC indicates the cell granularity 
or internal complexity (typically referred to as cell debris or dead cells). Both groups 
similarly show good healthy cells (homogenous population). Gating for sub-population (Rj) 
was consistently applied in all experiments. From this Dot-plot, there is no significant 
difference in terms of cell morphology and size between FDA-treated and control groups. 
This ensures that the effects observed in all the following experiments are based on the 
temporary membrane effect in healthy cells and no artefacts from permanent cellular damage 
(loss of membrane integrity) are included in this study.
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Figure 4.23 Example of a typical Dot-plot diagram of whole FEK4 cells population, (i) 
negative control group (cells with FDA only) and (ii) sample group (cells with FDA 10 
pg/well and treated with A'Vv^-dioleoylspermine at 11 pg/ml).
The analysis of FDA release was performed by using the same sub-population marking (M l 
and M2) as previously described for poly APS. As an example, in Figure 4.24, A^V9- 
dioleoylspermine at 11 pg/ml (blue line) shows that the FDA-loaded cells were less 
fluorescent and the number o f FDA-released cells were increased, compared to the control 





Figure 4.24 Example of typical histograms in FDA release studies (grey shade = control 
group with FDA only, blue line = A^A^-dioleoylspermine 11 pg/ml) show sub-population 
Mi and M2 groups o f FEK4.
In Figure 4.25, the % FDA released cells mediated by A^A^-dioleoylspermine and N ]- 
cholesteryl spermine carbamate was found to be similar. The level o f membrane disturbance
is increased when the vector’s concentration is increased. Both vectors showed a 
comparable effective membrane disturbance (20%) to poly APS reference at high 
concentrations. Cells treated with /V1 -cholesteryl spermine carbamate displayed slightly 
higher FDA release.
N4, N9-dioleoylspermine 
-a- N1-cholesteryl spermine carbamate
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Figure 4.25 Effect of lipopolyamines on fluorescein release in FEK4 cells. FDA (10 pg/well) 
was pre-loaded for 30 min in FEK4, and A^^-dioleoylspermine or N *-cholesteryl spermine 
carbamate was then added. The M2 population (cells with reduced fluorescence) was 
measured by FACS and reported as a percentage (M2 = 0% in control cells with no 
lipopolyamine treatment), (n = 3, error bars are S.D.)
The concentration range of vector used in this experiment is below the level of target (70% 
survival) and all cells measured are from R| (healthy cells). A^A^-Dioleoylspermine at 11 
fig/ml (equal to N/P charge ratio = 5.0, for DNA 2 pg/well was used in transfection) shows 
high FEK4 transfection (70% efficiency) and membrane disturbance (20%). Nl-Cholesteryl 
spermine carbamate at N/P charge ratio = 12.40 (equal to 12.4 (ig/ml) delivers DNA at 60% 
efficiently and membrane disturbance (25%). Thus, it is highly probable that the increase in 
membrane interaction of vectors is related to transfection efficiency.
Figure 4.26, the fluorescence intensity of cells (Ml), when treated with lipopolyamines, 
showed a similar decrease in fluorescein intensity in both vectors: A^A^-dioleoylspermine 
and jV1 -cholesteryl spermine carbamate. Cells treated with A1-cholesteryl spermine 
carbamate also showed slightly higher FDA-release and lower cellular fluorescein intensity, 
in the concentration range of vector used in these studies.
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Figure 4.26 Mean fluorescence of FDA-loaded cells (M l) after treatment with A^A9- 
dioleoylspermine or A 1-cholesteryl spermine carbamate. The M l population was measured 
by FACS for its fluorescence intensity. (Mean fluorescence o f M l = 100% in control cells 
with no lipopolyamine treatment), (n = 3, error bars are S.D.)
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Figure 4.27 Example of typical histograms in PI uptake studies (grey shade = control group, 
yellow line = A 1-cholesteryl spermine carbamate 12.4 pg/ml) show a sub-population M t 
group of FEK4 used in analysis.
To further understand the membrane effect of lipopolyamines, PI uptake studies were 
performed. Figure 4.27 is an example o f the histograms obtained, A 1-cholesteryl spermine 
carbamate at 11 pg/ml (yellow line) shows that the treated cells were more fluorescent and 
the number of Pl-uptake cells was slightly increased, compared to the control group (grey 
shade), indicating the change of membrane permeability. In Figure 4.28, the % Pl-uptaken 
cells mediated by A4^ V9-dioleoylspermine and TV1-cholesteryl spermine carbamate was found 
to be different. The level o f membrane disturbance is highly increased with the vector’s
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concentration, in the case of A1 -cholesteryl spermine carbamate. However, both vectors 
showed less membrane disturbance (less than 10%) than that of polyAPS reference (30%). 
The similar finding in Figure 4.29 showed that A/^A^-dioleoylspermine is less membrane- 
active than Nl -cholesteryl spermine carbamate at all concentrations used. This difference in 
membrane activity of both vectors is not highly noticeable in the FDA leakage assay.
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Figure 4.28 Effect of lipopolyamines on PI uptake in FEK4 cells. PI (10 pg/well) was pre- 
loaded for 30 min in FEK4, and A^A^-dioleoylspermine or A1-cholesteryl spermine 
carbamate was then added. The M2 population (cells with reduced fluorescence) was 
measured by FACS and reported as a percentage (M2 = 0% in control cells with no 
lipopolyamine treatment), (n = 3, error bars are S.D.)
N4,N9-dioleoy!spermine 
N1-cholesteryl sperm ine carbam ate
4 6 8 10
concentration (pg/ml)
Figure 4.29 Mean fluorescence of cells which uptake PI (Ml) after treatment with A^A/9- 
dioleoylspermine and N1 -cholesteryl spermine carbamate. The Ml population was measured 
by FACS for its fluorescence intensity. (Mean fluorescence of Ml = 100% in control cells 
with no lipopolyamine treatment), (n = 3, error bars are S.D.)
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The difference in FDA release and PI uptake assay may be explained by the nature of the test 
design and its sensitivity. Ross and co-workers reported that it is recommended to use FDA 
assay as a first discriminating test, then PI is used as the second test.234 In our studies, FDA 
intensity (PI value, typically in the region of 103-104) and the number of cells (which release 
fluorescein, 20-30%) are higher than those of PI (P3 in the region of 10°-10' and % cell with 
PI at less than 10%). Thus, it is concluded that both A^A^-dioleoylspermine and Nl- 
cholesteryl spermine carbamate are membrane active (according to the FDA assay) and A1- 
cholesteryl spermine carbamate shows superiority in membrane activity. The membrane 
effect of A1-cholesteryl spermine carbamate is in agreement with the work of on hemolytic 
steroidal lipopolyamines by Fujiwara et al.1A In our studies, the selected concentration of A1- 
cholesteryl spermine carbamate used is not in the toxic range. So there is no permanent cell 
break detected as reported in the erythrocyte hemolysis model.74 However, it is expected 
that membrane activity of A1-cholesteryl spermine carbamate must be optimised. As 
previously discussed in the Chapter 2, A1-cholesteryl spermine carbamate shows higher 
toxicity in cells which may also be associated to its higher membrane activity compared to 
A4,A9-dioleoylspermine.
The findings on vector-membrane interaction may be extended to the effects of 
lipopolyamines on endosomal membranes. The liposomal vesicle leakage assay was used as 
a model of endosomal escape in a membrane model used by Behr et al.235 Unilamellar 
liposome (egg phosphatidylcholine (EPC):egg phosphatidylethanolamine 
(EPE):cholesterol:egg sphingomyelin (ESM) = 10:3:5:2 (mole ratio)) at 100 nm, was loaded 
with fluorescent dye (calcein, Figure 4.30) to measure membrane fusion activity of fusogenic 
peptides. However, the FDA release assay we used in our studies is based on the intact 






Even though nuclear membranes236also contain double phospholipid layers, they also 
incorporate more complicated structures than those in cellular and endosomal membranes, 
such as nuclear pore complex, endoplasmic reticulum network, nuclear lamina proteins.
-120-
These proteins and membrane structure are important for a variety of cell functions, 
including nuclear assembly, replication, transcription, and nuclear integrity. More studies 
are needed to apply the lipopolyamine-membrane interactions to the nuclear membrane 
especially any interactions of lipopolyamines and nuclear proteins. This will eventually 
promote the nuclear entry ability of NVGT vectors.
Fluorescent DNA as a tool in NVGT studies
Fluorescent DNA is a useful probe to gain insight in the NVGT process and barriers, such as 
cell entry92,128, intracellular trafficking and nuclear entry.92,128,129 This information is 
important to the development of safe and effective gene delivery vectors. In these 
experiments, pEGFP was covalently labelled with tetramethylrhodamine (TMR) and 5- 
carboxy-X-rhodamine (CXR) by alkylation to nucleic base (guanine) on DNA double helix. 
The labelling protocol is described in the Experimental chapter.
Figure 4.31 (i) Label IT-TM-rhodamine (TMR) and (ii) Label IT CX-rhodamine (CXR)
DNA alkylating reagents shown in Figure 4.31 offer a simple way to label plasmid DNA in 
one step without using enzyme or radioactive probes. Both molecules (Label IT-TM- 
rhodamine (TMR) and Label IT CX-rhodamine (CXR)) contain the aromatic nitrogen
fluorophores allowing the tracking of DNA within cells.237 The base/dye mole ratio obtained 
from UV measurement at 260 and 546 nm (for TMR) or 597 nm (for CXR) was 
approximately 165. Thus, the labelling molecules are present on every 80 base-pairs or 
calculated as 1 % of plasmid bases. The transfection experiments by introducing these
.nCH3COOH
.nCH3COOH
mustard group which bind covalently to the N1 of guanine residues in DNA, and different
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fluorescent plasmids were performed to evaluate the impact of labelled guanine in DNA 
transcription process and to determine the optimal labelling ratio.
Given the high cost of labelling chemical, DNA (1 pg/well) was used in the smaller amount 
than the general FEK4 transfection protocol (2 pg/well). In the previous study regarding the 
dose-response effect of lipoplexes (Chapter 2), the level of gene expression in the low DNA 
scheme is comparable to the standard amount used. The N/P charge ratio 2.0 was chosen in 
these studies due to its high transfection efficiency and safety. Non-labelled plasmid (1 
pg/well) was used as control at same N/P ratio.
FACS analysis of transfected FEK4 with TMR-pEGFP by A^A^-dioleoylspermine were 
operated by using dual emission detection i.e. FI and F2. FI (530 +/- 15 nm) was able to 
detect EGFP, a fluorescent protein decoded from pEGFP. F2 (575 +/-15 nm) was able to 
detect TMR-pEGFP (fluorescent plasmid) at single excitation at 488 nm. Though the of 
TMR is at 546 nm, the fluorescence spectrum obtained with this labelled plasmid shows that 
it is possible to excite TMR at 488 nm to gain emission at 576 nm.
From Table 4.1, it was found that TMR labelled DNA at 1% of plasmid bases appears to 
have no effect to the transfection level. Both intact pEGFP and TMR-pEGFP reached the 
similar transfection efficacy at 20%. However, from the F2 measurement, fluorescence 
intensity at 576 nm (which detect TMR-labelled plasmid) was detected at higher level in 
FEK4 cells transfected with TMR pEGFP (8% difference). This is an evidence of 
intracellular delivery of TMR-labelled DNA into FEK4 cells.
Table 4.1 Gene expression and cellular entry level of TMR-pEGFP in FEK4 using N4^ -  
dioleoylspermine
FEK4 cells sample FI % Transfection efficacy 
at N/P 2.0 (%)
F2%
TMR-pEGFP 1 pg/well 23.25 % 19.08 % 16.66 %
pEGFP 1 pg/well 22.48 % 18.31 % 8.47 %
Figure 4.32, CXR was used to label pEGFP in FEK4 transfection using N \ i V 9 -  
dioleoylspermine. The result of pEGFP expression in both intact and labelled plasmid was 
comparable in both N/P charge ratios. Recently Slattum et a V s research group also reported 
that the covalently labelled plasmids (pCILuc, pEGFP, pEYFP-Nuc) remains expression
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competent.237 Fluorophores and labelling ratio are the key factors contributing to level of 
gene expression. However, gene expression was still remained in highly labelled (50 
label/plasmid), possibly from the transcriptional read-through of the modified bases or repair 
of modified bases.237
100










Figure 4.32 Transfection results of intact pEGFP and CXR-labelled pEGFP in FEK4 using 
A^A^-dioleoylspermine.
It is concluded that covalently fluorescent labelling to DNA provide a safe (non-radiative) 
and convenient way to probe DNA for NVGT research. It can be used as a tracking tool of 
DNA in cells. Additionally TMR and CXR labelled DNA can also be used in fluorescent- 
pair study, or FRET (fluorescence resonance energy transfer). FRET is a technique where 
the energy change of donor-acceptor is measured. For example, fluorescein (donor, which 
may be conjugated to gene vectors) was excited at A^ x = 490 nm), it emits the fluorescence 
(energy) at = 513 nm and this further excite TMR-or CXR-labelled plasmids (acceptor). 
The fluorescence at their respective emission wavelength is then measured, and it is possible 
to derive the distance and interactions of donor (vector) and acceptor (DNA) molecule.195
Fluorescent lipopolyamine synthesis
From our studies, fatty-acid based lipopolyamine was established as an efficient DNA 
condensation agent and in vitro transfecting reagent. Aiming to maintain the DNA- 
condensing properties of A^/v^-dioleoylspermine, the key structures we incorporated in our 
fluorescent lipopolyamine are (1) polycation moiety with two primary amine groups 
maintained at terminal carbon atoms, (3) lipophilic moiety selected from fatty acids with 
C l2-18, and (3) small or no bulky effect from fluorophores. The example of fluorescenct 
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Figure 4.33 Fluorescent lipopolyamines with three major moiety (i) polyamine moiety, (ii) 
lipophilic moiety, and (iii) fluorophore.
The fluorescent probes derived from lipopolyamines are initially designed by conjugating 
fluorophores at fatty acid chain position, and not through the conjugation at the polyamine 
backbone. Unsaturated long-chain fatty acids (to resemble oleoyl chain) with functional 
group (e.g. OH, NH2) would be essential in fluorophore conjugation. Our preferable fatty 
acids should have 12-18 carbons to mimic the fatty acids in cellular membrane phospholipids. 
For example, 12-hydroxy-(c/.s)-9-octadecenoic acid (ricinoleic acid, Figure 4.34) is 
commercially available. However, the fluorophore molecule may provide a bulky-group 
effect to the whole structure so a fatty acid with -OH or -NH2 at the terminal carbon atom is 
more preferable. In our synthetic scheme, 16-hydroxy-7-hexadecenoic acid was chosen for 
the synthesis. It was prepared by the alkaline hydrolysis (saponification) of ambrettolide, as 
shown in Figure 4.35.
Figure 4.34 Ricinoleic acid
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(i) N aO H  (2 eq ), 
pH 11
(ii) HCI (2 eq ), pH 1, 
extract with 
DCM an d  H -O
Figure 4.35 Preparation of Z-16-hydroxy-7-hexadecenoic acid
Considering the problem with bulky effect from fluorophore, a polyamine conjugate with 
only one fatty acid chain with fluorophore is most preferable. Giving this, spermidine 
backbone was chosen in our synthesis, as it provides two primary amine groups and one 
available secondary amine group for conjugation with a fatty acyl moiety. From chemistry 
aspects, fluorophores (examples are shown in Figure 4.36) typically contain OH-reactive or 
NH2-reactive groups, such as thiocyanate, acid chloride, or otherwise -COOH group which 
form amide/ester bond using DCC/HoBt as catalysts. However, most fluorophores are big 
molecules, thus may affect the physico-chemical property of lipopolyamines. A small 
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Figure 4.36 (i) Fluorescein isothiocyanate (FITC), (ii) lissamine rhodamine B sulfonyl 
chloride, and (iii) A-methylanthranilic acid (A-MANT)
Synthetic procedure of fluorescent lipospermidine
Spermidine was used in this experiment, as it supports our designed fluorescent 
lipopolyamine. Similar to the synthesis of A4rA9-dioleoylspermine (Figure 2.3 in Chapter 2), 
spermidine was trifluoroacetylated at A1 and A9 to yield the di-protected spermidine with one 
available amino group at A4. Protected spermidine was then conjugated to Z-16-hydroxy-7- 
hexadecenoic acid, using DCC/HOBt catalysis. In these experiments, FITC and MANT 
were chosen as fluorophores of choices. The synthetic procedure of A4-(16-FTTC-7- 
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Figure 4.37 Synthesis of Af-(16-FITC-7-hexadecenoyl) spermidine
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N*-( 16-FITC-7-hexadecenoyl)-spermidine obtained from this synthesis show the comparable 
fluorescence spectra (A.ex = 492 nm, Aem = 516 nm) to its parent fluorophore (FITC, A,ex = 490 
nm, A-em = 513 nm) as shown below. This shows the lipospermidine moiety do not affect the 
fluorescence of FITC, which is a desirable characteristic of fluorescent lipopolyamines.
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Figure 4.38 Fluorescence spectrum of A^-(16-FITC-7-hexadecenoyl) spermidine in MeOH; 
(blue line) emission spectrum (A,em = 516 nm) and excitation spectrum (A,ex= 492 nm) (slit 
width 5 mm, scan rate 100 nm/min
N*-( 16-MANT-7-hexadecenoeyl) spermidine is another fluorescent lipopolyamine we 
synthesised. V y/V9-Di-trifluoroacetyl-A^4-(16-hydroxy-7-hexadecenoyl)-spermidine was 
prepared in the same way (Figure 4.38). This protected lipospermidine was then conjugated 
to MANT using DCC/HOBt as catalysis. The last stage of deprotection was carried out 





ethyl trifluoroacetate 2 eq




16-hydroxy-7-hexadecenoic acid 1.2 eq, DCC 1.2 eq, 
HOBt 0.5 eq, MeOH, stirring 18 h, 20 °C
F F
NH
° 1 . f
F F
re-dissolved in DCM,
then DCU removed by filtration
+ MANT 1.2 eq, DCC 1.2 eq, HOBt 0.5 eq, 
MeOH, stirring 18 h, 20 °C
NH4OH (pH 11.0)
Figure 4.39 Synthesis of A^-C^-MANT-T-hexadecenoyO-spermidine
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In addition to fluorescent lipospermidines, we also prepared A^A^-di-trifluoroacetyl-Af4-
oleoylspermine which can be used as a starting lipopolyamine (similar to the starting 
spermidine in the previous examples in Figures 4.37 and 4.39) to construct fluorescent 
lipopolyamines.
Figure 4.40 Synthesis of A^A^-di-trifluoroacetyl-A^-oleoylspermine
The synthesis involves a two-step orthogonal protection of amino group of spermine. Firstly, 
spermine was protected by using the selective trifluoroacetylation at Nl and Nn . Diprotected 
spermine was then protected with Boc (Boc:spermine = 1:1 mole ratio) to yield Nl,Nn-di- 






ethyl trifluoroacetate 2 eq
acetonitrile, 80 °C, 18 h
Boc20 (1.2 eq), DCM, stirred 12 h
oleic acid 1.2 eq, DCC 1.2 eq, HOBt 0.5 eq, 
MeOH
F
TFA, DCM, 12 h, then add TEA (pH 9.0)
F
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acid (1 eq of spermine) to yield /V’.A^-di-trifluoroacetyl-A^-Boc-A^-oleoylspermine. 
A^iV^-Di-trifluoroacetyl-A^-oleoylspermine was obtained by Boc removal. The summary of 
this synthesis is shown in Figure 4.40.
This mono-oleoyl spermine can be used as the starting chemical to conjugate with Z-16- 
hydroxy-7-hexadecenoic acid, to obtain the lipospermine with one oleic acyl chain and one 
hydroxyl fatty acyl chain, with the hydroxyl functional group available for fluorophore 
conjugation. This probe will resemble A^A^-dioleoylspermine in the aspects of two lipid 
chains with two terminal primary amino groups. It should occupy a similar 3D shape 
(isosteric) and possess a similar charge pattern (isoelectronic).
Due to time constraints in the project, the evaluation of DNA condensation of two 
fluorescent lipopolyamines, N*-( 16-FTTC-7-hexadecenoyl)-spermidine and A/4-( 16-MANT-7- 
hexadecenoyl)-spermidine, has not been performed. However, fluorescence techniques are 
highly sensitive and it is possible to use these probes at low concentrations. These probes 
may be used as reporting tools in NVGT studies, even if not as a principal DNA delivery 
agent. In the systems to be studied using these probes, the gene vectors of interest should 
play the major role in DNA condensation and delivery into cells. Additionally, the 
transfection experiments were not conducted, as it is not expected that these probes to 
promote or inhibit the DNA delivery at the low concentration as a reporting probe.
Conclusions
The research described in this thesis covers the chemical, biological, and biophysical studies 
of lipopolyamines with respect to their applications in NVGT. A^^-Dioleoyl spermine was 
designed based on tetracationic spermine conjugated to two C18 oleoyl chains which 
resemble both membrane phospholipids (di-fatty acyl glycerol phosphate) and a synthetic 
helper lipid (DOPE - dioleoylphosphatidy 1-choline). N1-Cholesteryl spermine carbamate 
was produced in this work, incorporating cholesterol as the lipophilic moiety. EthBr 
fluorescence quenching assays were used to assess the DNA condensation ability of these 
synthetic lipopolyamine vectors. The DNA binding constants of A^^-dioleoylspermine and 
V1-cholesteryl spermine carbamate were similar to EthBr (Kb = 1 x 107 M'1) and 5-times 
higher than that of (unconjugated) spermine (Kb = 0.2 x 107 M'1). The quality of DNA 
condensation by these vectors is also significantly improved over that of spermine (90% 
reduction of fluorescence) at N/P charge ratios 2.0-2.5. Light scattering assays were used to 
confirm the presence of DNA complexes, apparent absorption being an indication of particle 
formation.
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The gene delivery efficacy of both vectors was studied in primary cells (FEK4) and in a 
carcinoma (HtTA-1 HeLa) cell culture model. These models represent applications in 
corrective and cancer gene therapy. In the transfection experiments using plasmid DNA 
with marker genes (pEGFP and pGL3), both A^^-dioleoylspermine and AT1-cholesteryl 
spermine carbamate were shown to be superior to Lipofectin, a common commercially 
available transfecting cationic lipid. We achieved high levels of transfection in both cell 
lines routinely reaching 60-90% for transfected cells. These are high efficiency values in 
primary cell lines. A1-Cholesteryl spermine carbamate showed higher transfection efficiency 
at higher N/P ratios than A4^-dioleoylspermine. The improvement in vectors resulted from 
the design of molecules incorporating both a polyamine and a lipophilic moiety. Both 
NVGT vectors showed low toxicity (survival greater than 70%) in the MTT cytotoxicity 
assay while maintaining their high transfection efficiency. Excess NVGT vectors in DNA 
complexes are generally known for increased toxicity when used at high N/P charge ratios, 
such as PEI. The uncomplexed form of our lipopolyamines showed no difference in cellular 
toxicity, compared to their lipoplexes when used at the same concentration. In conclusion, 
safe and highly efficient lipopolyamine vectors have been developed for non-viral DNA 
delivery. In particular, the new non-liposomal system with A4,A9-dioleoylspermine has the 
ability to transfect primary skin cells more efficiently than the commercially available 
liposomal Lipofectin. Whilst both our non-liposomal lipopolyamines are efficient at 
transfecting rapidly dividing cancers (HtTA-1 HeLa) cells.
DNA nanoparticle formation, the first important step in NVGT, was studied in detail. In this 
part of the research project, the DNA condensation process was investigated at a single 
nanoparticle (equivalent to a single molecule) level by using the technique of fluorescence 
correlation spectroscopy (FCS). A small fluorescent probe, PicoGreen (PG), was used as a 
reporter to monitor the interactions between the lipopolyamine and the polynucleotide.
We have studied two circular plasmid DNAs (pEGFP and pGL3) and linear DNA (calf- 
thymus DNA) using two lipopolyamines. The FCS confocal volume where DNA complexes 
were detected, was cylindrical in shape and small enough (0.9 ±0.1 femtolitre) with 
dimensions (coi = 0.29 ± 0.05 pm, o>2 = 1.69 ± 0.02 pm) which enabled us to detect a single 
DNA nanoparticle in this study. A4A 9-Dioleoylspermine is able to condense DNA into 
point-like molecules (a fully condensed particle) as shown by determining the particle 
number (PN) value in both DNA models, but A1-cholesteryl spermine carbamate showed 
poorer DNA condensation efficiency at similar N/P charge ratios. Lipid moieties are 
important to the quality of DNA nanoparticles obtained in the DNA condensation process. 
The technique of Time-resolved FCS (TR-FCS) was developed to monitor the dynamics of
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PG in interactions with DNA duplex. These results support the use of PG as a reliable probe 
for the nanoparticle formation process. From the decay kinetics of PG, we are able to 
establish the detailed steps of the fluorescence reporting mechanism of PG during the DNA 
condensation process. These steps are (i) PG-binding to DNA, (ii) PG release due to DNA- 
conformational change, and (iii) PG quenching. A reliable and novel PG-based platform to 
monitor the formation of a single DNA nanoparticle was established and validated, based on 
our understanding of the behaviour of this fluorescent probe.
Studies of the NVGT process, focusing on the cellular membrane barriers in lipopolyamine- 
mediated gene delivery, were performed to gain more insight into cell entry, endosomal 
escape, nuclear entry, and also the cellular toxicity of the vectors. Poly APS, a polymeric 
extract from a marine sponge comprising of C8 -alkylpyridinium monomer, was studied as a 
model of a membrane-active NVGT vector. In DNA condensation studies, polyAPS showed 
the equivalent binding affinity to pEGFP (Kb = 0.2 x 107 M 1) to that of spermine. However, 
polyAPS efficiently and fully condensed DNA with 10% residual fluorescence unlike 
spermine (50% residual fluorescence). This is possibly due to the polymeric nature of 
polyAPS. This novel vector also shows high membrane activity in our studies using 
fluorescein O-diacetate (FDA) release and propidium iodide (PI) uptake assays. PolyAPS 
highly induced pore formation (20-30% compared to 0% in untreated cells) on the 
membrane. This leads to the release of hydrophilic fluorescein (a fluorescent product of 
FDA hydrolysis by cellular esterase) from cells, or the uptake of PI in to cells. The mean 
fluorescence intensity of fluorescein of polyAPS-treated cells was significantly lower (2 
times) from untreated FEK4 cells. In PI studies, the mean fluorescence intensity of PI of 
polyAPS-treated cells was also higher from the control. The results from both assays 
indicate the change in membrane permeability caused by polyAPS.
Lipoplexes prepared from our synthetic vectors gain entry into cells mainly by endocytosis 
(70-90%), thus it is highly possible (30-10%) that both V4,V9-dioleoylspermine and N1 - 
cholesteryl spermine carbamate also interact with membranes by other pathways, possibly 
involving pore formation. Fluorescent dye transport studies showed that both NVGT vectors 
are membrane-active, compared to spermine and comparable to polyAPS. N * jf-  
Dioleoylspermine and V1-cholesteryl spermine carbamate were found to induce pore 
formation (1 0 -2 0 % comparing to 0 % in untreated cells) in a concentration-dependent manner. 
More research on the key moiety responsible for membrane-activity may lead the way to the 
development of membrane-disruptive lipopolyamine vectors, a new sub-class of 
lipopolyamines. This will ultimately enhance the overall efficiency of this novel NVGT 
gene delivery system.
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To better understand the efficiency of each step in non-viral gene delivery, more novel 
tracking molecules are needed. Fluorescent lipospermidine probes were therefore designed 
and synthesized. The aim is to use them as biosensors in gene delivery. Fluorescence 
techniques can potentially play important roles in all areas of NVGT research. Fluorescent 
lipopolyamines are tools enabling the intracellular tracking of DNA complexes to reveal 
(both spectroscopically and microscopically) the key steps and barriers in gene delivery. 
Additionally, the preparation of fluorescent-labelled DNA was also included in the study, 
which we established can be used in transfection without compromising its high efficiency in 
gene expression. Fluorescent labelling of DNA can be used as a complimentary tool with 
lipopolyamine probes for studies of fluorophore-interactions which represent the interaction 
of DNA and its cationic carrier. Advanced fluorescent techniques and their combination 
may be used with these fluorescent tools for future research towards the goals of even more 
efficient NVGT. Designed small molecule probes will play their part in this. The detail of 





General information about materials used in experiments
Equipment used in chemistry experiments
Analytical thin layer chromatography (TLC) was conducted on pre-coated silica gel plates 
(Merck TLC aluminium sheets silica 60 F254). Chromatograms were visualised with UV 
light (254 or 366 nm) or stained with ninhydrin (0.3 % w/v solution in methanol (MeOH)). 
Flash column silica gel was obtained from BDH. Preparative flash column chromatography 
was performed on columns packed with a slurry of silica gel 60 (35-75 pm), either under 
gravity or under pressure with an aquarium-type pump.238 Sand (acid washed) was used to 
cap the column of silica gel, and pre-washed with the solvent used in each separation system.
Infra-red spectra was recorded as a film (liquid sample), or prepared as a slurry with liquid 
paraffin (one drop by using a Pasteur pipette) on a NaCl disc, using a Perkin Elmer Spectrum 
RXI FT-IR spectrophotometer. A JOEL EX400 instrument at 400 MHz was used to record 
*H NMR and 13C NMR spectra. Chemical shifts (8 , in parts per million) are measured by 
reference to tetramethysilane in ‘H NMR spectra and solvent signals in 13C NMR spectra. 
High and low resolution FAB mass spectra (positive ion mode, unless otherwise indicated) 
were measured on a VG AutoSpec Q spectrometer, using m-nitrobenzyl alcohol as the 
matrix.
Semi-preparative RP-HPLC was performed with a Jasco PU-980 pump with either a Jasco 
UV-975 detector or a Water 470 scanning fluorescence detector (Millipore), and a printer 
with chart speed set at 1 cm/min. The stationary phase was a Supelcosil ABZ+ Plus, 5 |im 
(25 cm x 10 mm) column. LC-MS was performed on a Waters Alliance 2790 LC module 
connected to a Waters Micromass ZQ (Waters, UK).
The UV spectrophotometer used in particle light-scattering experiments was a Helios UV 
spectrophotometer. Fluorescence studies were run with Perkin-Elmer Fluorescence 
Spectrophotometer Model LS50B with a 3 ml glass cuvette (1 cm pathlength), slit width set 
at 5 nm, with FLWinLab version 2.00 for data processing.
Equipment used in cell biology experiments
A temperature-controlled flask shaker (New Brunswick Scientific, NY, USA) was used to 
cultivate transformed E. coli for plasmid propagation. Centrifuges used in experiments 
include a Beckmann floor centrifuge model J2-MC (Beckman Coulter, Buckinghamshire, 
UK), a bench-top centrifuge (MicroCentaur MSE, UK), and a cells centrifuge (Falcon 6/300 
MSE Sanyo, UK). Microbial incubation was performed in a temperature-controlled 
incubator (Heraeus Instrument, UK).
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All aseptic techniques for cell culture were carried out in a laminar flow cabinet (Intermed 
MDH Ltd, UK) designed for vertical re-circulation of air. A temperature-controlled 
waterbath (Grant, UK) was used to warm the media used in cell biological studies at 37 °C. 
Cells were cultured in a LEEC PF2 humidified atmosphere at 37 °C with 5% C 0 2 95% air 
(v/v) incubator (Sanyo, Japan). For experiments using low temperature, a refrigerator (Lee, 
UK) with the temperature controlled at 12°C was used without C 0 2 supply. Cells were 
visually assessed daily for evidence of microbial contamination under an inverted light 
microscope (Wilovert, UK).
Biochemical reactions in 96-well plates were generally mixed on a plate shaker (Gyro- 
Rocker STR9, Bibby, UK) and read using a plate-reader, either a Dynatech MR 5000 with 
Biolinx assay software or a VERSAmax™ spectrophotometer. Becton Dickinson FACS 
Vantage dual laser instrument (argon ion laser 488 nm) was used in all FACS experiments.
A TD-20/20 luminometer (Turner Designs, USA) was utilised to measure luminescence.
Disposable items in experiments
Sterile 75 ml and 150 ml top tissue culture flasks were obtained from TPP (Trasadingen, 
Switzerland). Multi-well (6 , 12, and 96 wells) plates and 8 -chamber cuvettes were obtained 
from NUNC (Leicestershire, UK). Plastic plates ( 6  cm diameter), pipettes (5,10, and 25 ml), 
pipette tips and Pasteur pipettes were obtained from Fisher (Leicestershire, UK). 
Cryopreservation ampoules used for storing frozen cells in liquid nitrogen were obtained 
from Coming Ltd. (Leicestershire, UK). Ultracentrifuge tubes were obtained from 
Eppendorf Ltd. (Leicestershire, UK). Polypropylene tubes for a luminometer were obtained 
from Promega (Southampton, UK). Sterile Falcon polypropylene tube (15 and 50 ml) and 
FACS polystyrene test tubes (12 x 75 mm) were obtained from Falcon (Leicestershire, UK).
Chemicals used
Chemicals used in media preparation were all purchased from Gibco (Paisley, UK). 
Ambrettolide was a gift from IFF-Benicario, Spain. PicoGreen was obtained from 
Invitrogen (Paisley, UK). Label IT ® nucleic acid labelling kits were purchased from Mims 
(Madison, USA). Luciferase assay kits were purchased from Promega (Southampton, UK). 
Lipofectin and Lipofectamine were obtained from Invitrogen (Paisley, UK). Other 
chemicals were purchased from Sigma-Aldrich-Fluka (Dorset, UK). All chemicals were 
used without further purification. MilliQ water, which was obtained from a MilliQ PF Plus 
system with ultrafiltration cartridge (Millipore UK, Ltd., Watford, UK), free of DNase and 
RNase, was used in all biological and HPLC experiments. Unless otherwise specified, 
distilled water was used in all other experiments. All organic solvents used were of GPR or
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HPLC grade and purchased from Fisher (Leicestershire, UK). Solvents were evaporated 
using a rotary evaporator (Buchi R411, UK) in a temperature-controlled water bath (Buchi 
B480, UK) under a vacuum system (Vario.PC2001, UK).
Synthesis of A^^-dioleoylspermine
Figure 5.1 A^A^-Dioleoylspermine 
Materials
Spermine, ethyl trifluoroacetate, 1,3-dicyclohexylcarbodiimide (DCC), V-hydroxy- 
benzotriazole (HOBt), oleic acid, and ninhydrin for TLC detection were obtained from 
Sigma-Aldrich (UK). Acetonitrile (MeCN), dichloromethane (DCM), ethyl acetate (EtOAc), 
absolute ethanol (EtOH), and MeOH were purchased from Fisher Chemicals (UK).
Ammonia solution (aq NH4OH, 33% v/v) was from BDH Laboratory (UK).
Preparation of / / ‘./V^-di-trifluoroacetvlspermine
Spermine 1 g (1 eq, 4.94 mmoles) was dissolved in MeCN (15 ml) and treated with 2 eq 
ethyl trifluoroacetate dissolved in MeCN (15 ml). The mixture was then stirred and heated 
under reflux (18 h) at 80 °C. Then, MeCN was removed by evaporation and 
trifluoroacetylated spermine products were washed twice with EtOAc. A pale-yellow 
coloured solid (m.p. 195-198 °C) was obtained after removal of all solvents. 137 The obtained 
sample, when analysed by TLC using MeOH/NH4OH (4/1 v/v), gave Rf = 0.8 which shows 
the increased lipophilicity compared to spermine (Rf = 0.1).
Preparation of Vl.V12-di-trifluoroacetvl-/V4JV9-dioleovl spermine
Protected spermine was dissolved in DCM (5 ml) and MeOH (as needed to dissolve all the 
spermine), then oleic acid (2.2 eq), DCC (2.4 eq), and HOBt (1.0 eq) were added. The 
reaction was carried out at 20 °C with thorough stirring for 18 h. After removal of all the 
solvents, the tetra-amide was re-dissolved in DCM which allowed DCU to precipitate. The 
mixture was filtered to obtain a clear yellow solution. The solution showed Rf = 0.8 when 
analysed by TLC with mobile phase MeOH/NFLOH (4/1 v/v) against oleic acid (Rf = 0.2). 
The TLC plate was then observed under UV for C=C double bond of oleic acid, and then 
derivatised with ninhydrin solution to detect amine groups. The product showed positively 
with both UV and ninhydrin solution (when heated).
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Deprotection of N1 JV12-di-trifluoroacetvl-A/4JV9-dioleovl spermine 
N^^-Di-trifluoroacetyl-A^^-dioleoyl spermine was re-dissolved in EtOH (20 ml) and 
DCM (as needed to dissolve all protected A/^A^-dioleoylspermine). Aq NH4OH was then 
added into the solution to achieve pH 11.0, and left at 20 °C (18 h) with constant stirring.
The final solution was evaporated to remove ammonia and all solvents. Then, the reaction 
products were redissolved in EtOH. Qualitative detection of A^^-dioleoylspermine was by 
using TLC (with CHCla/MeOH/N^OH at 25/10/1 v/v/v) (Rf = 0.24).
Separation of N4 JN^-dioleovlspermine and other byproducts
The ethanolic solution of A^^-dioleoylspermine (and other byproducts) was concentrated to 
2 ml by evaporation. Separation from unwanted compounds (e.g. oleic acid, DCU etc) was 
by column chromatographic elution over flash silica gel with CHClj/MeOH (5/3 v/v) as 
mobile phase. Then, A^A^-dioleoylspermine was collected by eluting with 
CHCls/MeOH/NHjOH (15/10/1 v/v/v). The obtained A^A^-dioleoylspermine sample from 
flash column chromatography was homogenous by TLC (CHCls/MeOH/NHtOH at 25/10/1 
v/v/v) (Rf = 0.24). The obtained yellow oil product displayed FAB+ m/s 731.7149 Da, 
C46H91N4O2 requires 731.7142 (M+H)+. A^^-Dioleoylspermine: NMR inter alia (C2HC13)
8  *H 0.90 (t, 2 x CH3), 1.24-1.70 (br m, many x CH2), 2.03 (apparent quartet, 4 x ally lie CH2), 
3.24-3.48 (br m, many x NCH2), 4.55-5.10 (br s, 2 x NH2), and 5.32-5.41 (m, 2 x CH=CH) 
ppm, 8 13C 130 (2 x CH=CH) and 173 (2 x CON) ppm.
Fluorescent detection of A^jV^dioleovlspermine
Dansyl chloride and triethylamine (TEA) were obtained from Sigma-Aldrich (UK). A4,7V9- 
Dioleoylspermine sample could be derivatized using dansyl chloride as a fluorophore. As a 
non-specific dansylation process, A^^-dioleoylspermine solution (0.2 mmoles 
approximately) was prepared by dissolving in EtOH (2 ml). TEA (1 eq, adjusted to pH 9.0), 
to prevent the formation of dansylic acid, was added to the polyamine solution and mixed 
well. DCM containing dansyl chloride (2.2 eq, 5 ml) was added to polyamine solution. The 
reaction was kept at 70 °C heating oil bath (10 min) or 20 °C in the dark (18 h) . 140,239
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Figure 5.2 Mono-dansylated and di-dansylated products of Af^-dioleoylspermine
HPLC for dansvlated products analysis 
Materials and apparatus
HPLC grade MeOH was purchased from Fisher Chemicals. HPLC pump (Jasco PU-980) 
was used and connected to a fluorimeter detector (Waters 470 scanning fluorescence 
detector, Millipore) and a printer with chart speed at 1 cm/min. From UV and fluorescence 
scanning of samples,240 the detection of samples was performed at 330 nm, Aem 510 nm 
(gain x l, attenuation 16).
Method
Based on Escribano’s protocol with minor modifications, 140 a reverse-phase HPLC column 
(Supercosil ABZ+ Plus 5 pm, 150 x 4.4 mm) was used. The injection volume was 20 pi.
An isocratic solvent system of MeOH/H20  (95/5 v/v) at a flow rate of 1.3 ml/min was used 
for dansylated products resolution. The column was washed using designated solvent for 20 
min or until a stable base line was obtained. The fluorescence emission peak was recorded 
on a chart paper. The first eluted dansylated product had tR at 11 min. The HPLC was run 
for 15 min and MeOH (100%) was pumped through the column at 1.3 ml/min for 1 h until 
all residual samples (typically as a broad peak) are eluted after every injection, for cleaning 
purposes.
HPLC-MS was also performed to determine the number of dansylated groups on A /^V9- 
dioleoylspermine. Supercosil ABZ+ Plus was used as a stationary phase column and 
MeOH/H20  (95/5 v/v, flow rate 1.6 ml/min) were used. CL (M-H)' m/s 962.74 Da (tR = 8.24
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min), C58H101N5O4S requires mass 962 (M-H)' and 1195.16 Da (tR = 12.99 min), 
C7oH112N60 6S2 requires mass 1195 (M-H)'.
Synthesis of A1-cholesteryl spermine carbamate
Figure 5.3 A1-Cholesteryl spermine carbamate
Materials
Spermine, di-tert-buty 1-dicarbonate ((Boc)20), TEA, ethyl trifluoroacetate, and 
trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich, UK. Cholesteryl 
chloroformate was purchased from Fluka, UK. All other solvents used were purchased from 
Fisher, UK.
A'.A^.A^Tri-Boc protection of spermine
Spermine 1 g (5 mmol) was dissolved in MeOH (70 ml), at -78 °C under anhydrous nitrogen. 
Ethyl trifluoroacetate (1 eq) was diluted in 10 ml MeOH to have enough volume to add 
dropwise into spermine solution over 30 min. The the reaction was stirred for another 30 
min and the temperature was then raised to 0 °C to obtain A1 -trifluoroacetyl spermine. Di- 
tert-butyl dicarbonate (excess, 8  eq) was dissolved in MeOH (10 ml), and added dropwise 
over 3 min. The mixture was stirred continuously at 20 °C for 15 h. The trifluoroacetyl 
group was then removed by adding aqueous NH3 (excess) into A'A^A^tri-Boc-A12- 
trifluoroacetyl spermine solution to achieve pH 11. The reaction was stirred for 18 h. The 
mixture was concentrated in vacuo, and the residue purified over silica gel 
(DCM/MeOH/NH3 = 50/10/1 v/v/v) to afford the product as a colourless oil, Rf = 0.6.
Carbamate formation
A'^A^Tri-Boc-spermine was dissolved in DCM ( 8  ml) and then TEA (3 eq) was added. 
Cholesteryl chloroformate (1.2 eq) in 3 ml of DCM (3 ml), was added to the solution over 30 
min dropwise at 0 °C under nitrogen. Stirring was continued for 30 min, then the 
temperature was increased to 20 °C. The reaction was stirred for 12 h, and then the solution 
was concentrated in vacuo. The residue was purified over silica gel (EtOAc/hexane, 4/6 v/v), 
yielding a foam Rf= 0.44.
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Boc removal
To a stirring solution of Boc-protected cholesteryl spermine carbamate dissolved in DCM 
(180 ml) under nitrogen at 25 °C, TFA (20 ml) was added. After 2 h, the solution was 
concentrated in vacuo. The residue was recrystallized in EtOAc to yield the purified white 
solid. The product was homogenous on analysis by TLC in DCM/MeOH/NH3 50/10/1 v/v/v 
and Rf = 0.2. The compound displayed FAB+ m/s 615.5577 Da, C38H7]N40 2 requires 
615.5577 (M+H)+. ]H and 13C NMR spectroscopic data were all superimposable upon 
literature values.69
Plasmid DNA amplification and purification
Plasmid may be isolated by many methods based on the differential denaturation and 
reannealing of plasmid DNA and chromosomal DNA. Alkaline lysis is the commonly used 
technique developed by Bimboim et a/.241 and modifications were made to improve its 
efficiency.242 Firstly, cell lysis was achieved by treating cells with aq NaOH and SDS 
(sodium dodecyl sulfate), followed by neutralization with a high concentration of low pH 
potassium acetate. Bacterial chromosomal DNA and other high molecular weight cellular 
components were selectively precipitated. The plasmid DNA remains in suspension and was 
precipitated with isopropanol. The process can be scaled up from small scale called 
Miniprep (yield less than 20 pg) to larger scale, Maxiprep. The latter provides high yields at 
2-5 mg plasmid DNA per 500 ml of culture.242,243 The DNA obtained can be quantified by 
employing the maximum UV absorption at 260 nm. This wavelength is an average of the 
absorption of the individual nucleotides which vary between 256 and 281 nm. The purity of 
nucleic acids was determined by examining at the maximum wavelength of DNA (260 nm) 
and protein (280 nm). Ratios of A26o/A28o between 1.75 and 1.90 were considered as 
acceptable for quality DNA.141'143
Plasmids used in experiments
pEGFP130 (4.7 kbp) is the plasmid encoding for EGFP, under CMV promoter, obtained from 
Clontech (Oxford, UK). pGL3 control vector133 (5.2 kbp), with SV-40 promoter, encoding 
for modified firefly (Photinus pyralis) luciferase, was purchased from Promega 
(Southampton, UK).
Media used in JM109 culture
LB broth base powder, producing a media formulation (%w/v): 1% tryptone (pancreatic 
digest of casein), 0.5% yeast extract, and 1% NaCl), was used in LB broth and agar 
preparation. LB broth was prepared in a bottle by dissolving LB broth base powder (5 g) in 
MilliQ water (200 ml). LB agar was prepared from LB broth base powder (12.5 g), agar (7.5
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g), and MilliQ water (500 ml). Both LB agar and broth media were autoclaved (121 °C, 15 
lb/inch2) for 30 min before use. After leaving LB agar and broth were cooled down to 40 °C, 
ampicillin solution (0.1 g/ml in MilliQ water, 500 pi) was added in both LB media (500 ml) 
and swirled to attain a homogenous solution. LB broth can be kept at 20 °C with a closed 
cap for one month. For LB agar, media (10 ml) was poured in a 6 cm plate, using aseptic 
techniques. LB agar plate was then left for 45 min until cooler. It was then incubated for 20 
min in a hot room (37 °C) upside down until dry. The solidified agar plate was kept in a cold 
room (4 °C) for use within 3 months of preparation.
E. coli JM 109 transformation and plasmid propagation
Competent E. coli JM109 cells high efficiency (108 cfu/pg) were purchased from Promega 
(Oxford, UK) and used for the propagation of all plasmids. The heat shock technique was 
employed to transform the bacteria. Competent cells were taken from a freezer (-70 °C), and 
warmed on ice until thawed. Temperature was kept at 4 °C. Then, cell suspension (100 pi) 
was transferred into cryotubes (1.5 ml). Plasmid solution (1 pg/ml, 10 pi) was added into 
separate cryotubes containing competent cells and left on ice for 30 min. The tubes were 
transferred to a water bath (43 °C) for exactly 45 s, and placed on ice for 2 min. LB (800 pi) 
was then added into cryotubes and the cell suspension was transferred to a 50 ml Falcon tube. 
The tube with transformed E. coli was finally put on the shaker at 37 °C, 300 rpm for 1.5 h.
Transformed cell suspension (200 pi) was inoculated on a plate with LB-ampicillin agar, and 
kept upside down for 18 h in an incubator (37 °C). Colonies of E. coli carrying the 
appropriate plasmid (i.e. ampicillin-resistant gene), which were able to grow on the plate, 
were used for inoculation. A single E. coli colony was transferred into 2 ml LB broth 
containing ampicillin (100 pg/ml) in a 50 ml Falcon tube. The starter culture was incubated 
for 8 h on a shaker at 37 °C, 300 rpm. The culture was then scaled up by adding the starter 
culture (2 ml) into a flask containing LB broth (250 ml) with ampicillin (100 pg/ml). The 
final culture flask was incubated on a shaker at 37 °C, 300 rpm for 18 h.
Plasmid isolation and purification
The plasmid was isolated and the cell lysate purification protocol was based on the modified 
alkaline lysis method.242 Maxiprep plasmid purification kit, purchased from Qiagen (West 
Sussex, UK) was used in the experiment. The anion-exchange resin for DNA purification 
was employed in this protocol for higher purity of DNA obtained. Positively charged 
diethylaminoethanol (DEAE) resin was used to separate negatively charged phosphate 
groups of DNA, by properly adjusting the NaCl concentration of the elution media. The
-142-
range of 1.2-1.6 M NaCl solution was used to elute DNA, and separate the plasmid from 
other contaminants, especially RNA.
Bacterial culture (250 ml) was transferred into a plastic bottle and cells were harvested by 
centrifugation at 6000 rpm, 4 °C for 15 min in a Beckmann floor centrifuge, using a rotor 
JA-10. Ice-cooled PI buffer (50 mM Tris-Cl, 10 mM EDTA, 100 pg/ml RNase A, pH 8.0) 
(10 ml) was added into the bottle to fully resuspend pelleted cells. P2 lysis buffer (200 mM 
NaOH, 1% w/v sodium dodecyl sulfate) (10 ml) was then added into the cell suspension.
The tube was then inverted gently 4 times and incubated at 20 °C for 5 min. Ice-cooled P3 
neutralisation buffer (3.0 M potassium acetate, pH 5.5) was added into the lysate and the 
mixture was inverted gently 4 times. The lysate was poured into the barrel of the QLAfilter 
cartridge and incubated for 10 min, with the outlet nozzle closed.
Buffer QBT (750 mM NaCl, 50 mM 3-[/V-morpholino]propanesulfonic acid (MOPS), 15% 
v/v isopropanol, 0.15 %v/v Triton ® X-100) (4 ml) was used to equilibrate the HiSpeed 
Maxi Tip (a syringe column with a filtration unit). The column was allowed to empty by 
gravity flow. The outlet nozzle cap of the cartridge was removed and the plunger was gently 
inserted into the cartridge. The filtrate was collected into the Maxi Tip and allowed to filter 
through the resin. Buffer QC (1.0 M NaCl, 50 mM MOPS, 15% v/v isopropanol, pH 7.0)
(60 ml) was added to wash the tip. DNA was entrapped in the resin and all flushed solution 
from filtration was discarded. DNA was eluted from the resin by adding buffer QF (1.25 M 
NaCl, 50 mM Tris-Cl, 15% v/v isopropanol, pH 8.5) (15 ml) into the tip. The eluted solution 
was kept in a 50 ml Falcon tube. Isopropanol (10.5 ml) was added and mixed well to 
precipitate the DNA solution. The resultant mixture was then incubated at 20 °C for 5 min. 
During incubation, QIA precipitator tip (DNA collection unit) was attached to the nozzle of a 
30 ml syringe from which a plunger was removed. The precipitated DNA was added into the 
precipitator unit, and the plunger was inserted into the syringe using constant pressure. DNA 
was entrapped in the precipitator unit and all the flushed solution from the filtration w as. 
discarded. Then, the tip and plunger were removed from the syringe. After that, the tip was 
connected to the syringe nozzle and 70% EtOH (2 ml) was added into the syringe. EtOH 
was pushed by inserting the plunger to the unit with constant pressure, to wash the 
precipitated DNA. Then, DNA was dried by removing the plunger from syringe and pushing 
air through the precipitator 2-3 times. The precipitated DNA remained on a tip was further 
left dried by air on absorbent paper.
Buffer TE (10 mM Tris-Cl, 1 mM EDTA, pH 8.0) (1 ml) was added into the new 5 ml 
syringe of which the nozzle was connected to the precipitator tip. The plunger was pushed
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gently into the syringe barrel. The obtained solution was collected in an ultracentrifuge tube 
(1.5 ml). Then, the tip and plunger were removed from the syringe. The obtained solution 
was then added into the same syringe with a tip connected, to elute the remaining DNA on 
the tip for the second time. The final DNA solution was kept at -20 °C, for further purity and 
quantification.
DNA sample purity and quantification
Plasmid DNA sample (5 pi) was diluted to 1 ml with TE buffer, in a microcuvette. The 
absorbance was measured at 260 nm (A 26o) and 280 nm (A 28o) on a GeneQuan II 
spectrophotometer. TE buffer (5 pi diluted to 1 ml in water) was used as a standard 
reference. The calculation for DNA concentration was determined by the dilution factor (20 
times) and conversion factor (for dsDNA, 50 pg/ml/A260 unit), using the equation:-
DNA (/ig /  ml) =  A260 x  1000 (1)
The absorbance at 260 and at 280 nm was converted into ratios:-
Ratio =  ^ 2 “  (2)
A280
Ratios of A 26o/A 28o obtained from this protocol were checked to ensure that they conformed 
to the acceptable ratio for quality DNA (between 1.75 and 1.90).141'143
Study of lipopolyamine-mediated DNA condensation by ethidium bromide fluorescence 
quenching assay
DNA condensing agents, both polyamines and synthetic lipopolyamines, were used in these 
Ethidium bromide (EthBr) experiments to determine their ability in DNA binding and 
packing.114 In general, the solutions of condensing agents were prepared in 2 different 
strengths, which allow the incremental volume to be added between 2-5 pi during the whole 
experiments. At the higher charge ratio,15’69 the more concentrated solution was used in the 
experiments to maintain the total volume of sample solution (which therefore minimised any 




Figure 5.4 Ethidium bromide 
Polvamine solutions
Spermine solutions were prepared using MilliQ water, at 0.02 and 0.2 pg/pl.
Lipopolvamine solutions
A^A^-Dioleoylspermine was prepared in a solution (2 pg/pl) using absolute EtOH as solvent. 
The working solution at 0.25 and 0.5 pg/pl was prepared by diluting the ethanolic stock 
solution with MilliQ water. Nx-Cholesteryl spermine carbamate was dissolved in MilliQ 
water to prepare solutions at 0.1 and 0.25 pg/pl.
DNA used in experiments
Plasmid DNAs (pEGFP and pGL3) were prepared using MaxiPrep, as noted in the section of 
plasmid preparation. Calf thymus DNA (CT-DNA) was purchased from Sigma-Aldrich 
(UK). All DNA solutions were diluted using TE buffer and their concentrations were 
measured by using a GeneQuant II spectrophotometer. The standard DNA solutions for 
experiments were made at 1 pg/pl.
Buffers used in EthBr quenching experiments
HEPES buffer was made of 2 mM HEPES, 20 mM NaCl, 10 pM EDTA, and MilliQ water. 
Final pH was adjusted to 7.4 with aq NaOH solution. The HEPES buffer was filtered 
through a 0.45 pm membrane prior to use.
Charge ratio calculations
The composition of DNA complexes is related to the net charge of the system and expressed 
as “N/P charge ratio”(N/P = ammonium/phosphate), using this equation:-
pj I p  _  ammonium equivalents o f  the cationic component 
phosphate equivalents o f  the DNA used
Ammonium equivalents of the cationic component were determined from the protonation 
degree (from the pAa of each amino group). In HEPES pH 7.4, spermine (pAa = 10.9, 10.1,
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8.9, 8.1) carries 3.8 ammonium eq/mole. A/^A^-Dioleoylspermine carries 2.0 ammonium 
eq/mole (pATa = 10.9,10.1) and A/1-cholesteryl spermine carbamate (pATa = 10.9, 8.6, 7.3) 
provides 2.4 ammonium eq/mole. The charge number was calculated by using the 
rearranged Henderson-Hasselbach equation (equation (4)). The number of phosphate eq was 
derived from the concentration of DNA measured at 260 nm.
n I
number o f  ammonium eq per  molecule =  (4)
,=i 1 +  10 p  a ‘
Fluorescence measurement
The fluorescence measurement was performed at = 260 nm (excitation through DNA 
bases), Xtrn = 600 nm, using 1 cm pathlength, 3 ml glass cuvette. DNA (1 pg/pl, 6 pi) was 
added into HEPES buffer (3 ml) in a glass cuvette stirred with a micro-flea. Fluorescence 
measurement was performed and regarded as a blank. Immediately prior to analysis, EthBr 
solution (3 pi, 0.5 pg/pl) was added to the DNA solution, stirred for 1 min to equilibrate the 
binding process, before the measurement. Aliquots (4 pi) of polyamines or lipopolyamine 
solutions were added to the stirring DNA solution and the fluorescence measured after 1 min 
equilibration for each incremental volume of DNA condensing agents. The emission 
intensity was reported as the percentage of maximum fluorescence (100%) when DNA was 
fully intercalated by EthBr without the DNA binding agents and corrected for the 
background fluorescence of total EthBr in buffer solution. Fluorescence percentage was 
plotted against N/P charge ratio to obtain the EthBr assay curves for each DNA and DNA 
condensing agents used in the experiments.
For the comparison of indirect excitation with the classical EthBr assay, the DNA 
condensation assay was also performed using the direct excitation of EthBr at A*.x = 546 nm, 
Xem= 600 nm. Only pEGFP condensation by spermine was analysed using this method.
The study on effect of DNA type in DNA condensations was studied using different DNAs 
which are pEGFP, pGL3, and CT-DNA. The EthBr assay protocol as described previously 
was employed. The % fluorescence was plotted against N/P charge ratios to compare their 
EthBr fluorescence quenching profile.
Binding constant estimation
From the EthBr assay curves for each DNA and DNA condensing agent used in the 
experiments, the binding constants of DNA condensing agent (vector) to DNA can be 
estimated and compared by the loss of EthBr fluorescence as a function of DNA condensing 
agent concentration.
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Cain244 established the binding equations of DNA vectors and EthBr binding to DNA as 
described: -
[DNA] + [vec to r]--------------[DNA-vector] (5)
[DNA] + [EthBr] -  ^  [DNA-EthBr] (6)
r. . [DNA -  vector] x [DNA -  EthBr]
From K b(vector) = ------------------------and K b(EthBr) =
[DNA] x  [vector] [DNA]x[EthBr]
a combined equation was expressed as:-
K A vector) =
[DNA — vector] x  [EthBr] x  K b (EthBr) 
[vector] x  [DNA — EthBr]
Morgan152 previously reported the binding constant of EthBr or Kb (EthBr) as to 107 M '\ and 
EthBr was used at 3.8 pM in all experiments. At 50% residual fluorescence, the ratio of 
[DNA-vector] over [DNA-EthBr] is 1. Given DNA used in the experiments was constant at 
6 pM (calculated as mononucleotide concentration), [vector] is equal to N/P multiplied by 
[DNA], Given this, Kb (as ammonium eq) is finally described as the following equation, in 
units of M'1:-
. 3.8X107K Jvec to r ) = --------------  (7)
6 ( N / P ) x 6
Light scattering study of lipopolyamine-DNA complex
DNA condensing agents both polyamines and lipopolyamines were used to form DNA 
complexes, and UV absorbance was measured at 320 nm, as there is absorption interference 
from free DNA. DNA complexes formed in a sample gave scattering of light, and 
“apparent” UV absorbance was increased (i.e. decreased light transmission output).69
Polvamine solutions
Spermine solutions were prepared using MilliQ water, in 0.2 and 2.0 pg/pl.
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Lipopolvamine solutions
A^^-Dioleoylspermine was prepared into a solution (2 pg/pl) using absolute EtOH as 
solvent. ^-Cholesteryl spermine carbamate was dissolved in MilliQ water to prepare 
solutions at 1.0 and 2.5 pg/pl.
DNA used in experiments
Plasmid DNAs (pEGFP and pGL3) were prepared by MaxiPrep, as noted in the section of 
plasmid preparation. Calf thymus DNA was purchased from Sigma-Aldrich (UK). All DNA 
solutions were diluted using TE buffer and their concentrations were measured by using a 
GeneQuant II spectrophotometer. The standard DNA solutions for experiments were 
prepared at 1 pg/pl.
Buffers used in experiments
HEPES buffer was made of 2 mM HEPES, 20 mM NaCl, 10 pM EDTA, and MilliQ water. 
Finally, the pH was adjusted to 7.4 with aq NaOH solution. The HEPES buffer was filtered 
through a 0.45 pm membrane prior to use.
UV absorbance measurement
The UV measurement was performed at XcX = 320 nm, using 1 cm pathlength, 3 ml glass 
cuvette. DNA (1 pg/pl, 60 pi) was added into HEPES buffer (2.94 ml) in a glass cuvette 
stirred with a micro-flea. UV measurement of this DNA-buffer solution was performed and 
adjusted to zero. Aliquots (4 pi) of polyamine or lipopolyamines were added to the stirring 
DNA solution and A32o was measured after 1 min equilibration for each incremental volume 
of DNA condensing agents. The absorbance values were then plotted against N/P ratios. In 
the study on effect of DNA type in DNA condensation, different DNAs (pEGFP, pGL3, and 
CT-DNA) were used in the study. Apparent UV absorbance was plotted against N/P charge 
ratios to compare their UV apparent absorption profile.
Human skin fibroblast (FEK4) transfection
FEK4 cell line was used as a model for human primary cells (mortal cell line). FEK4 is a 
normal human primary skin fibroblast cells derived from a foreskin explant.153 FEK4 cells 
were kindly provided by Professor R.M. Tyrell, Department of Pharmacy and Pharmacology, 
University of Bath, UK.
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Media and buffer used in cell culture
Cells were cultured in Earle’s Minimal Essential Medium (EMEM) supplemented with foetal 
calf serum (FCS) 15% (15% FCS EMEM). Each 500 ml media contains 50 ml EMEM (lOx),
13.5 ml NaHC03 (7.5%), 5 ml D-glutamine (200 mM), 25000IU penicillin G, 25000 pg 
streptomycin, 15% FCS in autoclaved MilliQ water (354 ml). FCS, prior to use, was heat- 
inactivated by putting in the water bath at 56 °C and incubated for 45 min. Phosphate 
buffered saline (PBS) solution was used in all experiments to wash cells, and contains 0.01 
M phosphate buffer, 0.0027 M KC1, and 0.137 M NaCl, pH 7.4, at 25 °C in autoclaved 
MilliQ water. Trypsin was diluted to a working concentration at 0.25% v/v with PBS.
Cell culture
A monolayer of FEK4 cells, at a density of 1 x 106 cells, was grown in a 150 ml flask with 
25 ml of 15% FCS EMEM. The culture was incubated at 37 °C, 5% C 02. The skin 
fibroblasts were passaged twice a week by trypsinization and used between passages 9 and 
16.156
Trvpsinisation technique for subculturing of cell line
The monolayers of cells in a 150 ml flask were rinsed with PBS (10 ml/flask) twice and 
buffer removed by aspiration, then trypsin (0.25%, 3 ml/flask) was added. The flask was 
incubated at 37 °C, 5% C 02 for 10 min, for trypsinisation reaction. The trypsinised cells 
were checked with a microscope to ensure 80% cell detachment, and 15% FCS EMEM was 
added to stop trypsinisation. The cell suspension was then transferred to a 50 ml Falcon tube. 
The cells suspension with known concentration was added to a new flask for next passage at 
1 x 106 cells/flask. When the cells reach passage 17, they were discarded.
Estimation of the cell numbers
A viable count was employed using a haematocytometer slide to determine the concentration 
of cells in a sample. Stained cell suspension was prepared by mixing trypsinised cells (50 pi) 
with nigrosin (50 pi). A cover slip was put over the raised sides of glass chambers (top and 
bottom) on a haematocytometer slide (0.1 mm). The cell sample (20 pi) was loaded into 
each etched glass chamber from the edge of the cover slip until the whole chamber was fully 
loaded. The slide was then placed under an inverted light microscope. Viable cells were 
detected using a bright halo light around their cell membrane, whereas dead cells were 
permeabilised by the dye and stained black. The viable cell numbers in the four squares 
surrounding the central square were counted. The same procedure was repeated for the other 
side of the haemocytometer chamber. The viable cell concentration in the original 
suspension was derived using the equation:-
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, „ . fx total cell counts in A squares , _ 4 
cell number (cells /  ml) = ------------------------------   x  10 (8)
DNA complexing
pEGFP and pGL3 were prepared according to the MaxiPrep plasmid amplification and 
purification protocol. For each well, solutions A (DNA solution) and B (DNA condensing 
agents) were prepared. Solution A was obtained by diluting DNA (2 pg) into Opti-MEM 
medium (serum-free EMEM media, 100 pi) in a sterile 1.5 ml microcentrifuge tube, gently 
mixed using a vortex (2 s) and incubated for 30 min at 20 °C. The transfection agents 
studied in FEK4 transfection include: Iipofectin (DOTMA/DOPE, 1:1 w/w), Lipofectamine 
(DOSPA/DOPE, 3:1 w/w), A^^-dioleoylspermine, and TV1-cholesteryl spermine carbamate, 
each added at different volumes into Opti-MEM medium (100 pi) to achieve the desired N/P 
charge ratio, as described in the N/P determination section of the EthBr assay.15 For 
liposomal transfection agents, DOTMA carries 1 ammonium eq/mole and DOSPA carries 4 
ammonium eq/mole. The obtained solution was briefly vortexed (2 s) and allowed to stand 
at 20 °C for 30 min. Solutions A and B together with a bench top vortex (2 s), were then 
incubated at 20 °C for 20 min for complete DNA complexing.245
The relationship of lipoplex concentration and transfection efficiency was also studied. 
pEGFP (1 pg/well) complexed with A^^-dioleoylspermine at N/P charge ratios 2.0 and 2.5, 
was used in the transfection and compared to lipoplexes formed with pEGFP (2 pg/ml). The 
transfection protocol is described in the next section.
Transfection of adherent cells
In a 6-wells or 35 mm tissue culture plate, 2.5 x 104 cells were seeded in 4 ml of 15% FCS 
EMEM. The cells were incubated at 37 °C, 5% CO2 in a CO2 incubator for 48 h, until the 
cells were 50-70% confluent. Prior to transfection, cells were washed with PBS (2 ml/well) 
twice and Opti-MEM medium (1 ml/well) once. Serum-free Opti-MEM media (800 pi) and 
DNA complex solution (200 pi) were added to each well. For control wells, the DNA 
complex was replaced by Opti-MEM media at the same volume. The transfection process 
was allowed for 4 h in a 37 °C, 5% C 0 2 incubator. After the incubation, the DNA- 
containing medium was replaced with 2 ml of 15% FCS EMEM, then the transfected cells 
were incubated at 37 °C, 5% C 02 for another 44 h.245 Sample preparation and transfection 
efficiency determination are based on the gene expression marker used in the delivered 
plasmid DNA. pEGFP expression assay was carried out by fluorescent-activated cell sorting 
(FACS), while firefly luciferase production from pGL3 transfected cells was determined by 
luminometry.
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In the study on transfectivity of FEK4 cells from different passage numbers, FEK4 from 
passages 13,14, and 15 were chosen. Transfection of pEGFP was performed using A^N9- 
dioleoylspermine at N/P charge ratios 2.0 and 2.5. The transfection protocol was used as 
described previously.
HtTA-1 HeLa cells transfection
Human cervix carcinoma, HeLa derivative and transformed cell line (HtTA-1) was used as a 
model for carcinoma cells (an immortal cell line). The HtTA-1 cells being stably transfected 
with a tetracycline-controlled transactivator (tTA) consisting of the tet repressor fused with 
the activating domain of virion protein 16 of the herpes simplex virus (HSV). HtTA-1 cells 
were kindly provided by Professor R.M. Tyrell, Department of Pharmacy and Pharmacology, 
University of Bath, UK.
Media and buffer used in cell culture
Cells were cultured in Earle’s Minimal Essential Medium (EMEM) supplemented with foetal 
calf serum (FCS) 15% (15% FCS EMEM). Each 500 ml media contains 50 ml EMEM (lOx),
13.5 ml NaHC03 (7.5%), 5 ml L-glutamine (200 mM), 25000IU penicillin G, 25000 pg 
streptomycin, 10% FCS in autoclaved MilliQ water (354 ml). FCS, prior to use, was heat- 
inactivated in a water bath at 56 °C and incubated for 45 min. PBS solution was used in all 
experiments to wash the cells.
Cell culture
HtTA-1 HeLa cells, at a density of 1 x 106 cells, were grown in a 150 ml flask with 25 ml of 
10% FCS EMEM.161,164,165,246 The culture was incubated at 37 °C, 5% C 02. The cells were 
passaged every 3 days. Trypsinised cells were added to the next passage at 1 x 106 
cells/flask. Trypsinisation procedures were carried out using the same protocol for FEK4 
subculturing.
DNA complexing
pEGFP and pGL3 were prepared according to the Maxiprep protocol. For each well, 
prepared the solution A by diluting DNA (2 pg) into Opti-MEM medium (serum-free 
media, 100 pi). The transfection agents studied in FEK4 transfection include Lipofectin 
(DOTMA/DOPE, 1:1 w/w), Upofectamine (DOSPA/DOPE, 3:1 w/w), N*j f -  
dioleoylspermine, and Af1-cholesteryl spermine carbamate each added at different volumes 
into Opti-MEM medium (100 pi) to achieve the desired N/P charge ratio, as described in the 
N/P calculation section of the EthBr assay protocol. Solution B was vortexed for 2 s and left
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at 20 °C for 30 min. Mixed solutions A and B were then vortexed together (2 s), incubated 
at 20 °C for 20 min for complete DNA complexing.245
The study using naked (uncomplexed) DNA was also performed to assess if there was any 
transfection efficiency from this naked DNA system compared to lipoplexes. In each well 
treated with naked DNA, pEGFP 2 pg/well was prepared by adding pEGFP (2 pg) in a 
microcentrifuge tube and adjusted with Opti-MEM media to 200 pi. The same transfection 
protocol as described in the next section was used.
Transfection
In a 6-wells or 35 mm tissue culture plate, 2.5 x 104 cells were seeded in 4 ml of 10% FCS 
EMEM. The cells were incubated at 37 °C, 5% C 02 in a C 02 incubator about 24 h, until the 
cells were 50-70% confluent. The transfection protocol used was the same as in FEK4 cell 
transfection.245 The 48 h post-transfection samples were analysed using FACS (for EGFP) 
or using a luminometer (for luciferase levels).
Fluorescent-activated cell sorting experiments
The fluorescent-activated cell sorting (FACS) technique was used to determine the 
fluorescent molecules (or biomolecules) inside the studied cells. In this study, FACS 
technique was used in pEGFP gene expression and membrane integrity (dye loading) study. 
Becton Dickinson FACS Vantage dual laser instrument (argon ion laser 488 nm, excitation) 
was used in all experiments. Filter lens (F) for emission detection was chosen based on the 
fluorophore. EGFP and fluorescein diacetate (FDA) were detected by FI = 530 ± 15 
nm), while propidium iodide (PI) was monitored by F3 (Xem = 670 nm and higher).
Preparation of cell samples for FACS analysis
The 6-wells plate cells (either transfected or dye-loaded cells) were harvested by washing 
with PBS (1 ml/well, twice) and trypsinisation (trypsin 0.25%, 0.5 ml/well) for 5 min. Cell 
detachment (80%) was then confirmed by light microscopy. The collected trypsinised cells 
were transferred to a FACS tube filled with 2 ml of 15% FCS EMEM. The suspension was 
centrifuged at 1000 rpm, 20 °C for 5 min, and the supernatant was decanted. The pellet was 
resuspended in PBS (1 ml/tube) for further centrifugation at 1000 rpm, 20 °C for 5 min. Cell 
suspension for FACS analysis was obtained by dissolving the pellet in 500 pi PBS/tube. A 
sample with untreated cells was used as a control in the measurement.
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Data analysis
CELLQuest v.1.0 was used for cytometry data acquisition. Either CELLQuest v.1.0 or 
WinMDI was used to analyse FACS data. Only a subset of the data obtained from healthy 
cells data (major population) was analysed through a gate setting. This gating was 
determined from the dot plots between forward-scattered light (FSC) and side-scattered light 
(SSC). FSC is a parameter proportional to cell size and SSC indicates the cell granularity or 
internal complexity. In the histogram of events at different fluorescence intensity control 
group, the fluorescence intensity range (Mi) was set as a constant range throughout the 
experiments. For EGFP detection, the % fluorescence cells sorting events in the established 
range (MO was reported with the correction of the background fluorescence of the control 
sample. The detail on data analysis for FDA and PI assay are described in their respective 
experimental parts.
Bioluminescence assay of luciferase
Luciferase assay kit from Promega was used to evaluate pGL3 transfection in FEK4 and 
HtTA-1 HeLa cells. The luciferase activity was reported in RLU (relative luminescence 
units) and was normalised for the amount of cellular protein, which was analysed using the 
Bradford assay.
Cell lvsates preparation
15% FCS EMEM media was removed from a 6-wells plate containing transfected FEK4 or 
HtTA-1 HeLa cells with pGL3. The attached cells were rinsed with PBS (1 ml/well). The 
equilibrated IX reporter lysis buffer at 20 °C (250 (ll/well) was added to cover the cells 
thoroughly. The culture plate was rocked on a shaker for 20 min at 20 °C. The 6-well plate 
with lysed cells was put in a freezer (-70 °C) for 20 min, and then taken out to settle at 20 °C, 
for complete lysis. The attached cells were scraped from the well using a scraper, then 
transferred to microcentrifuge tubes (1.5 ml size) and placed on ice. The tubes were 
vortexed for 10-15 s and centrifuged at 12,000 x g for 2 min (at 4 °C). The supernatant was 
collected in a new tube and stored at -70 °C for luminometric analysis.133,247
Luminescence analysis
Luciferase assay reagent (100 pl/tube), which contains luciferin as a substrate and coenzyme 
A as a catalyst, was dispensed into a luminometer tube. The luminometer was programmed 
at 2 s measurement delay and 10 s measurement read. The cell lysate obtained was added 
into a luminometer tube containing assay reagent. The solution tube was vortexed for 2 s 
and then immediately placed in the luminometer for reading records, using a tube filled with 
only assay reagent as a control.247 The RLU obtained was calculated in RLU/protein (mg).
-153-
Protein assay (Bradford’s assay")
A protein calculation standard curve was prepared by a Bradford reaction of standard bovine 
serum albumin (BSA) at different amounts. BSA (1 mg/ml) at 0 ,1 , 2, 3,4, 5, 6, and 7 |ig 
was added to each standard well in a 96-well plate. Then, Bradford reagent (Brilliant BlueG 
in phosphoric acid and MeOH) (250 pi) was added into each BSA concentration.
Autoclaved MilliQ water was added to make 260 pi volume in total. The cell lysate samples 
(5 pi), Bradford reagent (250 pi), and autoclaved water (5 pi) were added into the sample 
wells. The plate with standard and sample mixtures was rocked for 30 s and incubated at 20 
°C for 5 min which allows protein-dye complex to be formed. The absorbance of each well 
was recorded by a 96-well plate reader at 595 nm.248 The standard curve was plotted and 
protein amounts in the cell lysates were calculated using Biolinx software.
Toxicity assessment of DNA condensing agents by MTT assay 
M i l '  assay is a colorimetric assay to evaluate the ability of viable cells to covert a soluble 
tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, (MTT)] into 
an insoluble formazan crystal. This assay is used to determine the cytotoxic effects of 
lipopolyamines and lipoplexes (pEGFP complexes).
Lipopolvamine solutions
A^jA^-Dioleoylspermine was prepared in a solution (2 pg/pl) using absolute EtOH as solvent. 
The stock solution was diluted with MilliQ water to obtain a solution (1 pg/pl). N1- 
Cholesteryl spermine carbamate was dissolved in MilliQ water to prepare a solution at 1.0 
pg/pl. The stock solution was used at different volumes, to achieve the various 
concentrations, and diluted with Opti-MEM to a total volume of 100 pl/well.
Lipoplex solutions
A^A^-Dioleoyl spermine and A1-cholesteryl spermine carbamate were complexed with 
pEGFP (0.2 pg/well) to achieve the different N/P ratios (range from 0-20), by preparing 
solutions A and B in the similar way as the transfection protocol. For each well, solution A 
was prepared by dilution of pEGFP (0.2 pg) in Opti-MEM medium(50 pi), then the solution 
was vortexed (2 s) and left at 20 °C for 30 min. DNA condensing agents (A^^-dioleoyl 
spermine and A1-cholesteryl spermine carbamate) were added into Opti-MEM media (50 
pl/well) to attain solution B at the desired N/P ratios. Solution B was then vortexed (2 s) and 
left at 20 °C for 30 min. Solutions A and B were mixed and vortexed together (2 s), and then 
incubated at 20 °C for 20 min for complete DNA complexing.
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Cell culture and sample loading
FEK4 and HtTA-1 HeLa cells were seeded in 96-well plates at 8000 cells/well and incubated 
for 24 h at 37 °C in 5% C 02, to achieve 50% confluence. Lipopolyamine or lipoplex 
solutions at different concentrations (100 pi) were loaded into each well (n = 3 wells/sample). 
In the study of lipopolyamine toxicity, Opti-MEM (100 pi) was used as a control. DNA 
solution (100 pi) (pEGFP 0.2 pg in Opti-MEM, without DNA condensing agents) was used 
as a control for the study of lipoplex toxicity. The plate was then incubated at 37 °C in 5% 
C 02 for 4 h. After cells were exposed with lipopolyamine and lipoplex for 4 h, medium was 
aspirated out and replaced with 15% FCS EMEM (for FEK4) or 10% FCS EMEM (for 
HtTA-1 HeLa) (100 pi). The plate was put back in an incubator 37 °C in 5% C 02for a 
further 39 h. After incubation, sterile filtered MTT solution (5 pg/pl) (10 pi) was added into 
each well and the 96-well plate was further incubated at 37 °C in 5% C 02for 5 h.
UV measurement of M 'lT product
After incubation (total time 48 h), the media and the unreacted dye were aspirated and the 
formed blue formazan crystals were dissolved in 200 pl/well of dimethyl sulfoxide (DMSO), 
and the blue solutions was pipetted up and down to ensure the complete dissolution of 
crystalline product. The produced colour was measured using a plate-reader at X = 550 nm. 
The % viability41 was calculated by the following equation:-
% cell viability =
f A^^sample  ^
y A 550control
xlOO (9)
General information on FCS experiments
PicoGreen concentration determination
PicoGreen (PG) is patented, and its concentration was not provided by Molecular Probes 
(USA). Diluted PG solution absorbance was measured with a UV spectrophotometer at 500 
nm. The molar concentration was then calculated by using the molar absorptivity from the 
literature (70,000 M 1 cm'1 at 500 nm).185 The PG solution supplied by Molecular Probes 
was found to be 220 pM and therefore its 1/200 dilution (i.e. at the recommended dilution by 
the company) is 1.1 pM.
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Figure 5.5 PicoGreen
DNA sample preparation and quantification
pGL3 DNA (5.3 kbp) was purchased from Promega UK. and pEGFP (4.7 kbp), obtained 
from Clontech. Both plasmids were amplified and purified by MaxiPrep kit (Qiagen UK.) 
and confirmed by gel electrophoresis for these experiments. Calf thymus DNA (minimum 
size 13 kbp) was purchased from Sigma-Aldrich (UK). Each DNA sample was dissolved in 
HEPES buffer and stored at -80 °C. For quantification of DNA, a 5 pi sample was diluted to 
1 ml with water and the UV absorbance measured at 260 nm and 280 nm on a GeneQuan II 
spectrophotometer. TE buffer (5 pi diluted to 1 ml in water) was used as a standard 
reference. The A260/A280 ratio was calculated to analyze the purity of the DNA. 141,142
ConfoCor instrument setup
FCS was performed on a ConfoCor® 1 (Carl Zeiss Jena, Germany). ConfoCor 1 is a PC- 
controlled fluorescence correlation-adapted AXIOVERT 135 TV microscope, equipped with 
an x-y-z adjustable pinhole, avalanche Photodiode SPCM-200-PQ, ALV-hardware correlator 
and CCD camera. The ArMaser beam (excitation wavelength 514 nm, excitation intensity: 1 
mW) was focused by using a water-immersion microscope objective at an open focal light 
cell. The same objective, a dichroic mirror, proper bandpass filters, and a pinhole in the 
image space block collected fluorescent light. The volume of the confocal excitation 
element, calibrated with Alexa488 or Rhodamine6 G, was determined to be about 1 
femtolitre (0.9 ± 0.1 femtolitre).
Studies of DNA binding of PicoGreen using FCS
A DNA sample for measurement (1 nM DNA, 200 pi) was loaded into one of an 8 -chamber 
cover glasses (NUNC®) with the glass bottom facing the ConfoCor water-immersion 
microscope objective. A small volume of PG (1:200 v/v dilution in HEPES buffer) was 
added stepwise into the DNA solution and incubated for 10 min before recording the 
fluctuation signal (30 s/time, 20 times/measurement). A calibration curve of DNA
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intercalation by PG was then prepared to determine the optimal dye/kbp ratio for FCS 
experiment.
Studies of lipopolyamine-mediated DNA condensation using FCS
A DNA sample for measurement (1 nM DNA, 200 jil) was loaded into one of an 8-chamber 
cover glasses, followed by the addition of PG at the optimal dye/kbp ratio. After 10 min 
incubation, the DNA solution was titrated by DNA condensing agents. FCS reading was 
also recorded (30 s/time, 20 times/measurement).
FCS data analysis
FCS analysis was processed using the ConfoCor® II software. The fluorescence intensity 
signal /(t) fluctuating around a temporal average [I(t) = < I(t) > + 8 1(t)] was processed with a 
digital hardware correlator interface yielding the normalized autocorrelation function or G(t). 
This function is expressed as:-
(10)
Assuming small point-like non-interacting molecules freely diffusing in a space much larger 
than the detection volume, showing up only triplet state dynamics, G(r) takes the form:-
G(t ) = 1 + (l -  7" + Te~TlT"
i  Y  v
, 1/2
P N [1 - r ]  j ^ l  + (t / td ) Jt l + (t / td \ o)x / (O>2)
( 11)
where T is a triplet fraction, xtr is a triplet decay time, PN is the apparent particle number, rD 
is a diffusion time, and a>i and co2 are the lateral and axial radii of detection volume. The 
shape of the confocal volume for calculation purposes was assumed to be a cylinder, based 
on a special optical situation where the pinhole diameter and/or the objective lens were 
adjusted, and this volume (V) is V = 7tcoi2(2cD2). The derivation of equations for the applied 
models makes use of the natural laws applied in classical methods of perturbation kinetics as 
the only difference is in the source of fluctuations. The parameters td and PN are related 
with macroscopic values of concentration c, and the rate of diffusion, called the diffusion 
constant179 or diffusion coefficient (D)170 via:-
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(12)
and P N  = cna% (13)
The diffusion coefficient (D) for spherically symmetric molecules is related to the 
hydrodynamic radius rh via the Einstein-Stokes equation:-
d = ^  = _ m _  ( 1 .
4 rD Jjr„
where kB is the Boltzmann constant, here T  is thermodynamic temperature, rf is dynamic 
viscosity, and rh is hydrodynamic radius. The hydrodynamic radius can be calculated from 
molecular mass M  using: -
where p is the mean density of the molecule and NA is Avogadro’s number.
The translational diffusion coefficient (D) depends largely on the shape of the molecule. For 
rod-like molecules, such as a DNA, D can be estimated as:-
D = M  b T  (16)
i i c t j L
where L corresponds to the length of the rod (for a DNA it is the rise per base-pair (0.34 nm) 
multiplied by the number of base-pairs), d is a diameter of the rod (2.38 nm for DNA), and A 
represents a correction factor:-
(15)
A  = \n (L /d )+ 0 .312  + 0.565/ (L /d ) -  0. l /  {L/d f (17)
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This shows that the diffusion coefficient (D) of a 1000 bp DNA is approximately 5-times 
smaller and xD 5-times larger for a rod-like shaped molecule than for a spherical one.
Time-resolved fluorescence correlation spectroscopy
ConfoCor and Time-correlated single photon counting (TCSPC) apparatus setup205 
FCS was performed on a ConfoCor®l (Carl Zeiss Jena, Germany). ConfoCorl is a PC- 
controlled fluorescence correlation-adapted AXIOVERT 135 TV microscope, equipped with 
an x-y-z adjustable pinhole, avalanche Photodiode SPCM-200-PQ, ALV-hardware correlator, 
and CCD camera.
PicoQuant laser-head emitting beam (excitation wavelength 470 nm, excitation intensity:
0.97 mW, repetition rate: 40 MHz) was focused by a water-immersion microscope objective 
at an open focal light cell. Pinhole adjustment was performed by using Alexa488 (100 nM) 
(20 pi) dissolved in MQ water (500 pi). The same objective, a dichroic mirror, proper 
bandpass filters, and a pinhole in the image space-block collected fluorescent light. This 
laser head was driven from a single PDL800-D driver, which provides electrical pulses 
synchronous with light pulses (SYNC signal) necessary for TCSPC data acquisition.
For TR-FCS measurement, the SPCM-200-PQ was replaced by a Perkin-Elmer SPCM- 
AQR-13-FC single photon avalanche diode (SPAD), to allow the fast electrical response to 
photon impact required by time-correlated single photon counting (TCSPC). The FWHM of 
the final instrument response function (IRF) is 450 ps. PicoQuant TimeHarp 200 TCSPC 
board with dedicated software (MicroTime200) was placed in a PCI slot of a separated PC 
with fast processor, from the hardware autocorrelator PC. The SPAD output was fed directly 
to the Time-Harp's START input through a 20 dB inline rf attenuator.
Alexa488, at concentration approximately 0.4 nM, was added into one chamber of an 
8-chambers cuvette to determine the volume of the confocal excitation element. As typically 
observed in classical FCS, excitation volume was determined to be about 1 femtolitre (0.9 ± 
0.1 femtolitre).
TCSPC acquisition analysis
PG calibration assay and DNA condensation were performed using the same protocol as the 
classical FCS. The data acquisition mode is called time-tagged time-resolved (TTTR) mode. 
The photon events were recorded individually without on-line data reduction (which was 
typically performed by the autocorrelator). Three pieces of information were gathered for all 
photons and stored as one photo record: (a) timing between the excitation pulse and
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fluorescence photon detection (35 ps resolution), (b) coarsely tagged-timing (100 ns 
resolution) in relation to the start time of experiment, and (c) routing bits which were 
generated simultaneously to identify the actual detector channel.
Multiple-exponential decay model was used to derive the lifetime of each fluorescent species 
being monitored. TTTR data were processed by using MicroTime200 software. The decay 
is expressed as:-
7 (0  = ar, * exp (-t / r ,  ) (18)
i= 1
where I(t) = intensity of fluorescence at time t, or, = amplitude of the components at time 
zero, n = number of lifetimes, and x,= lifetime (the average amount of time a fluorophore 
remains in the excited state following excitation). The decay kinetic was calculated using 
tail-fitting mode with constant range of channel time. Decay model was fit-tested by using 
F-statistics, and calculated^ should be around 1.0.
Fractional intensities, a value to indicate the fraction of fluorescent species with different 
lifetimes, were obtained by amplitude-weighted formula and 'L f  was normalized to unity:-
cxf.
f i  a
i=i
For double-exponential decay, average lifetime ( T ) was expressed as:-
-  a.T,2 + a2r 2
t  =  —  LJ-  =  / , « , + / 2« 2 (20)
FCS data analysis
FCS analysis was processed using the time-tagged TTTR data. Time-gating is employed to 
reject scattered light or background noise. Statistical filters are derived from the difference 
of fluorescent species “decay curves”.249 The fluorescence intensity signal 7(t) fluctuating 
around a temporal average [I(t) = <I(t)> + & I(t)] was processed through filters to yield the 
normalized autocorrelation function, G(x). Other FCS parameters were calculated in a 
similar manner as the classical FCS.
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FEK4 and HtTA-1 HeLa transfection at 12 °C
Transfection protocols used were modified from the standard transfection at 37 °C. The 
processes of endocytosis are temperature dependent as temperature affects both rate of 
ligand binding and mobility of ligand-receptor complexes in membranes. Endocytosis 
processes are usually blocked at temperatures below 12 °C. This transfection experiment at 
low temperature was chosen to study the effect of ATP-dependent processes in gene delivery. 
Lipopolyamines and liposomal NVGT vectors (Lipofectin and Lipofectamine) were used in 
these pEGFP delivery experiments.
Buffer medium used during the 12 °C incubation
HEPES-NaCl buffer is a NaCl-based extracellular solution used in all incubations at 12 °C. 
This buffer was prepared from 130 mM NaCl, 3.0 mM KC1, 2.0 mM CaCl2, 0.6 mM MgCl2, 
1.0 mM NaHC03, 10.0 mM HEPES, and 5.0 mM glucose in autoclaved MilliQ water. The
pH and osmolarity of extracellular solutions were adjusted to 7.4 and 310-320 mOsmol/1 
with aq NaOH and sucrose respectively.
DNA complexing
DNA complex solution for each well was prepared from solution A and solution B. For 
solution A, pEGFP (2 pg/well) was diluted to 100 pi with Opti-MEM medium (serum-free 
media). Solution B was prepared from various DNA condensing agents: N4^ 9- 
dioleoylspermine, N1-cholesteryl spermine carbamate, Lipofectin, and Lipofectamine, which 
were diluted to 100 pi with Opti-MEM medium. Each solution was vortexed (2 s) and left at 
20 °C for 30 min. Solutions A and B were then mixed together by vortexing (2 s), and then 
incubated at 20 °C for 20 min for complete DNA complexing.
Transfection
In 6-well tissue culture plates, FEK4 or HtTA-1 (2.5 x 104 cells/ml) were seeded in 15%
FCS EMEM (4 ml, for FEK4) or 10% FCS EMEM (4 ml, for HtTA-1) respectively. The 
cells were incubated at 37 °C with 5% C02 in an incubator for 24 h, until the cells were 50 -  
70% confluent. Media was then removed and cells were washed with PBS (2 ml/well) twice 
and HEPES-NaCl buffer (1 ml/well) once. Ice cool HEPES-NaCl buffer was then added 
(800 pl/well). The 6-well plates were pre-cooled by placing in a temperature-controlled 
refrigerator for 10 min before the transfection. The DNA complexes solution (200 pl/well) 
was then added, and cells were incubated at 12 °C in the refrigerator for 4 h. After the 
incubation, the DNA-containing medium was replaced with 15% FCS EMEM (2 ml, for 
FEK4) or 10% FCS EMEM (2 ml, for HtTA-1), then the transfected cells were incubated at
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37 °C, 5% C02 for another 44 h. The 48 h post-transfection samples were analysed using 
FACS for EGFP level.
DNA condensation studies of polyalkylpyridinium salt
Materials
Polyalkylpyridinium salt (PolyAPS) solutions (0.1 and 0.25 ug/pl) were prepared in MilliQ 
water. Plasmid DNAs (pEGFP and pGL3) were prepared using MaxiPrep, as noted in the 
section on plasmid preparation. Calf thymus DNA was purchased from Sigma-Aldrich (UK). 
All DNA solutions were diluted using TE buffer and their concentrations were measured by 
using a GeneQuant II spectrophotometer. The standard DNA solution for experiments was 1 
pg/pl.
N/P charge ratio was calculated using equation (3). PolyAPS (pyridinium) carries 1 
ammonium eq/monomer. The number of phosphates was derived from the concentration of 
DNA measured at 260 nm.
Buffers used in experiments
HEPES buffer was made of 2 mM HEPES, 20 mM NaCl, 10 pM EDTA, and MilliQ water. 
The final pH was adjusted to 7.4 with aq NaOH solution. The HEPES buffer was filtered 
through a 0.45 pm membrane prior to use.
Fluorescence measurement
The fluorescence measurement was performed at A«x = 260 nm (excitation through DNA 
bases), A«m= 600 nm, using 1 cm pathlength, 3 ml glass cuvette. DNA (1 pg/pl, 6 pi) was 
added into HEPES buffer (3 ml) in a glass cuvette stirred with a micro-flea. Fluorescence 
measurement was performed as a blank. Immediately prior to analysis, EthBr solution (3 pi, 
0.5 pg/pl) was added to the DNA solution, stirred for 1 min to equilibrate the binding before 
measurement. Aliquots of poly APS solutions were added to the stirred DNA solution and 
the fluorescence measured after 1 min equilibration for each incremental volume of DNA 
condensing agents. EthBr fluorescence quenching was plotted as explained in the previous 
Experimental - DNA condensation studies using lipopolyamines. Binding constant 
estimation was calculated for its approximate value using equation (7).
Light scattering study of DNA complexed with polyAPS
Polvamine solutions
Polyalkylpyridinium salt (PolyAPS) solutions (1.0 and 2.5 pg/pl) were prepared in MilliQ 
water.
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DNA used in experiments
Plasmid DNAs (pEGFP and pGL3) were prepared by MaxiPrep, as noted in the section on 
plasmid preparation. Calf thymus DNA was purchased from Sigma-Aldrich (UK). All DNA 
solutions were diluted using TE buffer and their concentrations were measured by using 
GeneQuant II spectrophotometer. The standard DNA solutions for experiments were made 
at 1 ixg/jxl-
Buffers used in experiments
HEPES buffer was made of 2 mM HEPES, 20 mM NaCl, 10 pM EDTA and MilliQ water. 
The final pH was adjusted to 7.4 with aq NaOH solution. The HEPES buffer was filtered 
through a 0.45 pm membrane prior to use.
UV absorbance measurement
The UV measurement was performed at A*x = 320 nm, using 1 cm pathlength, 3 ml glass 
cuvette. DNA (1 pg/pl, 60 pi) was added into HEPES buffer (2.94 ml) in a glass cuvette 
stirred with a micro-flea. UV measurement of this DNA-buffer solution was performed and 
adjusted to zero. Aliquots (4 pi) of polyamine or lipopolyamine solutions were added to the 
stirring DNA solution and A32o was measured after 1 min equilibration for each incremental 
volume of DNA condensing agent. The absorbance values were then plotted against N/P 
ratios.
Fluorescein O-diacetate release assay of polyAPS
Fluorescein O-diacetate (FDA) is a non-fluorescent dye which readily diffuses through intact 
cells. FDA undergoes hydrolysis by cellular esterase into fluorescein which is hydrophilic 
and non-permeant. The cellular retention of FDA is compromised in cells with disrupted 
membrane. Lipopolyamines and pore-forming PolyAPS were studied using this FDA assay, 
to determine their interaction with membranes which may play important roles in facilitating 





Polyalkylpyridinium salt (PolyAPS) solution (0.2 pg/pl) was prepared in MilliQ water. This 
compound with known pore-forming activity was used as a positive control in the
215-217experiments.
Cell culture and sample loading
FEK4 cells (1 x 105 cells/well) were seeded in 6-well plates and 15% FCS EMEM media (4 
ml) was added. The cell cultures were incubated at 37 °C, 5% C02 for 24 h, to obtain 70% 
confluence. Opti-MEM without PR is a media formulation containing minimum essential 
amino acids, but without serum and no added phenol red (PR), was only used. This was the 
media used in the dye loading stage. 15% FCS EMEM media was aspirated out and replaced 
with Opti-MEM without PR (799 pl/well) and FDA solution (in DMSO, 10 pg/pl) was 
added at 1 pl/well. The blank well was filled with only Opti-MEM without PR (800 pi).
The 6-well plates were then rocked for 1 min to ensure thorough mixing. Then the plates 
with FDA-loaded cells were incubated at 37 °C, 5% C02 for 30 min.
After FDA was fully uptaken into cells, a stock solution of PolyAPS (5 pi) was added to 
obtain a final concentration of 1 pg/pl, and the total volume was also adjusted to 1 ml with 
Opti-MEM without PR. For negative control wells, only Opti-MEM without PR (200 pi) 
was added. The 6-well plates were then rocked for 1 min to ensure thorough mixing. The 
plates were incubated for another 30 min, and the total time of incubation is 1 h.
FACS analysis of samples
After incubation, cell samples were prepared by following the protocol described in the 
FACS experimental section. The samples were analysed by FACS using an FI filter, 
compared to the control.
Data analysis
CELLQuest v.1.0 was used for cytometry data acquisition. Either CELLQuest v.1.0 or 
WinMDI was used to analyse FACS data. Only a subset of healthy cells data (major 
population) was analysed through a gate setting. In the histogram of events at different 
fluorescence intensity control group, the highly FDA fluorescence intensity range (Mi) was 
set as a constant range throughout the experiments. Mean intensity of fluorescent cells (M0 
in each sample ( F san ip ie )  was compared to the mean fluorescence of control tubes (F c o n tr o l) -  
The relative FDA fluorescence in percentage was calculated from the equation:-
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The % fluorescent cells in the established range (M2) was reported. The M2 sub-population 
is a group of cells with fluorescent intensity less the mean value of Mi population, which 
represents cells with fluorescein leakage.
Propidium iodide uptake assay of polyAPS
Propidium iodide (PI) is a fluorescent dye which intercalates between nucleic bases of 
nuclear DNA. Due to its hydrophilicity, PI is not able to diffuse through intact cell 
membranes. The cellular uptake of PI is compromised in cells with disrupted membranes. 
Lipopolyamines and pore-forming PolyAPS were studied using this PI assay, to determine 
their interaction with membranes which may play important roles in facilitating gene 
delivery. The primary cell line, FEK4 was chosen as a model for the membrane integrity 
study.
Figure 5.7 Propidium iodide 
PolyAPS solution
PolyAPS solution (0.2 pg/pl) was prepared in MilliQ water. This compound with known 
pore-forming activity was used as a positive control in the experiments.215' 217
Cell culture and sample loading
FEK4 cells (1 x 105 cells/well) were seeded in 6 -well plates and 15% FCS EMEM media (4 
ml) was added. The cell cultures were incubated at 37 °C, 5% C 0 2 for 24 h, to obtain 70% 
confluence. Similar to the FDA release assay, only Opti-MEM without PR was used to 
avoid any interference from PR. 15% FCS EMEM media was aspirated out and replaced 
with Opti-MEM without PR (900 pl/well) and PI solution (in MilliQ water, 10 pg/pl) was 
added at 2 pl/well. The blank well was filled with only Opti-MEM without PR (1 ml).
Fluorescent cells (FDA release) (%) = %M 2 . -  %M  2sample control (22)
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A stock solution of polyAPS (5 jil) was added to obtain the final concentration of 1 pg/|il, 
and the total volume was also adjusted to 1 ml with Opti-MEM without PR. For control 
wells, there is no polyAPS added and .the total volume was also adjusted to 1 ml with Opti- 
MEM without PR. The 6-well plates were then rocked for 1 min to ensure thorough mixing. 
Then the plates with Pi-loaded cells were incubated at 37 °C, 5% C 02 for 60 min.
FACS analysis of samples
After incubation, cell samples were prepared by following the protocol described in the 
FACS experimental section. The samples were analysed by FACS using an F3 filter, 
compared to control cells and polyAPS-added cells.
Data analysis
CELLQuest v.1.0 was used for cytometry data acquisition. Either CELLQuest v.1.0 or 
WinMDI was used to analyse FACS data. Only a subset of healthy cells data (major 
population) was analysed through a gate setting. In the histogram of events at different 
fluorescence intensity control group, the PI fluorescence intensity range (Mi) was set as a 
constant range throughout the experiments. The number of positive cells and their 
fluorescence intensity were analysed, by removing the background fluorescence from control 
samples (Pi-only treated cells). The mean intensity of fluorescent cells in each sample 
(Fsampie) was compared to the mean fluorescence of control tubes (F comroi)- The relative PI 
fluorescence in percentage was calculated from the equation:-
P l fluorescence  (%) =
( p  ^sample
F\  control y
xlO O  (23)
The % fluorescent cells in the established range (Mi) was also reported, which represents 
cells which uptake PI.
Fluorescent cells (P I uptake) (%) = % M lsample -  % M ^control (24)
Membrane integrity study of spermine and oleic acid
Spermine solution was prepared in MilliQ water at 1 |ig/|il. Spermine was used at 2 pl/well 
to achieve the final concentration of 2 pg/ml. Oleic acid solution was prepared in absolute 
EtOH at 10 p.g/|il and used at 20 jil/well, to achieve the final concentration 200 jig/ml. FDA 
release and PI uptake assays were performed, by employing the same protocol as described 
in the section of polyAPS-membrane interaction study. In both FDA and PI assays, 
spermine and oleic acid solutions were added at different volume to achieve the desired
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concentration, and the total volume was adjusted to 1 ml/well with Opti-MEM without PR. 
The procedure on FACS analysis and data treatment was the same as previously described in 
the section of polyAPS’s membrane study.
Membrane integrity study of synthetic lipopolyamines
A^^-Dioleoylspermine was prepared in a solution (2 pg/pl) using absolute EtOH as the 
solvent. The stock solution was diluted with MilliQ water to obtain a solution (1 pg/pl). N 1- 
Cholesteryl spermine carbamate was dissolved in MilliQ water to prepare a 1.0 pg/pl. 
solution. FDA release and PI uptake assays were performed, by employing the same 
protocol as described in the section of polyAPS-membrane interaction study. In both FDA 
and PI assays, lipopolyamine solutions were added at different volume to achieve the desired 
concentration, and the total volume was adjusted to 1 ml/well with Opti-MEM without PR. 
The concentration of lipopolyamines used in the studies is in the range of 0-13 pg/ml. The 
procedure on FACS analysis and data treatment was the same as previously described in the 
section of polyAPS’s membrane study.
Fluorescent labelling of plasmid DNA
Fluorescent probes based on DNA alkylating agents (Label IT ®) were utilised to label 
plasmid DNA for same transfection studies. This method provides higher efficiency in 
labelling than the enzymatic process using “labelled nucleotide” (i.e. nick translation). The 
DNA was covalently labelled at guanine nucleotide bases, thus it is suitable to use as a probe 
or marker in transfection studies. Label IT® nucleic acid labelling kits, i.e. tetramethyl- 
rhodamine (TMR), MIR 4125 (A^ x 546 nm, Xem516 nm) and 5-carboxy-X-rhodamine (CXR), 
MIR3125 (A«x 576 nm, A*m597 nm) were used to label both pGL3 and pEGFP.
Labelling reaction
Reconstitution solution (DMSO, 25 pi) was added into labelling reagent pellet (in an 
ultracentrifuge tube) to obtain the final labelling reagent. This reagent was thoroughly 
mixed by vigorous pipetting up and down. The labelling reaction was performed by adding 
MilliQ water (35 pi), lOx labelling buffer A (200 mM MOPS, pH 7.5,5 pi), plasmid DNA 
(1 mg/ml, 5 pi) and labelling reagent (5 pi) into a microcentrifuge tube, then incubated at 37 
°C for 1 h. The reaction mixture should be quickly vortexed (2 s) after 30 min of incubation 
to minimise the effect of evaporation and change in concentration. Unreacted labelling 
reagent was removed from the labelled plasmid by EtOH precipitation.250
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Labelled DNA purification bv EtOH precipitation
NaCl solution (3M, 5 pi) and ice cold 100% EtOH (100 |Lil) were added to the reaction (50 
jllI ) ,  mixed and placed in a -20 °C (or colder) freezer for 15 min. The reaction 
microcentrifuge tube was centrifuged at full speed (13000 rpm) for 30 min to obtain the 
pellet of labelled DNA. The pellet was carefully collected by EtOH removal, and washed 
with 70% EtOH (30 pi) without disturbing the pellet. The labelled DNA was centrifuged at 
full speed (13000 rpm, 10 min) and all traces of EtOH were removed with a micropipette. 
TE buffer (50 pi) was added to redissolve the labelled DNA.250 The final DNA solution was 
stored at -20 °C until use.
Labelling ratio determination
Labelled DNA was measured for UV absorbance at A 260 nm (A26o) and at Aex of labelling 
agents (Adye) respectively in a microcuvette (1.5 ml). As dyes used in the experiment may 
also absorb UV at 260 nm, the corrected A26o value (Adna base) must be obtained by using the 
dyes’ correction factor (C.F.) and the following equation:-
AD N A  base =  “^ 2 6 0  _  (A fy e  X  ^ ' ^ ' 2 6 0  )  ( ^ 5 )
given C.F.260 for TMR and CXR is 0.27 and 0 (negligible) respectively. The labelling ratio, 
expressed in dye/kbp, was calculated from the equation:-
dye /kbp  = dye
y  A q n A base X  ^  dye J
x(1.32xl07) (26)
given £dye(TMR) and £dye(cxR) are 100,000 and 82,000 M^cm'1 respectively.250
Human skin fibroblast (FEK4) cells transfection with labelled DNA
Transfection protocols used were the same as described earlier. Fluorescent tagged plasmids 
were used to determine their ability in transfection efficacy and applicability as NVGT 
probes.
Fluorescent DNA
pEGFP was labelled with TMR and CXR Label IT® as mentioned in the DNA labelling 
section, using the DNA/dye reagent volume ratio =1:1. Non-labelled plasmids were used as 
controls at the same N/P ratio.
-168-
DNA complexing
For each well, solution A was prepared by diluting fluorescent plasmid DNA (1 pg/well) 
into 100 pi Opti-MEM medium, then the solution was vortexed (2 s) and left at 20 °C for 30 
min. A^A^-Dioleoylspermine was added at different volumes into 100 pi Opti-MEM 
medium to achieve the desired N/P ratio, vortexed (2 s) and left at 20 °C for 30 min. 
Solutions A and B were then vortexed together for 2 s, and then incubated at 20 °C for 20 
min for complete DNA complexing.245
Transfection
In 6 -well or 35 mm tissue culture plates, 2.5 x 104 cells were seeded in 4 ml of 15% FCS 
EMEM (for FEK4). The cells were incubated at 37 °C, 5% C 0 2 in a C 0 2 incubator about 24 
h, until the cells were 50-70% confluent. The 48 h post-transfection samples were analysed 
by FACS (for EGFP) or using a luminometer (for luciferase levels).
Synthesis of fluorescent lipospermidine
Materials
Spermidine, Boc20 , TEA, ethyl trifluoroacetate, /V-methylanthranilic acid (MANT), and 
fluorescein isothiocyanate (FITC) were purchased from Sigma-Aldrich, UK. Ambrettolide 
was given as a gift from IFF, Spain. All other solvents used were from Fisher, UK.
Preparation of 16-hvdroxv-7-hexadecenoic acid
o
Figure 5.8 16-Hydroxy-7-hexadecenoic acid
Ambrettolide (1 eq, 1 g) was dissolved in MeOH (10 ml). NaOH (2 eq, 317 mg) was 
dissolved in MeOH (50 ml) and the solution was heated if necessary to ensure full solubility. 
This methanolic NaOH solution was added to the ambrettolide solution and the mixture (pH 
11) was stirred (2 h) at 20 °C. The reaction solution was then put in an ice bath, and adjusted 
to pH 1.0 (HC1) to convert the product salt into the desired protonated carboxylic acid 
alcohol. The solution was extracted using DCM (3 x 40 ml). The DCM layer (lower layer) 
was collected and concentrated in vacuo. The sample, when analysed by TLC using 
EtOAc/hexane (4/6 v/v), give a single spot Rf = 0.4 by UV. An additional signal at 3417 
cm' 1 was found in the IR spectrum, indicating the presence of an alcohol functional group. 
The obtained colourless oil product displayed FAB' m/s 269.2 Da, C |6H30O3 requires 269 
(M-H)'. Mass peak at 252.4 (starting material lactone) was not found in the mass spectrum.
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Preparation of Afl./V9-di-trifluoroacetvlspermidine
Spermidine 1 g (1 eq, 6 . 8 8  mmoles) was dissolved in MeOH (15 ml) and treated with 2 eq 
ethyl trifluoroacetate dissolved in MeOH (15 ml). The mixture was then stirred (18 h) at 20 
°C. Then, MeOH was removed in vacuo and a colourless oil was obtained. 137 TLC analysis 
using DCM/MeOH/NH3 (25/10/1 v/v/v), Rf = 0.14, showing the increased lipophilicity 
compared to spermidine which was immobile and stayed at the baseline. FAB+ m/s 338.1 
Da, CnHnFftNsOj requires 338 (M+H)+.
Preparation of N1./V9-di-trifluoroacetvl-yV4-n6-hvdroxv-7-hexadecenovl)-spermidine 
/V'^-Di-trifluoroacetylspermidine (1 eq, 450 mg) was dissolved in DCM (5 ml) and MeOH 
(as needed to dissolve the starting material), then 16-hydroxy-7-hexadecenoic acid (1.2 eq), 
DCC (1.2 eq), and HOBt (0.5 eq) were added. The reaction was carried out at 20 °C with 
thorough stirring for 18 h. After concentration in vacuo, the tri-amide was re-dissolved in 
DCM so that DCU was precipitated. The mixture was filtered to obtain a clear yellow 
solution, which was concentrated in vacuo. The residue was purified by flash silica gel 
column chromatography, using DCM/MeOH/NH3 (60/10/1 v/v/v). The fraction with TLC Rf 
= 0.50 DCM/MeOH/NH3 (60/10/1 v/v/v) was collected. The obtained yellow oil product 
(540 mg, 69% yield) displayed FAB+ m/s 590.0 Da, C27H45F6N30 4 requires 590 (M+H)+.











Al,/V9-Di-trifluoroacetyl-/V4-(16-hydroxy-7-hexadecenoyl)-spermidine (1 eq, 100 mg) was 
dissolved in anhydrous DMSO (10 ml). FTTC (1.1 eq, 72 mg) was added, and stirred at 
20 °C (2 h) in the dark. Aq NH4OH was then added to pH 11.0, and stirred at 20 °C (36 h) in 
the dark. The solution was then concentrated in vacuo. The residue was redissolved in 
MeOH and purified by flash silica gel column chromatography, using DCM/MeOH (25/10 
v/v). The fraction with Rf = 0.33 on TLC in DCM/MeOH (25/10 v/v) was collected. The 
obtained brown solid product (56 mg, 42% yield) displayed FAB+ m/s 827.4 Da (M+K)+ (?) 
and 865.3 Da (M-H+2K)+(?), and requires 787 (M+H)+. In the MS spectral
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data, the observed (M+K)+ and (M-H+2K)+ were found at 10% relative intensity each with 





yV1,N9-Di-trifluoroacetyl-A^4-(16-hydroxy-7-hexadecenoyl)-spermidine (1 eq, 100 mg) was 
dissolved in MeOH (10 ml). MANT (1.2 eq, 31 mg), DCC (1.2 eq, 206 mg), and HOBt (0.5 
eq, 135 mg) were added to the solution, and stirred for 18 h at 20 °C in the dark. Directly, 
the two trifluoroacetyl protecting groups were removed by treatment with aq NH4OH (to pH 
11.0), and stirred at 20 °C (36 h) in the dark. The solution was then concentrated in vacuo. 
The residue was redissolved in MeOH and purified by flash silica gel column 
chromatography, using DCM/MeOH (25/10 v/v). The fraction with Rf = 0.43 on TLC in 
DCM/MeOH/NH3 (25/10/1 v/v/v) mobile phase was collected, which showed two close 
spots. HPLC-Fluorescence detection (Supercosil ABZ+ Plus) eluting with MeOH/H20  
80/20 (v/v) (1 ml/min) was used to resolve this mixed fraction. A single peak (A*x 368 nm, 
X«m 437 nm) was eluted with tR 2 min (no starting material MANT peak at tR 4.2 min was 
found). N*-( 16-MANT-7-hexadecenoyl)-spermidine: NMR inter alia (C2H30 2H) 8  'H 1.24-
1.70 (br m, many x CH2), 1.99 (apparent quartet, 2 x allylic CH2), 3.28-3.56 (br m, 2 x NCH2 
and OCH2), 5.37-5.42 (m, CH=CH), and 7.29-7.78 (m, 4 x CH aromatic) ppm. The FAB 
mass spectral data showed the MANT fatty acid ester, but also spermidine, and no mass ion 
for the desired product was observed.
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Synthesis of V'A^-di-trifluoroacetyl-A^-oleoylspermine
Figure 5.11 A/^A^-Di-trifluoroacetyl-A^-oleoylspermine 
Materials
Spermine, ethyl trifluoroacetate, DCC, HOBt, oleic acid, TFA, and ninhydrin for TLC 
detection were obtained from Sigma-Aldrich (UK). MeCN, DCM, EtOAc, and MeOH were 
purchased from Fisher Chemicals. Ammonia solution (aq NH4OH, 33% v/v) was from BDH 
Laboratory (UK).
Preparation of N1,N12-di-trifIuoroacetvlspermine
Spermine 1 g (1 eq, 4.94 mmoles) was dissolved in MeCN (15 ml) and treated with 2 eq 
ethyl trifluoroacetate dissolved in MeCN (15 ml). The mixture was then stirred and heated 
under reflux (18 h) at 80 °C. Then, MeCN was removed by evaporation in vacuo and 
trifluoroacetylated spermine products were washed twice with EtOAc. A pale-yellow 
coloured solid (m.p. 195-198 °C) was obtained after concentration in vacuo.131 The obtained 
sample, when analysed by TLC using MeOH/NH4OH (4/1 v/v), gave Rf = 0.8 showed 
increased lipophilicity compared to spermine (Rf = 0.1).
Preparation of N1.N12-di-trifluoroacetvl-7V4-Boc-spermine
Di-tert-butyl dicarbonate (1.2 eq, in 10 ml MeOH) was added to A^A^-ditrifluoroacetyl 
spermine (440 mg, 1 eq) dropwise over 3 min. The mixture was stirred at 20 °C for 4 h. 
MeOH was then evaporated in vacuo and the residue was purified by silica-gel 
chromatography using DCM/MeOH/NH3 (75/10/1 v/v/v) (Rf = 0.7) to afford the desired 
orthogonally protected spermine (410 mg, 74% yield).
Preparation of iV1.yV12-di-trifluoroacetvl-7V4-Boc-/V9-oleovlspermine 
A'.A^-Di-trifluoroacetyl-A^-Boc-spermine (1 eq, 84 mg) was dissolved in MeOH (10 ml). 
Oleic acid (1.2 eq, 54 mg), DCC (1.2 eq, 40 mg), and HOBt (0.5 eq, 25 mg) were added to 
the solution, and stirred for 18 h at 20 °C. The solution was concentrated in vacuo, and 
redissolved in DCM (10 ml). The precipitate of DCU was removed by filtration to yield a 
yellow solution which was taken directly into the final deprotection step.
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Boc removal
To a stirred solution of /V^^-di-trifluoroacetyl-A^-Boc-A^-oleoylspermine in DCM (180 ml) 
under nitrogen at 25 °C, TFA (20 ml) was added. After 2 h, the solution was concentrated in 
vacuo. The residue was purified by silica-gel chromatography using DCM/MeOH/NH3 
(60/10/1 v/v/v). The yellow semi-solid product was analysed by TLC in DCM/MeOH/NH3 
60/10/1 v/v/v and Rf = 0.5. The desired product (40 mg, 36% yield) N l,Nn-di- 
trifluoroacetyl-A^-Boc-A^-oleoylspermine displayed FAB' m/s 656.3 Da, C32H56F6N4 0 3 
(M-H)' requires mass 657.
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Purpose. T o study the effect o f  synthesized 7V4,N 9-d ioleoyl sperm ine on D N A  condensation and then  
m easure its transfection efficiency in cell culture.
Methods. T he lipopolyam inc was synthesized from the naturally occurring polyam inc sperm ine. T he  
ability o f this novel com pound to  condense D N A  was studied using cthidium  brom ide fluorescence  
quenching and light scattering assays. Transfection efficiency was studied in primary skin cells (F EK 4) 
and in an im m ortalized cancer cell line (H tT A ), and com pared with the com m ercially available  
transfection form ulations L ipofcctin  and Lipofectam ine.
Results. T he synthesized /V4,/Vy-diolcoyl sperm ine form ula is efficient at condensing calf thym us and 
circular plasmid D N A  and effectively  transfects both primary skin cells and cancer cell lines at low  
charge ratios o f  ( + / -  am m onium /phosphate) 2.5.
Conclusions. N 4,N 9-D ioleoy l sperm ine condenses D N A  and achieves high transfection levels in 
cultured cells.
KEY WORDS: FEK4; gene delivery; lipopolyam inc; A 4JV9-diolcoyl spermine; transfection.
INTRODUCTION
It is widely believed that gene therapy will become an 
efficient medicine for the treatment of diseases such as 
cancer, cystic fibrosis and for vaccination. The essential 
requirements for gene delivery are the transport of DNA 
through the cell membrane and ultimately to the nucleus. 
The design of an efficient formula for the delivery of genetic 
material requires a detailed understanding of the mechanism 
of gene delivery to the nucleus. Different strategies have 
been used for the delivery of genetic material into target 
cells, classified as viral or non-viral delivery systems (1-3). 
Viral delivery systems depend on the development of 
genetically-modified viruses to utilize their capability of 
efficiently delivering DNA into cells without their pathogenic 
characteristics (3). Although high efficiency is achieved by 
viral vectors, there are concerns about their use which 
include: a limit in the size of the DNA delivered (the 
“payload”), endogenous viral recombination, unexpected 
anti-vector immune response, and oncogene activation
1 D epartm ent o f Pharmacy and Pharm acology, U niversity o f  Bath, 
Bath B A 2  7A Y , U nited  Kingdom.
2 T o  w hom  correspondence should be addressed, (e-m ail: prsisb@  
bath.ac.uk)
A B B R E V IA T IO N S: D C C , d icy c lo h ex y lca rb o d iim id e; D O G S ,
dioctadecylam idoglycylsperm ine; D O S P E R , 1,3 -d io leoy loxy-2-(6 -  
carb oxysp erm in e; E G F P , enhan ced  green  flu orescen t protein; 
E M E M , E a r le ’s m in im al e ssen tia l m edium ; E thB r, eth id iu m
bromide; FCS, fetal calf serum: H O B l, hydroxybenzotriazole; NPC, 
nuclear pore com plex; PEI, polyethylenim ine; PLL, poly-L-lysine.
(4-7). Since the design and formulation of Lipofectin by 
Feigner and co-workers, reported in 1987 (8), the focus on 
nonviral vectors for DNA delivery has shown a remarkable 
increase worldwide (9-15).
Efficient nonviral formulation should be able to deliver 
safely the required DNA across the various cellular barriers 
to the nucleus. These barriers that hinder the delivery of 
DNA to its physical site of action (the nucleus) have been 
summarized in Fig. 1. They include complex formation 
between the DNA and cationic lipid or polymer that leads 
to condensation of DNA into nanoparticles. Cell-membrane 
entry is thought to be mediated by cationic substances, which 
interact with the DNA payload, and can then cause 
adsorptive endocytosis and internalization of the complex. 
Also, the lipid moiety in cationic lipids interacts with the 
phospholipid bilayer of the cell membrane that facilitates cell 
entry. The internalized material is fused with early endo- 
some. That leads to sorting to the late endosomal compart­
ment, at this stage the DNA complex should escape the 
endosomal vesicle before the later stage of the lysosome 
where the DNA will be degraded. After endosomal escape, 
the DNA (either complexed or dissociated from the con­
densing agent) should find its way to the nucleus and cross 
the nuclear membrane which is thought to occur through the 
nuclear pore complex (NPC) or by direct association with the 
chromatin during mitosis. After nuclear entry, the payload 
DNA should successfully be able to give the desired protein 
through the processes of transcription and translation.
For drug formulators, it is difficult to deliver a drug 
molecule of 3.3 kDa molecular weight carrying 10 negative 
charges, but in the case of the (prodrug) DNA, a 5 kbp
0724-8741/05/0600-0972/0 &  2005 Springer Science + Business Media. Inc. 972
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Fig. 1. Steps in the process o f  nonviral gene therapy by endocytosis show ing the barriers for D N A  
nanoparticles, from the form ation o f the D N A -polycation  com plex (condensed D N A  particles) to  
protein  synthesis.
plasmid has a molecular weight of about 3.3 megadaltons and 
carries 10,000 negative charges. So the first key step in gene 
formulation is DNA condensation into a nanoparticle form 
through masking the negative charges of the phosphate 
backbone which causes alleviation of charge repulsion 
between remote phosphates on the DNA helix leading to 
collapse into a more compact structure (2,16). The impor­
tance of DNA condensation is attributed to the correlation of 
the transfection efficiency with the formation of DNA 
nanoparticles that are essential for the delivery of DNA 
through the cell membrane (16-20).
Cationic lipids are considered to be the major gene 
carriers among the non-viral delivery systems. They have the 
ability to condense DNA into particles that can be readily 
endocytosed by cultured cells, and facilitate endosomal 
escape leading to efficient delivery to the nucleus (21). They 
can be classified as liposomal and non-liposomal nonviral 
delivery vectors. Liposomal delivery vectors usually contain 
two types of lipids, a cationic lipid (positively charged 
amphiphile) for DNA condensation and cellular membrane 
interaction, and a neutral helper lipid (phospholipid), most 
use dioleoylphosphatidyl-ethanolamine (DOPE) (Fig. 2) to 
increase transfection efficiency as it has a membrane fusion 
promoting ability (8,22,23). Nonliposomal cationic-lipid de­
livery vectors combine both the characteristics of cationic 
and helper lipids.
The synthesis of the lipopolyamine dioctadecylamido- 
glycylspermine (DOGS) by Behr and co-workers (24) as a 
promising transfecting agent, encouraged several laboratories 
to focus on the synthesis of novel cationic lipids based on the 
naturally occurring polyamine spermine, for example, 
RPR120535 (25) and l,3-dioleoyloxy-2-(6-carboxyspermine) 
DOSPER (26) (Fig. 2). The design of a novel lipopolyamine 
formula for DNA condensation and cellular delivery relies 
on previous and continuing studies of the structure-activity
relationships of DNA binding and condensation by poly­
amines (16,27-30). Although lipopolyamines are less efficient 
in comparison with viral vectors, their promising lower 
toxicity than viral vectors ensures a continuous effort to 
design novel lipopolyamines with improved transfection 
efficiency. In this study, we synthesized and formulated a 
novel lipospermine in which the tetra-amine spermine (the 
cationic moiety) and dioleoyl chains (the lipophilic moiety) 
that is reported to improve the transfection efficiency by 
fusion with cellular membrane (31). These unsaturated chains 
are linked by amide bonds at the secondary amino groups of 
spermine to form A4,A9-dioleoyl spermine (commercially 
available as LipoGen) (32). These amide linkers have the 
advantages of being both biodegradable and less toxic than 
the ether bonds in DOTMA (33,34). The ability of this 
synthetic lipopolyamine to condense DNA was studied using 
ethidium bromide (EthBr) fluorescence quenching and light 
scattering assays. Transfection efficiency was studied in an 
immortalized cancer cell line (HtTA), and in primary skin 
cells (FEK4) for the first time. The difficulties found in 
efficiently transfecting primary cell lines were largely 
overcome with this nonliposomal formulation comprising a 
vector with two covalently bound oleoyl chains. The results 
are compared with two commercially available (liposomal) 
transfection formulations, Lipofectin® and Lipofectamine 
that incorporate such oleoyl or oleyl (Cl 8) chains.
MATERIALS AND METHODS
Materials
Chemicals, including polyamines spermine, polyethyle- 
nimine (PEI), and poly-L-lysine (PLL), reagents, solvents, 
buffers, and DNA were routinely purchased from Sigma- 
Aldrich, UK, except where indicated. Lipofectin and Lipo-
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Fig. 2. C hem ical structures o f sperm ine, PEI, PLL, D O P E , D O T M A , and sperm ine based lipopolyam ines.
fectamine reagents from Invitrogen (Life Technologies 
Gibco BRL) and cell cultures materials from Life Technol­
ogies (Paisley, Scotland).
Synthesis of A 4JV9-Dioleoyl Spermine
Spermine was used as the starting material for the syn­
thesis process (35), outlined in Fig. 3. Spermine was protected 
on the primary amino functional groups with ethyl trifluoro- 
acetate (2.2 eq) in methanol and the reaction mixture was 
stirred for 18 h at 25°C. The solvent was evaporated to 
dryness in vacuo to form A^.A /^-ditrifluoroacetyl-l,^- 
diam ino-4.9-diazadodecane. D icyclohexylcarbodiim ide 
(DCC, 2.5 eq), 1-hydroxybenzotriazole (HOBt, 0.2 eq) and 
oleic acid (2.2 eq) were added to the diprotected spermine 
solution in CH2C12 and methanol (1:1). The solution was 
stirred for 18 h at 25°C. The solvent was evaporated to
dryness in vacuo. The residue was dissolved in CH2C12 and 
the solution filtered and evaporated to dryness in vacuo to 
form A^A^-dioleoyl-TV1 ,iV12-ditrifluoroacetyl-l ,12-diamino- 
4,9-diazadodecane. For the removal of the di-trifluoroacetyl 
groups, the tetra-amide was dissolved in methanol and the 
pH of the solution was increased by saturating with ammonia 
gas, then it was left (18 h) and evaporated to dryness in 
vacuo to give a residue which was purified over silica gel 
(CH2Cl2-MeOH 5:3 v/v, then CH2Cl2-MeOH-conc. aq. NH3 
25:10:1 v/v/v) to afford /V4,/V9-dioleoyl spermine R f 0.3 
(CH2Cl2-MeOH-conc. aq. NH3 25:10:1 v/v/v).
Amplification and Purification of Plasmid DNA (pEGFP)
DNA plasmid encoding enhanced green fluorescent 
protein (pEGFP) purchased from Clontech was transformed 
into Escherichia coli JM 109 bacterial strain (Promega). The
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Fig. 3. Synthesis o f  JV^A^-dioleoyl sperm ine.
transformed cells were grown in larger quantities of Luria- 
Bertani (LB) broth supplemented with 125 mg/L ampicillin. 
pEGFP plasmid was produced in large-scale using HiSpeed 
plasmid purification Maxi kit (Qiagen) according to the 
manufacturers protocol. DNA yields and purity were deter­
mined spectroscopically (OD26o/OD28o = 1-80 to 1.90 OD, 
optical density) and by agarose gel (1% agarose) analysis.
Ethidium Bromide Fluorescence Quenching Assay
Each concentration of the DNA stock solutions (ap­
proximately 1 pg/pl, 1 ml) was determined spectroscopically 
(Milton Roy Spectronic 601 spectrometer, 1 cm path length, 
3 ml cuvette) (2) and 6 pg (approximately 6 pi) of DNA was 
diluted to 3 ml with buffer (20 mM NaCl, 2 mM HEPES, 
10 pM EDTA, pH 7.4) in a glass cuvette stirred with a micro­
flea. Immediately prior to analysis, EthBr solution (3 pi, 
0.5 mg/ml) was added to the stirring solution and allowed to 
equilibrate for 10 min. Separately for each polyamine or 
lipopolyamine (spermine, poly-L-lysine (average molecular 
weight 9600 Da, PLL 9.6k), polyethylenimine (average 
m olecular weight 2000 Da, PEI 2K), A4,jV9-dioleoyl 
spermine, Lipofectin, and Lipofectamine) aliquots (5 pi, 
according to the ammonium/phosphate (+ /-)  charge ratio 
required) were then added to the stirring solution and the 
fluorescence measured after 1 min equilibration using 
Perkin-Elmer LS 50B luminescent spectrometer (XeXCit = 260 
nm and Xemiss = 600 nm with slit width 5 nm) while stirring 
using an electronic stirrer (Rank Bros. Ltd.) (36). The total 
polyamine solution added to the DNA solution did not 
exceed 5% of the total volume of the solution, so no cor­
rection was made for sample dilution. The fluorescence was 
expressed as the percentage of the maximum fluorescence
when EthBr was bound to the DNA in the absence of 
competition for binding and was corrected for background 
fluorescence of free EthBr in solution.
Light Scattering Assay
DNA (60 pg, 60 pi of 1 mg/ml solution) was diluted to 
3 ml with HEPES buffer (2 mM HEPES, 20 mM NaCl, 
10 pM EDTA, pH 7.4) in a cuvette with a micro-flea, and the 
concentration determined spectroscopically (Milton Roy 
Spectronic 601 spectrometer, 1 cm path length, 3 ml cuvette). 
Then aliquots (5 pi, according to the ammonium/phosphate 
(+ /-)  charge ratio) of the tested polyamines were then added 
to the stirring solution and the absorbance (light scattering) 
at 320 nm was measured after 1 min stirring to allow the 
mixture to reach equilibrium. The increase in absorbance due 
to the scattered light was expressed as the percentage of rel­
ative maximum apparent absorbance (% rel. max. app. abs.) 
due to light scattering of the bound polyamine with DNA.
Cell Culture and Transfection Experiments
Two cell lines were used in the transfection experiment, 
a human primary skin fibroblast cells FEK4 (37) derived 
from a foreskin explant and a human cervix carcinoma, HeLa 
derivative and transformed cell line (HtTA). The HtTA cells 
being stably transfected with a tetracycline-controlled trans­
activator (tTA) consisting of the tet repressor fused with the 
activating domain of virion protein 16 of the herpes simplex 
virus (HSV). Cells were cultured in Earle’s minimal essential 
medium (EMEM) supplemented with foetal calf serum 
(FCS) 15% in the case of FEK4 and 10% in the case of 
HtTA cells, penicillin and streptomycin (50 IU/ml each), 
glutamine (2 mM), and sodium bicarbonate (0.2%).
For the transfection (gene delivery) and the resultant 
gene activity (transfection efficiency), FEK4 and HtTA cells 
were seeded at 1 x 105 cell/well in 6 well plates in 4 ml EMEM 
media with FCS for 24 h to reach a plate confluency of 
50-60% on the day of transfection. The complex was prepared 
by mixing 2 pg of pEGFP with the cationic liposomes or 
lipopolyamine in Opti-MEM (serum free media, Gibco BRL) 
according to the charge ratio at room temperature for 30 min 
and then incubated with the cells for 4 h at 37°C in 5% C 0 2. 
Then the cells were washed and cultured for further 44 h in 
growth medium at 37°C in 5% C 0 2 before the assay.
Levels of enhanced green fluorescent protein (EGFP 
positive cells) in the transfected cells were detected and 
corrected for background fluorescence of the control cells 
using a fluorescence activated cell sorting (FACS) machine 
(Becton Dickinson FACS Vantage dual Laser Instrument, 
argon ion laser 488 nm). The transfection efficiency was 
calculated based on the percentage of the cells that expressed 
EGFP (positive cells) in the total number of cells.
Cytotoxicity (MTT) Assay of the Formed Lipoplexes
FEK4 and HtTA cells were seeded in 96 well plates at 
8000 cell/well and incubated for 24 h at 37°C in 5% C 0 2. 
/V4,A9-Dioleoyl spermine complexed with pEGFP was added 
in the same way as the transfection protocol. After incubation 
for 44 h, the media was replaced with 90 pi of fresh media and
976
10 jil of sterile filtered MTT solution (Sigma-Aldrich, UK) 
(5 mg/ml) to reach a final concentration of 0.5 mg/ml. Then 
the plates were incubated for a further 4 h at 37°C in an 
atmosphere of 5% v/v C 0 2. After incubation, the media and 
the unreacted dye were aspirated and the formed blue 
formazan crystals were dissolved in 200 pl/well of dimethyl 
sulfoxide (DMSO). The produced color was measured using 
a plate-reader (VERSAmax) at wavelength 570 nm. The % 
viability related to control wells containing cells without 
DNA and/or polymer and is calculated by (test absorbance/ 
control absorbance) x 100 (38). The same protocol was 
applied in case of the commercially available reagents 
Lipofectin and Lipofectamine.
RESULTS
Synthesis of Ar4, /V9-Dioleoyl Spermine
The synthesized /V4,/V9-dioleoyl spermine (Fig. 3) was 
homogenous on silica gel thin-layer chromatography and was 
fully characterized by !H-NMR (at 400 MHz) and 13C-NMR 
and high-resolution accurate mass spectroscopy.
Ethidiuin Bromide Fluorescence Quenching Assay
To study the ability of/V4,/V9-dioleoyl spermine to condense 
calf thymus DNA and pEGFP as well as compared this effect 
with the effect of different known polycations spermine, PLL 
(39) and PEI (40) (Fig. 2) to condense DNA. Figure 4 shows 
the ability of the studied polyamines to displace EthBr from 
DNA. The binding ability was in the order PEI 2K > N 4JV9- 
dioleoyl spermine > PLL 9.6K > spermine according to the 
charge ratio. The charge ratio was calculated according to the 
ammonium/phosphate (+ /-)  ratio for: spermine, 202.35 g/mole 
with four nitrogen atoms that can be protonated; PLL 9.6K. one 
positive charge/lysine monomer; 7V4,A9-dioleoyl spermine, with 
two positive charges. In the case of PEI 2K the charge ratio was 
calculated as 25% of the amino groups in the polymer that can 
be protonated, assuming that 43.1 g/mol is the repeating unit of 
PEI that contains one nitrogen atom (41,42). It seems to be that 
there is no agreement in the literature for the calculation of the 
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Fig. 4. P lot o f EthBr displacem ent assay o f ca lf thym us D N A  
com plexed with PLL 9.6K, PEI 2K, /V4,/Vy-d ioleoyl sperm ine, and 
sperm ine.
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Fig. 5. P lot o f E thB r displacem ent assay o f calf thymus D N A  com ­
plexed with A/4,N9-d ioleoyl sperm ine, L ipofectin , and Lipofectam ine.
phosphate (40) not as charge ratio, it is reported that every third 
atom of PEI polymer is a protonatable nitrogen (40), but one in 
five of the protonatable nitrogens in PEI are protonated at pH 
7 (43). However, Wagner (11) reported that one of every seven 
nitrogens within PEI polymer is protonated at pH 7. The 
polycations (PEI 2K and PLL 9.6K) are known for their ability 
to condense DNA efficiently at a relatively low charge ratio 
compared to spermine. On the other hand, the results revealed 
that A/4,/V9-dioleoyl spermine is able to condense DNA at a 
lower charge ratio than PLL 9.6K and spermine (Fig. 4), and 
produces a 50% fluorescence decrease at charge ratio 0.52. 
Also, Fig. 5 shows DNA condensation ability of 7V4,/V9-dioleoyl 
spermine in comparison with the commercially available, cationic 
lipid, liposomal formulations Lipofectin and Lipofectamine. All 
three cationic lipid formulations have the ability to condense 
completely DNA through the displacement of EthBr leading to 
fluorescence quenching. At lower charge ratios /V4,/V9-dioleoyl 
spermine has better ability to suppress the fluorescence than 
Lipofectin and Lipofectamine. On studying the effect of /V4,/V9- 
dioleoyl spermine on the type of DNA (calf thymus DNA, and 
plasmid pEGFP), it was found that there is no significant 
variation in the condensation ability of the studied 
lipopolyamine on the type of DNA.
Light Scattering Assay
This experiment has been carried out to investigate the 
condensation of DNA by polyamines and the formation of 
particles (44). The apparent UV absorbance at 320 nm 
(where there is no DNA absorbance above 300 nm) was 
measured (28,45,46) showing light scattering. The results 
from Fig. 6 indicated the formation of particles upon 
interaction of spermine, PLL 9.6K and PEI 2K. In addition, 
Fig. 7 shows that the light scattering due to particle formation 
increases with the increase in the displaced EthBr and 
reaches the maximum at approximately the same charge 
ratio at which there is a maximum EthBr displacement, 
although the concentration of DNA used in light scattering 
experiments is ten times the concentration used in fluores­
cence quenching experiments which is related to the lack of 
sensitivity of light scattering experiment in comparison with 
fluorescence assay. Also, from light scattering results, there 
is a decrease in the % relative maximal apparent absorbance 
(% rel. max. app. abs.) after reaching the maximum absor­
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PEI2K
N 4,N 9-Dioleoyl spermine 
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Fig. 6 . L ight scatterin g assay (%  rela tive  m axim um  apparent 
absorbance at k  = 320 nm ) o f ca lf thym us D N A  com plcxed with  
PLL 9.6K , PEI 2K, A/4, A y-dioIcoyl sperm ine and sperm ine.
bance, which could be attributed to the formation of poly- 
amine-DNA aggregates as reported by Gosule and Schellman 
(47).
Transfection Experiments
The transfection efficiency of pEGFP into FEK4 primary 
cell line and the cancer HtTA cells was studied using N*,Nq- 
dioleoyl spermine and the commercially available reagents 
(Lipofectin and Lipofectamine). The transfection results of 
pEGFP into FEK4 indicated higher transfection ability of 
N4,iV9-dioleoyl spermine (75%) and Lipofectamine (66%) 
formulations over Lipofectin (18%); there is no significant 
difference in the transfection activity between /V4,/V9-dioleoyl 
spermine and Lipofectamine (Fig. 8). On the other hand, 
both N 4,N 9-dioleoyl spermine and Lipofectamine formu­
lations show a similar transfection activity in HtTA cells 
(about 70%), higher than Lipofectin (58%). A4„/V9-Dioleoyl 
spermine transfects the cells best at charge ratio (+ /-)  2.5 
(5.54 pg/ml), Lipofectin at charge ratio 0.6 (5.0 pg/ml), while 
Lipofectamine transfect both cell lines at charge ratio 3.7 
(10.0 pg/ml).
E3 N4,N 9-Dioleoyl spermine 





Fig. 8. L ipofcction o f FEK 4 and H tT A  cells transfected with pE G F P  
com plcxed with A/4jV y-diolcoyl sperm ine, Lipofectin or L ipofectam ine 
(at their respective N /P ratios for best transfection). The data represent 
3 different experim ents (3 replicates each) and the error bars represent 
the standard deviation.
In Vitro Cytotoxicity
The cytotoxicity of N4,Af9-dioleoyl spermine was studied 
in FEK4 and HtTA cells using MTT assay (48) (Fig. 9). The 
IC50 (the concentration at which cell growth is inhibited by 
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Fig. 7. Com parison o f EthBr displacem ent and light scattering assays 
o f calf thym us D N A  with N 4,W9-diolcoyl sperm ine.
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Fig. 9. V iability o f H tT A  cells (ab ove) and FEK 4 primary skin cells  
(b elow ) after application o f different concentrations o f /V4JVy- 
diolcoyl sperm ine cither free or com plcxed with pEG FP.
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Fig. 10. Cytotoxicity effect o f  pE G F P (2 pg/m l) com plcxed with 
either /V4,/V9-dioleoyl sperm ine (5.54 pg/m l), L ipofectin (5 pg/m l) or 
L ipofectam ine (10 pg/m l) in FEK 4 and H tT A  cells.
cells were 20.47 and 6.31 pg/ml respectively, and for the 
lipoplex were 19.82 and 8.35 pg/ml respectively. The results 
indicate that there is no significant difference in the toxic 
effect (ICso) of the free polycation over the lipoplex in 
the case of HtTA cells and FEK4 cells for the studied li­
popolyamines. /V4,/V9-Dioleoyl spermine show a significant 
difference in the % viability comparing to either Lipofectin 
and Lipofectamine in the primary skin cell line FEK4, but 
there is no difference in the case of the cancer cell line HtTA 
(Fig. 10). These results also revealed that /V4,/V9-dioleoyl 
spermine toxicity is higher (lower concentrations) in the case 
of HtTA cells more than with the primary cell line FEK4 
which could be attributed to the ease of transfection of 
immortalized cancer cell lines over primary cell lines.
DISCUSSION
Non-viral delivery systems can be defined to include the 
use of plasmid DNA alone (so-called naked DNA) (49,50) as 
well as DNA complexed to synthetic carriers such as cationic 
lipids (51-54) or polymers (55). The use of an efficient carrier 
for nucleic acid delivery is considered to be a determinant 
factor for the successful application of gene therapy (56). 
This carrier is responsible for the complex process of gene 
delivery to the nucleus (57).
Ethidium bromide (EthBr) (2,7-diamino-10-ethyl-9-phe- 
nylphenanthridinium bromide, Fig. 11) is a cationic dye that 
displays a marked increase in the fluorescence upon binding 
with DNA and RNA through the intercalation between the 
EthBr phenanthridinium-moiety and adjacent base-pairs of 
DNA sequences (36,58). Within the prerequisites for delivery 
of DNA across intact cytoplasmic membrane are condensa­
tion and masking the negative charge of the phosphate 
backbone. Condensation of DNA occurs when about 90% 
of the charge on DNA is neutralized (16,47).
The ability of the cationic lipid /V4jV9-dioleoyl spermine 
to compact DNA more efficiently than both spermine and 
the powerful condensing agent PLL a cationic polymer (9), 
(Fig. 4) shows the importance of the lipid moiety we have 
bound to the cationic polyamine in order to achieve 
improvements in its ability to condense DNA, cellular 
entry, and lowering the toxicity of the polyamine conjugate 
(11,59,60).
The form ation of /V4,/V9-dioleoyl sperm ine-D NA  
lipoplex at lower charge ratio decreases the toxicity of 
the DNA delivering lipopolyamine. As the mammalian 
cell membrane is a semipermeable membrane formed 
of phospholipids bilayer that allows the transport of 
macromolecules by endocytosis, neutralization of the 
negative charges on the DNA by polycations will improve 
the delivery of DNA through the cell membrane because of 
the presence of negative charges on both DNA and cell 
membrane. Also, the positively charged lipid complex will 
mediate transfection by fusion with cell membranes (60,61). 
It was found that both the number of positive charges and 
their distribution on the surface of the molecule have 
profound effects on DNA condensation (28,62,63).
In addition, in a study on the transfection activity of 
cholesterol carbamate cationic lipids (28), Blagbrough and 
co-workers reported that the carbamate with a spermine 
polyamine moiety has the highest transfection activity with 
its ability to condense DNA efficiently. Our findings are in 
agreement with the literature, the cationic liposomal formu­
lation Lipofectin, with its cationic moiety DOTMA contain­
ing one positively charged quaternary ammonium group, has 
lower ability to displace the EthBr from DNA than Lip­
ofectamine formulation that contains DOSPA (Fig. 2) with 
its four positively charged nitrogens (15) and 7V4,/V9-dioleoyl 
spermine with its two positively charged nitrogens. The 
higher ability of 7V4,./V9-dioleoyl spermine (two positive 
charges) over Lipofectamine (four positive charges) in 
DNA condensation, though /V4,/V9-dioleoyl spermine has 
a lower number of positive charges/molecule, may be 
attributed to the distribution of the positive charges on the 
molecule allowing a higher affinity of the vector for DNA 
and leading to the efficient displacement of EthBr. Another 
variable is the liposomal formulation of Lipofectamine 
compared to the non liposomal formulation of N *,N 9- 
dioleoyl spermine.
The helper lipid DOPE which is the second component 
of the cationic liposomes is used to increase the transfection 
activity of the cationic liposome through its ability to 
destabilize lipid bilayers leading to endosomal destabilization 
with subsequent increase in the total cellular uptake of the 
delivered DNA (23,64). Lipospermines (Fig. 2) with their 
cationic headgroup sometimes form micelles (in the absence 
of DNA) rather than the bilayer produced by the small 
cationic quaternary ammonium headgroup of DOTMA (Lip­
ofectin formulation) (43,65). /V4,/V9-Dioleoyl spermine 
combines in its structure the two oleoyl chains that have the 
characteristics of the fusogenic lipid DOPE and the cationic 
polyamine spermine (Fig. 2). Thus, DNA is condensed by the
NH.
Fig. 11. Structure o f ethidium  bromide.
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two primary amines and coated by the dioleoyl lipophilic 
moiety. The DNA condensation results of iV4,yV9-dioleoyl 
spermine (Fig. 5) show a higher efficiency than either li­
posomal formulation. The transfection results reveal higher 
transfection ability (levels of expression) of N4,A9-dioleoyl 
spermine compared to Lipofectin (Fig. 8) in FEK4 and HtTA 
cells. These results indicate the roles of both number 
and distribution of positive charges along the polyamine 
backbone on the ability of the compound to condense DNA. 
On the other hand, there is no significant difference in the 
transfection activity between jV4,yV9-dioleoyl spermine and 
Lipofectamine in both FEK4 and HtTA cell lines, which 
indicates the importance of lipid coating over the DNA 
molecule on both the condensation and cellular delivery of 
DNA in case of the liposomal and non liposomal formu­
lations (65). /V4,/V9-Dioleoyl spermine achieved high levels 
of transfection in both a cancer cell line and a primary skin 
cell line (73%), which indicates the ability of this vector to 
deliver DNA. Cell viability results revealed improved FEK4 
viability more than the cancer cells HtTA (Fig. 9). Also, 
yV4,yV9-dioleoyl spermine showed a significant improvement 
in primary FEK4 cell viability over the liposomal formu- 
latios (Fig. 10), but no significant difference in HtTA cells. 
Previous studies on Lipofectin and Lipofectamine on 
different cell lines showed the cytotoxic effects of these 
liposomal form ulations (66-70). In conclusion, a lipo­
polyamine vector has been developed for DNA delivery. 
This new non-liposomal formulation has the ability to trans­
fect primary skin cells more efficiently than the commercially 
available liposomal Lipofectin formulation.
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DOTAP N-[ l-(2,3-Dioleoyloxy)propyl]-N,JV,N-trimethylammonium chloride
DOTMA AJ-[l-(2,3-Dioleyloxy)propyl]-N,N,N-trimethylammonium chloride
EGFP (Enhanced) green fluorescent protein
EthBr Ethidium bromide
FACS Fluorescence-activated cell sorting
FCS Fluorescence correlation spectroscopy
FLIM Fluorescence lifetime microscopy
FRET Fluorescence resonance energy transfer




N/P Ammonium/phosphate charge ratio
NPC Nuclear pore complex
N-Rh-PE l,2-Dioleoyl-sn-glycero-3-phosphatidylethanolamine-N-lissamine rhodamine B
sulphonyl
NVGT Non-viral gene therapy
PEI Polyethylenimine
PNA Peptide nucleic acid
Ru-BD [Ru(bpy)2(dppz)]2+ (bpy=2,2'-bipyridine, dppz=dipyrido[3,2-a:2',3'-c]phenazine)
12.1
Introduction to  Non-Viral G ene Therapy and its D eve lop m en t
Gene therapy has been defined as “the opportunity for the treatment of genetic 
disorders in adults and children by genetic modification of human body cells” 
(UK Health Minister’s Advisory Committee, 1995) [1]. There have been 636 cli­
nical gene therapy studies run worldwide, mostly in the USA (79.4%) and in the 
UK (6 .8 %) [2]. Recent experiments show that gene therapy is not exclusive to 
genetic diseases such as cystic fibrosis, cancer, melanoma, or severe recombined 
immunodeficiencies, but it is also possible for other types of diseases including 
viral infections [1,2]. These new opportunities make gene therapy research chal­
lenging in a highly competitive area.
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The delivery of a DNA medicine into target cells is currently (mainly) 
achieved by two means: viral vectors and non-viral vectors. Though viral vec­
tors are found to be highly efficient in transfection, the severe immune re­
sponse/toxicity from the viral genome and the limited DNA packing size (the 
“payload”) are major therapeutic problems. As a result, non-viral gene therapy 
(NVGT) vectors have been synthesized as an alternative safe system with 
possible control over their DNA payload and their manufacture, suitable for 
clinical use [1,3-10]. According to Feigner et al.’s NVGT nomenclature guide­
lines, the two major synthetic gene delivery systems are: lipoplex (cationic 
lipids-nucleic acid complex), e.g. lipopolyamines, cationic liposomes; and 
polyplex (cationic polymer-nucleic acid complex), e.g. polyethylenimine 
(PEI), polylysine [11]. Though initially the efficiency of NVGT vectors was 
less than that of viral vectors [1,3-10,12,13], the performance gap has been 
rapidly closed [14].
Gene therapy is a complex pro-drug strategy [15]. It is currently believed 
that the delivered plasmid DNA must dissociate, at some point, from the lipo­
plex for gene expression, transcription and translation to the desired thera­
peutic protein. There are intracellular barriers to these processes [ 16-18]. Poly­
amines and lipopolyamines have recently been developed from a natural DNA 
condensing agent, spermine, for applications in NVGT (Fig. 12.1). The me­
chanisms involved and the rate-limiting steps are still not well understood [3].





Step 3 -  endosomal acidification leading to 
vesicles swelling and rupture
Step 5 -  nuclear localisation and entry
Step 1 -  DNA condensation by lipopolyamines 
to form toroid-shape particles
Lysoeome
Mitochondria
Ribosom e a n d  Endoplasmic 
re ticu lum  (E R )
Step 2 -  endocytosis o f  DNA nanoparticles
Step 4  -  endosomal escape o f  DNA complex
Step 6 -  DNA dissociation from complex 
for gene expression
Fig. 12.2. The key steps in the mechanism of non-virai gene therapy
In the first step in the mechanism of NVGT (Fig. 12.2), the phosphate 
anions of DNA are neutralized by lipopolyamines (ammonium ions) to form 
condensed nanoparticles [3,19,20]. DNA complexes then enter cells by endo­
cytosis. Endosomal escape, involving proton pumping, releases the delivered 
complexes to the cytoplasm. Nuclear entry, a crucial step for gene expression 
in NVGT, is achieved by nuclear localization and then transport through the 
nuclear pore complex (NPC) [3,17].
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12.2
Using F luorescence T echniques to  D eterm ine th e  Efficiency o f  DNA 
C ondensing A gents: an Im portant First S tep  in th e  M echanism  o f  NVGT
The development of gene-based medicines as a new class of pharmaceuticals is 
clearly important. DNA condensation by polyamine conjugates is a key first step, 
and fluorimetric, high-throughput assays have been developed to aid in the 
characterization of NVGT delivery systems. Negatively charged (due to the phos­
phate groups) DNA was bent by the addition of NVGT delivery agents carrying 
positive charges. This change in conformation (bending) presumably starts at 
certain specific nucleic acid sequences, as studied by Hud and co-workers [21], 
and results in condensed nanometre-sized particles in the range 10-180 nm, 
typically 50-150 nm in outer diameter. Nanoparticles, toroidal in shape, were ob­
served in polyamine-induced DNA condensation [ 19,22]. This DNA compaction 
facilitates the stability in extracellular compartments, cellular uptake and other 
intracellular processes such as nuclear entry [17,19]. Additionally, the aggrega­
tion issue of DNA particles is important to the bioavailability of therapeutic 
DNA. The adjustment of complex charge and ionic strength is critical to their 
colloidal stability. However, the presence of an excess of positive charges may lead 
to undesired interactions with negatively charged extracellular molecules such 
as serum albumin [23,24].
DNA intercalating agents have been widely used to determine DNA confor­
mational changes, including the characterization of NVGT delivery systems, e.g. 
ethidium bromide (EthBr) (Fig. 12.3),YOYO-l,acridine orange and PicoGreen 
[25]. The EthBr assay, first introduced by LePecq and Paoletti in 1967, has been 





Fig. 12.3. Ethidium bromide, Picogreen, fluorescamine, and the reaction of fluorescamine 
with a primary amine















































.4. EthBr and LS assay of pEGFP (above) and pGL3 (below) by spermine
of vector systems. EthBr, intercalated in stacks of DNA base pairs, fluoresces at 
600 nm by direct excitation at 546 nm, or more efficiently through energy trans­
fer from DNA base by excitation at 260 nm. On DNA condensation at increasing 
ammonium/phosphate (N/P) charge ratio [ 11 ],a decrease in EthBr fluorescence 
intensity was measured [26,27]. This improved methods reported by Geall and 
Blagbrough [26] offers a rapid and sensitive analysis of lipoplex formation.
Fluorescamine, a non-fluorescent molecule, is also useful in studying NVGT 
[28,29]. Fluorescamine easily reacts with primary amine functional groups of 
polyamines, forming a fluorescent molecule (Fig. 12.3). On salt formation 
between DNA phosphates and polyammonium ions, the reactivity to fluoresc­
amine of these primary amine groups is eliminated. This observation allowed
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a study of DNA-polyamine interactions [30], including polyamine-mediated 
DNA condensation. Thus, the reaction between free (i.e. unbound to DNA) 
primary amines on polyamines and added fluorescamine was used to deter­
mine the level of condensation. There is fluorescence from the product formed 
between fluorescamine and these amine functional groups, observed using 
Aex=392 nm and Aem=480 nm.
PicoGreen, an (expensive commercial) cyanine dye, becomes intensely 
fluorescent with high quantum yield and molar extinction coefficient when 
binding to as little as 25 pg/ml dsDNA [31,32]. The binding between chitosan 
(i.e. copolymers of glucosamine and N-acetyl glucosamine) and DNA was 
confirmed by PicoGreen, a fluorescent nucleic acid stain which only reacts 
with free (uncomplexed) DNA. Free DNA was extracted by gradient centrifu­
gation and mixed with PicoGreen to form a fluorescent complex (Aex=480 nm 
and Aem=520 nm) [28]. The unbound DNA level was used to determine the con­
densation performance of chitosan. Additionally, DNA loading can be studied 
by the PicoGreen assay of DNA after the digestion of nanocomplexes with 
chitosanase and lysozyme [33]. PicoGreen was compared to a large number 
of common nucleic acid stains based on EthBr, acridine orange, YOYO-1, etc. 
Fluorescence spectroscopy was compared to agarose gel electrophoresis 
for the biophysical characterization of DNA condensation [25]. In addition 
to these fluorescence techniques, the formation of nanoparticles by DNA 
condensation can be observed in a light scattering (LS) assay [34, 35]. This 
is complementary to the DNA condensation assay (Fig. 12.4); UV apparent 
absorption is measured at A>300 nm (where there is no absorption by DNA). 
Precipitation after aggregation follows a plateauing of the LS signal, and it 
does not increase the absorption above 300 nm. However, the DNA concen­
tration used in this assay was in tenfold excess compared to the EthBr assay, 
given the low sensitivity of this experiment and the lack of a fluorescence 
indicator.
12.3 
C onjugation o f  L ipopolyam ines to  Fluorophores: 
Probes Derived from  DNA D elivery A gents
Fluorescent lipopolyamines were synthesized by Fmoc (fluoren-9-ylmethoxy- 
carbonyl) chemistry in order to label a specific position with a chosen fluoro- 
phore [3,36,37]. Fluorescence techniques, such as fluorescence correlation spec­
troscopy (FCS) [38-40], fluorescence resonance energy transfer (FRET) [41,42] 
and confocal fluorescence microscopy [43], have recently been applied in NVGT. 
Thus, by introducing these probes to the DNA to be delivered during the con­
densation process, NVGT events can be followed by a range of available fluo­
rescence techniques either spectroscopically or microscopically. Our designed 
fluorescent lipopolyamines (Fig. 12.5) are important tools for studying the intra­
cellular fate of DNA nanoparticles (Fig. 12.6) [3,36,37].
Byk, Scherman and co-workers [44-46] have designed and synthesized poly- 
amine-hydrocarbon lipid conjugates. A rhodamine derivative of a lipopoly­
amine (RPR 121653) was also synthesized and studied as an NVGT probe
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Fig. 12.5. An example of our novel fluorescent lipopolyamine conjugates, carrying a DNA 
condensing moiety (from spermine), a lipophilic steroid (a frans-AB-oxygenated chole- 
stane), and coupled to a fluorescent tag
(Fig. 12.7) [44]. Structure modification was also carried out by introducing a 
disulphide bridge (a reduction-sensitive functional group) at different posi­
tions in the backbone of the lipids. The disulphide is incorporated in order 
to afford another escape mechanism for the DNA from the lipopolyamine 
carrier, taking advantage of the cytosolic cellular reducing medium, such as 
the plasma membrane or cytoplasmic reductases. Early reduction led to un­
desirable DNA release, i.e. total disruption of the particles in the early phase 
of delivery yielded total loss of transfection, but some positions for the disul­
phide bridge afforded increased transfection efficiency [45,46].
Fluorescent derivatives of a small lipid molecule such as N-Rh-PE (1,2- 
dioleoyl-5 M-glycero-3 -phosphatidylethanolamine-AMissamine rhodamine B 
sulphonyl) and NBD-PE (N-4-nitrobenzo-2-oxa-l,3-diazole phosphatidyl- 
ethanolamine) are commercially available (Avanti Polar Lipids, AL, USA). 
These molecules (Fig. 12.7), incorporated into cationic liposomes in NVGT, 
enable the ability to track fluorescently the progress of transfection from lipo­
somes (vide infra) [42,47]. Fluorescent labelling of polyplex NVGT carriers 
has also recently been reported, with Oregon Green-PEI [43] and Texas Red- 
chitosan (vide infra) [48].
Ideal fluorophores are primarily chosen for their photostability profile. 
Naylor et al. [49] showed in interesting experiments that the cellular uptake 
and metabolism of fluorescent fatty acid analogues were different. The polar 
fluorophore has poor cellular uptake, and anthracene or pyrene fluorophores 
were regarded as the most extensively incorporated into cellular lipids. From 
these findings, it is expected that the molecular hydrophobicity of fluoro­
phores may play an important role in fluorescent lipid (fatty acid)-based 
NVGT vector design.
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(i) CF3COOEt, MeOH
(ii) Boc20 , MeOH 
(ii) Conc. aq. NH3
Cholesteryl chloroformate, Et3N, CH2CI2
Fmoc
(i) Hydroboration and alkaline work-up
(ii) Fmoc-bAPA-OH, DCC, DMAP, CH2CI2
(i) TBAF, THF
(ii) FITC, Et3N, CH2CI2
(iii) TFA, CH2CI2
Fig. 12.6. Synthesis of a fluorescent lipopolyamine







n 0 2 NBD-phosphatidylethanolamine (NBD-PE)
(Szoka and co-workers42)
Fig. 12.7. Recently reported fluorescent probes
12.4 
Preparation o f  F luorescent M acrom olecules
DNA can be labelled with fluorescent molecules by chemical techniques such 
as photocrosslinking (e.g. ethidium monoazide [50-52], p-azido-tetrafluoro- 
benzyl-lissamine [53], or dinitrophenyl [54]). Aryl azides can be photoactivated 
with UV light to generate highly reactive aryl nitrenes which bind to the aromatic 
bases of DNA. Covalent labelling without photoactivation is also possible, such 
as the Label IT kit (Mirus Ltd.) [41,55]. Fluorescent DNA has also been used to 
study NVGT barriers, such as cell entry [52,56] and nuclear entry [52,57].
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Some fluorophores for DNA labelling are sequence specific, for example 
Hoechst 33258 for AT-bases and minor groove [58-61], and 7-aminoactino- 
mycin D for GC-bases [58-61]. Lakowicz and co-workers reported the imaging 
of cell nuclei based on fluorescence resonance energy transfer (FRET) and fluo­
rescence lifetime microscopy (FLIM) to obtain unbiased maps of spatial dis­
tribution of the AT- and GC-rich DNA regions in nuclei. In FLIM, the image 
contrast is insensitive to concentration, but sensitive to the local environment 
and interactions of fluorophores such as FRET, allowing examination of the 
proximity between donors and acceptors. This selective labelling may lead to 
a better understanding of the starting point for DNA bending, the first step for 
condensation to form nanoparticles [58-61 ]. This labelling strategy can also 
be used together with DNA intercalating dyes, such as propidium iodide, to 
form a FRET pair [62]. Better fluorophores are being continually developed to 
increase sensitivity and photostability. Recent studies have demonstrated that 
silver metallic particles can increase the quantum yield and decrease the life­
times of nearby fluorophores, including double-stranded DNA oligomers 
labelled with Cy3 or Cy5 in close proximity to silver particles [63]. The metal - 
ligand complex, [Ru(bpy)2(dppz)]2+ (bpy=2,2/-bipyridine, dppz=dipyrido- 
[3,2-a:2',3'-c]phenazine) (Ru-BD), was utilized to study nucleic acid dynamics. 
This Ru-BD complex has both a long lifetime and a molecular light switch 
property on DNA binding, due to protection of its dppz ligand from water. The 
slow rotational correlation times appeared to be consistent with the bending 
motions of the plasmids [64,65].
In addition to using fluorescent plasmids as a probing strategy for NVGT, 
protein markers have been employed to follow the transfection outcome, i.e. 
gene expression. Such protein markers include: (enhanced) green fluorescent 
protein (EGFP), which fluoresces naturally; /J-galactosidase, which can turn­
over a pro-fluorescent substrate, e.g. one based on umbelliferone; and luci-
Fig. 12.8. The fluorophore in EGFP. (i) EGFP amino acid sequence L(64)TYGV(68) shown, 
(ii) Post-translational cyclization of amino acids 65-67 forming hydroxybenzylidene- 
imidazolidinone, an EGFP fluorophore with Aex=488 nm (red-shifted from wild GFP 
protein) and Aem=507 nm
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Fig. 12.9. The biochemical reaction of luciferin oxidation by luciferase to oxyluciferin
ferase, which drives luciferin oxidation and generates light. The chemistry that 
underpins the use of these reporter systems is highlighted below. By using 
pEGFP [6 6 ] as delivered DNA, the EGFP chromophore (a substituted 4-hydro- 
xybenzylidene imidazolidinone Fig. 12.8) was detected in successfully trans­
fected cells by FACS (fluorescence-activated cell sorting). Luminescence in­
volves chemical reactions producing structurally different products which 
emit light. This bioluminescence method has also been used to quantify 
NVGT efficiency [67]. Firefly luciferase (Photinus pyralis) [67], which is widely 
used for gene expression, catalyses luciferin oxidation (Fig. 12.9) generating 
oxyluciferin and detectable yellow light.
L ipopoiyam ines and C ationic Lipids Used in Transfection
LipoGen (Invivogen) (Fig. 12.10) is a lipospermine with two oleoyl groups at N2 
and N3 of spermine and therefore only two positively charged (primary) amines. 
It was prepared as a non-liposomal formulation. The lipophilic modification aims 
to facilitate the transfection process (e.g. potentially through enhanced DNA 
condensation, cell entry, endosomal escape). This lipophilic modification of 
the spermine structure resulted in a more efficient pEGFP cDNA condensation 
(Fig. 12.11) (15% residual fluorescence in the EthBr assay, at N/P charge ratio 2.5) 
compared to tetracationic spermine (50% at N/P charge ratio 3.0). The in vivo 
transfection of pEGFP (2 pg/well) with LipoGen was carried out using FEK4 [6 8 ] 
(2.5X104 cells/well at 50% confluence), incubated for 4 h, then the transfection 
was stopped by removal of the DNA complex and replacement with foetal calf 
serum-containing media; FACS analysis was performed 48 h post-transfection. 
Lipofectin (DOTMA/DOPE=l:l w/w,Invitrogen) (Fig. 12.10), the commonly used 
transfection liposomal reagent containing cationic lipid (with one positive charge) 
and helper lipid (DOPE), was also used in this experiment for a comparison. 
The fluorescent cell counts observed in all N/P ratios were higher in LipoGen-
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Fig. 12.11. pEGFP-EthBr fluorescence quenching by LipoGen and spermine
mediated transfection. Thus, the lipid moiety in lipospermine is playing an im­
portant role in in vitro transfection. The optimal charge ratio for FEK4 trans­
fection with pEGFP-LipoGen complex is around 2.5, which corresponds to the 
optimal DNA condensation N/P ratio (from the EthBr assay). Though increased 
condensation leads to higher transfection efficacy (Fig. 12.12), the high N/P ratio 
(more than 5.0) results in less efficient gene delivery overall. A similar relation­
ship between N/P charge ratio and transfection efficiency was also observed in 
Lipofectin-mediated transfection.
A highly fluorescent preparation of plasmid DNA was generated by hybrid­
izing a fluorescently labelled peptide nucleic acid (PNA) to the plasmid and 
using this to study the biodistribution of conformationally and functionally 
intact plasmid DNA in living cells after cationic lipid-mediated transfection. 
This method enables the mechanism of plasmid delivery and nuclear import 
by synthetic gene delivery systems to be elucidated [69]. Using a fluorescent 
plasmid expressing GFP enabled simultaneous co-localization of both plas­
mid and expressed protein in living cells and in real time. GFP was shown to 
be expressed in cells containing detectable nuclear fluorescent plasmid; 
though conjugated, it still underwent transcription and translation [69].
Double-charged 1,4-dihydropyridine (1,4-DHP) amphiphiles condense 
ethidium monoazide-crosslinked fluorescent DNA and efficiently transfect 
cells in vitro. Confocal laser fluorescence microscopy was used to investigate 
the intracellular distribution of these nanoparticles. The biophysical proper­
ties, as a function of structure-activity relationships, determine the intra­
cellular kinetics and transfection efficiency. Not one property among high 
cellular uptake, membrane destabilizing activity or buffering capacity alone 
is sufficient to achieve high transfection yields. Overall, there is a complex 
interplay of various factors that determine intracellular kinetics and, con­
sequently, transfection [70,71].
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Fig. 12.12. FEK4 transfection of pEGFP complexes by LipoGen (above) and Lipofectin (below)
Cationic liposomes are useful to transfer genes into eukaryotic cells in vitro 
and in vivo. However, liposomes with good transfection efficiency are often 
cytotoxic, and often require serum-free conditions for optimal activity. A new 
cationic liposome formulation efficiently delivered a plasmid DNA for GFP 
into more than 80% of the cultured human cell hybrids derived from HeLa 
cells and normal fibroblasts. FACS analysis revealed that the efficiency of the 
GFP gene expression was 40-50% in a tumour-suppressed cell hybrid, while 
it was greatly reduced in the tumorigenic counterpart. The enhanced GFP ex­
pression in tumour-suppressed cell hybrids was quantitatively well correlated 
with a prolonged presence of the plasmid DNA, which had been labelled with 
the fluorescent probe ethidium monoazide, within the cells. The stability of 
the plasmid DNA inside the cell is a crucial step in this liposome-mediated 
gene expression. The mechanisms by which cationic liposomes mediate gene 
transfer into eukaryotic cells are being studied [72].
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Polylysine-molossin is a 31 amino acid synthetic peptide that acts as a DNA 
vector in vitro for cell lines and for the cornea. It incorporates the 15 amino 
acid integrin-binding domain of the venom of the American pit viper, 
Crotalus molossus molossus, as the targeting moiety and a chain of 16 lysines 
as the DNA-binding moiety. Binding and tissue distribution of the vector- 
DNA complexes were followed using fluorescein-labelled DNA. Long exposure 
times (2-3 h) to the transfection medium were essential for substantial gene 
transfer. Although exposure to chloroquine for 8-10 h after uptake of vector/ 
DNA complexes was essential for optimal gene transfer, exposure of com­
plexes to even 1% serum before transfection markedly inhibited gene transfer. 
Careful attention to several parameters of little importance in vitro needs to 
be paid for optimal in vivo application of DNA vector systems [73].
12.6
A ssociation  and D issociation  S tu d ies o f  DNA C om plexes Through  
Fluorescence Correlation Spectroscopy (FCS)
FCS is a technique where fluctuations in the detected fluorescence from small 
molecules (such as DNA intercalating probes) are used to study the dynamic pro­
cesses on the molecular scale, including DNA conformational changes resulting 
from polycation-mediated condensation [74], This technique, first introduced 
by Magde et al. in 1972, to measure the EthBr diffusion and binding to double­
stranded DNA, has been undergoing major technical improvements following the 
implementation of confocal microscopy in 1993 [74]. The count rate, diffusion 
time and particle numbers observed by FCS at the single molecule level and their 
correlations can be used to differentiate the nature of polycation-DNA [38-40, 
75, 76] and oligonucleotide condensation [77]. Krai et al. reported the DNA 
complex association mediated by spermine. The pHbetaAPr-l-neo (10 kbp; 
contour length 3.4 pm) was labelled with EthBr and propidium iodide, and then 
titrated with spermine to form condensed DNA particles. The diffusion time, 
count rate and particle number decreased when the charge ratio (N/P) was in­
creased, suggesting the dissociation of dyes from condensed DNA [38,40]. The 
correlation plots of these FCS parameters versus condensing agent concentration 
can be a source of additional information about the nature of cationic com- 
pound-DNA interactions. In similar experiments, hexadecyltrimethylammon- 
ium bromide (HTAB)-mediated DNA condensation showed different correla­
tion plots from spermine, and possible differences in DNA conformation were 
deduced [39].
FCS with two-photon excitation was used to characterize the complexes 
formed by rhodamine-labelled 25-kDa PEI or DNA plasmid molecules by 
Clamme et al. [75,78]. FCS results revealed that fluorescent PEI in the complex 
solution at the N/P ratio used in transfection was 8 6 % in a free PEI form 
leading to cell toxicity. As an application, FCS was also used to monitor the 
purification of PEI/DNA complexes by ultrafiltration as well as the heparin- 
induced dissociation of the complexes. Purification of the complexes is there­
fore important in lowering possible toxicity from uncomplexed polycations 
along NVGT vectors [75].
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12.7 
DNA C om plexes and Their Intracellu lar Trafficking: 
M onitoring by F luorescence (Forster) R eson an ce Energy Transfer (FRET)
FRET is gaining in importance as a technique for studying the mechanism and 
barriers in NVGT. A change in conformation on condensing DNA leads to a 
change in the distance between two fluorophores, which can be demonstrated 
through the random double labelling of DNA for FRET [41] or double labelling 
of the DNA and carriers [79,80]. The stability in physiological media (in the pre­
sence of 2 0 % serum) of polyplex- and lipoplex-non-viral gene delivery vectors, 
e.g. Lipofectamine, poly-L-lysine and poly(ethylene glycol)-poly(L-lysine) block 
copolymer, has been evaluated by detecting the conformational change in plasmid 
DNA labelled simultaneously with fluorescein (energy donor) and X-rhodamine 
(energy acceptor) and examining the condensation by FRET [41,81]. FRET was 
also used to estimate the distance of closest approach of supercoiled plasmid DNA 
to the lipid bilayer of cationic liposomes. The structure of the negatively charged 
complexes is consistent with DNA extending from the surface of the particles, 
whereas those possessing an excess of positive charge were multi-lamellar aggre­
gates with the DNA effectively condensed between lipid bilayers. Complexes be­
tween these two states consisted of weighted fractions of these two species [79].
FRET has also been used to monitor interactions between Cy3-labelled 
plasmid DNA and NBD-labelled cationic liposomes. Significantly, the time 
allowed for complex formation affected the in vitro luciferase transfection 
efficiencies of DOPE-based lipoplexes. Lipoplexes prepared with a 1 h incuba­
tion had much higher transfection efficiencies than samples with 1 min or 5 h 
incubations. The molar charge ratio of DOTAP to negatively charged phos­
phate in the DNA also affected the interaction between liposomes and plasmid 
DNA, and interactions stabilized more rapidly at higher positive charge ratios. 
Lipoplexes formulated with DOPE were more resistant to high ionic strength 
than complexes formulated with cholesterol [80].
Prior to cell entry of DNA nanoparticles, binding of DNA complexes with 
extracellular serum, which results in lower NVGT bioavailability, can also be 
studied by FRET [23]. Clear implications for clinical intravenous lipofection 
come from FRET and EthBr intercalation studies of intravenous gene delivery 
using cationic lipid vectors to achieve systemic gene expression in the (mouse) 
lung. DOPE vectors stayed poorly in the lung and were barely active in trans­
fecting cells. However, cholesterol-containing vectors had a rapid aggregation, 
a slow disintegration, and were highly efficient in transfecting cells in vivo 
[23]. Endosome escape is also a key barrier to study microscopically. Fluo­
rescent lipids in the bilayer membranes, as a FRET probe complementary pair 
to the fluorescent DNA carriers, were used in membrane fusion/leakage studies 
[82,83]. FRET interaction of fluorescent lipopolyamine-DNA complexes with 
NLS can be studied to gain insights into nuclear localization, nuclear entry 
processes and the timing of DNA release from the lipoplex [42].
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12.8
Fluorescence M icroscopy in NVGT
The intracellular processes in NVGT can be imaged by scanning and confocal 
fluorescence microscopy [42,47,48,84]. Szoka and co-workers were pre-eminent 
in this research area. They proposed a mechanism for fluorescein-labelled oligo­
nucleotide (ODN) release from cationic rhodamine-labelled liposome complexes, 
showing that the fluorescent lipid remained in the cytoplasm. ODN displacement 
from the complex was studied by FRET. They proposed that the complex, after 
internalization by endocytosis, induces flip-flop of anionic lipids from the cyto­
plasmic facing monolayer. Anionic lipids laterally diffuse into the complex and 
form a charged neutralized ion pair with the cationic lipids. This leads to dis­
placement of the ODN from the cationic lipid and its release into the cytoplasm 
(Fig. 12.13) [42].
A lung inflation-fixation protocol to examine the distribution and gene 
transfer efficiency of fluorescently tagged lipoplexes using fluorescence con- 
focal microscopy within thick lung tissue sections was used to investigate the 
observation that intravenous (i.v.) administration of lipoplex was superior to 
intratracheal (i.t.) administration for gene transfer in the murine lung. A fluo­
rescent ODN was used as a marker for cytoplasmic release of nucleic acids. 
Not unexpectedly, toxicity was associated with high local concentrations of
Fig. 12.13. Intracellular distribution of fluorescent lipids and fluorescent oligonucleotide 
(F-ODN). F-ODN were associated with DOTAP/N-Rh-PE at a 10:1 charge ratio. CV-1 cells 
were incubated in serum-free medium with complexes for 3 h at 37 °C and imaged using a 
confocal microscope. (Zelphati O, Szoka FC Jr, Proc Natl Acad Sci USA, 1996, 93:11493- 
11498; Copyright (1996) National Academy of Sciences, USA)
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Fig. 12.14a—f. Simultaneous fluorescent oligonucleotide (red) localization and GFP (green) 
expression in the mouse lung after i.v. lipoplex administration (a, b), i.t. lipoplex admin­
istration (a, c, e at xlOO) and high magnification (b at x400, d and f  at x600). GFP expres­
sion shown by arrowheads. In panels a and b, a fluorescein-PE marker was also used and 
can be distinguished as green punctuates, distinct from GFP expression (arrowheads). The 
green reticular fluorescence observed in panels b  and f  is due to autofluorescence that is vi­
sualized at the gain used to image the section. No fluorescent lectin was used in these stu­
dies [47]. (Used with permission of Nature)
cationic lipoplexes. The ratio of GFP-expressing cells to fluorescent nuclei 
indicated that capillary endothelial cells were more efficient in gene expression 
per delivery event than were pulmonary epithelial cells. Thus, the greater gene 
expression efficiency of i.v.-administered lipoplexes was due not only to the 
initial distribution, but also to the greater efficiency of the vascular endothelial 
cells to appropriately traffic and express the foreign gene (Fig. 12.14) [47].
The seminal work carried out by Godbey, Wu and Mikos, reported in 1999, 
on PEI stands as a major contribution in this research area of NVGT [43].
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/
Fig. 12.15a, b. Tracking of double-labelled PEI/DNA complexes. The fluorescence patterns for 
single-labelled complexes are also seen for double-labelled complexes, a At 2 h post-trans­
fection, visible complexes appear as clumps on the cell’s exterior, as indicated by arrows. 
b At 3 h post-transfection,both surface aggregation and endosomes are visible. The arrow 
indicates endosomal formation, c, d s. p. 220
Their rigorous proof of mechanism, using fluorescent labelling and confocal 
microscopy, followed PEI/DNA complexes from endocytosis to gene expres­
sion. Significantly, the cationic polymer PEI (with or without DNA) underwent 
nuclear localization (Fig. 12.15) [43].
Chitosan, a polymer of glucosamine and N-acetylglucosamine, is useful 
as a non-viral vector for gene delivery. Although there are several reports 
of chitosan in gene delivery, studies of the effects on transfection and the 
chitosan-specific transfection mechanism are still few. Sato and co-workers 
have recently studied the transfection mechanism of plasmid/chitosan com­
plexes as well as the relationship between transfection activity and cell uptake 
using fluorescein isothiocyanate-labelled plasmid and Texas Red-labelled 
chitosan. Factors that increased transfection activity and cell uptake included; 
molecular mass of chitosan (40 or 84 kDa), stoichiometry of the chitosan 
nitrogen to DNA phosphate (N/P ratio) in the complex was 5, and the trans­
fection medium contained 10% serum at pH 7.0. For details of the transfec-
2 2 0 Fluorescence Techniques in Non-Viral Gene Therapy
Fig.12.15c,d. c At 4 h post-transfection,endosomes containing both PEI and DNA are visible 
throughout the cell cytoplasm, d  At 4.5 h post-transfection, fluorescent structures con­
taining both PEI and DNA inside the cell nucleus are present, as indicated by the arrow. 
(Bar= 10 pm). (Godbey WT, Wu KK, Mikos AG,Proc Natl Acad Sci USA, 1999,96:5177-5181; 
Copyright (1999) National Academy of Sciences, USA)
tion mechanism, they found that plasmid/chitosan complexes condense to 
form large aggregates (5-8 pm) which absorb to the cell surface. Plasmid/ 
chitosan complexes are endocytosed and then released from endosomes due 
to osmotic swelling of endosome, in addition to possible swelling of plasmid/ 
chitosan complex, causing the endosome to rupture. These complexes were 
observed to accumulate in the nucleus using confocal laser scanning micro­
scopy (Fig. 12.16) [48].
Polyethylenimine (PEI) is one of the most efficient polymeric non-viral 
vectors for gene therapy, but one suffering from the serious limitation of
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Fig. 12 .16 A, B. Intracellular distribution of FITC-plasmid/chitosan complexes ( A , green) and 
Texas Red-dextran (B , red) were observed by a confocal fluorescence microscope at 1 h post­
incubation in SOJ cells. The confocal images show overlaid images of the fluorescent probe 
and the phase contrast. Molecular mass of chitosan was 40 kDa. (Bar= 10 pm) [48]. (Used 
with permission of Elsevier)
significant cytotoxicity when used in large amounts for transfection. What is 
the role of endocytosis in the transfection of synchronized L929 fibroblasts 
by PEI/DNA complexes? Employing a combination of confocal microscopy 
and FACS, using the endocytosis marker FM4-64 and PEI/DNA complexes 
labelled either with the DNA intercalator YOYO-1 or with fluorescein co­
valently linked to PEI, Mely and co-workers showed that nanoparticles were 
typically taken up within 1 0  min in endosomes that did not exceed 2 0 0  nm 
in diameter. The location then became perinuclear and fusion between late 
endosomes was shown to occur. In L929 cells, escape of the complexes from 
the endosomes is a major barrier in transfection [84]. Comparison with 
the intracellular trafficking of the same complexes in EA.hy 926 cells (Godbey, 
Wu and Mikos [43]) revealed that endocytosis of PEI/DNA complexes is 
strongly cell-dependent (Fig. 12.17) [84].
Mely and co-workers [85] have recently reported their continuing studies 
on PEI. Fluorescence probes such as Nile red, cSNARF-1 and cyanine dye 
DiSC2(3), coupled with the technique of picosecond time-resolved fluores­
cence microscopy, were used to show that cytoplasmic pH increased by 0.1- 
0.4 units when cells were treated with PEI. Mely, Behr and co-workers [8 6 ] 
have also developed and studied a new cysteine detergent, ornithinyl-cysteinyl- 
tetradecylamide (C-14-CO),able to convert itself, via oxidative dimerization, 
into a cationic cystine lipid. Using fluorescence techniques, they characterized 
the structures of plasmid DNA lipoplexes [8 6 ].
12.8.1
New Emerging Fluorescence Techniques to  Explore in NVGT Research
The non-invasive technique of FCS, with its high spatial resolution of less than 
0.5 pm, extracts information about molecular dynamics from the tiny fluctua­
tions that can be observed in the emission of small ensembles of fluorescent
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Fig. 12.17 A, B. Transfection of L929 fibroblasts with a GFP-coding plasmid complexed with 
PEI. The cells were incubated with a GFP-coding plasmid complexed with either unlabel­
led (A) or FITC-labelled PEI (B). At 24 h post-transfection, a positive transfection is noted 
by the expression of the diffuse fluorescence of the green fluorescent protein (A) that could 
be easily differentiated from the fluorescence of the FITC-labelled complexes (B). (Bar= 
50 pm) [84]. (Used with permission of Elsevier)
molecules in thermodynamic equilibrium. More non-invasive fluorescence tech­
niques were developed and this allows NVGT research to be performed with 
intact cells directly, such as in vivo FCS [87, 8 8 ]. FCS is becoming increasingly 
popular as a technique to add chemical and biophysical information, e.g. particle 
mobility, local concentrations, rate constants for association and dissociation 
processes, enzyme kinetics and molecular interactions, to live cell images ob­
tained by microscopy or other techniques. Recent examples of both auto- and 
cross-correlation applications further demonstrate the potential of FCS for cell
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biology [87]. Thus, FCS is a versatile technique,particularly attractive for afford­
ing quantitative assessment of interactions and dynamics of small molecular 
quantities in biologically relevant systems [88]. Additionally, the combination of 
fluorescence techniques is a newly emerging strategy to obtain more information 
for a better understanding of the complex biological events in NVGT, e.g. the FCS 
measurement of FRET between the donor (Alexa488) and acceptor (Cy5) fluoro- 
phores, and in particular studying fluctuations generated by trans-cis iso­
merization of the acceptor dye, which can be conveniently measured by FCS [89]. 
The dissociation events of rhodamine green-labelled oligonucleotide (ODN 
20-mer) and DNA from rhodamine green- or Cy5 red-labelled cationic polymer 
carriers (e.g. PLL) can also be studied by dual-colour fluorescence fluctuation 
spectroscopy (FFS), as recently reported by Lucas et al. [90]. In their studies, both 
the ODN and the cationic polymers were fluorescently labelled, and the results 
were compared with data obtained from single-colour FFS in which only the 
ODN or the cationic polymers were fluorescently marked [90].
Single-molecule fluorescence techniques have been increasingly used in bio- 
molecular studies [91,92]. The kinetics of spermidine-mediated linear DNA con­
densation were monitored by optical tweezers and fluorescence imaging at the 
single molecule level. Two steps, i.e. medium flow speed-dependent lag period 
and collapse, were observed in the DNA condensation process. The observed lag 
time suggests that loop formation at the end of the DNA may be a prerequisite 
for DNA condensation [93].
12.9 
C onclusions
Fluorescence techniques can potentially play important roles in all areas of NVGT 
research. EthBr and other DNA intercalating dyes (as a simple, rapid analytical 
screen) contribute to the discovery of novel DNA condensing agents. The NVGT 
efficiency can be evaluated by using plasmid carrying fluorescent protein and 
luminescence-associated enzymes. Fluorescent lipopolyamines were designed 
and synthesized, enabling the intracellular tracking of DNA complexes to reveal 
(both spectroscopically and microscopically) the key steps and barriers in gene 
delivery. Fluorescence microscopy (e.g. GFP monitoring) has been intensively 
employed in NVGT imaging. Since the introduction of confocal microscopy, FCS 
has undergone major developments and has been used to monitor biological 
events including transfection. Moreover, fluorescent labelling of DNA can be used 
together with lipopolyamine probes for studies of fluorophore interactions, e.g. 
by FRET for studies of the (diss-)association of DNA and its cationic carrier, NLS 
or other biomolecules or intracellular organelles. Newly developed fluorescence 
techniques, e.g. in vivo FCS and FRET by FCS, are certainly valuable tools for 
ongoing research towards the goal of efficient NVGT. Designed small molecule 
probes will play their part in this.
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CHAPTER 16
SPERM INE AND LIPOPOLYAM INES AS GENE DELIVERY AGENTS
I.S. BLAGBROUGH, N. ADJIMATERA, O.A.A. AHMED, A.P. NEAL and C. POURZAND 
Department o f  Pharmacy and Pharmacology, University o f  Bath, Bath, BA2 7AY, U.K.
1. INTRODUCTION TO SPERMINE AND LIPOPOLYAMINES
Polyamines are polycationic at physiological pH and play a variety o f important biological 
roles. Many mammalian cells also possess an active polyamine uptake system, although little 
is known about its function.1 Spermine (Fig. li) (3.4.3 methylene count between the amine 
groups) and spermidine (Fig. lii) (4.3 methylene spacings) were first discovered in the nuclei 
o f  sperm, where these polycations help histone proteins to package DNA by charge 
neutralization o f the phosphate anions along the DNA backbone. Most cells use histone 
proteins and polyamines to condense DNA in the nucleus. The histones found in chromatin 
are categorized as core histone (subunit H2A, H2B, H3, H4) (Fig. 1) and linker histone (HI), 
forming an octomer (108kDa) that binds to DNA. Lysine (Lys, K) and arginine (Arg, R), the 
most important o f the positively charged amino acids, are found in significant sequences 
along most histone proteins. Lys has its (CH2)4NH3+ (basic) side-chain, and Arg is the 
naturally occurring (mammalian) amino acid containing a guanidine functional group, the 
most basic functional group in biological chemistry. Thus, the side-chains o f these amino 
acids (together with ornithine and histidine) can be positively charged in the cell. The p ^ as of 
Lys and Arg (side-chains) are 10.5 and 12.5 respectively. DNA-histone complexes are 
dissociated on treatment with acids or dilute salt solutions.2 This is evidence of ionic and 
non-covalent interactions; the phosphate anions are titrated by the ammonium cations. O f 
course, there also has to be some consideration o f spermine (i) and spermidine (ii) and their 
conjugates as neurotoxins; such neurotoxication can be due to high levels of free polyamines, 
or similar effects achieved by polyamine amides in the mammalian brain by mechanisms 
involving glutamate receptors. This latter process parallels the modes of action o f the spider 
and wasp polyamine amide (invertebrate) neurotoxins.
2. OVERVIEW OF NON-VIRAL GENE THERAPY (NVGT)
Gene therapy is a new treatment strategy for some difficult-to-cure diseases, introducing a 
therapeutic gene into body cells and aiming for desired gene expression. The therapeutic 
outcome is not only limited to missing proteins in patients (such as a chloride ion channel in
the lungs of patients with cystic fibrosis), but also an inhibitory protein signal to stop the 
progression of disease, especially as a potential treatment for certain cancers.4 The design and 
synthesis of efficient DNA delivery vectors are major research areas in non-viral gene therapy 
(NVGT). Lentiviral and other viral vectors show efficient transfection, however, there is the 
possibility of severe toxicity from the viral genome, as well as immunogenicity, and there is 
the drawback of a limited DNA payload. Naked DNA is used even in current clinical trials. 
NVGT vectors have been produced to retain or to improve upon the performance of viral 
vectors and to provide a safe alternative for clinical gene therapy.4 Recently, Feigner et al. 
reported a system of NVGT nomenclature guidelines to aid in NVGT research, dividing the 
vectors into the two major synthetic gene delivery systems: lipoplex (cationic lipid-nucleic 
acid complex) e.g. lipopolyamines, cationic liposomes, and polyplex (cationic polymer- 
nucleic acid complex) e.g. polyethylenimine (PEI), poly-L-lysir.e (PLL) etc.5 Gene therapy is 
a complex drug (DNA) delivery strategy which must overcome intracellular barriers. The 
contributions from these barriers in blocking efficient NVGT are not well understood. We are 
aiming to understand (Fig. 2) and, thereby, to design a significant improvement over current 
transfection yields.
Figure 1 Spermine (i), spermidine (ii) and histone 2A (iii) K(13)AKTRSSR(20) (underlined 




Figure 2 Barriers to NVGT (I -  DNA condensation and particle formation, II  -  endocytosis, 
III -  endosome escape, IV  - nuclear localization, V - nuclear entry and VI - gene expression).
Negatively charged DNA (due to the phosphate anions), when neutralized by salt formation 
with positively charged lipopolyamine vectors, results in condensed nanometer-sized particles 
typically 50-150nm in outer diameter (Fig. 4). Nanoparticles, toroidal in shape, were 
observed in polyamine-induced DNA condensation.6,7 This DNA compaction facilitates its 
stability in extracellular compartments, cellular uptake, and other intracellular process such as 
nuclear entry.7,8 The electrostatic interactions between the surface o f DNA particles and cell 
membranes is expected to be an initial process leading to internalization by endocytosis of 
DNA nano-complexes, with the involvement of clathrin-coated pits on the cell membrane.9,10 
It has been shown that endosome escape of the DNA is one major critical barrier to efficient 
transfection.8 Early endosomes are formed by the inversed cell membrane upon DNA 
particles endocytosis, which are eventually degraded into late endosomes by internalization 
into lysosome vesicles. The “proton sponge” hypothesis has been proposed for endosome 
escape o f NVGT cationic polymer. The protons are pumped into endosomes (at pH 7.4) by 
V-ATPase proton pump at their membrane, while polycations (the pATa o f a primary amine is 
around 10.5)11 work as a pH buffer material. This results in an increased proton/water flux 
and lower pH at 5.5. Membrane disruption by swelling and finally osmotic lysis allows DNA 
complexes to escape from these vesicles prior to enzymatic degradation. Alternatively, the 
mechanism of lipid membrane mixing between endosomal membrane and lipidic gene carrier 
has also been hypothesized as an alternative means by which cationic lipids/liposomes might 
facilitate the endosome escape process, although this process is not well understood.8,12,13
Also, the mechanism of DNA nuclear translocation is not well understood. However, the 
transport through nuclear pores has been considered as the most likely possible route in 
conjunction with help from nuclear localization signals (NLS). NLS are peptides that help 
DNA complexes (which are typically bigger than 50kDa and cannot pass through the nuclear 
pore complex) to reach the nucleus. NLS binds with the a-subunit o f the cytosolic importin 
receptor, then the (3-subunit o f the importin binds to the nuclear pore complex with the help of 
GTP binding protein (called Ran). The [3-subunit will be retained at the inner face o f pore 
complex.14 Based on amino acid sequence analysis of NLS such as SV40 T-antigen, HIV-tat 
protein etc., positively charged amino acids are also found as their unique characteristic.14 
The nuclear envelope contains double phospholipid layers, with the membrane space directly 
connecting to the endoplasmic reticulum lumen. The inner and outer membranes join 
together at the nuclear pore complex (NPC). The NPC is a large structure with an assembly 
o f eight spokes attached to rings on the cytoplasmic and nuclear sides o f the nuclear envelope, 
accordingly named “the cytoplasmic ring” and “the nuclear ring”, with a formed central 
channel approximately 40nm in diameter for the transportation o f large particles across the 
nuclear membrane. The pore diameter is 120nm and the molecular mass is about 125 million 
Da. The small molecules (size o f 9nm diameter, size less than 50kDa), for example, ions, 
metabolites and small proteins, use passive diffusion to get in and out o f the nucleus freely. 
Bigger molecules, including DNA, are transported by an energy-dependent mechanism 
through this NPC. The selective transport of these macromolecules to and from the nucleus 
requires a NLS to direct their traffic through the NPC.14
3. SPERMINE MEDIATED DNA CONDENSATION AND PARTICLE FORMATION
Spermine (i) is a natural biomolecule involved in cell growth and differentiation control. In 
vitro studies have shown that the binding o f spermine to DNA induces structural changes in 
DNA. The spermine cations neutralize the negatively charged phosphodiester groups of 
DNA, initiating the DNA helix’s axis bending resulting in DNA condensation. This gene
packing enables efficient gene therapy by non-viral vectors. The results show that the 
nanoparticle (50-150nm) is able to go across the cell membrane and lead to the gene 
expression of delivered DNA.7,15 The ethidium bromide (EthBr) assay was used to measure 
DNA condensation. EthBr is a cationic dye (Fig. 3) that intercalates between DNA base 
pairs. This intercalation increases the fluorescence yield of EthBr (excitation 546nm, 
emission 595nm). Many compounds that bind to DNA, including spermine, can displace 
EthBr from the EthBr-DNA complex. The EthBr displacement by these chemicals is related 
to DNA bases as well as environmental conditions (e.g. buffer composition, ionic strength). 
So, EthBr fluorescence quenching can be used to measure the DNA-polyamine binding 
efficiently.15,16
n h 2
Figure 3 Ethidium bromide.
The EthBr assay method is a modified literature protocol of Cain and co-workers17, regarded 
as an “exclusion assay” requiring the pre-forming of DNA and DNA binding drugs, before 
EthBr is added. The excitation wavelength used is 546nm, which is based on the excitation of 
EthBr. In 2000, the modified reproducible EthBr “displacement assay” was reported by Geall 
and Blagbrough.16 The excitation wavelength was optimized at 260nm, so (only) intercalated 
EthBr is indirectly excited by energy transfer from the DNA. The proposed protocol also 
allows the experiment to be run without pre-complexing DNA and its binding molecule. This 
method is named as “displacement assay”.16 Additionally, the EthBr-DNA complex 
formation restricts the internal rotational freedom of EthBr. The fluorescence polarization is 
calculated from the emission intensity from polarizer and analyzer in a spectrofluorimeter. 
The polarization increase is observed when DNA is condensed due to the limited movement 
of EthBr. The measurement of steady-state fluorescence polarization can be used to indicate 
the EthBr-DNA complex conformation upon binding of spermine.15
In addition to the intercalating assay using EthBr, the UV absorbance at over 300nm (e.g. 
320nm) was useful in confirming the formation of nanoparticles. The double helix DNA was 
bound by polyamines and formed the nanoparticles which scatter the light resulting in the UV 
absorbance increase above 30011m.18 So, light scattering (LS) is being measured rather than 
(apparent) UV absorption. Some precipitation of the DNA may be visible, but it does not 
increase the absorption above 300nm. However, the DNA concentration used in this assay 
was in a 10-fold excess compared to the EthBr assay given the low sensitivity of this 
experiment and the lack of fluorescent indicator.11
DNA used in gene therapy research is normally prepared as plasmids, usually with a protein 
marker that can be followed in the gene expression quantification. pEGFP 9 (4.7 
kilobasepairs) is the plasmid encoding for enhanced green fluorescent protein, under CMV 
(cytomegalovirus) promoter, obtained from Clontech. Successfully transfected cells with 
pEGFP shows the distinct fluorescence detectable by a Fluorescent Activated Cell Sorter 
(FACS). Modified firefly (Photinus pyralis) luciferase pGL3 control vector20 (5.2 
kilobasepairs), with SV-40 promoter, was from Promega. In this luciferase assay, luciferin 
was added to transfected cells that underwent oxidation and generated the yellow light, 
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pEGFP and pGL3 were condensed by spermine to about 50%, measured using the EthBr 
assay (Fig. 5). Particle formation was also confirmed by the LS assay, with significantly 
increased apparent absorbance at an N/P ratio > 3.00. We conclude that (simple) spermine- 
mediated condensation may provide less compacted particles; also these are only really 
significant at high N/P ratios. Additionally, the condensation profiles of both plasmids were 
found to be similar, possibly relative to their similar plasmid sizes. We and others have shown 
that lipopolyamines are more efficient DNA condensers (though not necessarily NVGT 
vectors) than these simple polyamines.21
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4. DEVELOPMENT OF POLYCATION VECTORS IN NVGT
A variety of polycations, but nevertheless small molecules compared to histones or DNA, 
have now been reported for studies in NVGT (Fig. 6). The examples chosen serve to 
illustrate the current range of molecular diversity within lipopolyamines. From one of the 
earliest steroid conjugates, DC-Chol containing only one positively charged N-atom, through
Genzyme’s GL#67, Behr’s Transfectam (DOGS), Scherman and co-workers’ RPR-120535 
and DOSPA (all containing spermine in different ways), through to vitamin D and modified 
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Figure 6 A selection o f lipopolyamine-based NVGT vectors (lipoplex). 21
Polymer polycationic NVGT vectors (Fig. 7) for the formation of polyplexes are based upon 
linear and branched polyethylenimines, PLL, poly-L-arginine and poly-L-histidine. These 
representative examples demonstrate the distribution of positive charge in the presence of a 
lipid region, cationic lipids.
Linear and branched polyethylenimine (PEI)24
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Figure 7 Polymer polycationic NVGT vectors (polyplex).
5. PHYSICOCHEMICAL PROPERTIES OF POLYAMINES-BASED DNA CONDENSING 
AGENTS
The effects of the regiochemical distribution of positive charges along the polyamine moiety in 
DNA condensing agents were studied by Geall et al.u '21 DNA condensation is dependent upon
three characteristic properties of polyamines: the number of positive charges, the regiochemical 
distribution of charges (determined by the ipKa o f each amino group), and the local salt 
concentration. From the pKa investigation and calculation, spermine (i) carries 3.8 charges and 
its cholesterol conjugate has a positive charge distribution similar to that found in spermidine 
(ii) (4.3) (Fig. 8). Such spermidine mimics (lipospermidines) are still effective as DNA 
condensing agents, significantly more so than spermidine itself, which is but a weak DNA 
condensing agent.
p K. = 8.9
P*a
Figure 8 pK a o f  spermine and a cholesteryl lipopolyamine.11
We have designed and prepared lipopolyamines (Fig 9) and monitored their efficiency in 
DNA condensation into particles by LS and their salt-dependent binding affinity for DNA by 
fluorescence quenching.11,27 Lipopolyamines were prepared from cholesterol, lithocholic and 
cholic acids (5(3-cholanes) by acylation of tri-Boc-protected tetra-amines spermine and 
thermine. These ligands are polyammonium ions at physiological pH.28
LipoG en (W ^AA dioleoylsperm ine)
• 1 1 2 8  Figure 9 Lipopolyamines based on cholesterol , bile acids and fatty acids.
LipoGen (from InvivoGen) is an example of a lipopolyamine with two oleoyl groups at N2 
and N* of spermine, therefore with only two positively charged nitrogens. Modifying the 
lipophilicity of spermine (3.4.3) led to efficient DNA condensation (15% residual 
fluorescence at N/P charge ratio 2.5) comparing to the tetracationic spermine (50% at charge 
ratio more than 3.50) (Fig 10). According to Vijayanathan et a l29 the A,-phage DNA 
condensed particles (by spermine) are in the size range 50-100 nm. Lipospermine was shown 
to condense pSfiSVneo, pSifiSV19 and pCISfi-yEFN DNA to smaller particle sizes at 50- 
70nm.30 The efficient condensation o f DNA by lipospermine over spermine, resulting in 
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Figure 10 pEGFP condensation by LipoGen vs spermine.
6. TRANSFECTION IN HUMAN SKIN FIBROBLAST CELLS (FEK4)
LipoGen (Invivogen) is a lipospermine with two oleoyl groups at N2 and N 3 of spermine (i) 
and, therefore, only two positively charged primary amines. It was prepared as a non- 
liposomal formulation. The lipophilic modification aims to facilitate the transfection process 
(e.g. potentially through enhanced DNA condensation, cell entry, endosomal escape). This 
lipophilic modification of the spermine structure resulted in a more efficient pEGFP DNA 
condensation (15% residual fluorescence, in the EthBr assay, at N/P charge ratio 2.5) 
compared to tetracationic spermine (50% at N/P charge ratio 3.0). The in vivo transfection of 
pEGFP (2fig/well) with LipoGen was carried out using FEK431 (2.5 x 104 cells/well at 50% 
confluence), incubated for 4h, then the transfection was stopped by removal of the DNA 
complex and replacement with foetal-calf serum containing media; FACS analysis was 
performed 48h post-transfection. By using pEGFP as delivered DNA, the EGFP 
chromophore (a substituted 4-hydroxybenzylidene imidazolidinone) was detected in 
successfully transfected cells by FACS (fluorescent-activated cell sorting). The EGFP amino 
acid sequence L(64)TYGV(68) transcribed from pEGFP was cyclised in the post-translational
steps (at amino acids 65-67) forming an EGFP fluorophore with X ex = 488nm (red-shifted 
from wild GFP protein) and X em = 507nm.19 Lipofectin (DOTMA/DOPE = 1:1 w/w, 
Invitrogen). the commonly used transfection liposomal reagent containing cationic lipid (with 
one positive charge) and helper lipid (DOPE), was also used in this experiment for a 
comparison. The fluorescent cell counts observed in all N/P ratios were higher in LipoGen- 
mediated transfection. Thus, the lipid moiety in lipospermine is playing an important role in 
in vitro transfection. The optimal charge ratio for FEK4 transfection with pEGFP-LipoGen 
complex is around 2.5, which corresponds to the optimal DNA condensation N/P ratio (from 
the EthBr assay). However, from Fig. 11 it appears that increased condensation leads to 
higher transfection efficacy. The high N/P ratio (more than 5.0) results in less efficient gene 
delivery overall. A similar relationship between N/P charge ratio and transfection efficiency 
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Figure 11 FEK4 Transfection o f  pEGFP complexed by LipoGen (above) and Lipofectin 
(below).
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7. CONCLUSIONS
Our research has advanced neurotoxic polyamine amides from spider and wasp natural 
products,32 with their exquisite sensitivity in modulating glutamate receptors, from 
pharmacological tools towards therapeutic neurochemistry, thereby highlighting their 
potential as therapeutic agents.34 So, whilst polyamines and polyamine amides are potent and 
selective receptor probes for a variety of voltage- and especially for ligand-gated cation 
channels,35 they also are now seen to have potential as synthetic vectors and can be exploited 
in NVGT.21’35 Using our designed steroidal lipopolyamine probes (Fig. 9), we are studying 
DNA-lipopolyamine complexes with respect to their formation by DNA condensation. 
Comparable DNA-binding efficiency to that of the unlabelled lipopolyamines and robust 
fluorescent spectral properties across the varying cellular pH range are desirable properties in 
fluorescent ligands, but this requires experimental verification. Have we designed and 
prepared fluorophore-substituted lipopolyamines or lipopolyamine-substituted fluorophores? 
Only time and experimental results will tell. However, we have achieved a controlled chain 
extension of suitably protected polyamines using reductive alkylation to mimic spermine (i) 
rather than spermidine (ii) in the target molecules.21 A practical method for the efficient 
hydroboration of cholesteryl carbamates has allowed us to prepare our designed trans-AB 
steroidal lipopolyamines, together with the corresponding cis-AB  ring junction as the minor 
product of hydroboration or from naturally occurring bile acids.21 We are able to introduce 
fluorophores of choice by our Fmoc-chemistry route. The design in our versatile synthetic 
route to Fmoc protected aminoesters of cholesteryl carbamate and lithocholic acid polyamine 
amides allows a range of selected fluorophores to be readily incorporated. The design and 
synthesis of these novel fluorescent lipopolyamines allows us to study the intracellular events 
during transfection. As well as our studies on lipopolyamine-mediated DNA condensation, 
we are optimising these probes to employ them monitoring the intracellular hurdles to NVGT. 
At present, a poor understanding of the molecular mechanisms of action of non-viral vectors 
remains an important, but unresolved issue. With a greater knowledge of these mechanisms, 
new (possibly spermine based) lipopolyamine vectors with improved transfection efficiency 
can be rationally designed and used as gene delivery agents in vivo.
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Non-viral gene therapy (NVGT) has the potential to revolutionize the way difficult-to-cure diseases are 
treated, by inserting genes coding for missing proteins (e.g. enzymes or signals) into patients’ target cells. 
DNA nanocomplex formation is the first crucial step in NVGT. This enables lengthy polynucleotides to 
be stored as nanoparticles which it is feasible to deliver to target cells. DNA nanostructures (50-150 nm 
in outer diameter) can self-assemble by the interactions of the cationic lipid vectors with the negative 
charges of DNA phosphate. This DNA compaction protects DNA from degradation and facilitates gene 
delivery.
Small molecule sensors for DNA intercalation, e.g. ethidium bromide (EthBr), PicoGreen® (PG), have 
been widely used to determine polycation-DNA interactions, by measuring the fluorescence intensity of 
probes during condensation. As well as these fluorescent techniques, the formation of DNA 
nanoparticles can be observed in a light scattering (LS) assay, measuring UV apparent absorption at X > 
300 nm.
Fluorescence correlation spectroscopy (FCS) is a new technique where fluctuations in the detected 
fluorescence from small sensors are also used to study dynamic processes of DNA nanocomplex 
formation (Krai et al 2002; Adjimatera et al 2005). The advantages of the FCS approach in comparison 
to standard fluorescence techniques are; a) use of lower dye concentration; b) use of lower (nM range) 
DNA concentration; c) information about possible condensed plasmid sub-populations; d) the possibility 
of monitoring the condensation process at the single molecule level. Employing PicoGreen® (PG), a 
high affinity DNA intercalating agent that only fluoresces when intercalated, we have used FCS to 
provide more insight e.g. diffusion time and particle number (PN), than the steady-state fluorimetric 
method. PG does not change the hydrodynamic properties of DNA and does not influence the 
lipopolyamine concentrations necessary for condensation. Additionally, PG requires 10-fold lower 
staining when compared with previously used markers because of the polyamine moiety structural 
modification which efficiently forms salt bridges with DNA phosphate anions, and taken together with 
the DNA intercalation, this is higher affinity from biphasic binding.
We have studied the condensation of linear calf thymus DNA (ct DNA, 13 kilobase pairs) and circular 
plasmid DNA (pEGFP, 4.7 kilobase pairs) using two lipopolyamines, A^A^-dioleoylspermine (Ahmed et 
al 2005) and V1-cholesteryl spermine carbamate. A4,A/ -Dioleoylspermine efficiently condensed both ct 
DNA and pEGFP into point-like molecules with diffusion coefficient (D) = 1.8 x 10'12 m2/s and 2.3 x 10' 
12 m2/s, and particle number (PN) = 0.7 and 0.9 (the theoretical PN under this point-like molecular model 
is 0.6). Cholesteryl spermine carbamate showed poorer DNA condensation efficiency, even at higher 
N/P (ammonium/phosphate) charge ratios. Ultimately, a better understanding of DNA condensation, 
using new probes and analytical techniques, will lead to the development of more efficient DNA 
condensing agents.
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Agency of the Czech Republic (203/05/2308).
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We are designing novel, small molecule DNA-condensing agents, modified synthetic polyamine- 
conjugates (lipopolyamines) (Blagbrough et al 2003) using spermine as the polyammonium ion moieties 
conjugated with lipophilic groups (such as steroids e.g. cholesterol, bile acids, long alkyl or alkenyl 
chains e.g. Q g fatty acids), to develop more efficient non-viral gene delivery systems in order to improve 
DNA uptake by target cells for safe non-viral gene therapy (NVGT). Non-viral vector mediated cell 
transfection remains a poorly understood phenomenon, but it is inherently safer (less immunogenic)and 
can transport a significantly larger DNA payload than using a viral vector.
A/\A/®-Dioleoylspermine (LipoGen) (Ahmed et al 2005) is a lipospermine with two oleoyl chains 
acylating both secondary amines. This small molecule combines the characteristics of both a cationic 
lipid and a fusogenic (lipid bilayer disrupting) lipid in its structure. Trifluoroacetylation with ethyl 
trifluoroacetate (2.0 eq) was successfully used to protect only the primary amino functional groups in 
spermine (1.0 eq). A^A^-DHtrifluoroacetyOspermine was reacted with oleic acid (2.2 eq) to form 
Ar4,A9-dioleoyl-A1,V12-di-(trifluoroacetyl)spermine using 1,3-dicyclohexylcarbodiimide (DCC) (2.4 eq) 
and catalyzed by 1-hydroxybenzotriazole (HOBt) (1.0 eq). The removal of the protecting groups was 
easily carried out at alkaline pH (11.0) in methanolic ammonia. Given A^.A^-dioleoylspermine carries 
two positive charges at neutral pH, the removal of unreacted starting materials and by-products (e.g. oleic 
acid, dicyclohexylurea etc) was carried out by column chromatographic elution over flash silica gel with 
DCM/MeOH (5/2 v/v) as mobile phase. Then, V ^-d io leoy lsperm ine was collected by elution with 
DCM/MeOH/NH4OH (25/10/1 v/v/v) and characterised by NMR and MS.
The ammonium ions interact with and then condense DNA, so we are studying the formulation and 
analytical chemistry of these polyamine conjugates acting as histone mimics. DNA condensation, the 
first step in gene delivery achieved by DNA phosphate charge neutralisation with cationic 
lipopolyamines, was studied by the fluorescence quenching of ethidium bromide (EthBr) (Geall & 
Blagbrough 2000) to monitor the formation of nanoparticles and to determine the efficiency of the 
condensation process. The fluorescence yield of EthBr (A,ex = 260 nm, = 600 nm) increased on 
intercalation between adjacent base-pairs, and then gradually decreased as the DNA phosphate anions 
were neutralised by titration with increasing ammonium/phosphate (N/P) charge ratio. We showed that 
lipophilic modification of spermine resulted in a more efficient Enhanced Green Fluorescent Protein 
(pEGFP) cDNA condensation (15% residual fluorescence, in the EthBr assay, at N/P charge ratio 2.5) 
compared to tetracationic spermine (50% at N/P charge ratio 3.0). Particle formation was confirmed by 
measuring UV light scattering (LS), recorded as increased absorption at A. = 320 nm. This can be 
compared to the efficiency of primary FEK4 cell line transfection with plasmid DNA encoding EGFP 
condensed by the same lipopolyamine; transfection efficiency (62% at optimal charge ratio 2.5) is 
significantly higher than in the control cells transfected with cationic lipid (DOTMA/DOPE) (10-40%). 
Thus, this is an efficient novel lipopolyamine for NVGT in vitro.
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Non-viral gene therapy (NVGT) has the potential to revolutionize the way difficult-to-cure 
diseases are treated. DNA nanocomplex formation is the first crucial step in NVGT. DNA 
nanostructures (50-150 nm in diameter) can be self-assembled by the interactions of cationic lipids 
with DNA phosphate negative charges. This DNA compaction protects DNA from degradation and 
facilitates gene delivery. Fluorescence Correlation Spectroscopy (FCS) fluctuations in the detected 
fluorescence from small sensors e.g. ethidium bromide (EthBr), PicoGreen® (PG), are used to study 
dynamic processes of DNA nanocomplex formation [1,2]. The advantages of the FCS approach in 
comparison to standard fluorescence techniques are: a) use of lower dye concentrations; b) use of low 
(nM) DNA concentrations; c) information about possible condensed plasmid sub-populations; d) the 
possibility of monitoring the condensation process at the single molecule level. Employing PG, a high 
affinity DNA intercalating agent that only fluoresces when intercalated, we have used FCS to provide 
more insight e.g. diffusion time and particle number (PN), than the steady-state fluorimetric method.
We have studied two circular plasmid DNAs (pGL3 and pEGFP) using two lipopolyamines. 
/vW ^Dioleoylspermine efficiently condensed both plasmid DNAs into point-like molecules with 
similar diffusion coefficient (D) = 4 x 10'12 m2/s, and particle number (PN) = 1.6 and 1.0 (theoretical 
PN under this point-like molecular model is 0.6). V 1-Cholesteryl spermine carbamate showed poorer 
DNA condensation efficiency at similar N/P (ammonium/phosphate) charge ratios. A better 
understanding of DNA condensation, using new probes and fluorescence techniques will lead to the 
development of more efficient DNA condensing agents.
We acknowledge the financial support of Universities U.K. (ORS award to N.A.) and of the 
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Spermine is a natural polyamine which plays important roles in DNA condensation. We are 
studying lipospermines, spermine conjugated with lipophilic groups (such as steroids e.g. cholesterol 
or long alkyl or alkenyl chains e.g. Qg fatty acids), as part of a programme to develop more efficient 
non-viral gene delivery systems for effective and safe non-viral gene therapy (NVGT). The use of a 
variety of fluorescence techniques enable the intracellular monitoring of NVGT at the molecular level. 
DNA condensation, the first step in the gene delivery mechanism, was studied by the fluorescence 
quenching of ethidium bromide (EthBr) to monitor the formation of nanoparticles [1-3]. The 
fluorescence yield of EthBr (A*x = 260 nm, Xcm = 600 nm) increased on intercalation between adjacent 
base-pairs, and then gradually decreased when DNA phosphate anions were neutralised by increasing 
the ammonium/phosphate (N/P) charge ratio. Formation of DNA complexes was confirmed by UV 
light scattering (LS) at A, = 320 nm. The plasmid encoding enhanced green fluorescent protein 
(pEGFP) under the control of CMV promoter (Clontech) was chosen as the DNA to be delivered. 
Transfected cells with fluorescent imidazolidinone-labelled protein were analysed by fluorescent- 
activated cell sorting (FACS). Similar experiments were also conducted using the luciferase plasmid 
(pGL3). N2, W3-Dioleoyl spermine (i.e. LipoGen®) showed more effective DNA condensation than 
spermine, at all N/P charge ratios. The in vitro transfection results using LipoGen were also 
significantly higher in both primary cell lines (skin fibroblast) and carcinoma, comparing to 
Lipofectin® (liposomal cationic lipid). Designed fluorescent-tagged lipopolyamines were prepared 
by Fmoc chemistry [1]. These probes are designed for studies tracking the major intracellular barriers 
to efficient NVGT, e.g. cell entry, endosome escape, nuclear localisation. The trafficking of DNA 
complexes can be monitored by fluorescence microscopy. These conjugate probes can be reporters at 
different stages of plasmid delivery by the use of Fluorescence Correlation Spectroscopy (FCS) 
studying the change in fluorophore diffusion behaviour within DNA complexes. Fluorescent tagged 
plasmid DNA was also prepared by non-enzymatic (random) covalent conjugation and shown to 
transfect as efficiently. With fluorophores labelling both DNA and vector, the Fluorescence 
Resonance Energy Transfer (FRET) effect may be observed to offer more insights about NVGT 
kinetics and barriers, with even the possibility of in vivo studies. A clearer understanding of the 
complexity of the barriers to NVGT is crucial in the development of novel efficient vectors.
We acknowledge the financial support of the EPSRC (studentship to A.P.N.) and an ORS 
award from Universities U.K. (to N.A.). We are grateful to Prof R. M. Tyrrell (University of Bath) 
for the FEK4 cell line.
[1] I.S. Blagbrough, A.J. Geall, A.P. Neal, Biochem. Soc. Trans. 31 (2003) 397-406.
[2] A. J. Geall, LS. Blagbrough, J. Pharm. Biomed. Anal. 22 (2000) 49-859.
[3] H. Gershon, R. Ghirlando, S.B. Guttman , A. Minsky, Biochemistry 32 (1993) 7143-7151.
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Sensing DNA nanocomplex delivery by fluorescent probes
Noppadon Adjimatera, Adrian P. Neal, and Ian S. Blagbrough.
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DNA condensation, an important molecular event in life, enables lengthy polynucleotides to be 
stored as chromosomes. We have designed and prepared biomimetic lipopolyamines conjugated to 
fluorescent probes as sensors to aid in the development of novel and more efficient therapeutics 
for gene therapy. These DNA nanostructures (50-150 nm outer diameter) are prepared by the 
interaction of cationic lipid vectors with the negative charges of the DNA phosphate i.e. self­
assembled nanostructures. This DNA compaction facilitates gene delivery, and the fluorescent 
sensors allow us to monitor stability in extracellular compartments, cellular uptake, and other 
intracellular processes such as endosome escape and nuclear entry, eventually leading to protein 
synthesis (which can be another biosensor). Small molecule DNA intercalators have been used as 
sensors to determine the polycation-DNA phosphate interaction, e.g. ethidium bromide, and a 
cyanine dye, (a poly amine conjugate of benzo-l,3-thiazole and 1-phenylquinoline) PicoGreen, by 
measuring the steady state fluorescence intensity over the condensation process. In addition to 
these fluorescence techniques, the formation of nanoparticles by DNA condensation was observed 
in a light scattering assay. Fluorescence correlation spectroscopy (FCS), a new technique where 
fluctuations in the detected fluorescence from small sensors is monitored, was also used to study 
dynamic processes at the single molecule level. Using these probes, we were able to obtain more 
insight by FCS than by the steady-state fluorimetric method, such as change in diffusion time of 
the complex, and “particle number” (photons). Ultimately, a better understanding of DNA 
condensation will come from new sensors and techniques leading to the development of more 
efficient DNA condensing agents for therapeutic non-viral gene therapy. Designed small molecule 
fluorescent sensors will play an important part in this nanoparticle research area. We acknowledge 
the financial support of the EPSRC (studentship to A.P.N.) and an ORS award from Universities 
U.K. (to N.A.).
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Monitoring formulation and intracellular delivery of plasmids by lipopolyamines
Noppadon Adjimatera, Ian S. Blagbrough, and Charareh Pourzand.
Department o f Pharmacy and Pharmacology, University o f Bath, Bath BA2 7AY, United Kingdom
There remain significant challenges in the development of biopharmaceutical formulations for 
efficient non-viral gene therapy. The mechanisms of the initial intracellular steps are currently 
poorly understood, making the effectiveness of therapeutic gene delivery difficult to predict and 
manage. Transfection efficiency cannot be improved without a greater knowledge of the 
molecular detail of these important intracellular events. Our novel delivery agents, lipopolyamines 
/V2,/V3-dioleoylspermine and /V'-cholesterylspermine carbamate, are developed from the tetra- 
amine spermine conjugated with a lipophilic moiety (e.g. long-chain oleic or other unsaturated 
fatty acids, steroids e.g. cholesteryl or cholic and other bile acids, and other research groups have 
incorporated lipophilic vitamin D). These lipopolyamine vectors are produced and purified on a 
gram scale for our formulation and gene delivery research. These excipients have been developed 
by considering the optimal positive charge number and the regiochemical distribution of those 
charges, as well as the important role of the lipid moiety in aiding DNA complexation. DNA 
condensation, that is nanoparticle formation (including characterization at 50-150 nm diameter), is 
a critical first step in NVGT formulation. When successful, this condensed formulation helps to 
protect the plasmid DNA from physical, chemical, and biological degradation, and it facilitates 
cell entry with integrity for gene delivery. We used spectroscopic assays for monitoring DNA 
condensation in our novel formulations, including a fluorescence quenching ethidium bromide 
assay and a light scattering assay. Using these techniques, we have shown that our synthetic 
lipopolyamine excipients condense DNA more efficiently than the natural polyamines spermidine 
and spermine. Transfection efficiency was monitored in carcinoma and in primary skin cell lines 
which confirmed the novel formulation's improved biological integrity in plasmid delivery 
(generating 70% fluorescent cells compared with Lipofectin's typical 10% efficiency). We thank 
Universities U.K. for an ORS award to N.A.
7. 229th ACS (POSTER)
Synthesis and biological testing of lipopolyamine wVv3-dioleoylspermine: Self-assembly of a 
nanopharmaceutical for plasmid delivery
Noppadon Adjimatera, Charareh Pourzand, and Ian S. Blagbrough.
Department o f Pharmacy and Pharmacology, University o f Bath, Bath BA2 7AY, United Kingdom
Novel gene delivery excipients have been designed based upon modified synthetic polyamine- 
conjugates (lipopolyamines), using spermine as the polyammonium ion moiety conjugated with 
lipophilic groups (steroids e.g. cholesterol, bile acids, long alkyl or alkenyl chains), to develop 
more efficient non-viral gene delivery systems in order to improve DNA uptake by target cells for 
effective non-viral gene therapy (NVGT). N2,N3-Dioleoylspermine (LipoGen®) is a 
lipospermine with two oleoyl chains acylating both secondary amines. This small molecule 
combines the characteristics of both a cationic lipid and a fusogenic (lipid bilayer disrupting) lipid 
in its structure. Selective protection of the primary amino groups was achieved with ethyl 
trifluoroacetate (2.0 eq). Nl,N4-Bis-trifluoroacetylspermine was reacted with oleic acid (2.2 eq) 
to form the ^^-b is-p ro tected  /V^A^-dioleoylspermine using 1,3-dicyclohexylcarbodiimide 
(DCC) (2.4 eq) and catalyzed by 1-hydroxybenzotriazole (HOBt) (1.0 eq). Facile deprotection at 
alkaline pH (11.0) preceded purification over silica gel yielded /V2,/V3-dioleoylspermine. DNA- 
bending was monitored by fluorescence quenching to analyse and quantify the efficiency of DNA 
condensation. The fluorescence yield of ethidium bromide increased on intercalation between 
adjacent base-pairs, and then gradually decreased when the DNA phosphate anions were 
neutralised by increasing the ammonium/phosphate (N/P) charge ratio. We showed that lipophilic 
modification (dioleoyl addition) of spermine resulted in a more efficient Enhanced Green 
Fluorescent Protein cDNA condensation (15% residual fluorescence, in the EthBr assay, at N/P 
charge ratio 2.5) compared to tetracationic spermine (50% at N/P charge ratio 3.0). Particle 
formation was confirmed by UV light scattering, increased absorption at 1 = 320 nm. The 
transfection efficiency (70% at optimal charge ratio 2.5) is significantly higher than in the control 
cells transfected with cationic lipid DOTMA/DOPE (10-40%). Given the superiority of this novel 
lipopolyamine (to spermine), we are studying its mechanisms and kinetics in NVGT. We thank 
Universities U.K. for an ORS award to N.A.
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Fluorescent lipopolyamines: a new class of molecular probes in non-viral gene therapy
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prsi sb @ bath. ac. uk
Spermine is a natural polyamine which plays important roles in DNA condensation. We are 
studying lipospermines, spermine conjugated with lipophilic groups (such as steroids e.g. 
cholesterol or long alkyl or alkenyl chains e.g. Qg fatty acids), as part of a programme to 
develop more efficient non-viral gene delivery systems for effective and safe non-viral gene 
therapy (NVGT). The use of a variety of fluorescence techniques enable the intracellular 
monitoring of NVGT at the molecular level. DNA condensation, the first step in the gene 
delivery mechanism, was studied by the fluorescence quenching of ethidium bromide (EthBr) 
to monitor the formation of nanoparticles (Gershon et al 1996, Geall & Blagbrough 2000). 
The fluorescence yield of EthBr (A*x = 260 nm, A*™ = 600 nm) increased on intercalation 
between adjacent base-pairs, and then gradually decreased when DNA phosphate anions 
were neutralised by increasing the ammonium/phosphate (N/P) charge ratio. Formation of 
DNA complexes was confirmed by UV light scattering (LS) at A = 320 nm. The plasmid 
encoding enhanced green fluorescent protein (pEGFP) under the control of CMV promoter 
(Clontech) was chosen as the DNA to be delivered. Transfected cells with fluorescent 
imidazolidinone-labelled protein were analysed by fluorescent-activated cell sorting (FACS). 
Similar experiments were also conducted using the luciferase plasmid (pGL3). N2, V3- 
Dioleoyl spermine (i.e. LipoGen®) showed more effective DNA condensation than spermine, 
at all N/P charge ratios. The in vitro transfection results using LipoGen were also 
significantly higher in both primary cell lines (skin fibroblast) and carcinoma, comparing to 
Lipofectin® (liposomal cationic lipid). Designed fluorescent-tagged lipopolyamines were 
prepared by Fmoc chemistry (Blagbrough et al 2003). These probes are designed for studies 
tracking the major intracellular barriers to efficient NVGT, e.g. cell entry, endosome escape, 
nuclear localisation. The trafficking of DNA complexes can be monitored by fluorescence 
microscopy. These conjugate probes can be reporters at different stages of plasmid delivery 
by the use of Fluorescence Correlation Spectroscopy (FCS) studying the change in 
fluorophore diffusion behaviour within DNA complexes. Fluorescent tagged plasmid DNA 
was also prepared by non-enzymatic (random) covalent conjugation and shown to transfect 
as efficiently. With fluorophores labelling both DNA and vector, the Fluorescence 
Resonance Energy Transfer (FRET) effect may be observed to offer more insights about 
NVGT kinetics and barriers, with even the possibility of in vivo studies. A clearer 
understanding of the complexity of the barriers to NVGT is crucial in the development of 
novel efficient vectors.
We acknowledge the financial support of the EPSRC (studentship to A.P.N.) and an ORS 
award from Universities U.K. (to N.A.). We are grateful to Prof R. M. Tyrrell (University of 
Bath) for the FEK4 cell line.
Blagbrough, I. S. et al (2003) Biochem. Soc. Trans. 31: 397-406 
Geall, A. J., Blagbrough, I. S. (2000) J. Pharm. Biomed. Anal. 22: 49-859 
Gershon, H. et al (1993) Biochemistry 32: 7143-7151
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DNA condensation, one of the important events in life, enables lengthy polynucleotides to be stored as 
chromosomes in the nucleus of a cell, but utilising a minimum of space. This nanostructure can be achieved by the 
interactions of cationic lipids with the negative charges of DNA phosphate. Naturally occurring histones (lysine and 
arginine rich protein) and spermine help to maintain the folded conformations of DNA in cells. The use of spermine and 
its conjugates to compact DNA by condensation has been recently studied1'5, with an aim to use self-assembled DNA 
nanoparticles in gene therapy. The condensed DNA particles are in the range 10-180 nm, typically 50-150 nm in outer 
diameter. This DNA compaction facilitates several key aspects of self assembly: its stability in extracellular
compartments, cellular uptake, and other intracellular processes such as nuclear entry.
H N — ' N — '  N— N  5— N H , Spermine2 H H 2
DNA intercalating agents have been widely used to determine the polycation-DNA interaction, e.g. ethidium 
bromide (EthBr), propidium iodide, PicoGreen. EthBr steady state fluorescence assay is the mostly used simple 
technique to monitor the conformation change of DNA over the condensation process3. EthBr, intercalated in stacks of 
DNA base pairs, fluoresces at 600 nm by direct excitation at 546 nm, or more efficiently through energy transfer from 
DNA base by excitation at 260 nm4. On DNA condensation at increasing ammonium/phosphate (N/P) charge ratio, a 
decrease in EthBr fluorescence intensity was measured. Spermine-mediated DNA condensation occurred at N/P charge 
ratios ranging from 0.25 to 3.00. In addition to these fluorescence techniques, the formation of nanoparticles by DNA 
condensation can be observed in a light scattering (LS) assay, measuring UV apparent absorption at X > 300 nm. DNA 
complexes were formed at N/P charge ratios ranging from 0.50 to 3.00. The optimal N/P charge ratio for both EthBr 
and LS assays was 3.05.
Fluorescence correlation spectroscopy (FCS) is a technique where fluctuations in the detected fluorescence from 
small molecules (such as DNA intercalating probes) are used to study dynamic processes on the molecular scale. We 
have demonstrated for the first time that FCS is able to monitor the condensation process of DNA-plasmids on a single 
molecule level6'8. DNA plasmids are loaded with fluorescent dyes: ethidium bromide, propidium iodide, or PicoGreen 
and the diffusion coefficient of single plasmids are determined by FCS. Condensation induced by positively charged 
condensing agents like e.g. spermine leads to a dramatic increase in the diffusion coefficient. The advantages of the 
FCS approach in comparison to standard fluorescence techniques are: a) use of lower dye concentration, b) information 
of possible plasmid sub-populations, c) the possibility to monitor the condensation process on a single molecule level.
Considering the success in using FCS, more fluorescence techniques have been developed from FCS e.g. in vivo 
FCS, fluorescence resonance energy transfer (FRET) by FCS. These would reveal more detailed nanostructure and 
physical chemistry of DNA condensation. Ultimately a better understanding of DNA condensation will lead to the 
development of more efficient DNA condensing agents. Designed small molecule fluorescent probes will play an 
important part in this2,5.
We thank Universities U.K. for an ORS award to N.A.
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Polyamines and their conjugates electrostatically interact with DNA to form self-assembled nanoparticles1. 
Spermidine, a tri-amine, was first reported to condense DNA2. The DNA collapse was explained by the counterion 
condensation theory further developed by Manning3. Naturally occurring and biologically useful polycations (such as 
the tetra-amine spermine and spermidine) were found to lower the energy of transition for DNA nanoparticle self- 
assembly4. From structure-activity relationships (SAR) within naturally occurring and synthetic polyamines, the 
importance of positive charge distribution in DNA condensation efficacy has been highlighted1. In addition to this 
polyamine SAR, DNA bending (conformational change) seems to exhibit selectivity for certain base sequences. 
Toroidal DNA particles were formed in which the DNA is organized within a series of equally sized contiguous loops 
that precess about the toroid axis5'9. The size of the nucleation loop has a direct effect on the diameter of the formed 
toroid, whereas solution conditions govern toroid thickness5'9.
Ethidium bromide (EthBr) intercalates between base pairs of DNA and fluoresces at 600 nm when excited 
(indirectly through the DNA bases) at 260 nm or at 546 nm (direct excitation of EthBr). Upon changes to the DNA 
conformation, the fluorescence is decreased due to a complex mechanism for the loss of EthBr intercalation binding 
sites. Thus, EthBr has been widely used in DNA-polyamine interaction studies including polyamine vector-based gene 
therapy. The fluorescence assay was performed by titrating polyamine against DNA to achieve different interactions. In 
addition to these fluorescence techniques, the formation of nanoparticles by DNA condensation was also confirmed by a 
light (320 nm) scattering assay10.
Ethidium bromide
Computer modelling of bent DNA containing intercalated ethidium was performed to obtain theoretical data to 
complement the above experimental results. Bent DNA was constructed using a newly designed algorithm, NASDAC 
(Nucleic Acids: Structure, Dynamics, and Conformation), using an algorithm for the computation of 2'-deoxyribose- 
phosphodiester backbone conformations that are stereochemically compatible with a given arrangement of nucleic acid 
bases along a DNA structure. The algorithm involves the sequential computation of 2'-deoxyribose and phosphodiester 
conformers beginning at the 5'-end of a DNA strand. Regardless of the conformational complexity of these structures, 
we are able to compute backbone conformations for each structure. Hence the algorithm, which is currently 
implemented within the new computer program NASDAC, should have generally applicability to the computation of 
DNA structures11. Intercalation sites based on X-ray data were included at regular intervals in the duplex, and ethidium 
was docked into these sites. The duplex was progressively bent in a systematic manner, and the affinity of ethidium for 
each bent duplex was calculated. The results provide a basis for the interpretation of the fluorescence quenching data, 
and the modelling provides insights into the mechanisms of DNA bending as found in the bending by polyamines and 
especially by lipopolyamines leading to the self-assembly of nanoparticles.
We thank Universities U.K. for an ORS award to N.A.
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Spermine is a natural tetra-cation polyamine which plays important roles in DNA condensation, and especially 
(together with histones, naturally occurring polymers of lysine and arginine) in maintaining the folded conformations of 
DNA in the nucleus. We are designing novel small molecule DNA-condensing agents, modified synthetic polyamine- 
conjugates (lipopolyamines), using spermine as the polyammonium ion moieties conjugated with lipophilic groups (such 
as steroids e.g. cholesterol, bile acids, long alkyl or alkenyl chains e.g. Ci8 fatty acids), as part of a programme to 
develop more efficient non-viral gene delivery systems in order to improve DNA uptake by target cells for safe and 
effective non-viral gene therapy (NVGT). Non-viral vector mediated cell transfection remains a poorly understood 
phenomenon both in vitro and in vivo, but it is inherently safer and can transport a significantly larger DNA payload 
than using a viral vector1.
W2,W3-Dioleoylspermine (LipoGen) is a lipospermine with two oleoyl chains acylating both secondary amines. 
This simple, small molecule combines the characteristics of both a cationic lipid and a fusogenic (lipid bilayer disrupting) 
lipid, such as dioleoyl phosphatidylethanolamine (DOPE), in its structure. Protection of amino groups is crucial to 
efficient synthetic control of polyamines2’3. Trifluoroacetylation with ethyl trifluoroacetate (2.0 eq) was successfully 
used to protect only the primary amino functional groups in spermine (1.0 eq)2-4. V1 ,W*-Trifluoroacetylspermine was 
reacted with oleic acid (2.2 eq) to form N2,/V3-dioleoylspermine using 1,3-dicyclohexylcarbodiimide (DCC) (2.4 eq) and 
catalyzed by 1-hydroxybenzotriazole (HOBt) (1.0 eq). The removal of this protecting group was easily carried out at 
alkaline pH (11.0). Given V2,V3-dioleoylspermine carries two positive charges at neutral pH, the removal of unreacted 
starting materials and by-products (e.g. oleic acid, dicyclohexylurea etc) was carried out by column chromatographic 
elution over flash silica gel with DCM/MeOH (5/2 v/v) as mobile phase. Then, /V2,/V3-dioleoylspermine was collected 
by elution with DCM/MeOH/NH4OH (25/10/1 v/v/v). The obtained sample was pre-column derivatized with dansyl 
chloride and its homogeneity analysed by HPLC with fluorescence detection5-6; full spectroscopic identification was 
carried out by using NMR and MS.
DNA-bending experiments were monitored by UV-fluorescence spectroscopic techniques to analyse and quantify 
the efficiency of DNA condensation. This condensation was achieved by DNA phosphate charge neutralisation with 
cationic lipopolyamines. The ammonium ions interact with and then condense DNA, so we study the formulation and 
analytical chemistry of these polyamine conjugates acting as histone mimics. DNA condensation, the first step in gene 
delivery, was studied by the fluorescence quenching of ethidium bromide (EthBr) to monitor the formation of 
nanoparticles7. The fluorescence yield of EthBr (A^ x = 260 nm, = 600 nm) increased on intercalation between 
adjacent base-pairs, and then gradually decreased when the DNA phosphate anions were neutralised by increasing the 
ammonium/phosphate (N/P) charge ratio. We showed that lipophilic modification of spermine resulted in a more 
efficient Enhanced Green Fluorescent Protein (pEGFP) cDNA condensation (15% residual fluorescence, in the EthBr 
assay, at N/P charge ratio 2.5) compared to tetracationic spermine (50% at N/P charge ratio 3.0). Particle formation was 
confirmed by measuring UV light scattering (LS)8, recorded as increased absorption at A. = 320 nm. This is compared to 
the efficiency of cell line transfection with plasmid DNA encoding EGFP, and condensed by the same lipopolyamine. 
The transfection efficiency (62% at optimal charge ratio 2.5) is significantly higher than in the control cells transfected 
with cationic lipid (DOTMA/DOPE) (10-40%). Given the superiority of this novel lipopolyamine (to spermine), we are 
studying its mechanisms and kinetics in NVGT.
Lipogen
We thank Universities U.K. for an ORS award to N.A.
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Spermine is a natural polyamine which plays important roles in DNA condensation. We are studying 
lipospermines, spermine conjugated with lipophilic groups (such as steroids e.g. cholesterol or long 
alkyl or alkenyl chains e.g. C l8 fatty acids), as part of a programme to develop more efficient non- 
viral gene delivery systems for effective and safe non-viral gene therapy (NVGT). Designed 
fluorescent probes and the use of a variety of fluorescence techniques will enable the intracellular 
monitoring of NVGT. DNA condensation, the first step in the gene delivery mechanism, was studied 
by the fluorescence quenching of ethidium bromide (EthBr) to monitor the formation of nanoparticles. 
The fluorescence yield of EthBr (k^x = 260 nm, Xem = 600 nm) increased on intercalation between 
adjacent base-pairs, and then gradually decreased when DNA phosphate anions were neutralised by 
increasing the N/P charge ratio with spermine. DNA condensation occurred at N/P ratios ranging from 
0.25 to 3.00. Particle formation was confirmed by UV light scattering (LS), recorded as increased 
absorption at X = 320 nm. The particles of condensed DNA were formed at N/P ratios ranging from 
0.50 to 3.00. The optimal N/P ratio for both EthBr and LS assays was 3.00. The plasmid encoding 
enhanced green fluorescent protein (p-EGFP) under control of CMV promoter (Clontech) (1-6 p.g/p.1) 
was chosen as the DNA to be delivered. Different charge ratios of N2, A^-dioleic acid-spermine 
conjugate (LipoGen from InvivoGen) to DNA (2.0 (ig /well) were used in a primary human skin 
fibroblast cell line at 2.5 x 104 cells/well. Transfected cells with fluorescent imidazolidinone-labelled 
protein (X«x= 488 nm, Xem = 507 nm) were analysed by fluorescent-activated cell sorting (FACS). The 
transfection efficiency (62%) is significantly higher than in the control cells transfected with cationic 
lipid (DOTMA/DOPE) (10-40%). Similar experiments were also conducted using the luciferase 
plasmid (pGL3). A novel lipopolyamine fluorescent tagging strategy is being used to study the major 
intracellular barriers, e.g. endosome escape, nuclear localisation, to efficient NVGT. We thank the 
EPSRC for a PhD studentship to A.P.N.
